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Background. Aspects of genetics/genomics are increasingly being incorporated into medicine. 
Nurses are crucial in helping transform healthcare through genomic nursing (Loud, 2010). 
However the integration of genetics/genomics into nursing education has been sporadic 
(Dodson and Lewallen, 2011). Influencing its uptake into practice may be via nurses who are 
already utilising genetics/genomics in their practice (adopters) and nurses who may lead the 
way and encourage others (opinion leaders) to do likewise. Identifying the characteristics of 
such adopters and opinion leaders within nursing may provide useful information for more 
wide-scale detection of these individuals to support a strategy for the inclusion of 
genetics/genomics into nursing practice.
Methods. Five change behaviour theories were used to inform the study including the Theory 
of Planned Behaviour and the Diffusion of Innovations. A mixed methods approach was taken 
over two phases. In Phase 1 experts in the field of genetics/genomics and nursing were 
contacted to gain a consensus on four potential genetic indicators of adoption (GIAs), which 
would identify a nurse who had adopted genetics/genomics. In Phase 2, oncology nurses and 
practice nurses completed a questionnaire to identify the characteristics and demographic 
indicators of nurse genetic adopters and opinion leaders.
Results. A consensus (>75%) was achieved for all four GIAs to be included as indicators of 
adoption of genetics/genomics within nursing practice (Phase 1). Individuals identified (in 
Phase 2) were subcategorised into six different groups, including genetic adopters and opinion 
leaders. There were 18 identifying features that defined an adopter, with some of the main 
features being Openness to Experience (p<0.001), seeing the relevance of genetics/genomics 
to their patient group (p<0.001) and talking to colleagues about genetics/genomics (p<0.001). 
There were six features that identified an opinion leader, including academic achievement 
(p=0.007), level of perceived influence over others (p<0.001) and being high on the opinion 
leadership scale (p<0.001). Two of the biggest barriers to incorporation by nurses were lack of 
time for adopters and a lack of local study sessions for opinion leaders.
Conclusion. It has been identified that nurses can be categorised in terms of their relationship 
to genetics/genomics, through a number of distinguishing characteristics. It will be important 
to further identify and clarify these and other characteristics through the development of 
additional tools. These data can inform approaches to promote a greater integration of 
genetics/genomics into nursing practice, ultimately improving patient healthcare.
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Chapter 1. Introduction
'It's the "Year of Perfect Vision/' 2020. Amy, age 21 years, visits with her 
physician and elects to have complete genome sequencing. At a follow-up visit, Amy 
chooses to learn of her genetic risk factors for heart disease, diabetes, breast cancer 
and colon cancer. Amy's physician provides her with risk scores for those disorders, 
and with suggestions for lifestyle modifications. Specifically, Amy is alerted to her 
particularly high risk of developing type 2 diabetes, and her physician recommends a 
rigorous program of diet and exercise that had been shown in a controlled study to 
delay or prevent disease onset. The next year, Amy develops mild asthma and her 
physician selects an optimal therapy based on Amy's genetic profile. Five years later, 
Amy informs her physician that she and her husband are planning to start a family, and 
they request information regarding the risk of having a child affected by a serious 
genetic disease, based on their genome sequence data. She learns that both her and 
her husband are carriers for the recessive lethal childhood disorder spinal muscular 
atrophy, and they seek further counselling. When Amy turns 40, she begins colorectal 
cancer screening based on her higher than average risk factors, and at the age of 45 a 
precancerous polyp is detected in her colon and is successfully removed.'
Although this scenario (Feero et al. 2008} was presented four years ago, the impact of 
genetics/genomics is only slowly becoming known in healthcare, with applications in health 
promotion, disease prevention and diagnostic and treatment strategies as seen above 
(Thompson and Brooks, 2011). The scenario, whilst currently technically feasible is becoming 
increasingly financially possible and could be used in future routine genomic medicine as the 
rate of genetic discovery increases (Feero et al, 2010). The need for genetically educated 
nurses is therefore essential. Professor Sir John Burn (Hill, 2012) believes that there needs to 
be a greater sense of urgency with genomics and that the economically important aspects of 
genetics/genomics in healthcare are overlooked for a more traditional approach.
It is deemed helpful at this stage of the introduction to distinguish between the terms 
'genetics' and 'genomics'. Genetics is the study of the structure and function of genes and the 
genetic features occurring in individuals, families and populations
(www.genome.wellcome.ac.uk/resources/glossarv), whereas Genomics is the study of the 
entire genome, essentially all the genes found in an organism
(http://www.genome.gov/Glossary/index.cfm?id=532&textonly=true). The World Health 
Organisation believes that the main difference between genomics and genetics is that genetics
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concentrates solely on the function and composition of a single gene whereas genomics is the 
study of a gene's relationship with other aspects of the genome and the environment, in order 
to ascertain the overall influence on the growth and development of an organism 
(http://www.who.int/genomics/geneticsVSgenomics/en/). Throughout the thesis 
genetics/genomics is used to relate to all aspects of healthcare and knowledge required by 
nurses. Individual terms (ie. genetics or genomics) are used when either stated by an author 
or when referring to a particular technique or gene. Genetics/genomics is used when referring 
to nurses acquiring skills in this area because nurses will need knowledge of both genetics 
(single gene disorders) and genomics (common complex/multifactoral disease).
A seminal paper by Bell (1998) nearly 15 years ago highlighted how important 
genetics/genomics would become in healthcare. He predicted that genetic information would 
lead to disease being redefined through biochemical events due to known pathogenesis. This 
would create a large scale change in healthcare, altering drug prescribing and diagnosis. 
Therefore with an increasing understanding of disease. Bell (1998) supposed that the need for 
genetic screening would rapidly increase and would be used as a predictive tool as well as in 
diagnosis and management of disease. He believed that the increase in genetic screening 
would come from doctors and patient demand and that the increase would be linked to the 
development of drugs, due to treatment responses becoming defined through genetics (now 
known as pharmacogenomics). From all of the above improvements, Bell (1998) stated that 
clinical medicine would be rapidly transformed and that genetics/genomics would be an 
essential part of future practice.
Bell's predictions were indeed correct, but the pace at which healthcare has changed is 
perhaps slower in some areas than some would have expected. However, the challenge of 
integrating genetics/genomics within healthcare has become more important in a society with 
an increased availability to genetic information. From a US perspective Murray (2009, p21) 
states that 'We face challenges integrating genetics/genomics into the practice of medicine, 
into public health and into our social institutions and practices'. These challenges could be due 
collectively to public misunderstanding or misuse of information, legislation and recreational 
genomics (e.g. consumer genetic testing) as well as financial issues and lack of 
genetic/genomic education. Although genomic medicine has moved on considerably, future 
genomic approaches will be important in continuing to identify the interactions between genes 
and environment and to fully explain disease states (Tang et al, 2009). The development of 
genomic medicine will need to find a balance between the research dynamics in new areas of 
genomics in combination with the knowledge development about previously known genomic
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conditions (Propp and Moors, 2009). Burton (2011) believes that genetic healthcare provision 
needs to change from specialist genetic units into a more 'mainstream' approach, with clinical 
areas expanding to integrate new clinical expertise. However she states that the quality, 
capacity and integration of regional genetic services still needs to be maintained (Burton, 
2011).
Genomics has contributed greatly to fundamental knowledge surrounding biology and its role 
in health and disease; an understanding which in turn is driving a transition into genomic 
medicine (Green et al, 2011; Lea et al. 2011). Further advances in this field will depend on new 
policies, practices and other developments as well as research (Green et al, 2011). This also 
includes genetic education for healthcare providers including the largest sector of the NHS 
workforce: nurses. The diagnosis and management of patients will require a greater 
genetic/genomic awareness by healthcare staff and nurses will be required to employ their 
knowledge of genetics/genomics more routinely. Genetics/genomics is no longer exclusively 
for nurses who choose it as a specialism, because nurses play an important role in the delivery 
of both specialist and non-specialist genetic services to patients and their families in the NHS 
(House of Lords 2009). Genomic knowledge is being translated into nursing practice and as 
such nurses are expected to understand the link between genomics and disease risk, to 
monitor this link with their patients and provide genetic information to families (Loud, 2010, 
Quevedo Garcia et al. 2011). Nurses are the largest health professional group and are pivotal 
in helping to transform healthcare through genomic nursing (Tonkin et al. 2011; Genetics in 
Nursing and Midwifery Task and Finish Group, 2011). However nurses' awareness of 
genetics/genomics is lacking and the increasing relevance of genetics/genomics is not being 
adopted on a wide scale (Kirk et al, 2007a). The integration of genetics/genomics into nursing 
education throughout Europe and the US has been sporadic (Dodson and Lewallen, 2011), but 
it is important that genomic content is included within both postgraduate and undergraduate 
nursing education to prepare nurses for new practice environments and to provide evidence 
based care (Thompson and Brooks, 2011). This is a significant challenge to the NHS and the 
nursing profession. The many different specialities make the diffusion of genetics/genomics 
into nursing practice a lengthy and complicated process. Therefore all possible routes and 
influences need to be considered and utilised.
One such way of influence may be via nurses who are already utilising genetics/genomics in 
their practice (adopters) and who may lead the way and encourage others (opinion leaders) to 
do so too. Such adopters and opinion leaders of genetics/genomics within nursing are a 
potentially important influence. The identification and use of opinion leaders and adopters to
19 | P a g e
be role models for others in the use of genetics/genomics in nursing practice has not been 
considered before in the UK. The common characteristics among these individuals need to be 
identified and utilised to drive the need for change amongst other nurses. For the purpose of 
this research, the following definitions of opinion leaders and adopters will be used: a nurse 
opinion leader of genetics/genomics is defined as a nurse who is a role model to those she/he 
works with in terms of their use of genetics/genomics. He/she is an innovator, is respected, 
has influence over colleagues in adopting genetics/genomics and someone whose views are 
sought by others. A nurse adopter of genetics/genomics is defined as a nurse who has 
actively incorporated genetics/genomics into his/her nursing practice and has the 
willingness/mindset to gain knowledge on genetics/genomics. Importantly for the purpose of 
this research a nurse may adopt genetics/genomics without being an opinion leader of 
genetics/genomics and there may be individuals who are opinion leaders who have not 
necessarily adopted genetics/genomics, however their ability to influence others will be useful.
Based on the evidence suggesting that genetics/genomics is increasingly important in nursing 
practice and on the potential for existing staff to be a vehicle through which the use of 
genetics/genomics in nursing practice is communicated, the aims of the thesis are to:
1. Articulate the identifying characteristics of a nurse adopter of genetics/genomics 
through a expert consensus
2. Identify nurse adopters and opinion leaders of genetics/genomics
3. Identify the factors and processes that might facilitate or inhibit the adoption of 
genetics/genomics into nursing practice
4. Apply knowledge and understanding about the identified groups gained through the 
study to three behaviour change theories in order to formulate potential applications 
for how the characteristics of those individuals who are adopting genetics/genomics 
could help inform the strategies of other societies and organisations seeking to engage 
nurses (and other health professionals) in genomic healthcare
It is hoped through this PhD research that potential applications will be created for the 
identification and utilisation of genetic adopters and opinion leaders within nursing in order to 
facilitate the transition into a new era of healthcare provision.
The research is split into two Phases and seeks to answer the following research questions.
1. What are the identifying characteristics of a nurse adopter of genetics/genomics?
(Phase 1 and 2)
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2. What sets nurse opinion leaders apart from nurse adopters? (Phase 2)
3. What are the barriers that prevent nurses adopting genetics/genomics into their 
practice? (Phase 2)
4. How can an understanding of the characteristics of nurse adopters and opinion leaders 
be utilised within their field to promote the incorporation of genetics/genomics into 
nursing practice? (Discussion)
Phases 1 and 2 of the research aimed to identify nurses who had adopted genetics/genomics 
into practice and then to gain an understanding of the common characteristics of nurse 
adopters in order to consider how these can be utilised to advance the incorporation of 
genetics/genomics into nursing practice. Whilst the author recognises that an individual is 
influenced by their surrounding social setting (e.g characteristics of the workplace, time 
pressures), it is known that even within the same social setting, some nurses will be more 
willing or able to adopt new workplace practices than others (Greenhalgh et al, 2004). A full 
exploration of the nature and extent of workplace demands and their effect on the adoption of 
genetics/genomics into practice was beyond the scope of this PhD scheme of study. However 
such issues will be discussed on occasions where their importance has been identified. The 
trial element of the research aimed to provide potential applications to aid the development of 
a model for the wider integration of genetics/genomics into nursing utilising the findings in 
Phase 2. These findings could inform the NHS National Genetics Education and Development 
Centre (NGEDC), the Department of Health (DOH) and other healthcare organisations which 
are working to promote integration across all areas of healthcare. Figure 1.1 highlights the 
importance of identifying the factors that affect a nurse's decision (at step B) to adopt 
genetics/genomics into practice and how understanding these factors can encourage others to 
adopt genetics/genomics (step C). Knowledge gained from addressing the thesis aims (1-3) has 
been used to formulate potential applications on the incorporation of genetics/genomics into 
nursing practice (Aim 4) (Chapter 8, Section 3).
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1.1 Scope of thesis
The literature is reviewed within chapters two to chapter five. Chapter two discusses the 
impact and role of genomics within healthcare. The importance of genetics/genomics, 
including the role of genetics/genomics in everyday life and how genetics/genomics is linked to 
disease will be discussed. This will then focus on the role of genetics/genomics within 
healthcare delivery. Chapter three discusses the nursing role and service provision, beginning 
with an overview of nursing history and the present role of nurses, which includes sections on 
the changing role of the nurse and external factors affecting this. Chapter four explores the 
literature around genetics/genomics within nursing education. The topic is then opened up to 
include current genetic education for other health professionals and educational provision 
outside of the UK as well as nurses' attitudes to genetic education. Chapter five examines the 
underpinning theories of the thesis: the Diffusion of Innovation, opinion leadership. Stages of 
Change, Theory of Planned Behaviour and Openness to Experience. The five theories and how 
they relate to healthcare and lifestyle have been discussed including their relation to the 
current research project.
Chapter six explains the methodological approach of the research. This presents an in-depth 
explanation of the Phase 1 methodology, including the development and distribution of the 
questionnaire and the Phase 1 focus group. The chapter then leads on to discuss the Phase 2 
methodological approach. The layout of this section is similar to the Phase 1 methodology and 
includes the demographics of participants, the research tools used in this phase and the 
process of selecting participants. Chapter seven contains a summary of the results, potential 
applications for the future identification of opinion leaders and nurse adopters of 
genetics/genomics and study conclusions. Chapter eight discuses the research findings in 
relation to the Theory of Planned Behaviour, as well as the identified barriers and facilitators
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to the incorporation of genetics/genomics into nursing practice. The study limitations and a 
strategy for the engagement of nurses in genetics/genomics are also discussed. Chapter nine 
contains a summary of the key findings, my reflections on the project and the future steps that 
could be taken to further develop the research.
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Chapter 2: Genetics, genomics, health and society
Introduction
This chapter provides an overview of the history of genetics/genomics and the impact that it 
has on everyday life. It includes the role of genetics/genomics within medicine and the ethical, 
legal and social issues that come with this knowledge. Knowledge of genetics/genomics has 
been developing over a lengthy period of time, from very early genetic observations such as 
Mendel's discovery of inheritance in the 1866 (Kampourakis, 2010), to the era of personalised 
genetic medicine that we are now entering. The knowledge and advancements in 
genetics/genomics are very likely to continue at a rapid pace into the next century and 
beyond, which includes pharmacogenetics and consumer testing (section 2.4.4, p37). New 
knowledge and advancements may well lead to an inappropriate and misuse of genetic 
information if the correct protections are not in place (Khoury et al, 2000). Issues around the 
ethical, legal and social aspects will be discussed including genetic disclosure and gene patents. 
The chapter will outline how genetics/genomics is shaping our healthcare and lives and the 
social responsibility that comes with it.
2.1 Development of genetics/genomics
2.1.1 Short overview and timeline
An interest in genetics/genomics has been around for centuries, however it has not always 
been linked to disease and understood as thoroughly as it is today. Pythagoras made the first 
pharmacogenetic observation in 510 B.C. in Southern Italy when the dangers from eating the 
fava bean were highlighted. It is now known that an X-linked trait (more prevalent in males of 
Southern Italian and Sardinian origin) causing a deficiency in glucose-6-phosphate 
dehydrogenase causes a haemolytic response to eating broad fava beans (Nebert at al, 1999). 
Around the same time Hippocrates proposed that the body's constituents are endogenously 
determined due to him believing that epilepsy was hereditary (Sykiotis et al, 2006). Despite 
Pythagoras not understanding the genomic science behind what caused the illness, this 
observation and others like it still have relevance and impact upon genomics in 2012 (Fig 2.1).
There were many small discoveries made between this time and the 18th century. Kolreuter 
studied plant hybrids between 1761-66 and recognised that hybrids were intermediate 
characteristics between parents and that sterility was often found in hybrids (Sturtevant, 
2001). Darwin then noted different hereditary variations such as continuous and 
discontinuous variations. He claimed that dominance was often transmitted unchanged 
through many generations (Sturtevant, 2001). Mendel provided an understanding about
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homozygous and heterozygous patterns of inheritance through studying many generations of 
peas by looking at their characteristics in 1854/55. However the significance of his findings 
was realised in 1900 and his results were substantiated through various repeat experiments 
between 1900-1924 (Sturtevant, 2001).
August Weismann recognised the germ line (now known as germ-plasm theory) in 1883 and 
this was the defining breakthrough in genetics between 1866-1900. In 1889, Altman split the 
nucleus into protein and nucleic acids which was the breakthrough needed in order to fully 
understand heredity (Sturtevant, 2001). Human blood groups, A, B and O were discovered in 
1900 by Landsteiner with the 4th blood group, AB being discovered in 1902 by Decastello and 
Sturli, although the genetic link between parental and offspring blood type was not clarified 
until 1908-1910 (Sturtevant, 2001). Levene then discovered the chemical distinction between 
DNA and RNA, with thymine being replaced by uracil in RNA in 1903.
Genetics advanced considerably during the 1900s with major discoveries paving the way for 
the knowledge that we have today. In 1906, Doncaster and Raynor discovered sex linkage 
through experiments on the currant moth (Sturtevant, 2001). Linkage between sex-linked 
genes was discovered by Morgan in 1911 (where by inherited genes lie close to one another 
along the chromosome). This in turn allowed the mechanism of crossing over to be 
understood. Polyploidy (having more than two complete sets of chromosomes) was then 
recognised for the first time by Winge in 1917 (Sturtevant, 2001).
Wright in 1932, discovered a shift in gene frequencies in small populations that were not 
controlled by selection, known as genetic drift (Sturtevant, 2001). Recombination in 
bacteriophage was discovered in 1946 by Hershey (Sturtevant, 2001) which subsequently led 
to the ability to study spontaneous mutations, gene expression and allowed the development 
of techniques for cloning and gene manipulation.









































































































































































































































































































































































































































































































































































































































From these very early observations to the sequencing of the human genome, these discoveries 
have allowed healthcare to enter a new era of personalised medicine (Fig 2.1). Genome-wide 
association studies to identify the association of genes with a variety of common diseases (Agurs - 
Collins et al, 2008) have identified several genetic loci which have affected clinical medicine 
(Hirschhorn and Gajdos, 2011), through predictive medicine and the elucidation of biological 
pathways. Genome-wide association studies have changed our understanding of numerous 
diseases, including Type 1 Diabetes and obesity (Hall et al, 2010); with a vast number of 
susceptibility loci being identified (www.genome.gov). These loci provide an individual risk level 
of developing a condition. In the future genome-wide association studies may aid in the 
development of new therapies based on the biological insights gained from these studies 
(Hirschhorn and Gajdos, 2011).
2.2 Importance of genetics/genomics
2.2.1 The role of genetics/genomics in everyday life
Genetics and genomics have always been a part of our lives and is becoming increasingly central 
to everyday living and the choices we make. Genetics/genomics has been linked to our exercise 
choices (Brito and Franks, 2008), our coffee consumption (Laitala et al, 2008) and migraine 
frequency (Stam et al, 2010). All these areas once believed to be idiosyncratic to daily living are 
now linked to our genes and the choices that we make that influence these genes. A few 
examples are presented below to provide a 'snapshot' of genetics/genomics in everyday life, all of 
which may have an impact on healthcare delivery in years to come as technology is advancing. 
After this the focus of this section will be on genetics/genomics in healthcare as its impact 
permeates every branch of medicine (Sir John Burn, 2012).
Genetics/genomics and lifestyle
Exercise has been credited with enhancing good health and longevity since the third millennium 
B.C. (Rankinen and Bouchard, 2007). More recently the concept of exercising to improve one's 
health has been made more complex through the knowledge that human genetic variation affects 
physical activity, fitness and mortality (Rankinen and Bouchard, 2007). What was once a simple 
part of everyday living is now deemed to be far more complex. It has been found that the 
variants of over 200 genes can affect athletic performance, which is witnessed especially in elite 
athletes. These variants affect blood flow to muscles, muscle structure, oxygen transport, lactate 
turnover and energy production (Ostrander et al, 2009). In the future it is possible that an 
individual's genotype will be used to provide personal exercise interventions, which in turn will be 
useful for disease prevention (Brito and Franks, 2008). This is already being implemented in 
regard to genetic cardiac conditions in athletes (e.g. sudden cardiac death) (Myerson et al. 2012).
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However Brito and Franks (2008) do not state whether the link between genotypes and exercise 
regime will alter people's views and perception of exercise. Hence with this knowledge we could 
maximise the effects of exercise, including disease prevention of diseases such as diabetes, heart 
disease and various cancers by knowing the type of exercise we should be participating in.
Genetics/genomics and education
Another example of genetics/genomics in everyday living is the roles our genes play in language, 
reading and mathematical skills (Hart et al, 2010). Moderate and significant estimates of 
heritability have been linked to vocabulary, decoding, reading comprehension and general 
mathematics. This heritability has also been shown to have an effect across performance levels. 
Hart et al (2010) used a sample dating back to 1994 but only used US participants. However the 
findings can still influence and alter the way education is approached and delivered, although 
there is always a possibility that it could be detrimental to those with an inheritance pattern that 
does not match the educational approach. An earlier study but with more recently gained results 
by Hart et al (2009) studied twin development in Ohio. It was found that there was genetic and 
environmental overlap between reading maths, reading and cognitive ability, but for maths 
ability, independent genes, different from the others identified were significant. The authors 
believe that these findings are of social importance and that they can be used to improve the 
education children receive and help to monitor a child's academic progress. These findings could 
influence nursing education in the future, in terms of the way universities and other educational 
organisations approach nursing education to best suit the individual. These results could aid the 
development of a study in the future to identify whether there is an underlying genetic trait that 
means some nurses may find it easier than others to understand genetics/genomics and 
incorporate it into practice.
2.3 Genetics/genomics and medicine
'A big change is taking place in medicine, where far more interest needs to be directed at genetic 
data and genetically inherited diseases, as this is how we will reduce disease and illness in the 
future.' David Cameron (House of Commons, Debates, 2011)
Genomic medicine has been defined as 'the use of genomic information and technologies to 
determine disease risk and predisposition, diagnosis and prognosis and the selection and 
prioritisation of therapeutic options' (House of Lords, 2009) and has made great advances towards 
improving human health (Phimister et al. 2012). An increased understanding about the links 
between genomic and nongenomic factors resulting in health and disease is helping to build a 
new era of 'genomic medicine', allowing new diagnostic and therapeutic approaches to be used
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(Feero et al, 2010). Genomics is now changing our biological understanding in nearly all medical 
conditions (Feero et al, 2010) (Section 2.3.1 for a full discussion).
Genomic medicine is now able to use molecular fingerprints to identify health and disease states, 
use genome-wide data to understand the mechanistic pathways, create meaningful patient 
groups and will move from intervention care to prevention care (Willard et al, 2005; Ginsburg et 
al, 2005), following the sequencing of the human genome (Ginsburg et al, 2005). For example, 
genome wide association studies are allowing for better developments in the prevention and 
treatment of conditions such as inflammatory bowel disease (Feero et al, 2010; Hirschhorn and 
Gajdos, 2011). New approaches such as population-level sequencing provide genetic information 
from thousands of individuals to allow comparisons to be made between DNA sequences, 
providing even more insight into genotype-phenotype correlations than we already have (Feero et 
al, 2010). However, the time lag between gaining knowledge of the particular relevant genes and 
biological pathways, and the creation of new therapies can be long (Hirschhorn and Gajdos, 
2011), hence the link between research and its effect on clinical application is not always direct. 
Further research is needed to interpret the genes and mechanisms identified from genome wide 
sequencing to create appropriate interventions (Phimister et al. 2012). It has been realised that 
population genetic screening is unlikely to have the impact on preventative health that was 
predicted 10 years ago, due to genetic and environmental risk factors needing better 
characterisation and the current high cost of screening (Hall et al, 2010; Hirschhorn and Gajdos, 
2011). The justification for a screening programme is often dependent on the treatment or 
environmental change being available to be implemented and effective.
Another area where genetics is beginning to impact medicine is the influence of the environment 
on gene changes, known as epigenetics (Alegria-Torres et al. 2011). Epigenetics is fast growing in 
all areas of biomedical fields (Esteller, 2011). The association between genes and environmental 
factors for many common diseases are now being established (Bell and Beck, 2010). Common 
illnesses have different levels of genetic influence, but the traits can also be affected by 
environmental effects such as ageing, stress, diet and alcohol consumption and pollutants (Bell 
and Beck, 2010; Alegria-Torres et al. 2011). One area where epigenetics is becoming significantly 
recognised is oncology (Esteller, 2011). Epigenetic changes (changes in a gene's expression but 
with no change in the primary DNA sequence) are being used to create biological markers for 
early detection of cancers, disease monitoring and risk assessments, which are improving cancer 
management and monitoring (Brait and Sidransky, 2011). Cancer management has been 
improved in some cases by the identification of specific treatment protocol for certain types of 
cancers (e.g. BRCA1 breast cancer) depending on epigenetic variants in the individual (Esteller, 
2011). Epigenetic processes play a role in the increased risk of cancer (Mohammed et al. 2012).
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Mohammed et al (2012) have noted a difference in cancer disparities (including incidence rate, 
mortality and tumour type) between various ethnic and racial groups. The authors believe that 
these disparities are due to socioeconomic status, biology and culture affecting gene expression. 
Esteller (2011) believes that the wider use of epigenetic technology will create more knowledge of 
epigenetic changes which can be studied to enhance the management of oncology patients. 
Mohammed et al. (2012) follows on by stating that more research needs to be completed to 
understand the epigenetics of cancer so that therapy and risk assessment can be improved and 
specialised for all ethnic and racial groups. This also will extend to understanding the epigenetic 
effects of a number of genes linked to a wide range of chronic diseases so that improved 
healthcare can be provided across socioeconomic borders and various societies.
2.3.1 Strategies: treatment to prevention
Strategic health planning will be necessary to make sure that cost effective treatment allows a 
shift from disease treatment to disease prevention (Ginsburg and Willard, 2009). The advances in 
genomic medicine are allowing more interaction between healthcare delivery (treatment of 
patients) and public health system (disease prevention), thus creating a new 'population health' 
focus permitting genomic medicine to be used appropriately and effectively to prevent disease 
(Khoury et al, 2007a). With this in mind it is expected that public health interventions will use 
genomic science and medicine to target disease prevention programmes for susceptible 
individuals or subgroups of a population. It is thought this will be achievable if the right strategies 
are implemented at a local healthcare level initially (Georgieva and Burazeri, 2005). Ginsburg and 
Willard (2009) describe the input of genomics into medicine as a paradigm shift. Despite all the 
scientific genomic advances, current tools such as health risk assessment, family health history 
and clinical decision support will be just as important for genomic medicine. These tools along 
with the scientific genomic information will provide a more comprehensive approach to inform 
and affect patient care and to guide clinical decision making (Ginsburg and Willard, 2009). It will 
therefore be important for the healthcare world to remember the value of the fundamental, long- 
standing tools and to use these alongside new and advanced genomic medical approaches, in 
order to make sure the correct medical approaches are offered to appropriate patients.
2.3.2 Genetics/genomics and healthcare delivery
"In just 25 years, genomic knowledge has made the amazing leap from research in microbes to 
delivering improved patient care" McCreery, 2011
The importance of engagement in genetic healthcare
In order for medicine to benefit fully from genomic progress; public and healthcare professional 
engagement will need to be gained to enhance the role of genomics in healthcare. Buchanan et al
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(2009) describe the process of involving a range of individuals in the healthcare process as the 
'cycle of information' (Fig 2.2), involving patients, clinicians, scientists and caregivers. All these 
individuals need to have access to the relevant information, so that all involved in different 
aspects of genomic medicine have the knowledge to make their relevant decisions. Hence 
genomic medicine will involve various individuals, not just medical care providers. Figure 2.2 
pictorially explains how genomic medicine progresses, through the formation of research 
questions created by genome investigation which in turn produces outcomes which are then 
portrayed to individuals, populations and families, ultimately having an impact on health.
Fig 2.2. The cycle of patient and genomic questions and answers in medicine (Buchanan et al. 
2009)
The relevance of genetics/genomics in healthcare reports and policies
In order for new genomic discoveries to have an impact on healthcare, a greater input of 
integrative approaches is needed to allow significant research findings to be transferred to the 
clinic (Avard and Knoppers, 2009). For example developing health delivery models will assist the 
successful implementation of genomic medicine (Willard et al, 2005). There have been various
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initiatives and reviews to analyse and create recommendations for the inclusion of genomic 
medicine into healthcare (Fig 2.3). For example, in the UK, the government's White Paper report 
on Genetics published in 2003, with a progress review published in 2008 (See Chapter 4, p53 for 
further detail) created a vision of how patients within the NHS could benefit in the future from 
advances in genetics/genomics, raised awareness of the potential for genetics/genomics in 
healthcare and created a three year plan for the implementation of genetics/genomics in the 
NHS. Genetic competencies for nurses, midwives and health visitors (2003) were published 
following the White Paper report, these were the first set of guidelines outlining what genetic 
knowledge nurses and midwives in the UK should demonstrate. Many of these published 
guidelines and reports on the integration of genetics/genomics into healthcare depend upon 
research scientists working with policy experts and healthcare professionals to keep genomic 
medical policy and infrastructure updated and relevant in order for genomics to become 
appropriately and routinely used (Ginsburg and McCarthy, 2009 and Ginsburg and Willard, 2009). 
This is important as many new discoveries are being made by research scientists and in order to 
be adopted correctly, scientists, healthcare professionals, policy makers and educators need to 
work together to create policies and implement findings that allow a range of individuals to be 
informed of new approaches to healthcare and the associated knowledge required to underpin 
these.
2.3.3 Genomic healthcare in other countries
The World Health Organisation (WHO) lists Cuba, Brazil, India, China and South Africa as being 
countries that offer excellent examples of genetic technology utilisation and services to address 
their population's health needs. They also use 'genomic innovation as a way of stimulating 
development and generating products and services to address local needs' (WHO, 2009). Despite 
the WHO making the above statement it does not make any reference to the source of this 
information or any date as to when this was made public. The UK, US and Japan but to name a 
few have provided significant investments to increase knowledge surrounding genomics and to 
translate this into healthcare (Hardy et al, 2008). These countries are constantly thinking about 
the next step in research and development, not only to benefit their own populations but also to 
identify the market niche in areas of genomic medicine (Hardy et al, 2008). Those countries that 
have not yet made significant advances in genomic medicine, will implement research and 
development in genomic healthcare based on their current 'life-sciences innovation 
infrastructure' (Hardy et al, 2008). Each country's policy and genomic healthcare initiative will 
depend on their past understanding and knowledge level.




























































































































































































































































































































































































































































































































































































It is likely that different countries will have diverse approaches towards the incorporation of 
genomics into mainstream public health. This in part will also depend on each countries' 
demographics, politics and gross national income.
There are collaborations that involve the incorporation of genomic medicine worldwide. The 
Genome-based Research Population Health International Network (GraPH-Int) is one such global 
collaboration network which promotes the establishment of public health services and 
programmes in genomics through education, research, communication and training (Hardy et al, 
2008). The Pharmacogenetics for Every Nation Initiative (PGENI) aims to increase the 
understanding of pharmacogenetics by 'promoting the integration of genetic information in the 
developing world and providing guidelines for medical prioritisation' (Hardy et al, 2008). These 
initiatives hopefully will improve the role of genetics/genomics in several countries, however a 
standard approach to the integration of genetic information into a variety of developing countries 
may have its difficulties.
In Europe many countries that are in the European Union (ED) are joined together on governance 
policy regarding human genetics/genomics, however finding a balanced medium is not always 
easy (Salter and Jones, 2002). As of 2002, the UK refused to sign the Convention on Human Rights 
and Biomedicine. Believing it has a leading role in Research & Development in the genomics area 
the UK was concerned that the convention would potentially affect its economic stance. It would 
also prevent the UK from establishing any future world leading role in the development of stem 
cell research; the convention inhibits therapeutic cloning (Salter and Jones, 2002). Each country 
within the EU has its own individual research and development agenda, which in the long run 
could affect their own economies but also their reputation as a leading scientific research nation. 
However if each country is preparing to make their own governance policy, a complete EU signing 
of any European Council Convention will not occur. This is also somewhat reflected in each 
country's social and cultural stance on the role of human genetics/genomics (Salter and Jones, 
2002). Each country in the EU does have its own individual regulations concerning the provision 
of genetic services as well as regulations and laws on genetic procedures (Godard et al, 2003). 
Despite the convention being against advances such as therapeutic cloning, the EU was 'rocked' 
by the USA's lead over the EU regarding development of human genetics/genomics (including 
cloning); political concern was increased when the realisation of the industrial potential of human 
genetics/genomics was made apparent (Salter and Jones, 2002).
2.4 Legal, ethical and social issues of genetics/genomics
The initiation of the human genome project raised many ethical, legal and social issues as it was 
believed that findings from the project would have a great impact on individuals and their families
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(Khoury et al, 2000). Inappropriate use and misuse of genetic information could occur without 
the correct protections in place (Khoury et al, 2000). Even several years after the completion of 
the human genome, with continuing advancement in genomics, ethical, legal and social issues will 
continue to be raised and a selection are discussed below.
2.4.1 Society and healthcare
Newly advancing technology and its consequent cost can have an effect on social wide access to 
healthcare. History, culture and socioeconomic factors all account for differences in healthcare 
between ethnicities (Pearce et al, 2004). An example of ethnicity affecting access to healthcare 
can be seen when studying New Zealand Maori death rates from asthma in 1980's. The drug 
fenoterol was used to treat asthma at the time and it was discovered that Maori individuals were 
more likely to overuse the drug resulting in higher death rates (Ellison-Loschmann et al, 2002). 
When access to the drug was reduced, the death rate fell and is now considered low. However it 
was discovered that Maori children did not 'grow out' of asthma and a higher incidence of asthma 
in adult Maori has been connected to poor asthma education and reduced health care access 
(Ellison-Loschmann and Pearce, 2000). Although this example could be considered rare, equity in 
access to healthcare is an issue, even in the UK. Rare conditions do not receive the same level of 
research input and financial pharmacology backing as common diseases, despite there being over 
7000 classified rare diseases (Fishman and Skrepnek, 2012). According to Rare Disease UK, up to 
30,000 people in the UK may be affected by a rare disease. The organisation also states that 
funding for research into rare diseases is limited and that care for people with rare diseases is 
varied throughout the UK (www. Rarediseases.org.uk). It is important; especially in UK societies 
where there is free healthcare access, that all medical needs and each society has an equal chance 
of obtaining diagnosis, management and treatment whatever the reasons for present inequalities.
2.4.2 Genetic disclosure
There have been cases where a physician's conduct has been called into question regarding their 
willingness to disclose information about their patients to family members when a familial genetic 
risk is present. Consider the case of Safer V. Pack; a daughter sued her father's physician for not 
informing her of her risk of multiple polyposis, following her father's death at the age of 47, when 
she was 10 years old. The complaint was not upheld as the court felt that the physician had 'no 
legal duty to warn a child of a patient of a genetic risk' (Court of New Jersey, 1996). It is cases like 
these that bring to light the ethical and legal questions surrounding genomics and genetic 
information. Even within research there is no consensus on whether participants should be 
informed about their genetic data (Bredenoord et al. 2011). Biesecker (2012) believes that there 
are no simple rules associated with what and when to tell patients about incidental findings from 
research. She believes that the decision needs to be dependent on the reliability of the findings,
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the clinical utility of the findings and the psychosocial impact (Biesecker, 2012). Genetic testing 
has brought a greater awareness of our predispositions to particular diseases, this has caused 
societies to worry about genetic discrimination from employers and insurance companies 
(Feldman, 2012). However Feldman (2012) states that these discriminations have not become a 
significant problem yet, although the US government believed it was enough of a problem to sign 
a law protecting Americans from genetic discrimination in the workplace and by insurers which 
came into effect in 2009 (Hudson, 2011). Healthcare professionals do require an understanding 
about genetic disclosure and how it might affect patients and their families. This also extends to 
being clear about the need to act within the confines of the law, to protect themselves and their 
employer.
New advances in genetics/genomics bring many social and legal aspects to the forefront. 
Decisions about science, especially genetics/genomics, influences societies' understanding of 
personal and social identity and could possibly shift our population drastically (Benner, 2003), 
both ethically and morally. The impact of new advances in genetics/genomics on society need to 
be carefully considered and legal complications need to be decided and argued before being 
advances are widely implemented.
2.4.3 Gene patents
Another major concern among health care providers is the use of patents on human genes and 
gene sequences (Walpole et al, 2003), this has been a particular problem in the US. One such 
patent has been created by Myriad Genetic Inc. over the BRCA1 and BRCA2 genes. Myriad has 
commercially linked with Genetic Technologies in Australia and uses its patents for commercial 
benefit by only licensing BRCA testing to a limited number of commercial genetic laboratories. 
The ethical argument and concern for this patenting practice is that it blocks complete genetic 
testing for BRCA cancers and prevents patients from receiving a full clinical genetics/genomics 
service, as there can be an increased cost for a particular patented genetic test. In 2010, a judge 
in the US ruled that Myriads Patents were invalid, stating that isolated DNA is part of nature and 
therefore cannot be patented, however in 2011 the US court went against the 2010 decision and 
declared that isolated DNA could be patented (Hudson, 2011). As the patenting of genes 
increases, it will be important for politicians, researchers and law-makers to strike a balance 
between providing the healthcare that people are entitled to and protecting commercial property 
rights (Kevles, 2011). It is important to safeguard human rights whilst at the same time allow 
research to continue to grow. There is strong opposition to patents in Europe and this is now 
growing in the US (Kevels, 2011). It will be interesting to observe over time how gene patents 
materialise, particularly after the Myriad BRCA patenting court case.
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2.4.4 Future of genetics/genomics
The future of genetics/genomics and biotechnology is not confined to cloning and stem cells. It 
encompasses organ and tissue transplantation to extend lives, genetically modified food and 
altering genes in foetuses to try and make them healthier and happier (Caplan, 2002). It is 
believed by some that this century will be defined by biology, compared to the 20th century that 
was driven by physics and chemistry. 'The global economy and social outlook for this century will 
be propelled by the new science of genomics' (Coile, 2001). There have been a lot of new 
developments within genetics/genomics and healthcare, including metabolomics (Veenstra, 
2012), psychiatric genomics (Burmeister et al, 2008) and cancer genetics/genomics (Sandoval and 
Esteller, 2012). All of these areas and developments will have an impact on nursing practice. 
However I have chosen to focus on pharmacogenetics and direct to consumer testing because 
they are growing areas currently impacting healthcare.
Direct to Consumer testing
"My biggest concern is that members of the public are getting tests that they don't understand 
and their physicians may not understand, and they are making big decisions that are ill-informed". 
Sharon Plon, Chief of the Cancer Genetics Clinic at the Baylor College of Medicine, Houston 
(Wolfberg, 2006).
Genetic tests ordered directly by the consumer, are growing at a rapid rate (Lippi et al. 2011). 
Companies offering these tests include deCODEme, 23andMe and Navigenics (Howard and Borry, 
2011, Caulfield and McGuire, 2012). Like others in the market, 23andMe analyses genome wide 
Single Nucleotide Polymorphisms to reveal the risk that a consumer faces of developing a number 
of diseases (The Lancet Oncology, 2008). Many of these companies are decoding consumers' DMA 
not just for health reasons but also to identify ancestry and to plan health strategies. Social 
networking is becoming particularly important in the marketing strategy of many testing 
companies, for example 23andMe will tell a customer about whether they have a genetic 
variation that makes brussel sprouts taste bitter to them (Kaye, 2008). This is meant to be a fun 
fact that you can share with your friends on social networking sites such as Facebook, however 
this could be seen as belittling the importance of our genome and the underlying secrets that it 
holds (Howard and Borry, 2011). There is concern among healthcare professionals that genetic 
risk information could be misused by companies to promote the harmful consumption of things 
such as alcohol, smoking and gambling (Hall et al, 2010).
One of the biggest concerns surrounding 'direct to consumer testing' is the consumer's 
understanding of results and the statistical significance behind them (Lippi et al. 2011). A study by 
Gollust et al (2012) found that early consumer adopters (n=369) of personalized medicine wanted
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genetic risk information to improve their health, but that they had unrealistic expectations and 
misunderstandings about personalized genetic risk. They could not differentiate between genetic 
disorders and genetic risk information. Gollust et al (2012) believe that more information is 
needed on how these early adopters respond to and act upon information when they receive it. 
For example, a negative/positive or inconclusive result does not necessarily mean that a client will 
not/will develop that specific disease (Pirzadeh-Miller, 2011). It also does not mean that the 
client can enjoy a high risk lifestyle because they can assume they are "immune" to various 
diseases (The Lancet Oncology, 2008). This is where a doctor-patient relationship is important 
and one that Howard and Borry (2011) feel is too often lacking in consumer genetic testing. 
Decisions based on misunderstood tests can have devastating consequences (Wasson, 2008) and 
this is why the need for appropriate counselling to support and interpret the results when offering 
tests is so important (Pirzadeh-Miller, 2011). For example, when undergoing direct to consumer 
testing, many people are told they will have an increased risk of developing heart disease 
(Williams, 2006). Due to the prevalence of the disease, this risk could relate to many who submit 
their DNA for private testing, therefore this warning is so ambiguous that it almost becomes 
meaningless (Pirzadeh-Miller, 2011). The impact that this could have on public health could be a 
step backwards, not a step forwards as the possible identified risk would not be specific enough 
to each individual. In the UK, the Human Genetics Commission (2010) published a framework of 
principles for direct to consumer testing. They recommended the information provided to clients 
should be simple to understand, the test should only be provided to individuals who have had 
access to pre and post test counselling and information about health professionals who can offer 
further advice should be provided. They also state that the results should be statistically accurate 
and should be described to the consumer in an understandable form (Human Genetics 
Commission, 2010). It has been recommended by the UK Task and Finish Group Report into 
genetics/genomics in nursing and midwifery (2011) that a code of practice should be established 
which provides information about laboratory credibility and an evidence base for the test being 
offered. This would aid consumers in their decision to undergo a genetic test and would also 
inform healthcare professionals when guiding them with their decision.
Lack of understanding by health professionals in relation to these tests and the associated 
genetics/genomics knowledge required will create problems. As the control of genetic testing 
moves from the clinician to the consumer (Evans et al, 2010), it will be important to create a 
national framework (this paper focuses on a US framework, but the author believes this will also 
be important in the UK) so that information coming from these services can be tailored (Magnus 
et al, 2009), both for the consumer and the health care professional. Patients are embracing the 
ability to order genetic tests online (for example BRCA testing) without consulting healthcare
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professionals, however consumers will seek healthcare professionals for post test advice (Evans et 
al, 2010). Nurses and other relevant healthcare professional will need to understand genetic 
testing and the risk linked to certain genes and SNPs. Patients may well come to them needing 
guidance around genetic testing, patients will need reassurances and explanations involving the 
validity and utility of the test, confidentiality and interpretation of results (Lea et al, 2011).
Pharmacogenetics
Pharmacogenetics and pharmacogenomics is the influence that heredity has on drug responses. 
The associated research in this area aims to identify new drug targets and genomic features useful 
for optimising drug therapy1 .
This field of medicine will allow knowledge of the patient's genetic information to predict which 
drug they will most benefit from and at what dose (Mutsatsa and Currid, 2012) as well as helping 
to reduce adverse drug reactions. The availability of drugs based on interactions with an 
individual's genes are currently limited, although they are rapidly being developed. There has 
been significant research into pharmacogenetics/genomics and its role in personalised medicine 
(Feero et al, 2008) and has enormous implications for the future of healthcare (Mutsatsa and 
Currid, 2012). It is believed that the use of pharmacogenetics (PGx) will decrease healthcare costs 
and provide a more exact treatment programme for patients. Pharmacogenetics will provide 
more effective medicines as patients will receive safer and more robust drugs within the initial 
treatment phase and drug doses will be more accurately determined (van Schie et al, 2011). 
Drugs will be developed easier and quicker due to previously defined genome targets and the 
ability of the drugs to target specific genetic population groups (Szucs, 2005).
Pharmacogenetics has become an area of great medical potential (Dodson, 2011) and is beginning 
to be utilised within several areas of medicine. In the area of mental health and psychiatry, 
variations in response to the drug clozapine are due to polymorphisms in the genes 5-HT2A and 
D3 (Altamura et al, 2005). A pharmacogenetic approach is also being used in the treatment of 
polycystic ovary syndrome; a SNP has been identified in the STK11 gene that decreases the 
chance of ovulation in patients treated with metformin (Goldenberg and Glueck, 2008). One of 
the most recognised examples of pharmacogenetics is the use of herceptin or trastuzamab for the 
treatment of breast cancer. The use of this treatment is based upon the level of her-2-oncogene 
expression in the patient's tumour (Lindpaintner, 2002). The knowledge of this expression level 
enables the patient to receive the correct treatment that will benefit them the most, without 
using costly drugs on those who will not respond. Drugs used in many cancer treatments are 
selected based on the patient's genomic data. Roche Diagnostics has developed a gene chip
1 http://www.geneticseducation.nhs.uk/teaching-Renetics/pharmacogenetics/explanation-of-terms.asDX
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which allows a wide range of diagnostic tests to be performed simultaneously. The AmpliChip 
CYP450 is based on the Cytochrome P-450 system and provides a patient's predicted phenotype 
based on two genes (Dunbar et al. 2012). This allows for a detailed understanding of a patient's 
metabolic system and the way that their body could metabolise various types of drugs and 
subsequently aids the provision of the correct treatment for patients quicker. One of the genes 
that the AmpliChip tests for metabolises many common drugs and aids the doctor in making sure 
the patient is prescribed the correct drug and is relevant to the majority of the population for 
many diseases (Carlson, 2009). In the future, when this type of pharmacology does become 
regularly used, healthcare professionals will need to have knowledge of these tests and their 
outcomes, in order to be able to understand a patient's treatment and to discuss such treatment 
with that patient. Nurses will need to have an understanding of drugs and genetics/genomics in 
order to explain to patients and to understand the right drug that needs to be administered and 
why it is being given (Lea et al, 2011; Prows, 2011).
Conclusion
Great advances in genetic and genomic sciences have occurred over the last 100 years and many 
more are anticipated, however the advancements in genetics/genomics and its role in healthcare 
has already been significant. Medicine is also slowly moving from a treatment to prevention 
strategy, allowing patients to be identified and screened before their condition needs treatment. 
This has been shown through the advancements in for example, cardiac care in which gene 
signatures provide a correlation between treatment response and survival rate. As technology 
increases genomic medicine will hopefully benefit from pharmacogenetics and consumer testing. 
However it is important that education along with these technologies is provided, to allow 
healthcare professionals to support and explain to patients as well as being involved in creating 
policies to protect patients from the misuse of information. The UK can also learn from other 
countries' genomic policies. It will interesting to observe whether the UK will eventually join with 
the EU Convention on Human Rights and Biomedicine and whether it will be willing to reduce its 
leading role in genomic Research & Development (Salter and Jones, 2002). Following on from 
highlighting the advances that genetics/genomics is bringing to healthcare, chapter three will 
focus on the role of nursing within healthcare and current clinical genetic services within the NHS. 
The role of genetics/genomics within nursing will be discussed as well as the various genetic 
resources available for nurses.
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Chapter 3: Nursing role and service provision
Introduction
Chapter two focused on the history of genetic discoveries and how these discoveries play a role in 
our everyday lives. This chapter follows on from the role of genetics/genomics in medicine and 
healthcare to focus on the role of nurses within healthcare and their changing role through 
history. Specifically, genetics/genomics within nursing will be addressed with some focus on the 
two areas of nursing practice being studied in the thesis, oncology and primary care (practice 
nursing). Current NHS genetic services will be discussed as well as the current stage of 
genetics/genomics integration into nursing practice and the NHS. This chapter will outline the 
way genetics/genomics is changing nursing practice and the importance of nursing staff to the 
healthcare service and hence their need to embrace genetics/genomics as a new form of 
healthcare.
3.1 Overview of nursing history and present role
Nursing was originally intrinsically linked with religion; nuns were the first women depicted as 
'nurses'. However the skills of these nursing nuns were lost during the 16th Century as Henry VIM 
banished nursing nuns through the destruction of the monasteries (Meehan, 2005). During this 
time nursing was based on 'caritas' which included, self-sacrifice and spiritual love, these 
qualities were highly valued in the 15th and 16th centuries (Hallett, 2007). Individuals who were 
sick were nursed at home by a family member or servants up until around 1880 (Faculty of 
Medicine, Glasgow, 2012).
The onset of the Crimean War (1854-1856) brought a revival in nursing. During this time Irish 
nursing nuns had the nursing expertise, having been able to re-establish themselves quicker after 
the fall of Henry VIM. It was here that Irish nurses made a significant contribution to the 
development of modern nursing (Meehan, 2005). Nurses (including Florence Nightingale) were 
sent to the Crimea from London, with Mary Clare Moore as head nurse. It was during the 
Crimean war that Florence Nightingale became a leading figure for nursing in the UK, having 
learnt from the Irish nurses during this time (Meehan, 2005). In these early days of nursing 
practice, nursing was not seen as a respectful career choice but as domestic tasks to be 
performed by servants (Faculty of Medicine, Glasgow, 2012). It was events such as the Crimean 
war, Boer war and First and Second World Wars that advanced nursing over time (Hallett, 2007).
The year 1860 saw the first school for nurses opened at St Thomas' Hospital (London) and in the 
following years more were opened (Crowther, 2002). In 1881 nurse training was made more 
formal. After a year of training, including lectures, demonstrations and exams, nurses became full
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members of staff within the hospital (Faculty of Medicine, Glasgow, 2012). The image of the 'the 
lady with the lamp' had been set and nursing began to become a profession, no longer just for the 
lower classes and servants (Crowther, 2002). Nursing was seen as a good profession for women 
in contrast to medicine as nursing 'entails on those who pursue it much fatigue of the body, it calls 
for nimbleness of hand, as well as for gentleness and patience, and last..for implicit obedience, 
but it does not give scope for the higher power of mind and leave the cravings of the active 
intellect unsatisfied'. Nursing was also seen to prepare women for their domestic role in married 
life (Crowther, 2002). In the 1870s nurses' hours were reduced and domestic chores were ended 
so nurses could concentrate solely on patient care (Faculty of Medicine, Glasgow, 2012). The 
creation of nursing policies and councils became significant in developing the nursing profession.
3.1.1 Nursing and Midwifery Council
The College of Nursing was established in 1916 and played a major role in the creation of a 
regulatory system for nurses (NMC, 2012). The Nurses Registration Act was established in 1919 
along with the creation of the General Nursing Council, from which it was made a legal 
requirement that nursing training had to be standardised in England and Wales (Bradshaw, 2000). 
This was in part a result of to the demand for nurses during the First World War and the 
contribution they made (NMC, 2012). The nursing training syllabus was introduced in 1919 and 
was not revised until 1977 (Bradshaw, 2000). It was not until the Briggs Report in 1972 that a 
university degree in nursing was considered, combining both academic study and professional 
training (Faculty of Medicine, Glasgow, 2012). Following the Briggs Report, a unified central 
council was created, enveloping all bodies across the UK with separate educational boards 
created in all four countries. The United Kingdom Council for Nursing, Midwifery and Health 
Visiting (UKCC) was established in 1983 to maintain a register, handle professional complaints and 
provide guidance to registrants. The UKCC became the Nursing and Midwifery Council in 2002 
(NMC, 2012).
3.1.2 Change of the nursing role
An example of how nursing has changed throughout history is explicit within district nursing. 
Originally people were cared for in their own homes by Parish nurses during the Poor Law era 
(Toofany, 2007). In 1859 William Rathbone began a scheme in Liverpool; when he employed a 
nurse to care for the poor sick in his area (Blackman, 2009). Liverpool was divided into 18 districts 
for nursing purposes, which is the origin of the name 'district nurses' (Blackman, 2009). In 1887 
the Queen's Nursing Institute was founded to organise and train district nurses. At this time 
district nurses were employed by local district nursing associations and paid via fundraising or 
charging those patients who could afford it (Blackman, 2009). The creation of the NHS in 1948 
meant district nurses were then employed by local councils (Toofany, 2007). Until 1956 married
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women could not be district nurses and were trained as midwives, school nurses and health 
visitors. They were expected to care for all members of the family and were known as a 'friend of 
the family' (Blackman, 2009). Currently district nurses undergo a formal training course after they 
have completed their degree in nursing. District nurses no longer manage many infectious 
diseases due to the shift in public health demands, but are now managing patients with cancer, 
diabetes and heart disease (Blackman, 2009). As well as primary care nursing, a district nurse's 
role now includes multi-agency work, practice development and policy formation (Toofany, 2007).
Although the role of the nurse has changed considerably, the underlying qualities and 
characteristics of a nurse have not. Modern nursing has been defined as 'the use of clinical 
judgement in the provision of care to enable people to improve, maintain, or recover health, to 
cope with health problems, and to achieve the best possible quality of life, whatever their disease 
or disability, until death' (RCN, 2003). The Department of Health highlighted the 10 key roles for 
nurses as outlined by the Chief Nursing Officer for England. With the exception of roles seven and 
eight, all of the key roles have relevance to the application of genetics/genomics in nursing 
practice, either presently or in the future:
1. To order diagnostic investigations such as pathology tests and X-rays
2. To make and receive referrals direct, say, to a therapist or pain consultant
3. To admit and discharge patients for specified conditions and within agreed protocols
4. To manage patient caseloads, say for diabetes or rheumatology
5. To run clinics, say, for ophthalmology or dermatology
6. To prescribe medicines and treatments
7. To carry out a wide range of resuscitation procedures including defibrillation
8. To perform minor surgery and outpatient procedures
9. To triage patients using the latest IT to the most appropriate health professional
10. To take a lead in the way local health services are organised and in the way that they are 
run
3.1.3 External factors affecting the nursing role
The role of the nurse has also altered due to external factors such as an increase in the prevalence 
of long-term health conditions, a growing public health agenda and care being delivered closer to 
home (NHS, 2009). The nursing role looks very different now and it will continue to change as 
nursing policy also changes (NHS, 2009). The role of nursing is extending into more medical care 
and basic nursing care is often delegated to healthcare assistants, as they are cheaper to employ 
(Harmer, 2010). Nurses are required to keep up to date with practice as their role continues to 
evolve and this must be declared at registration. The developing nursing role is linked to the
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future of society and the future of health care (Standing Nursing & Midwifery Advisory 
Committee, 2005), which is why it is so important for nurses to 'keep knowledge and skills up to 
date throughout their working lives' and 'to take part in appropriate learning and practice 
activities that maintain and develop competencies' (NMC, 2008). Society and medicinal 
discoveries are forever changing and require a nursing workforce that understands and can utilise 
these discoveries. I believe this includes the understanding and use of genetics/genomics within 
the nursing role, as it applies within each nursing branch.
3.1.4 Different nursing branches
There are four main branches of nursing; adult, mental health, children's and learning disabilities. 
Each branch of nursing now requires a three year undergraduate degree as a basis for registration 
as a nurse. Each of these branches is described in detail in appendix 2.
3.1.5 Nursing specialisms
There are a wide variety of medical specialisms (Fig 3.1) that nurses can choose once they have 
qualified in any of the four branches. Some nurses undergo extra training and become specialist 
nurses in a chosen field. These nurses have a profound impact on patient care and NHS trusts, as 
they reduce hospital re-admissions, provide long term management of illness and reduce 
complications among patients, all of which saves the NHS millions of pounds (RCN, 2010). They 
offer specific care and support for patients and their families, they understand the specifics of the 
patient's disease and so are more able to overcome problems encountered by patients regarding 
their care (RCN, 2010). Advanced nurse practitioners (ANP) have a more specialised and 
expanded role than a specialist nurse (Srivastava et al, 2008). ANP's provide expert guidance to 
patients and families and carry out consultations. They practice at an advanced level in a 
specialist area and have expanded practice skills (Hamric et al, 1996).
3.2 Genetics/genomics within the nursing role
"All nurses [and midwives] at all levels of practice must be competent to deliver genomic 
healthcare and that professional leaders should be informing and shaping developments to 
incorporate genomic healthcare" Task and Finish Group Report (2011).
It has been said that nurses play an important role in the delivery of genetic services in the NHS, 
both in nursing practice and as genetic counsellors (House of Lords, 2009, p74). Nurses have the 
potential to influence the care of individuals, families and communities by taking into account the 
genetic influence on disease (Greco, 2003). Therefore all nurses, regardless of speciality or 
setting, need to grasp a basic understanding of genetics/genomics (Trossman 2009).
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Fig 3.1. Some nursing specialisms (Pronurse, 2010; NHS Careers, 2010; RCN, 2010)






Ear, nose and 
throat nurses
Healthcare professionals, (including nurses) will need to be aware of the impact of 
genetics/genomics upon their practice and will need to understand how a patient's family history 
and genetic make-up affects the likelihood of developing a disease or their response to medicines 
(Department of Health, 2003, p47). This also extends in some instances to having an 
understanding of the ethical aspects of reproductive decision making and feeling confident in 
addressing various ethical issues with patients and their families (Clancy, 2010). Nurses can be 
crucial in teaching parents about genetic disorders, providing treatment and psychosocial support 
and in counselling families at risk of genetic conditions (Gharaibeh et al, 2010). In order to be 
able to fulfil these roles adequately, they should be able to explain genetic health and disease 
processes, describe genetic tests and treatments and to support patients in genetic health 
education, genetic screening decisions and genetic risk evaluations (Metcalfe and Burton 2003; 
Calzone et al. 2010; Daack-Hirsch et al. 2011). They will also need to be able to identify 
individuals at risk from genetic predispositions (Greco, 2003; Calzone et al, 2010). Each branch of 
nursing may see different genetic disorders and aspects of these, however all areas of nursing will 
encounter genetics/genomics at some level, as genetics/genomics will relate to the fundamental 
practice of every nurse (Greco, 2003). A few examples of the role of genetics/genomics in 
specialist nursing areas are shown in table 3.1.
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Table 3.1. Examples of genetics/genomics in a selection of nursing areas
Nursing area/branch Genetics/genomics within nursing role
Oncology nursing Family history is important in this area of nursing as is the option of genetic testing
for patient family members.
There is continuing research into genetic markers for cancer diseases and drug
development (Kirk et al, 2006a) for example Herceptin.
Lea et al (2011) give the example of an oncology nurse explaining the results of
hereditary breast and ovarian cancer tests and providing information about genetic
testing for tumour profiling in order to inform treatment options.
Primary care nursing Primary care nurses have the potential to come across a wide range of genetic 
conditions, due to the variety of people within a GP practice and because they work 
with families.
Practice nurses can also identify genetic conditions (including at risk patients) and 
can be the access point to more specialist care (Kirk et al, 2007b).
Mental health nursing There are many disorders within mental health nursing that have a genetic 
component, including bipolar disorder, panic disorder, psychosis and suicidal 
behaviour (Cheng et al, 2006).
Taking a family history and identifying individuals at risk is important. 
Pharmacogenetics is also having an impact in mental health (Kirk et al, 2006b).
Learning disability 
nursing
Nurses need to be able to explain information about a confirmed condition in one or 
more children (Kirk et al, 2003a) to family members
Provide families with information about accessing genetic services (Kirk et al, 2003) 
Parents of children with a genetic condition with learning disabilities need support 
from nurses (Kirk et al, 2006c).
Nursing older people Some forms of dementia, which is a common condition among older people can be 
inherited, highlighting the importance of taking a family history. This is also 
important in other conditions such as Parkinson's disease and various cancers (Kirk 
etal, 2006d).
Providing relatives with information about inherited diseases is an essential part of 
geriatric nursing role.
Children's nursing Advances in children's health in areas such as neonatal diabetes, leukaemia, asthma 
and eczema require nurses to have the knowledge and skills to care for these 
children (Kirk et al. 2006e)
Children and young people may need additional support to understand their 
condition and the long term implications (Kirk et al. 2006e), this is also relevant for 
parents and careers
3.2.1 The nursing code and the role of genetics/genomics within it
The nursing code of professional conduct sets out the standards of conduct, performance and 
ethics for UK nurses (NMC, 2008). There are four main statements to the code with each 
statement being broken down to include specific conduct statements, including confidentiality 
and environment of care. The four statements are:
  Make the care of people your first concern, treating them as individuals and respecting 
their dignity
  Work with others to protect and promote the health and wellbeing of those in your care, 
their families and carers, and the wider community
  Provide a high standard of practice and care at all times
46 | P a g e
  Be open and honest, act with integrity and uphold the reputation of your profession
This code enables nurses and midwives to have set standards for the healthcare they provide, so 
all nurses and midwives should therefore be practising to the same set of values. However, 
neither the code nor the requirements for pre-registration nurses, midwives and health visitors 
made any reference to genetics (NMC, 2002). In 2003, in response to a call from an Expert Panel 
to provide national guidelines for a genetic curriculum in nursing (Kirk, 1999), and to support the 
genetics White Paper, the Department of Health commissioned the development of a genetics 
education framework for all nurses and midwives. This compromised seven competence standard 
statements which were subsequently endorsed by the NMC (Kirk et al 2003). Revised in 2010 to 
provide separate frameworks for nurses and midwives, the nursing framework is a set of basic 
standards that all nurses should be able to demonstrate at the point of registration (Kirk et al. 
2011a). The framework provides students, educators and practitioners with a guide of what 
genetic knowledge they need to have and what educators need to ensure their students know. 
The most recent set of genetic competencies for nurses (2010) were established through a 
meeting of nurse educators, practitioners, policy makers and patient representatives. However, 
the need for nurses to be aware of genetics/genomics within their practice is only signposted by 
the Nursing & Midwifery Council and the competencies are not mentioned within their revised 
education framework (NMC, 2010).
Role of nurses in genetic service provision
In the future nurses will be faced with an increased genomic aspect to the care they provide. 
Nurses will be expected to explain and counsel patients on the benefits of genomic based 
therapies versus traditional therapy for particular diseases. They will also need to educate 
patients about their disease and the rationale behind screening programmes (Kim, 2003). Nurses' 
knowledge of, and attitude towards genetics/genomics will help to determine whether they 
continue to improve their approach to patients with genetic conditions. Nurses need to 
understand that they have a key role to play regarding the quality of health service delivery and 
that this will be continually shaped by genetic related healthcare (Chen and Goodson, 2007a). 
Healthcare professionals, including nurses will be expected to be able to interpret genetic data, 
relevant to their practice and to be able to relate the risk to their patients (Green et al, 2011). 
Kirk et al. (2011a) state that safe and effective nursing practice must incorporate the needs of 
those with or at risk of a genetic condition. Hence it could be suggested that the current lack in 
nurses' genetic knowledge (Skirton et al, 2012) has limited the care provision for those patients 
with or at risk of genetic conditions. Therefore, all nurses need a basic knowledge about 
genetics/genomics and its application to clinical care so that they can provide adequate and
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informed healthcare to their patients, including psychological support for a patient and their 
family dealing with a genetic condition (Lea et al, 2011).
Genetics/genomics within oncology nursing and practice nursing are the two areas selected for 
inclusion in the current study. These two areas of nursing were chosen due to the expanding 
involvement of genetics/genomics in cancer care and the unique role a practice nurse has in 
dealing with many family members and with the early identification of diseases.
3.2.2 Genetics/genomics within oncology nursing
Oncology nurses have the potential to influence whether or not cutting- edge research discoveries 
are utilized at the bedside (Jenkins, 2011)
Genomic health care is the beginning of a new and exciting chapter in oncology nursing 
(McCreery, 2011). Genetics/genomics and its implications for cancer care is a fast growing area 
which applies to every aspect of the field. As such nurses have a duty to be knowledgeable in 
order to enable the integration of genetics/genomics into patient healthcare (Twomey, 2011). 
The ability to communicate risk to clients along with basic concepts of disease susceptibility and 
influence of genetic factors is also important (Kirk et al, 2003). A report by the Association of 
Genetics Nurses and Counsellors outlined the expected capability in relation to genetics of breast 
cancer nurses. It included reassuring those who have a low genetic risk, understanding when 
genetic testing is applicable and screening options for at risk individuals (AGNC, 2002). The report 
also stressed that breast cancer nurses should have knowledge about the gene alterations 
associated with breast cancer and the psychosocial impact of having a family history of cancer.
Jenkins (2011) and McCreery (2011) believe that advances in genomics are altering oncology care, 
influencing risk management, care and management options. Jenkins states that oncology nurses 
have a role to play in helping patients and their families to understand information. However 
oncology nurses' lack of genomic knowledge and understanding, lack of education, inadequate 
communication of data and lack of clinical decision support tools is preventing new discoveries 
from being incorporated into patient care (Jenkins, 2011). Nurses need to be committed to 
gaining education in genomics and to understanding its relevance to their practice in order for the 
potential benefits to reach patients and their families (Jenkins, 2011). It does however, need to 
be recognised that there will be barriers to implementing genomic healthcare that are not linked 
to a lack of nursing commitment.
3.2.3 Genetics/genomics within practice nursing (primary care)
Primary care is likely to be an important focus area for the incorporation of genetics/genomics 
into patient care as it has the potential to play a bigger role in the service delivery of genetic
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Healthcare (Kirk et al, 2003). Practice nurses need to be able to offer pre-conceptual care and 
contribute to the development of policy guidelines for the screening of genetic conditions (AGNC, 
2002). It is also important that these nurses have knowledge around information resources for 
rare diseases and understand the psychosocial impact of genetic diagnosis (AGNC, 2002).
Eades et al (2010) suggest that one in 10 people who attend primary care have a genetic 
component to their condition, higher than most practitioners believe. They argue that new 
technologies are only going to increase the demand on primary care practices for genetic 
healthcare. They also contend that healthcare professionals cover genetics/genomics within their 
pre-registration training but then forget all about it when they are confronted by other demands. 
It is understandable that healthcare professionals are not going to have knowledge on a wide 
range of genetic conditions, but they should be aware of local screening programmes, be able to 
take a family history and possibly make a referral (Eades et al, 2010).
3.2.4 Integrating genetics into nursing
Whilst the relevance of genetics/genomics to oncology and practice nursing is clear, the literature 
appears to suggest that both the views towards genetics/genomics and the practical application 
of genetic education need to be addressed further. Kirk and Tonkin, (2008) concluded that the 
integration of genetic competencies and curriculum guidelines are not close to being 
implemented into education programmes but that 'real dialogue' and practical support will have 
the biggest impact on the integration of genetics/genomics into practice. The study completed by 
Metcalfe et al (2007) showed that despite 79% of midwife respondents (n=46) feeling that genetic 
activities were important, less than 20% felt confident in carrying out these procedures. There 
seems to be an interest in learning more about genetics/genomics but a lack of motivation to seek 
this knowledge may be an issue. In my view genetic interest and application of knowledge will be 
a gradual approach and may occur at different rates across different areas of practice according to 
the pace of clinical advance in the area. As indicated above, oncology nursing is one area where 
rapid advances in genomics are impacting on care. Once perceptions of genetics/genomics have 
changed, nurses' confidence and their application of genetic knowledge should increase. It has 
been identified that there is often a gap between research findings and the implementation of 
these into routine healthcare practice (Grimshaw et al, 2004). They argue that researchers should 
try to understand how implementation strategies vary across context, sometimes it is not always 
that healthcare professionals do not want to implement new ideas but that their healthcare 
settings do not easily allow this to happen (Grimshaw et al, 2004). Having a better theoretical 
understanding of behaviour change and organisational behaviour will allow researchers to 
identify modifiable and non-modifiable factors (Grimshaw et al, 2004). This is an important
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consideration when integrating genetics/genomics into nursing, the importance of which will be 
discussed in chapter four.
3.3 NHS and genetics/genomics - current services
A genetic condition can affect any one or more of the body's systems, hence a medical specialist 
in a specific clinical area will often provide healthcare. However Regional Genetic Centres (RGC) 
provide additional support for an individual and their family affected by a genetic condition, 
including genetic counselling, risk assessment and reproductive choice (www.bshg.org.uk). Figure 
3.2 shows an overview of specialist genetic services within the NHS.
3.3.1 Regional Genetic Centres
Regional genetic centres (RGC) have developed through networks of specialist genetic centres. 
The first genetics clinic was held at Great Ormond Street hospital in 1946 and specialist genetics 
nurses played an important role in their development since
(http://www.bshg.org.uk/for_patients/what_is_genetics.htm). Regional Genetic Centres are 
made up of clinical and laboratory services including consultant and specialist registrar clinical 
geneticists, genetic counsellors, laboratory staff and administrative staff
(http://www.nhs.uk/chq/Pages/2370.aspx?CategorylD=54&SubCategorylD=127). There are 
currently 27 NHS genetic centres in the UK, organised on a regional basis; 21 in England, 4 in 
Scotland and 1 in both Wales and Northern Ireland. Each serve a population of roughly 3-5 
million (http://www.nhs.uk/chq/Pages/2370.aspx?CategorylD=54&SubCategorylD=127). RGCs 
provide:
  Diagnosis
  Genetic counselling
  Patient information
  Speciality services and clinics
  Education and training for health professionals
  Telephone advice
RGC provide general genetics; specialist prenatal genetics; neuromuscular and 
neurodevelopmental services; dysmorphology services for adults and paediatrics; and cancer 
genetic services for individuals who may be at increased risk of developing cancer 
(http://www.wales.nhs.uk/sitesplus/864/page/41942). Individuals can self-refer, although are 
often referred by their GP or other healthcare professionals. The clinical component is outpatient 
based although patients are seen on wards, at GP surgeries and in the family home.









































































































































































































































































































































































































































































































































































































































































































































































































































































































There are three recognised units of care within genetic services (Westwood et al, 2006):
1. Outpatient appointment
2. An episode of interaction or advice
3. A finished clinical genetics episode of care - when a patient's question has been 
answered or a decision is made that nothing more can be offered.
Patients with or at risk of a genetic condition are often referred to genetic counsellors, within 
regional genetic services. Genetic counsellors advise and counsel individuals and their families 
affected by genetic disorders and they work mainly through Regional Genetic Centres (House of 
Lords Report, 2009). They also help the patient to understand the genetic risk presented to them 
and to guide them through the testing process (http://www.agnc.org.uk/howtobecomeaGC.htm). 
Genetic counselling arose from the nursing professions. The registration of the profession is now 
managed by the Genetic Counselling Registration Board, which sets and monitors standards 
within the profession (www.gcrb.org.uk) and now registers individuals who choose to train via a 
non nursing MSc route. It was noted in the House of Lords, Genomic Medicine Report (2009) that 
more counsellors need to be trained to meet the demand that increases yearly.
Conclusion
Nurses have an important role to play within genetic and genomic healthcare. The nursing code 
requires nurses to keep up to date with new knowledge and expertise (NMC, 2008) no matter 
what branch of nursing they practice in. The creation of nursing genetic competencies is a 
positive step forward and need to be continually endorsed and marketed. Genetic education 
within nursing is needed and will be discussed in the following chapter. The government has 
promised to incorporate genetics/genomics into the NHS by education and training, investing in 
information systems, supporting commissioners and supporting evidence based care (Department 
of Health, 2003). Having justified the need for genetic education for nurses, Chapter four (p46) 
will focus on the current education provisions for nurses, including pre-university education, pre- 
registration education and post-registration education. The genetic education provision and 
attitudes of nurses in the UK will then be compared to international perspectives in order to set 
the scene for the current study.
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Chapter 4: Genetic nurse education
Introduction
The last chapter focused on the development of the nursing role and the role of 
genetics/genomics within it. In Chapter Four an overview of the current education provisions for 
nurses will be provided and the attitudes of nurses towards genetics/genomics will focus 
specifically on their attitudes towards genetic education in particular. Genetic education 
provision both present and future needs will be described along with educational resources that 
can be used to encourage the incorporation of genetics/genomics into nursing practice will be 
discussed.
4.1 Genetics education provision for nurses
The 2008 progress review of the Government's White Paper into the potential of 
genetics/genomics in the NHS (DOH, 2008), emphasised that 'incorporating genetic education into 
professional practice at all levels is a priority' and that health care professionals need greater 
access to information about genetic conditions (Department of Health, 2008 P.25). They state 
that all healthcare professionals should be kept up to date about genetics/genomics in clinical 
practice. The Department of Health established a commitment to support the provision of 
education in genetics/genomics to all healthcare staff throughout their careers, however how 
exactly this will be achieved has not been stated, although the role of the NHS National Genetic 
Education and Development Centre is core to this aim.
Education and training are key to providing nurses with the skills and knowledge they need to 
utilise genetics/genomics within their practice (Green et al, 2011; Task and Finish Group Report, 
2011). Green et al (2011) believe that all health professionals, including nurses, need to acquire 
competencies in genetics/genomics in order to provide a better service to their patients. They 
believe that education, including nursing accrediting programmes need to focus more on 
genetics/genomics. Nurses will soon be expected to interpret genomic data and make evidence 
based decisions (Green et al, 2011). There is often a limited understanding by educators of how 
much genetics/genomics is influencing medicine and healthcare (Task and Finish Group Report, 
2011). It will be important for nurse educators to understanding the importance of providing the 
opportunities for students to take basic genetic information from patients and to be able to 
explore specific genetic conditions in more detail (Lea et al, 2011). Genetic/genomic education 
provision for educators will be an important link in enabling them to help students to identify the 
relevance of genetics/genomics in their practice. This includes enabling the students to 
understand which research findings are applicable to healthcare and the ethical consequences 
involved with genetics/genomics in healthcare (Lea eta/, 2011).
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4.1.1 Genetics education framework
The revised education framework (Kirk et al. 2011b) produced by the Genomics Policy Unit, 
University of Glamorgan, the National Genetics Education and Development Centre and the 
University of Plymouth states that all nurses at the point of registration should be able to:
1. Identify clients who might benefit from genetic services and/or information through a 
comprehensive nursing assessment
2. Demonstrate the importance of sensitivity in tailoring genetic/genomic information and 
services to clients' culture, knowledge, language ability and developmental stage
3. Advocate the rights of all clients to informed decision making and voluntary action
4. Demonstrate a knowledge and understanding of the role of genetic/genomic and other 
factors in maintaining health and in the manifestation, modification and prevention of 
disease expression, to underpin effective practice
5. Apply knowledge and understanding of the utility and limitations of genetic/genomic 
testing and information to underpin care and support for individuals and families prior to, 
during and following decision-making
6. Examine one's own genetic/genomic competency of practice on a regular basis
7. Obtain and communicate credible, current information about genetics/genomics, for self, 
clients and colleagues
8. Provide ongoing nursing care and support to patients, carers and families with genetic 
healthcare needs
The framework also includes learning outcomes and practice indicators linked to each 
competence to help nurses and educators understand what is expected to achieve each 
competence (see appendix 2 for the full framework).
The House of Lords Genomic Medicine report urged that 'the Nursing and Midwifery Council set 
the detailed standards across the curriculum on genetics and genomics for nurses, both for pre- 
registration nursing education and as part of post-registration education and practice' (House of 
Lords Genomic Medicine Report,2009. 7.24). This was mirrored by a recommendation from the 
Task and Finish Group Report (2011) that NMC standards should reflect the integration of 
genetics/genomics across all areas of nursing and midwifery practice and that this needs to be 
monitored within the quality framework. Although the need for genetic understanding in nursing 
is briefly mentioned by the NMC in their revised pre-registration framework (NMC, 2010), Higher
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Education institutions can interpret the framework in terms of how they choose to teach the 
content to their students (Kirk et al. 2011a). The Task and Finish Group Report (2011) believe that 
the NMC has not recognised the true impact of genomics on healthcare and that the single 
reference to genetics/genomics in its standards for pre-registration education does not help 
promote genetic integration into nursing practice. The continual recognition and support from 
policy makers, the public and other health professionals all help in the awareness of the 
competencies (Kirk et al, 2011a). Whether the advice is eventually followed will become 
apparent, as genetics/genomics within healthcare is more widely implemented and the need for 
genetic/genomic education recognised. However it could be argued that even though the 
genetic/genomic competencies have been produced (Kirk et al. 2011a), the importance and status 
they have and need is limited because they are not formally recognised by the NMC.
4.1.2 Level of science education upon entry to nursing programmes
In Metcalfe and Burton's study (2003), 50% of universities (n=38) commented that 
genetics/genomics was not included in any post registration courses for nurses, midwives and 
health visitors. It was noted that often only psychosocial and ethico-legal aspects of 
genetics/genomics were taught because nursing post-registration students lacked the scientific 
knowledge to understand genetics/genomics (Metcalfe and Burton, 2003). Many health 
professional pre-registration courses do not specify A-level biology (or any science) as a pre- 
requisite. Those students that have A-level or International Baccalaureate (IB) biology will have a 
reasonable genetic knowledge (Newton and Farndon, 2008); however those undergraduates 
without A-Level or IB biology may be at a disadvantage through not having basic biological 
comprehension. It could be argued that in order to be competent nurses, students should have 
studied biology to at least A-Level standard or equivalent. This then would mean all nursing 
students would have a similar understanding of core scientific concepts when starting their 
degree, for example like those studying medicine.
4.1.3 Pre-registration genetic education
The current genetics/genomics education in place for nurses and midwives is limited and varies 
across the country (Burke and Kirk, 2006, Gharaibeh et al. 2010). There is no single syllabus for 
the teaching of genetics/genomics to nurses and midwives and the syllabus and level of 
knowledge are decided by individual education facilities (Kirk, 2000). In a report by Kirk and 
Tonkin (2006), Deans and Heads of UK University Faculties for Nursing and Health Professionals 
were contacted (n=85) to nominate someone interested or involved in genetic education to 
complete a questionnaire. Respondents to the questionnaire indicated that 100% of pre- 
registration adult nursing programmes (n=31, response rate = 43%) were including 
genetics/genomics within their course, this dropped to 89.3% for mental health courses (n=25,
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response rate = 69.4%). However when asked whether the genetic syllabus on their courses was 
assessed only 31% (9/29) institutions teaching adult nursing courses included assessment and this 
dropped to 26% (6/23) for mental health courses (Kirk and Tonkin, 2006). This is significant 
because without any genetic assessment the amount of genetic information retained is unknown. 
Also if there is no assessment on the genetics/genomics taught it may be viewed a low priority 
area for students. Similar findings have also been identified in New Zealand nursing education. In 
a survey of tertiary Education Institutes (n=16), 66% of nursing programmes provided less than 10 
hours devoted to genetics/genomics and one programme did not include genetics/genomics at all 
(Nicol, 2002). This emphasises the inconsistency and lack of genetic education in nursing. 
Without a national genetics curriculum framework, nurses will not be fully equipped to deal with 
the rise in the use of genetics/genomics in healthcare (Quevedo Garcia et al. 2011).
Daack-Hirsch et al. (2011) and Tonkin etal. (2011) believe that genomics should be integrated into 
all aspects of the curriculum for undergraduate nursing students. This would also help to 
overcome the barrier of limited curriculum space. Daack-Hirsch et al. (2011) provide some unique 
and imaginative ways of engaging pre-registration nurses in genetics/genomics. Their ideas 
include bulletin boards highlighting the importance of genetics/genomics, various online learning 
tools such as WebQuests and Second Life, and blogs to highlight to nurse genetics/genomics 
within the news. Tonkin et al. (2011) also support the use of new media as well as virtual patients 
(VPs) to teach nurses about genetics/genomics. They believe in particular, that VPs will help to 
overcome a possible lack of genomic clinical experience among student nurses. Whilst these 
options are unique, not all university faculties would have the financial or work force backing to 
include such imaginative learning tools. However it could be argued that in an ever progressing 
multimedia learning environment that something unique and different needs to be explored in 
order to engage student nurses in genetics/genomics, which would impact their patient care from 
the outset. I believe this type of interactive learning could also be useful for educators wanting to 
understand more about genetics/genomics within nursing practice. It is axiomatic that we cannot 
expect nurses to be incorporating genetics/genomics into practice if they are not provided with 
the education to enable them to do this. A lack of knowledge and understanding of 
genetics/genomics at pre-registration stage will intern affect the level of post registration 
development (Task and Finish Group Report, 2011).
4.1.4 Post-registration genetic education
In 2001, a study of practice nurses (n=600) found that only 12% of respondents had attended an 
educational session on family history in the previous 12 months (Bankhead et al, 2001). Many 
nurses commented that they needed more training and information to be able to fulfil their role, 
with one respondent quoting that "Our role could be great if well informed. Similarly it could be
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devastating if not" (Bankhead et al, 2001). The use of genetics/genomics in nursing education is 
not going to improve until barriers such as insufficient genetic knowledge in nursing faculties and 
time constraints in the curriculum are overcome. Metcalfe and Burton (2003) contacted 38 UK 
educational institutions that offer post registration nursing education. Only 3 institutions offered 
whole genetic modules and 19/38 did not offer any genetic education at post registration level 
(Metcalfe and Burton, 2003). However, even if nurses do have genetic education provided at 
undergraduate level, genetics/genomics is an area that is constantly changing and requires 
postgraduate education to update knowledge. An American study by Edwards et al (2006) found 
that one of the reasons for the lack of genetics/genomics education within pre-registration 
nursing programmes was that educators lacked confidence in the subject as they felt they had not 
had enough training on various genetic topics themselves. This highlights the need for post- 
registration genetic training for educators as well as clinical nurses. In a study completed by Kirk 
et al, (2007c) 77.8% of post registered nursing respondents (n= 198) had not attended any 
courses in genetics/genomics since they qualified and only 10.7% said there were genetic courses 
available to them.
Quevedo Garcai et al. (2011) believe that barriers to genetics/genomics within nursing could be 
overcome by being knowledgeable about and strategic with the known facilitators that encourage 
the uptake of genetics/genomics and the variety of teaching strategies used. Moreover, Foster 
(2010) makes it clear that those nurses who want to specialise need to consider what extra 
genetic knowledge they require to fulfil their role and to provide effective care management 
plans. A study by Burke et al. (2012) into genetic education needs for haemophilia nurses found 
that whilst nurses had received their genetic education through clinical experience, they would 
have preferred to receive formal training sessions. The authors set out a strategy for the 
development of education among post-registered nurses that takes into account what the nurses 
actually need and require (Fig 4.1).
This strategy allows for practitioners to explore what their learning needs are and how they are 
related to their clinical practice. Phase 2 of the Burke et al (2012) study allows for the appropriate 
resources to be developed and then delivered to the nurses. The strategy finishes with a chance 
for the nurses to evaluate how the education impacted on their practice, what could be improved 
and whether they would like further education on a particular topic (Burke et al. 2012). They 
believe that this strategy allows for genetic education to be delivered with minimal time and 
expense, through identifying the specific educational needs of haemophilia nurses and delivering 
it in a way that is relevant to them. They also believe it increase the confidence of nurses and 
alters the way care is delivered.
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4.1.5 Genetic education provision for nurses in the United States
The National Coalition for Health Professional Education in Genetics (NCHPEG) promotes the 
education of health professionals and provides access to information about the advances in 
human genetics/genomics to improve the health care system. NCHPEG defined core 
competencies for all health professionals. The core competencies that they believe each health 
professional should be able to perform as a minimum are (NCHPEG, 2007):
a. Examine competence of practice on a regular basis, identify areas where professional 
development related to genetic and genomics would be beneficial
b. Understand that genetic information can have social and psychological implications for 
individuals and families
c. Know how and when to make a referral to a genetics professional
A similar lack of genetic education and provision for nurses is present in America, with Calzone et 
al. (2010) believing that current nursing education does not adequately prepare nurses for their 
ever developing role in the genomic era. Unlike in the UK, there is a greater pressure that nurses 
could face liability if they are not incorporating genetics/genomics into their practice (Calzone et 
al, 2010). Similarly to the UK, guidelines for genetic/genomic practice were created, as well as 
competencies and curriculum guidelines (Calzone et al. 2011). However it has been shown
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(Thompson and Brooks, 2011) that the essential nursing competencies (Calzone et al. 2011) have 
still not been disseminated outside those who have an interest in the subject matter. Nurse 
educators also had limited knowledge regarding both genetics/genomics as a whole and of the 
competencies, meaning that it is unlikely that the importance of genetics/genomics and the need 
to complete the competencies has been passed onto those they teach (Thompson and Brooks, 
2011).
A multifaceted genetics program was created in America for nursing faculty (Prows et al, 2003). 
The Genetics Program for Nursing Faculty held two Genetics Summer Institutes (GSI). The 
demand for the programme was such that it was continued annually. Genetic information was 
delivered in a condensed amount of time but 'their application of new knowledge [by the 
participants] resulted in increased amounts of genetics/genomics content in their (delivered) 
curriculum' (Prows et al, 2003). In my view the approach taken by Prows et al is a useful method 
to increase genetic education among registered nurses; however whether individuals would be 
granted that length of time as study leave in the UK would need to be considered. It might be 
that this is only possible for specialist nurses. It could be considered however that the number of 
nurses that attended the GSIs was likely to be considerably smaller than the size of the US nursing 
workforce, hence this need to be considered. The GSIs were funded by the Ethical, Legal and 
Social Implications research programme of the National Human Genome Research Institute at the 
National Institutes of Health. If a similar training programme was to be implemented in the UK, 
funding would need to be sought, which may prove difficult, especially with the current spending 
cuts in the NHS, but a condensed and intense programme may well help nurses to fully engage 
with genetics/genomics.
4.1.6 Current genetic/genomic education for other health professionals
Other health professional groups are also realising the need for an increased awareness of 
genetics/genomics. In dietetics the scientific advancements of nutritional genomics have a 
significant impact on ethics, policy and practice. For example the use of blood lipid profiles to 
inform diet choices is one area that has quickly advanced, as has the association of 
genetics/genomics with obesity and type 2 diabetes (Ryan-Harshman et al, 2008). The current 
curriculum for dieticians provides little or no genetic content despite these advancements 
(Vickery and Cotugna, 2005). In a study by Rosen et al, (2006) 60% of dietician respondents 
(n=415) had low confidence in applying nutrigenomics and 75% agreed that the benefit of 
applying nutrigenomics would be advantageous in managing and preventing certain disorders. 
The barriers to the adoption of genetics/genomics are similar to those found in nursing and 
midwifery as respondents felt they lacked the background knowledge and believed there was a
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shortage of experts to convey professional expertise. Rosen et al, (2006) believe that continuing 
education is needed at both undergraduate and postgraduate level.
The Government's White Paper, (Department of Health, 2003) also stresses in particular the 
importance of genetic training for General Practitioners (GPs). All branches of medicine, but 
especially primary care will be required to advise patients about genetic issues (Burke et al, 2005). 
A study by Burke et al, (2005) found that of current GP registrars responding to their survey 
(n=123), 70% said they had no genetic training at undergraduate level and 78% indicated they had 
received no genetic topics in their registrar training so far. Many felt unprepared for genetic 
issues and 45% stated that they needed to know more about genetics/genomics (Burke et al, 
2005). It appears that genetic education in other health professional groups such as dieticians 
and GPs is also lacking and on a similar par to that of nursing genetic education.
4.1.7 Educational needs of other Healthcare professionals
It is not just the UK that is lacking current genetic education for health professionals. Other 
countries including Japan, Israel and Korea are also limited in genetic education (Metcaife and 
Burton, 2003; Dodson and Lewallen, 2011; Kirk et al. 2011a). Sweden and the Netherlands have a 
similar system to the UK, in that genetic content within nursing programmes are at the discretion 
of individual universities (Challen et al, 2005). The US National Coalition for Health Professional 
Education in Genetics (NCHPEG) could play a useful role in supporting the development of genetic 
education for healthcare professionals in various other countries (Challen et al. 2005). It is an 
'organisation of organisations' which promote health professional education in genetics/genomics 
nationally. It aims to integrate genetics/genomics content into the knowledge base of health 
professionals and students (http://www.nchpeg.org/content.aspx?sc=about&sub=l).
The European Union have funded a project to 'harmonise genetic testing standards' called 
Eurogentest. Eurogentest has become a '"network of networks" through collaborations with 
various national and international bodies involved in genetic testing' 
(www.eurogentest.org/aboutus/). Much can be gained by studying the infrastructure and project 
strategy of Eurogentest, to aid the development of other genetic networks across Europe. An 
expert group working with the Eurogentest project and the European Society of Human Genetics 
Education Committee agreed to a set of competencies to be used across Europe (Skirton et al, 
2010a). The competencies are for a range of health professional groups working in primary, 
secondary and tertiary aspects of healthcare and are a benchmark for genetic/genomic education 
for these health professions. This may help to facilitate and encourage genetic education across 
Europe, allowing healthcare to move forward smoothly. Core competencies were agreed by 
representatives for 16 countries for the following (Skirton et al, 2010a):
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  General practitioner
  General nurse/midwife
  Medical specialist in fields other than genetics/genomics
  Specialist nurse, midwife and allied health professional
  Specialist dentist
  Clinical geneticist
  Genetic specialist nurse or genetic counsellor
  Molecular geneticist
  Cytogeneticist
  Biochemist/biomedical scientist
Competencies for nurses and midwives are based on the UK nursing framework. 
Midwives
Midwifery is one area of healthcare that has close links to nursing and one which also requires an 
increase in genetic knowledge and uptake. Studies into genetics/genomics and midwifery 
education provide a deeper understanding of the issues facing this group. One midwifery study 
that investigated midwives' educational needs surrounding newborn screening found that over 
60% of midwives who responded (n=607) felt they had not been given enough basic genetic 
information and some felt they needed an update on all genetic tests (Israel et al, 2005). 
Midwives were keen to receive more genetic education and understood that recent 
developments had made their previous knowledge outdated (Israel et al, 2005). This study was 
completed in Wales only, the results are therefore limited and cannot be guaranteed as 
generalisable across the UK. As shown by this study, educational needs should be considered 
further. Any previous genetic courses attended will now be outdated but qualified midwives have 
not been able to update their skills. It may be the case that the genetic knowledge midwives and 
nurses did have is no longer relevant. The study by Israel et al, (2005) does not include 
information on where practitioners trained, however. As various higher education institutes each 
have a different syllabus, a UK wide post-registration genetics/genomics course would be useful 
but would need to incorporate the needs of all NMC members in the UK. Although it is clear that 
midwives and nurses want to improve their knowledge, they have not acquired this knowledge to 
demonstrate the national genetic competencies for nurses, midwives and health visitors (Skirton 
eto/,2010a).
In a recent qualitative study by Houwink et al (2011), midwives and physicians (n=44) were asked 
about their genetic educational needs and the role of genetics in primary care. The participants
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were collected via purposive sampling, so it is possible that certain viewpoints were not captured 
in the study. Midwives did not perceive themselves to have a lack of genetic knowledge, however 
they were all on a masters programme and felt that they had been provided with sufficient 
genetic knowledge on the course (Houwink et al, 2011). The participants believed that primary 
care providers cannot be expected to know everything as many genetic diseases are rarely seen in 
primary care practice. Midwives said that both they and their patients felt insecure about the 
rapid development of genetics/genomics, despite having stated that they felt they had sufficient 
genetics/genomics knowledge. Both the midwives and physicians felt that their lack of skills and 
knowledge were leading to a perceived lack of genetics/genomics amongst primary healthcare 
provision and that genetics/genomics needed to be included in the primary care guidelines to 
make it an important issue (Houwink et al, 2011). This study identifies that little has changed in 
the six years since the Israel et al (2005) study, despite clinicians and academics working to 
highlight the relevance and importance of genetics/genomics in clinical practice.
4.1.8 The future of genetic education in nursing
'Education in Genetics has trailed behind the enormous scientific and technical advances in this 
field and the Royal Society strongly believes that the teaching of genetics to doctors, pharmacists 
and nurses at undergraduate, postgraduate and continuing medical education levels must be 
increased as a matter of urgency1 Royal Society, Department of Health, P.26
Feero and Green (2011) believe that many healthcare professionals have been provided with 
'push information'; where members of the genomic community provided information to other 
health professional groups and the development of genetic nursing competencies provide an 
example of this. However, it came with the assumption that an interest in genetics/genomics 
would follow. It was hoped that there would be a greater demand from healthcare professionals 
for genetic/genomic knowledge. In order to create this demand, healthcare professionals first 
need to understand the implications of genomic advances for their practice area. Genetic 
education for nurses is urgently needed, but there are various approaches that can be taken to 
improve the quality and access of the teaching for future nurses. A joint paper by authors from 
the US and UK believe that the development of 'champions' network' is a viable option and could 
help in engaging nurses and disseminating resources which would help to maintain a genetic 
education workforce (Williams et al, 2011). The recommendation by the Task and Finish Group 
Report (2011) to establish a local skills network would be beneficial in providing educational 
expertise to nurses and their educators.
Over time it is hoped that individual genetic courses will be started in universities as well as 
continuing genetic education within undergraduate and postgraduate nursing courses with the
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help of key educators and resources (Williams et al, 2011). In the UK, genetic counsellors are also 
being used in educating nurses about genetics/genomics and have been working as 
'genetics/genomics education facilitators' (Williams et al, 2011). If this strategy continues it could 
be very beneficial in helping nurses to understand the important of genetics/genomics. If all 
these current strategies to enable nurses to be acquainted with genetics/genomics can be utilised 
and built upon, this will help with the spread of genetic knowledge and also the appreciation that 
it does need to be given the time that it is due. Although the study was targeted at physicians in 
the US, Feero and Green (2011) say that incorporating genomics into the syllabus is prevented 
due to the time cost of trying to fit it in. Feero and Green (2011) believe that 'the genomics 
community must align the scope and depth of its educational priorities with those of the health 
professional group it wishes to educate'. When trying to educate nurses in genetics/genomics, 
making the subject very clearly relevant to nurses, so called 'meeting them at their level' is 
important and I believe will not be successful without it. The large number of healthcare 
professionals that require genetic education will also be a challenge. Moreover, 
genetics/genomics does need to be updated more regularly compared to conventional 
educational topics, because it is fast moving and encompasses all aspects of care. Some of this 
could be achieved through the proposals stated by Williams et al (2011), although nurses need to 
be given the support and time to be truly successful. This will largely depend on the attitudes 
towards this type of education from those delivering it to those funding it.
The Task and Finish Group Report (2011) believe that it is now time to move on from having to 
make a case for the engagement of nurses and midwives in genetics/genomics through education, 
policy and research, but to allow nurses and midwives to inform and shape care to incorporate 
genomic healthcare. Support at high levels of practice, policy, education and regulation needs to 
be gained along with strong leadership if nurses application of genetics/genomics is not to 
become patchy and stagnant (Task and Finish Group Report, 2011).
4.2 Attitudes to genetic education
In the early years of the new millennium, government spending boosted research programmes in 
molecular genetics/genomics and also the ethical, legal and social aspects of genomics. Despite 
this level of funding and support, educators and healthcare professionals have noticed little effect 
on genetics/genomics within practice (Burton and Zimmern, 2005). However there has been a 
shift in attitudes towards incorporating genetics within nursing (Kirk and Tonkin, 2008). 
Incorporating genetics/genomics fully into practice is still a future vision, but it is likely to begin 
with nurses of a similar grade (Sisk et al, 2004). Although it will take time before newly qualified 
nurses will have genetic knowledge and skills, it is the current qualified nurses that are needed to
provide genetic care for patients now. It has been highlighted that the greatest barrier of nurses
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to the incorporation of genetics/genomics into practice is the lack of perceived relevance to their 
practice (Kirk et al, 2008a). If the future generation of nurses are taught the science of 
genetics/genomics and its importance and relevance from legal, ethical and psychosocial 
perspectives is emphasised, then its incorporation into practice should slowly start to be seen.
4.2.1 Nurses' attitudes and knowledge surrounding genetics/genomics
Nurses are the members of the health care team who are in direct contact with patients and their 
families in all health care settings (Terzioglu and Dine, 2004), therefore their knowledge of, and 
attitudes towards genetics/genomics are important in influencing the quality of care patient 
receive and patients' perceptions of genetics/genomics. Understanding the attitudes that nurses 
have towards genetics/genomics and the genetic knowledge that they already possess will 
provide a clearer understanding of how to further incorporate genetics/genomics into nursing 
practice. Little empirical evidence has been published on nurses' knowledge and attitudes 
towards genetics, but two studies of relevance will be considered here. A study into hospice 
nurses' understanding and perceptions of genetics/genomics completed by Metcalfe et al (2010) 
found that almost half (42%) of participants believed it was of little importance. The hospice 
nurses also had little confidence in many genetic activities. Hospice nurses were least confident in 
clinical genetic activities (e.g. taking a three generation family history) and biological genetic 
activities (e.g. understanding inheritance patterns), with 87% of nurses saying that they did not 
feel confident with these tasks (Metcalfe et al, 2010). This increased to 90% of participants being 
not confident when the clinical and biological activities were represented in clinical scenarios, 
which included understanding genetic inheritance and the implications for family members and 
explaining genetic counselling and testing. In contrast over half of nurses felt very confident 
about undertaking the psychosocial activities (e.g. appreciate that patients have personal views 
about genetic testing). Confidence levels among the hospice nurses did differ depending on job 
role, clinical nurse specialists and senior managerial staff were more confident with clinical 
activities than staff nurses and clinical nurse specialists were more confident with biological 
activities than staff nurses (Metcalfe et al, 2010). Hospice nurses said they were most familiar 
with breast cancer and Huntington disease along with bowel, bladder, ovarian cancer, familial CJD 
and cystic fibrosis. Despite seeing patients with a variety of genetic illnesses, a tenth of nurses 
still believed that genetics/genomics and inheritance is a medical responsibility, which does not 
include nursing. Although the study was limited to England and Wales and had a response rate of 
29% (n = 328), a fifth of nurses did not believe that nursing had any role in genetics/genomics- 
based care and had not considered issues such as emotional and psychological care needed by 
patients and families suffering from a genetic condition (Metcalfe et al, 2010). Despite being an 
older UK study, Bankhead et al (2001) showed that 96% of practice nurses (n=600) believed that
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family history collecting was part of their role and knowledge about familial disorders was good. 
The practice nurses were however more confident in taking a family history for some diseases 
compared to others. Breast cancer, colorectal cancer and ischaemic heart disease were the most 
well known familial diseases, with lung and cervical cancer being less so. Despite having good 
knowledge however, many of the practice nurses were unsure what to do with the information 
and only a third would refer to a GP if they had a patient at risk (Bankhead et al, 2001). 
Respondents in the Bankhead et al study might have been more confident than the Metcalfe et al 
study due to the participants being practice nurses. Practice nurses are often the first point of 
contact for patients and they refer the patient to see the GP if necessary (Bankhead et al, 2001).
4.2.2 Senior nurses' attitudes towards genetic education
In a small study completed by Pfeil and Chi-Meih (2005) senior nurses (n=17) within ten major 
NHS Trusts were consulted about their perceptions of genetic education and genetics/genomics 
related knowledge among the nurses in their Trusts. It was acknowledged that genetic testing 
and advances in drug therapy were essential areas of information, as 71% of senior nurses 
thought that their nurses should have some core knowledge in genetics which draw from basic 
life sciences (Pfeil and Chi-Meih, 2005). All 17 senior nurses except one believed that 'genetics 
had not yet hit their nurses and any need for genetics education was expected to be mediated by 
the speed of medical, mainly technological advances and research' (Pfeil and Chi-Meih, 2005 
P.1129). In a survey by Kirk et al (2007c) post registration genetic education, 44.4% of 
respondents (n=198) felt that their line managers did not view genetics/genomics as important to 
a nurses' role and 45.5% thought that line managers did not view genetics/genomics as important 
for their own role. Interestingly a significant association was found between an individual's 
intention to learn and the support received from senior staff to attend genetics/genomics courses 
(p=0.033) and between senior staff who support attendance and those who see 
genetics/genomics as important to the nursing role (p=0.000) (Kirk et al, 2007c). Therefore senior 
nurses have an important role to play in encouraging genetic competence among their staff, not 
just in raising the relevance of genetics/genomics but also in supporting those nurses who wish to 
develop their competence. The contradiction shown above highlights a lack of communication 
and acknowledgement between senior nurses and their colleagues for the need of genetic 
education among nurses in the NHS.
In terms of the attitudes of NHS trusts towards genetics/genomics education, Pfeil and Chi-Meih 
(2005) found that representatives from ten East Anglia Trusts believed that genetics/genomics 
content was integrated into existing speciality post registration courses. One manager could not 
see how knowledge about genetics/genomics was going to help nurses' practice (Pfeil and Chi- 
Meih, 2005). These opinions limit the impact of increasing awareness of genetic education among
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nurses and midwives. Until the opinions of the senior nurses and midwives change there will 
most likely be a limited incorporation of genetic education by nurses and midwives. A nurse 
manager commented that 'every course I sign as a manager has to have a reason. I would need 
some assurance that it would help the individual nurse' (Pfeil and Chi-Meih, 2005 P.1131). Trusts 
are only going to realise that nurses need genetic training if the subject is deemed vital to their 
professional development. The importance of genetics/genomics within nursing and midwifery 
needs to be highlighted to senior nursing and midwifery managers in order to increase the 
educational development and importance of genetics/genomics.
4.2.3 Midwives' attitudes towards genetic knowledge
Newly qualified midwives, if they receive the appropriate genetic education at University, can 
enhance their genetic skills practically and academically instead of learning in an 'apprenticeship' 
style. In a survey by Metcalfe et al (2007) 38% of responding midwives (n=416) thought that a 
basic knowledge of genetics/genomics was essential to midwifery care, but 29% believe that 
genetics/genomics was a specialist area. Until individuals can identify genetic aspects within their 
role instead of it being a perceived specialism then it will be hard for genetics/genomics to be 
implemented throughout midwifery care. However, 89% of respondents would want to find out 
more about genetics/genomics and midwifery practice (Metcalfe et al, 2007). This is a very 
positive response and highlights the need for the NHS and other educational institutions to take 
advantage of this perceived need and supply genetics/genomics training. This study was limited, 
as the West Midlands was the only area studied, however the authors commented that the area 
served a large population (5.27 million) and included both urban and rural societies. The authors 
believe that the results are likely to be generalisable to the whole of the UK because of the 
national nature of the NHS (Metcalfe et al, 2007). Skirton et al (2010b) completed a literature 
review on the genetic competence of midwives. It was identified that midwives are still not able 
to demonstrate genetic competencies and they have little confidence in their genetic knowledge. 
However there is little research into assessing the genetic skills and knowledge of midwives 
(Skirton et al, 2010b). In my opinion, with little assessment occurring, it will not become a priority 
for midwives or nurses until they realise they need to improve their genetic knowledge for the 
sake of patient care. Finally, Skirton et al. (2010b) believe that information technology is essential 
for keeping up to date with new knowledge, however it was found that some midwives in the UK 
do not have access to and/or limited confidence in using computers, which could affect their 
ability to gain information.
Confidence levels in genetic procedures
A questionnaire based study conducted by Metcalfe et al, (2007) found that 79% of midwifery 
respondents (n=416) felt that various genetic activities, including clinical, biological and
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psychosocial activities were important but fewer than 20% felt confident carrying out these 
procedures. This confidence was linked to the clinical grade of respondents and their work 
environment; the higher the grade of midwife the greater the confidence (Metcalfe et al, 2007). 
It is logical to expect longer practising midwives to feel more confident about genetic tasks due to 
having greater experience, but if genetic education was incorporated better at pre-registration 
level, this lack of confidence might be overcome. If there is a lack of post registration genetic 
courses, then these longer practising midwives likely have acquired most of their current genetic 
understanding through practical application. However post-registration genetic education would 
enable qualified nurses and midwives to understand and apply a greater depth of genetic 
knowledge.
4.2.4 Nurses' attitudes towards genetics/genomics: evidence from the United 
States
There are few studies that have been conducted in the UK looking in particular at knowledge and 
attitudes of nurses towards genetics/genomics. Studies around the knowledge and attitudes of 
nurses in the US have been completed and although health systems differ, they have similar 
findings to the Metcalfe et al study and much can still be learned from these studies. One such 
study was conducted by Maradiegue et al (2005) in the US, which found that most advanced 
practice nursing students (n =46) were familiar with meiosis, mitosis and genetic mutations and 
had some knowledge on the subjects. Having identified their knowledge level it was therefore 
surprising that only 34% felt comfortable with speaking to families with a genetic condition, with 
only 22% being able to use their knowledge to draw a family pedigree (Maradiegue et al, 2005). 
However the findings in this study seem to reflect those found in the Metcalfe et al (2010) and the 
Dodson and Lewallen (2011) studies. Nurses lack knowledge in various genetic areas which 
causes them to lack confidence in genetic activities, leading to difficulties in talking to families 
with genetic diseases (Metcalfe et al, 2010). In Dodson and Lewallen's study (2011), participants 
felt confident defining common genetic terms but not in talking to patients about genetic 
diseases. There was an overall lack of comfort in integrating genetic into their practice. A study 
was conducted in America, looking at African-American nurses' attitudes towards 
genetics/genomics. Out of a total response of 77 nurses, 43 (56%) described their knowledge of 
genetic nursing as fair or poor and 33 (43%) as good (Spruill et al, 2009). Interestingly 31 
respondents (40%) said that they either were affected by a genetic condition personally or had a 
family member who was and 69% of participants knew someone with a genetic condition (Spruill 
et al, 2009). Nurses' contact with people affected by genetic conditions, be it family members, 
friends or even themselves, could have an impact on their attitude towards genetics/genomics 
within their practice and how knowledgeable and interested they are. Although this study was
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conducted with African-American nurses with a relatively small number of respondents (n=77) 
(response rate was not stated as it was a convenience sample), the lack of nurses' knowledge 
surrounding genetics/genomics appears to reflect those of Metcalfe et al (2010) participants. 
However the African-American nurses were more likely to have completed a family health history 
and 78% (n=60) were willing to learn more.
A study conducted by Chen and Goodson (2007b) into health educators' (n=1862) attitudes and 
knowledge towards genomics, identified 70% of the respondents did not know that genetic 
testing could be used to detect individual genotype and calculate an offspring's chance of 
developing an autosomal recessive disorder. This information is considered to be basic genomic 
knowledge (Chen and Goodson, 2007b). When asked about the relevance of genomic 
competencies, 88.6% agreed with the competencies, however less than half did not value the 
practice of the competencies. Only 52.3% believed that incorporating genomic competencies into 
community based education programs is worthwhile (Chen and Goodson, 2007b). Although they 
focused on health educators, parallels could be drawn with nurses and indeed nursing educators. 
For example, if nurse educators agree with the competencies but do not see the relevance in their 
application, the competencies become irrelevant. They need to be accepted and applied if the 
field of nursing is to grow in their knowledge of genomics. Chen and Goodson did point out 
however that health professionals and educators who have an applied role are more likely to have 
more applied knowledge on genomics than perhaps the basic knowledge. However it can be 
argued that one cannot exist without the other and that practice errors are likely to be made 
when basic genomic information is overlooked.
4.2.5 The attitudes towards genetics/genomics by nurses from other 
countries
There is limited literature focusing on nurses' attitudes towards genetics/genomics outside of the 
UK and US, however some examples are discussed below. Nursing students (n=162) in Turkey 
self-reported less genetic knowledge in the areas of recombinant DMA technology, inheritance 
and some knowledge in human chromosome abnormalities, Mendelian inheritance and genetic 
counselling (Vural et al, 2009). Students have a higher level of knowledge of some genetic 
disorders than others. An earlier study from Turkey found that the main reason nurses did not 
play an active role in genetics/genomics is because they felt they lacked the knowledge and more 
than half of nurses (n=270) believed that genetic activities such as family history, referring 
individuals to genetic services and providing test results were not part of their role (Terzioglu and 
Dine, 2004). Terzioglu and Dine state that nurses need to have knowledge about the genetic basis 
of disease and they should be aware that a lack of knowledge about genetics/genomics affects 
the quality of nursing services for individuals, families and communities and that this is relevant
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for nurses in all countries. An example of when lack of this knowledge could affect patient care is 
illustrated in a study by Lee and Tan (2006). Nurses (n=53) working on a neurological ward in 
Singapore were asked about their knowledge regarding Parkinson disease. Only 24.5% of nurses 
knew that genetics/genomics could be a cause of Parkinson disease with 24.5% of participants 
having no idea what could cause Parkinson disease (Lee and Tan, 2006). In a study by Kim (2003) 
in South Korea it was identified that 75.1% of 969 respondents had experience in caring for 
patients with genetic diseases. However, the majority of nurses considered themselves a 'little 
ignorant' about clinical genetics/genomics. When asked what prompted their interest in 
genetics/genomics, 57.6% believed that mass media and the internet were their main sources of 
information. Kim (2003) also studied the impact of demographics on nurses' attitudes and 
knowledge about genetics/genomics (n=969). Those with the highest level of genetic knowledge 
had worked less than five years or more than 20 years, and those nurses in internal medicine and 
obstetrics and gynaecology had more genetic knowledge than those working in special care or 
intensive care units (Kim, 2003). Interesting it appeared from Kim's study that nurses who had 
not long qualified, had a high awareness of genetics/genomics compared to those nurses who had 
worked between five and 20 years. The findings from the study by Kim (2003) need to be 
considered carefully as nursing in Korea will vary to that in the UK, hence attitudes and provision 
may be different.
These studies indicate that nurses lack knowledge on various genetic topics and diseases, with a 
lack of knowledge associated with a lack of confidence in their role to provide genetic healthcare. 
Although varying service needs and provision globally does need to be considered, it is important 
to increase the amount and level of genetic education given to nurses in order for them to be able 
to feel more confident in situations they find themselves practising in and to be able to talk 
confidently to families with genetic conditions. Hopefully, the more knowledge they receive and 
understand regarding genetics/genomics, the more explicit the relevance of genetics/genomics to 
all nursing practice, (regardless of speciality) will become.
4.3 Strategic approach to genetic education
The UK government's white paper report into realising the potential of genetics/genomics in the 
NHS (Department of Health, 2003) stated that it wants the NHS 'to lead the world in taking 
maximum advantage of the safe, effective and ethical application of the new genetic knowledge 
and technologies as soon as they become available'. The government said it would support 
specialist services and would encourage healthcare professionals to incorporate 
genetics/genomics into clinical practice. The government's strategy was: to expand the workforce 
in specialised genetic services, to support new initiatives in genetic based care in primary and
secondary practice, invest in education and training for the NHS workforce and to invest in
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genetic research and development (DOH, 2003). The strategies of specialised groups that have 
been established since the white paper report in 2003 are discussed below.
The Human Genomics Strategy Group (HGSG) has stated its vision clearly (HGSG, 2012). By 2020 
it sees the NHS as being the world leader in the development and use of genetics/genomics in 
healthcare and public health. Genomic information and clinical testing will be used across the 
NHS, which will in turn improve diagnosis and treatment. It sees healthcare providers confidently 
using genomic information within their roles, which is supported by the necessary education and 
training in genetics/genomics (HGSG, 2012). However, to reach this last vision of healthcare 
professionals using genetics/genomics, it has stated that this will only be realised through having 
a healthcare workforce will the skills and knowledge to make effective use of available genomic 
technologies (HGSG, 2012). This would involve specialists in genetics throughout the NHS but also 
at non-specialist level. The National Genetics Education and Development Centre created and 
started to incorporate a strategy to address this issue amongst nurses from 2004-2012.
The aim of the National Genetics Education and Development Centre's (NGEDC) nursing 
programme (2004-2012) was 'for all nurses to engage in genetics/genomics through integrating 
appropriate knowledge, skills and attitudes into their professional practice' (Kirk et al, 2008). Due 
to the size of the NHS nursing workforce and the attitudes held towards genetics/genomics, a 
strategic approach was needed and the Theory of Planned Behaviour (Ajzen, 1991) was selected 
to provide the underpinning theory. This theory aids the understanding of the way individuals 
change their behaviour, including the attitude one has towards the behaviour change, the social 
pressure to be utilising certain behaviour and the perceived ease or difficulty of adopting that 
behaviour change (Ajzen, 1991) (See Chapter 5, pl!2). Using this theory, the centre aimed to 
promote positive attitudes towards genetics/genomics through raising awareness of its 
importance in nursing practice, gaining the support of influential individuals and through the 
development of educational resources (Kirk et al. 2007a).
The vision of the Task and Finish group's report into genetics/genomics in nursing and midwifery 
(2011) is similar to the NGEDC's. It states that every nurse and midwife should recognise and act 
on the importance of genetics/genomics in patient care; that every nurse and midwife should be 
competent in genetics/genomics through educational provision and that every nurse and midwife 
will recognise that genetics/genomics is important and relevant go their practice (Task and Finish 
Report, 2011). They recommend that to achieve this vision the NMC should expand their 
standards to include the integration of genetics/genomics into healthcare, that education 
providers ensure that resources are up to date and relevant and that education providers should 
make use of the genetics/genomics within nursing competence framework. They also recognise
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the need to identify key individuals to drive the incorporation of genetics/genomics into nursing 
and midwifery and that research needs to be conducted into the translation of scientific advances 
into nursing and midwifery practice (Task and Finish Group Report, 2011).
4.3.1 Educational resources
It has been highlighted in a report looking at nursing towards 2015 that 'nurses will need to build 
upon a basic level of genetics/genomics to interpret the literature and communicate this, along 
with complex risk information, to patients' (Longley et al, 2007). Certain resources such as the 
Telling Stories, Understanding Real Life Genetics and the NHS Genetic Education and 
Development Centre websites have an important role to play in helping nurses and midwives gain 
new knowledge. The World Health Organisation's Genomic Resource Centre provides various 
links to resources for health care professionals seeking information on genetics/genomics. There 
is an array of information on further genetic education throughout the world and the site also 
provides links to online training modules (http://www.who.int/genomics/en/). This type of 
resource and information should be taken advantage of, although the literature suggests that if 
genetics/genomics is not a priority for many nurses, the inclination to seek out genetic 
information will simply not be there. Only 38% of midwives (n=46) thought that a basic 
knowledge in genetics/genomics was important (Metcalfe et al, 2007); it is likely that only this 
38% will actively seek genetic knowledge. As 77.8% of post-registered nurses have not attended 
any training in genetics/genomics since qualifying, the inclination to seek new courses has been 
lacking. New innovations aimed at gaining the support of nurses and midwives towards 
genetics/genomics in the future will in my view help to engage them in this important area and 
help move them into a situation where genetics/genomics can be applied at an everyday level. In 
the study by Kirk et al (2008) the 'need to review and make available the best educational 
resources' (p.89) was agreed by 18.4% of delegates (n=77), but the enthusiasm of genetic nurse 
specialists was also seen as an important aspect towards change. It has been identified that a 
useful tool for educational outreach among healthcare professionals is to send a trained educator 
to visit healthcare professionals within their workplace to provide the education. Genetic 
education for nurses also needs to include individual and family value systems, risk perception 
and decision consequences (Halsey Lea et al, 2011). Calzone et al. (2011) developed an online 
repository of genetic education resources for use by various health professionals in America, as 
they identified a need by faculty members to have easy access to a range of resources. Following 
questionnaire feedback, they found that educators were able to successfully locate resources 
needed and the resources being mapped to competencies were useful (Calzone et al. 2011). This 
resource was found to facilitate genetic education (Calzone et al. 2011) and could potentially be 
adapted and used by the NHS National Genetics Education and Development Centre to build upon
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the existing tools. There are now a wide range of curricula resources based on professional 
guidelines in both the UK and US (Williams et al. 2011, Tonkin et al. 2011). Some examples of 
genetic education provisions available are listed below.
Educational provisions
Various organisations and tools for the development and inclusion of genetics/genomics into 
nursing have been presented below. They range from broad genetic resources aimed at various 
healthcare professionals through to specific organisations that focus on particular areas of 
nursing. They have been included to provide an overview of current available resources and 
organisations both in the UK and abroad.
National Genetics Education and Development Centre
The National Genetics Education and Development Centre (NGEDC) was established in 2004 as a 
result of the Government's White Paper. The centre 'drives and co-ordinates genetic education 
for health professionals working outside specialist genetic services' (Farndon and Bennett, 2008). 
The NGEDC was launched to address the future role of genetics/genomics in healthcare and the 
need for a greater awareness among NHS employees, including nurses and midwives. NGEDC 
wants all health professionals to be 'prepared for the advances that will come from an increased 
understanding of the genetic contribution to common disorders and responses to medication' 
(NGEDC, 2008). It works to support this through development of education guidelines, learning 
and teaching resources and 'train the trainer' events (see www.geneticseducation.nhs.uk). The 
main objective in the NGEDC nursing programme was for 'all nurses to engage in 
genetics/genomics through integrating appropriate knowledge, skills and attitudes into their 
professional practice' (Kirk et al, 2007a p.2). The NGEDC has taken a lead role in providing 
genetics/genomics training and engagement within the clinical community (HGSG, 2012). The 
Human Genomics Strategy Group believes that in the future, the NGEDC could provide quality 
assurance for genetic education and training programmes.
Genetic/Genomic Competency Centre for Education (G2C2)
G2C2 is an online repository which holds various multidisciplinary curricula materials and 
resources for nursing and physician educators (Tonkin et at, 2011, Calzone et al. 2011). All 
resources are peer-reviewed prior to being added to the repository and new resources can be 
added by users of the site. All the recourse listed show details such as cost, audience, activity 
type and copyright information to aid the user in selecting resources (Tonkin et al, 2011). The 
resources are mapped dependent on competencies, knowledge areas, learning activities and 
outcome assessments (Calzone etal. 2011).
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Telling Stories, Understanding Real Life Genetics- Website
'This resource is an excellent tool for teaching other topics, thus allowing genetics to be integrated 
across curricula rather than being discussed in isolation' (Tonkin et al. 2011)
The Telling Stories - Understanding Real Life Genetics website (http://www.tellingstories.nhs.uk) 
was developed to provide understanding around the impact that genetics/genomics has on real 
life and its application to healthcare practice (Tonkin et al, 2011). The website provides access to 
over 100 stories of individuals with or at risk of a genetic condition or caring for someone with a 
genetic condition (Kirk et al. 2011c). This allows nursing students to have experience of situations 
that they may not come across during training (Tonkin et al. 2011). Each story allows educators to 
search under a particular genetic competence, inheritance pattern or clinical speciality and is 
linked to the nursing genetic competencies (Tonkin et al, 2011). The resource also provides video 
clips, activity points and links to further resources, all of which can supplement teaching (Kirk et 
al. 2011c). This could prove to be an effective teaching and learning tool, enabling nurses to be 
able to appreciate the importance of genetics/genomics through patient's stories.
British Society of Human Genetics (BSHG) and the Association of Genetic Nurses and Counsellors 
(AGNC)
The BSHG provides a forum for all individuals involved in genetics, both in a clinical aspect and in 
research. The society aims to promote public awareness of genetic/genomic disease, to offer 
informed opinions on specific aspects of genetics which have a public interest and to promote 
study and research into human genetics (www.bshg.org.uk).
The AGNC supports all clinical and non-clinical staff working within clinical genetics. The AGNC 
aims to provide forums for education, prescribe good standards of clinical practice and provide 
channels of communications among professionals. The AGNC is one of five constituent groups of 
the British Society of Human Genetics (BSHG) and has created several working groups to address 
issues that need a UK perspective (www.agnc.org.uk). There is a lot of expertise among the AGNC 
that could be further used to encourage and help more nurses with genetics in their practice and 
to become educators and mentors to such individuals. Their forums on education could be 
adapted and could make a useful tool for educating nurses on genetics.
International Society of Nurses in Genetics (ISONG)
ISONG is a 'global nursing speciality organisation dedicated to fostering the scientific and 
professional growth of nurses in human genetics and genomics worldwide' with a mission to
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'foster the scientific, professional and personal development of members in the management of 
genomic information' (http://www.isong.orR/about/statements.cfm).
ISONG grew from a Genetic Nurses Network, founded in 1984 (Anderson et al, 2000) and it now 
boasts a membership spanning six continents and includes nurse clinicians, nurse educators and 
nurse researchers (Lewis, 2004). 'ISONG is committed to working toward ensuring that the 
nursing workforce is well prepared to serve their patients' and the public's need for genetic 
information' (Lewis, 2004) and it has a growing list of links to educational resources on its 
website. This goal mirrors some of the aims and beliefs of the NHS National Genetics Education 
and Development Centre (NGEDC). It may be that both groups could utilise each other's expertise 
and work together to incorporate genetics into nursing practice efficiently and effectively. The 
underlying ideologies and dissemination strategies of ISONG could help and aid the dissemination 
of genetics education and information in the UK.
UK Oncology Nursing Society Genetics Forum
The UK Oncology Nursing Society has a forum dedicated to genetics which aims to 'enable cancer 
nurses to influence clinical care, practice and the future direction of cancer genetic services at a 
national level' (http://ukons.org/paRes/forums). The forum has been running since 2009 and 
involves national meetings as well as online tools and networking
(http://ukons.orR/paRes/forums. The forum allows oncology nurses who are interested in 
genetics to support each other and gain knowledge from others.
Association for Inherited Cardiac Conditions (AICC)
The Association for Inherited Cardiac Conditions (AICC) is an example of an organisation that is 
available for a specific clinical speciality. The association is made up of experts from cardiology 
and genetics and is open to all professionals allied with medicine
(http://www.improvement.nhs.uk/aicc/). The association aim to provide quality education and 
training as well as advice on management and best practice. The association also provides a 
forum for data collection and collaborative research (http://www.improvement.nhs.uk/aicc/).
Conclusion
Education is the key player for the incorporation of genetics into nursing practice, with current 
education being limited and varied; there is a lot that still needs to be achieved. However it has 
been highlighted that the greatest barrier to nurses for incorporating genetics into practice is the 
lack of perceived genetic/genomic relevance to their practice (Kirk et al, 2008). Attitudes first 
need to be altered before a true incorporation of genetics in nursing will be witnessed. Nurses'
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attitudes towards genetic/genomic education could be one of the important variables for nurses 
being successfully educated in genetics and genomics. The role of educators is important in 
improving genetic knowledge and practice among nurses. External bodies, such as the NGEDC, 
Telling Stories and ISONG also have a responsibility and are vital in promoting awareness and 
growth of genetics within nursing practice. Kirk eta/. (2011a) believe that strong leadership along 
with an international community of practice and the engagement of nursing professionals within 
government and regulatory bodies are important if nurses are to become engaged in genomic 
healthcare. Individual nurses also have a responsibility to ensure that they are keeping up to date 
with new knowledge. It may that certain individual characteristics of nurses make them more or 
less likely to seek and include new knowledge in their practice. It is possible that individuals with 
particular characteristics could be the driving force in encouraging other nurses to utilise genetics 
within their practice. Hence, the next chapter will focus on the underlying theories that will 
enable an identification of the character predictions and enable behaviour change. The 
identification and use of nurses who are utilising genetics/genomics and those who have the 
ability to influence the behaviour of others, especially concerning the incorporation of new 
initiatives will also be discussed.
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Chapter 5: Supporting theories
Introduction
Chapter four highlighted the lack of genetic/genomic education available for pre-registration and 
post-registration nurses and the need for an attitude change towards genetics and genomics. In 
Chapter 5 the main theoretical underpinnings of the present body of research will be discussed 
and justification. The theories (Fig 5.1) will be related to the concept of explaining why some 
nurses become adopters of genetics or opinion leaders compared to others and to highlight their 
potential influence on others.
The Diffusion of Innovation theory has been presented including the origins of the theory, stages 
of diffusion, how the theory can be related to healthcare and also the characteristics of those who 
disseminate information. Following this, opinion leadership is discussed in relation to the 
Diffusion of Innovation theory along with the characteristics of an opinion leader. The stages 
involved in behaviour change and understanding how these can be influence is approached 
through the Stages of Change Theory. The Theory of Planned Behaviour is discussed, with an 
overview of the theory, its relation to healthcare and limitations of the theory. Openness to 
Experience is the last theory to be discussed. This section includes an overview and sets out how 
it can be related to the characteristics of an adopter and opinion leader.





5.1 Diffusion of Innovation
"Getting a new idea adopted, even when it has obvious advantages, is difficult." Rogers, 2003, P.I
5.1.1 Diffusion of Innovations - The Theory
Origins of the Theory
The Diffusion of Innovation theory by Rogers (1962) sets out the process by which new ideas and 
initiatives are implemented into a society or organisation. The theory includes stages from the 
understanding of the innovation to the implementation of the innovation (Rogers, 2002). The 
concept was first described in 1943 by two rural sociologists, Ryan and Gross, who noted that 
despite the advantages of using hybrid seed, US farmers took an average of seven years to move 
from planting their first hybrid seed to planting 100% hybrid seed (Rogers, 2004). Their findings 
became the basis on which Rogers' Diffusion of Innovation theory was produced.
Diffusion is a type of social change. When new ideas are diffused, implemented or rejected social 
change occurs (Rogers, 2003). Although the theory began in agriculture it is now applied to 
various research interests throughout the academic world and is becoming more widely used in 
business initiatives in many organisations.
Understanding the Theory
Diffusion is defined as "the process in which an innovation is communicated through certain 
channels over time among the members of a social system" (Rogers, 2004 p.13). Rogers defines 
an innovation as "an idea, practice, or object that is perceived as new by an individual or other 
unit of adoption" (Rogers 2002 P.989). This in effect can be applied to any new idea and its 
implementation. The theory states that there are three stages of diffusion:
  the innovation is adopted
  the innovation is implemented by putting it into practice
  the innovation becomes institutionalised by its full incorporation into practice
(Dusenbury and Hansen, 2004 and Oldenburg et al, 1999).
Each innovation has form, function and meaning (Rogers, 2003). 'Form' is the directly observable 
physical features and substance of an innovation (e.g. more routine family history taking); 
'function' is the way an innovation impacts upon members' way of life within a social system (e.g. 
requests for continual professional development) and 'meaning' is the unconscious perception of 




In order for the three stages of diffusion (p70) to occur the diffusion of the idea goes through five 
stages (Fig 5.2) (Rogers, 2003).








Exceptionally, the sequence of stages of diffusion of an innovation can vary. For example, if an 
authority figure ordered the adoption of an innovation, the decision stage would come prior to 
the persuasion stage.
Through each of the diffusion stages (seen in Fig 5.2), the innovation gets communicated through 
various channels over a certain time period to members of a particular social system (Rogers, 
2002), this can be seen in the diffusion of innovation model (Fig 5.3). Figure 5.3 shows the various 
stages of diffusion that an innovation works through, including various influences upon the 
diffusion process and the consequences of adoption and non adoption. Table 5.1 takes each 
component in Figure 5.3 and applies it to the adoption of genetics/genomics in nursing practice. 
Each component of the figure will apply differently depending on the type of innovation being 













































Table 5.1. Components of the Diffusion of Innovations theory as applied to the incorporation of 


































Examples of how this is relevant to the adoption of genetics/genomics
Some nurses will have personality characteristics that allow them to be open to new 
ideas and have the enthusiasm to implement them. E.g. Certain nurses will have 
characteristics of an individual who is incorporating genetics/genomics.
Nurses may be hindered in adopting genetics/genomics into practice by those around 
them. E.g. The environment they work in may encourage or discourage openness to 
new ideas and inputs. A nurse's genetic/genomic education background will also play a 
role.
Genetics/genomics may or may not be seen by nurses as an essential and relevant 
need for nursing practice. E.g. Some nurses will have an awareness of how and why 
genetics/genomics does/should apply to practice.
*
Social pressure may affect whether a nurse adopts genetics/genomics into practice and 
may determine how easy it is to talk about genetics/genomics within the work social 
setting.
Some genetic/genomic nursing activities can go against nursing social norms E.g. A 
nurse who decides to take a family history as routine compared to the majority who 
think this is not routine practice.
A good communication approach towards nurses is important to convey the 
importance and relevance of genetics/genomics and genomics. Information needs to 
be disseminated, understood and exchanged. E.g. Sharing case studies and best 
practice.
If nurses are aware and accept the advantages that genetics/genomics can bring to 
their practice, then this will help the incorporation of genetics/genomics into nursing 
practice. E.g. The time taken to take a family history will benefit the family, although 
might reduce time available for other nursing tasks.
Genetics/genomics needs to be shown to be compatible with the nursing role and be 
an important aspect to their practice. E.g. Nurses supporting a family/individual with a 
condition, helping them to understand the condition and finding out accurate 
information.
Genomics can be complicated and nurses with a limited education background in 
science may be intimidated by this E.g. If a nurse does not feel knowledgeable in 
science, he/she may immediately reject genetics/genomics.
Nurses could incorporate genetics/genomics and explore its role in practice without 
feeling under pressure to use it straight away in practice. E.g. Asking about patient 
family history during a nursing assessment alongside a competent colleague, before 
building additional skills pedigree drawing.
This is difficult in genetics/genomics because outcomes can take many years. Often 





If nurses use genetics/genomics in practice and can see short term benefits and the 
long term outcomes then it may become something they will continue to use and 
develop. E.g. It becomes a normal part of everyday practice.
Discontinuance Genetics/genomics could be seen by some nurses and managers as a 'phase'. Another 
healthcare initiative could overtake genetics/genomics or nurses could incorporate 
genetics/genomics for a while and then drop it. ____
3.2 Rejection
Later adoption Some nurses may need longer to think about the benefits and advantages of 
genetics/genomics. This could also be affected by seeing successful genetic/genomic 
implementation by colleagues. E.g. Where a family history question has led to a referral 
and onto a diagnosis.________________________ _______
Continued 
rejection
Nurses may not adopt genetics/genomics regardless of the input by peers, colleagues 
and outside enthusiasts; this could be for several reasons. E.g. A nurse may understand 
the benefits of genetics/genomics but it is not a high priority for them, perhaps due to 
time pressure, workload and increasing role demands.___________________
5.1.2 Characteristics of Innovators
Innovators are individuals within a society who are the first to adopt an innovation, they are 
followed by early adopters and then the early majority, late majority and the laggards adopt an 
innovation last (Rogers, 2003). The innovators of a society are much fewer in number, whereas 
the most common groups are the early and late majority, with the laggards being the second 
largest grouping. Characteristics of innovators have been identified and are based on their 
perceived rate of adoption (Rogers, 2003). The rate of adoption (time vs. frequency) of an 
innovation normally follows a bell-shaped curve (Fig 5.4).
Fig 5.4. Rogers' Bell Curve of the Characteristics of Innovators taken from Rogers E M (1962)
Innovates
Time of Adoption
mean-2SD mean-ISO mean mean+lSD
Note. The chart shows that early and late majority adopters fall within 1 standard deviation (SD) of the 
mean time taken to adopt an innovation on either side, accounting for 34% of the population. Early 
adopters fall within 2 SD's of the mean (accounting for 13.5%) while innovators are greater than 2 SD's 
below (2.5%) and laggards are greater than 1 SD above (16%).
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The five adopter categories are exhaustive and mutually exclusive, however they do not include 
non adopters (full description of adopter categories can be found in appendix 2). The 
characteristics created by Rogers (Fig 5.4), make it easier to identify adopters of innovations and 
those individuals who can influence others to adopt within society, therefore allowing specific 
individuals to be targeted with an innovation in order to engage others in society who are less 
eager to change. Earlier adopters tend to have different characteristics compared to later 
adopters (Table 5.2). Different communication channels are often used within the different 
adopter categories, this is known as 'audience segmentation' (Rogers, 2003).
Table 5.2: Characteristics of earlier adopters compared to late adopters (Rogers 2003).
Earlier adopters
Socioeconomic characteristics
More years of formal education
More literate
Greater degree of upward social mobility
Later adopters
Socioeconomic characteristics
Fewer years in education
Less literate
Less likely to move up the 'social ladder*





Greater ability to deal with abstractions
More intelligent
Favourable attitude towards change
Favourable attitude towards science







Greater exposure to mass media
Greater exposure to interpersonal channels
Seek information about innovations
Have greater knowledge of innovations
Higher degree of opinion leadership
Personality variables
Less likely to 'put themselves in others shoes'
Likely to have a strong set of beliefs
Less able to rationalise
Observe innovation in the here and now
Lower intelligence level
Are not so positive about change
Less inclined towards science
Less likely to cope with uncertainty and risk
Perceive to have less control over their future
Don't aspire so highly
Communication behaviour
Less social participation
Less connected to others
Interpersonal networks likely within their system
Not so exposed to mass media
Fewer interpersonal channels
Less likely to seek information about innovations
Less knowledge of innovations
Less likely to be an opinion leader
5.1.3 Diffusion of Innovations related to healthcare
Applications of Diffusion of Innovations related to Healthcare
Rogers' theory of Diffusion of Innovations has been selected to help provide insight into how 
genetics/genomics can be diffused throughout the healthcare system. It has been applied to 
various clinical behaviours and the adoption of new procedures, information and drugs (Sanson-
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Fisher, 2004). Sanson-Fisher's examples of clinical adoption include prostate cancer tests, 
mammography screening, surgical techniques and clinical audits. There have been few studies in 
the past that have focused on the Diffusion of Innovations model within nursing.
One example of the Diffusion of Innovations being used in nursing practice is the adoption of the 
'Productive Ward' a UK initiative that encourages nurses to implement change at ward level 
(Robert et al. 2011). The paper identifies the important interactions that aided the rapid diffusion 
of the productive ward (PW) programme. The authors identified four key interactions that were 
essential to the adoption, implementation and assimilation of the programme:
  The ability to frame the message to various different audiences within the NHS,
  The relationship between the change agency and an adopting NHS hospital,
  Encouragement from professional organisations and organisational champions,
  The structural and cultural features of the hospital (Robert etal. 2011).
Similarly these four factors will be important to consider when implementing genetics/genomics 
into nursing practice within the NHS.
Diffusion of Innovations and education within healthcare
Jippes et al (2010) studied the dissemination of educational innovations for medical specialities 
via training or social networks. They found that the teach-the-teacher training had no effect on 
disseminating educational innovations, although this could have been due to the post training 
feedback technique being too complex. However social networks had a strong association with 
adoption. The links the participants had with their social network seemed more important than 
training and education. The researchers found that weak ties within networks were necessary for 
capturing innovations from outside the network and enabled early access to knowledge and 
resources. Strong ties within the social network allow for the implementation of the innovation 
(Jippes et al, 2010). The use of social networking needs to be considered for the incorporation of 
genetics into nursing practice. As shown by Jippes et al. (2010) it might be that social networks 
are more useful in the process of nursing adopting genetics/genomics than the use of formal 
educational strategies.
A study was conducted into applying new teaching methods in the nursing curriculum using the 
Diffusion of Innovations theory. The use of simulation as a teaching tool has its advantages, but 
many nursing programs (n=2 sites) and staff were against change and the implementation of such 
a technique (Starkweather and Kardong-Edgren, 2008). It was highlighted that the main barrier 
for the diffusion of the technique was the faculty and whether they adopted the idea 
(Starkweather and Kardong-Edgren, 2008).
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Barriers to Diffusion of Innovations related to Healthcare
In their study on uptake of guidelines for management of low back pain, Harting et al (2009) 
highlight the main barriers to each of the diffusion steps, along with strategies to overcome each 
barrier (Table 5.3). Applying this to genetics/genomics and nursing may be useful in promoting 
the uptake of genetics/genomics.







  Not familiar with 
  No interest
  No knowledge or understanding 
  Not aware of own performance
  Negative attitude 
  Not ready to change
  Not starting the implementation 
  Not continuing the 
implementation
Strategies
  Publications in physical therapy journals 
  Permanent topic at professional conferences 
  Thematic meetings {work groups)
  Guideline examination form (individual) 
  Thematic meetings (work groups)
  Discussing guideline (work groups) 
  Discussing guideline (collaboration with general 
practitioners)
  Guideline examination form (individual) 
  Discussion guideline (work groups) 
  Competency manuals (individual)
Factors influencing the uptake of innovations in Healthcare
Rogers (2003) believes that there are particular characteristics that influence how quickly an 
innovation is adopted, below are the five more important qualities of an innovation influencing 
rate of adoption:
a. Relative advantage. Is the degree to which an innovation is seen as better than the one 
that came before it. Different personality characteristics of adopters will mean different 
people see different aspects of the innovation as important. The perceived relative 
advantage of an innovation by individuals is proportional to the rate of adoption (Rogers, 
2003). Interestingly those individuals who would most benefit from an innovation are 
often the last to adopt it (Rogers, 2003). Nurses need to be able to be aware of the 
advantages that genetics/genomics may bring to their practice.
b. Compatibility. Is the degree to which an innovation is perceived as being consistent with 
existing values, past experiences and needs of the adopter. Old ideas are the basis for 
judging the compatibility of the new idea and giving them meaning. Individuals can only 
judge compatibility of an innovation when it is based on familiarity, this could occur in 
stages, with a more familiar version of the innovation introduced first followed by a less 
compatible version. When a healthcare system is making a decision about an innovation, 
it is important that information released is not conflicting. Conflicting recommendations 
were made by the National Institutes of Health and the American Cancer Society about
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the appropriate age for mammography screening; as a result the diffusion of a positive 
innovation was stalled (Cain and Mittman, 2002).
c. Complexity. Is the degree to which an innovation is perceived as relatively difficult to 
understand and use. The complexity of an innovation is negatively correlated to the rate 
of adoption (Rogers, 2003). Genetics/genomics needs to be made less daunting for 
nurses looking to utilise it within their practice.
d. Trialability. Is the degree to which an innovation may be experimented with on a limited 
basis. Trialability is positively correlated to the rate of adoption (Rogers, 2003). An 
example of 'Trialability' within healthcare includes the use of drug samples from 
pharmaceutical companies.
e. Observability. Is the degree to which the results of the innovation are visible to others. 
Observability is positively correlated to the rate of adoption (Rogers, 2003). If healthcare 
professionals cannot see the efficacy and acceptance of an innovation, then they will be 
putting their own professional reputations at stake by adopting the innovation (Lovejoy et 
al, 2009).
The greater the relative advantage, compatibility, trialability, observability and the lower the 
complexity the quicker the innovation is adopted (Fig 5.5).










Individuals looking to adopt an innovation initially have to have knowledge of the innovation, 
form an attitude about it, decide to adopt or reject it, implement the idea if they have adopted it 
and then verify the decision to adopt (Rogers, 2002). According to Dearing (2009) diffusion occurs 
through a combination of 1) individuals wanting to reduce uncertainty when faced with new 
information, 2) individuals responding to their perceptions of the credibility of what others are 
thinking and doing and 3) individuals feeling under social pressure to do as others are doing. It is 
also important to enable individuals to grasp why an innovation works, not just what it is about. 
Guided adaptation allows the individuals involved in the implementation of the innovation to 
understand the underlying components of the innovation as well as examples of how these 
components will work in practice (Dearing, 2009).
5.1.4 Diffusion of Innovations within organisations
Innovations spread among organisations and companies in a similar way that an innovation 
spreads among individuals in a social system (Rogers, 2003). An organisation has a more 
structured and complex leadership pattern, with much of the decision making occurring within 
the minority of the organisation (Lundblad, 2003). The larger organisations tend to be more 
innovative than smaller organisations (Rogers, 2003). The extent to which an organisation abides 
by rules will determine the inhibition of "innovativeness". The closer an organisation is with the 
social system the more innovative it will be (Lundblad, 2003). The structure of an organisation 
can facilitate or impede the Diffusion of Innovations and is related to the innovativeness of 
organisations (Rogers, 2003). The following five elements (a-e) of organisations can impact the 
spread of innovations (Rogers, 2003).
a. Centralisation - the degree to which power and control of an organisation are in the
hands of a relatively few individuals. This is often negatively associated with
innovativeness. 
b. Complexity - the degree to which members of an organisation possess a relatively high
level of knowledge and expertise, 
c. Formalization - is the degree to which an organisation follows rules and procedures in
terms of the role of it members, 
d. Interconnectedness - the degree to which the units in an organisation are linked by
interpersonal networks. This is positively related to organisational innovativeness. 
e. Organisational slack - degree to which uncommitted resources are available to an
organisation. This is positively related to organisations innovativeness.
The set up of the NHS organisation, in terms of the above five elements (internal organisation 
characteristics), could affect the way that innovations are implemented, in terms of speed of
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diffusion and overall uptake. These elements need to be considered when implementing genetics 
into the NHS nursing workforce. Figure 5.6 shows how innovativeness is related to individual 
characteristics, internal organisational characteristics and external organisation characteristics 
(Rogers, 2003).
Fig 5.6. Rogers' independent variables related to organisational innovativeness (Rogers, 2003, p 
411)
Independent variables Dependent variable 
Individual (leader) characteristics
Attitude toward change (+*)
Internal characteristics of organisational structure   ...
Organisational




5. Organisational slack (+)
6. Size (+)
External characteristics of the organisation
System openness (+)
*+ relates to an increase of that variable and - relates to a decrease of the variable
Leaders are an important asset to organisations; if a leader regards change as positive then the 
organisation as a whole will be more innovative (Rogers, 1995). If within an organisation there is 
an 'innovation champion' (similar to an opinion leader in a community) involved, the 
implementation of the innovation is likely to be more successful (Rogers, 1995). An innovation 
champion is often a charismatic individual who can enable an innovation to be implemented 
successfully into an organisation, helping the organisation to overcome any resistance towards 
the innovation (Rogers, 2003). Their role is to guide the organisation through the approval and 
implementation stage of an innovation after the initial implementation process. Rogers (2003) 
states that there are five main stages in the innovation process within organisations (Fig 5.7) (see 
appendix 2 for more detailed explanation). Characteristics of the overall team may have an effect 
on the successful adoption of an innovation (Holleman et al, 2009). Nurses often work in teams 
and teams tend to be part of a larger organisation. Individual members of the team contribute
skills, knowledge and abilities, therefore it will be important to identify individual characteristics
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within a team of nurses so that different individuals have different roles to play, which may 
enhance the uptake of genetics.
According to O'Neill et al (1998) there are three main factors that influence the pattern of 
diffusion within organisations: environment, characteristics of organisation and characteristics of 
the innovation. Environmental influences include certainty, if an organisation is in certain times, 
they are confident that they can produce a return on the innovation. The level of certainty will 
affect the continuing activities within the organisation as well as the evaluation of new 
innovations presented to them (O'Neill et al, 1998). Those organisations that have been 
successful for a long time, however, are unlikely to adopt new innovations, having confidence that 
things do not need to change. Managers who are successful and work in a successful organisation 
underestimate risks and overestimate the returns from innovations so are likely to adopt 
innovations regularly (O'Neill et al, 1998). O'Neill et al (1998) do appear to contradict themselves 
on these points. If an organisation has been successful for many years, but does not adopt new 
innovations willingly, then you would expect their successful managers to do the same, however 
they state that successful managers within successful organisations will tend to adopt new 
innovations. Finally the innovation itself affects the way the innovation is diffused among 
organisations. Those innovations that are highly visible will be diffused at a quicker rate, due to 
an organisations competitive nature and public placing, this is also similar for the ease of 
transferring the innovation (O'Neill et al, 1998). The rate of diffusion among organisations has 


































































































































































































































































































































The concept of 'small-world' models (models of networks, often referred to as six degrees of 
separation) was developed by Watts and Strogatz (1998). They built this concept on previous 
research completed by Granovetter (1973). A social network or 'small world' has 2 elements: 
cliquish sub-networks (individuals who interact extensively with one another) and bridges 
(connect diverse members from different networks) (Choi et al, 2010). Although most 
innovations reach a critical mass, there are variables which affect how quickly an innovation 
reaches capacity and whether it ever reaches this stage. Some innovations are diffused 
immediately and others take a long time to be implemented (Choi et al, 2010). Choi et al 
(2010) have identified certain organisation network structures that affect completion diffusion 
rates (Fig 5.8). A new product or innovation is less likely to reach diffusion in random networks 
(series of cliquish sub-networks) rather than regular networks (no cliquish networks).






Choi et al (2010) in their computational model found that random associations make it harder 
for an innovation to be spread among a network and often slow down the diffusion of the 
innovation at the beginning. However once the innovation has reached the critical mass, 
diffusion is quicker by these random connections, therefore 'random links facilitate rapid 
diffusion' (Choi et al, 2010). There are benefits in having regular (cliquish) networks. They 
enable an early build up of adopters of the innovation and the larger the number of initial 
adopters the quicker the innovation is diffused (Choi et al, 2010) which one assumes is due to 
the increased number of connections. It needs to be acknowledged however that due to the 
study by Choi etal being based on computer modelling it can only loosely be applied to society
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directly and needs to be interpreted with caution. The study was also aimed at product 
marketing which is a different society with different objectives. However I believe that 
similarities in these small-world networks may aid the incorporation of healthcare diffusions 
among NHS networks. The way nurses and other staff members interact may be linked, either 
via a regular or random network. A regular network among nurses may allow genetics to be 
diffused into practice more consistently, with the use of adopters within the network. A 
random network among nurses may mean that genetics is not fully implemented throughout 
all nursing staff smoothly, but is adopted in a more erratic fashion.
5.1.5 Consequences of Innovations
Consequences of an innovation relate to the changes that occur to an individual or social 
system due to adoption or rejection of an innovation. It could be argued that each one of the 
consequences in figure 5.9 could be either short term or long term depending on the specific 
situation or environment. For example, a short term consequence of nurses adopting 
genetics/genomics into their practice could be an increased demand on resources but longer 
term this could be offset by an increase in appropriate referrals to genetic services and the 
development of trained practitioners. The consequences of an innovation, especially long 
term can be hard to predict, which often adds to uncertainty when deciding to adopt an 
innovation. The consequences associated with the inclusion of an innovation into a social 
system (Rogers, 2003) are illustrated in Figure 5.9.
5.1.6 Analysis of the Diffusion of Innovations model
'We know too much about innovation successes and not enough about innovation failures. The 
later might be more valuable in an intellectual sense' (Rogers, 2003, pill).
It was assumed in early studies that adoption of an innovation should be more widely studied 
than non adoption or rejection (Greenhalgh et al, 2004). However it is likely that as much can 
be learnt from non adoption than from adoption. Non adoption or rejection could provide 
more information about the innovation, regarding perceptions of the innovation, informing 
alternative ways of diffusion and whether the innovation needs to be improved. However, 
often the individual innovator and the individual adopter are the main source of analysis; 
therefore rejection of an innovation on a larger group scale is not always easily applied. 
However, the Diffusion of Innovations model can be viewed as being beneficial in the 
incorporation of innovations that have subsequently failed 'because even if the innovation is 
rejected at the decision stage, it has at least been considered in a structured, logical way by 
those involved' (Pearceyand Draper, 1996 p.721).
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Dependent on whether the innovation has had a positive or negative effect on an organisation. An 
innovation can affect individuals whether they choose to adopt an innovation or not. An adopter 
may benefit immensely from adopting an innovation leaving a wider socioeconomic gap between 
them and non-adopters, which would be seen as an undesirable consequence for those non-adopters 
but as a desirable consequence for the adopter.
Indirect
An innovation can have an immediate effect on an individual or organisation or it can have an effect 
through a second party.
Vs Unanticipated
This is dependent on whether the changes brought by an innovation were intended or not. The 
more technically advanced an innovation, the increased number of consequences it is likely to create, 
both anticipated and unanticipated.
One of the shortcomings of the Diffusion of Innovations theory is the implication that an 
innovation should be adopted by all members of the social system and that it should not be re- 
invented or rejected. This is known as 'Pro-Innovation Bias' (Rogers, 2003). Rogers (2003) 
believes that there is less evidence to investigate non-adoption of an innovation than adoption 
of an innovation. Therefore the negative aspect of the diffusion process is often not 
researched. I disagree with this to an extent. There will be evidence when an innovation has 
not been adopted and there will most likely be reasons why. However, defining the reasons 
why an innovation failed may not always be possible. Diffusion of an innovation often takes 
place over varying time periods (see Fig 5.5, p85), whereas many diffusion studies only analyse 
a 'snap-shot' of time. Rogers (2003), recommends that an innovation is studied as a 'moving- 
picture of behaviour', that way information can be gained by observing an innovation as it 
spreads among a social system. It will be important when studying genetics/genomics within 
nursing practice, that the innovation is observed throughout all stages of the diffusion and not 
just the initial adoption stage.
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One major drawback is that the Diffusion of Innovations theory was identified over 60 years 
ago when there was no internet and business and commerce were very different as were 
people's attitudes and beliefs (Rogers, 2003). However, the theory is based on underlying 
human principles which rarely change dramatically over time. Diffusion of Innovations 
research into new areas and aspects of the diffusion theory is always ongoing, allowing the 
theory to become relevant for the 21st century.
Innovations should be introduced into a system at a rate that allows the organisation to adapt 
to the changes. It is important to create the right equilibrium between the social system and 
changes the innovation brings, there are three types of equilibrium (Rogers, 2003):
f. Stable equilibrium - there is almost no change in the structure or function of a social
system 
g. Dynamic equilibrium - rate of change within a social system occurs at a pace that
allows the system to adapt to the innovation changes 
h. Disequilibrium   the social system cannot adjust to the changes because they are
implemented too rapidly
A social system whose structure is already unequal is likely to become more unequal when an 
innovation is implemented, therefore a systems' social structure can partly determine the 
equality versus inequality of an innovations consequences (Rogers, 2003). When considering 
the idea of implementing genetics/genomics into nursing practice, it will be important to make 
sure that differences among members of the social system do not become too diverse.
Justification for the use of Diffusion of Innovation theory
The study presented in this thesis follows on from work by Lei-Shih Chen et al (2008) in the 
United States which focused on health educators' likelihood of adopting genetic competencies 
into health promotion. They used the Diffusion of Innovation theory in their research to help 
explain behaviour change. This included areas such as communication channels, 
genetic/genomic knowledge and awareness of the innovation. Jenkins and Calzone (2007) 
used the Diffusion of Innovation theory as the basis for the nursing programme developed for 
the National Human Genome Research Institute (NHGRI) in the US. They believed that the 
Diffusion of Innovation theory provides a building block for healthcare providers to translate 
their expertise in genetics/genomics into practice, with the help of a multi-pronged strategic 
plan by the institute (Jenkins and Calzone, 2007). This study also draws upon the Diffusion of 
Innovation theory. The Diffusion of Innovation theory allows a deep understanding of the way 
in which society adopts change and adapts to new ideas. Through understanding the 
characteristics that define the speed of adoption of an innovation, a greater level of control
Page | 93
and influence can be placed upon the integration of the innovation into a social system. 
Despite some of the limitations that are associated with the DOI, it remains one of the most 
widely studied diffusion theories. In the current study the DOI will aid the identification of 
nurse adopters of genetics and nurse opinion leaders and may indicate the pace of change (Fig 
5.5, p85). In doing so, it may also help to formulate recommendation for the future diffusion 
of genetics into nursing practice.
5.2 Opinion Leader Theory
5.2.1 Opinion Leaders- An Overview
Outline of Opinion Leader Theory
Opinion leaders are defined as "men (individuals) who exert an unequal amount of influence 
on the decisions of others" (Rogers and Cartano, 1962 P.436) and are often sought by other 
individuals through "consensual validation" to strengthen their opinions (Rogers and Cartano, 
1962). Opinion leaders can be used to incorporate change initiatives, follow training and 
education on innovations and help colleagues to overcome resistance to new innovations 
(Jippes et al, 2010). Although Rogers and Cartano had an influence on early studies into 
opinion leaders, the term was initially developed during the 1940 US presidential election by 
Lazarsfeld and colleagues. Opinion leaders are often used to promote behaviour change and 
often adopt an idea before the majority does (Valente and Pumpuang, 2007). The judgements 
of opinion leaders are often sought when response to an innovation is uncertain and when a 
potential adopter thinks the innovation is interesting and has potential benefits (Dearing, 
2009). An opinion leader is a social model through their interpersonal networks, allowing 
others to imitate their behaviour. According to Rogers (2003) an opinion leader can lose 
his/her respect if they deviate too far away from social norms (Russell-Babin, 2010). Rogers 
(2003, p27) believes that 'opinion leadership is earned and maintained by the individual's 
technical competence, social accessibility and conformity to the system's norms'. When a 
system has more traditional social norms, opinion leaders tend to be a separate group to the 
innovators. Russell-Babin (2010) believes that opinion leaders are most likely to be found not 
made. The use of opinion leaders as a method of diffusion has (Carlson, 2009) and could 
continue to be utilised with nurses. If opinion leaders are individuals capable of influencing 
others, it could be a useful way of promoting the importance of genetics/genomics to nurses.
Identifying Opinion Leaders
The identification of opinion leaders among nurses and midwives can be measured in four 
ways and are summarised in table 5.5. All can be used to identify opinion leaders from a social 
system and utilised to influence others' beliefs and adoption of ideas. Although for the first
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three approaches to be effective, respondents need to be approached to provide accurate 
information about potential opinion leaders (Feder and Savastano, 2006). Therefore for the 
purpose of this study the 'Sociometric Approach' and the 'Self-Designating Approach' could be 
the best methods for locating opinion leaders among a large number of people, within a 
quicker time period and allows for those individuals who are keen to encourage others in their 
work place environment to identify themselves.










Approach (Rogers and 
Cartano, 1962)
Method of identification
A group is asked to disclose 
whose opinion is most valued
Knowledgeable selected few 
are asked to identify opinion 
leaders
Researchers observe a social 
system and identify opinion 
leaders
Individuals identify the extent 
to which they believe 
themselves to be opinion 
leaders
Applying methods to the current 
research
  Popular and respected individuals 
identified 
  Quick method of narrowing down 
prospective opinion leaders 
  Have to approach a large number of 
people for a small number of 
opinion leaders
  Minority perspective only 
  Doesn't take into account 
anomalies and could be bias
  High validity 
  Works best with small social 
systems 
  Can be intrusive 
  Open to behaviour change by 
participants
  Locate opinion leaders among a big 
group of people 
  Quick method of identification 
  Best used on a random sample
Characteristics of an opinion leader
Opinion leaders often have 'status, expertise, links to external sources of knowledge or 
experience that enable them to provide information and advice about innovations to others 
within their community' (Feder and Savastano, 2006 P.1288). Nurse opinion leaders may not 
have all of the above characteristics, but when looking for opinion leaders among these groups 
it is important to reflect on typical characteristics of opinion leaders. However Locock et al, 
2001 believe that the definition of opinion leader is over-simplified and that opinion leaders 
can be placed at different points along a number of axes (Fig 5.10). Opinion leaders therefore 
cannot be stereotyped (Carpenter and Sherbino, 2010). This will be important when 
identifying nursing staff as opinion leaders. There are different types of opinion leaders within 
a social system. Some individuals act as opinion leaders for a wide variety of issues and topics,
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this is known as 'Polymorphic Opinion Leadership'. Others act as opinion leaders for single 
issues and topics only, known as 'Monomorphic Opinion Leadership' (Rogers, 2003).
Fig 5.10. An adaptation of 'The range of characteristics of an Opinion leader* taken from 
Locock et al (2001)







Leading by instruction (senior) -^ —————————— 
Conformist .4 ————————————————————
Nurse junior -4 ————————————————————







————————————— ̂  Leading by example 
—————————————————————— ̂ . Deviant
————————— >• Executive/managerial nurse
5.2.2 Opinion Leaders and their role in the Diffusion of Innovations theory
Relationship between opinion leaders and Diffusion of Innovations
If there is a positive correlation between the use of opinion leaders and the diffusion of an 
innovation then this correlation needs to be considered when identifying the predictors that 
make it most likely for nurses to adopt genetics/genomics into healthcare. If the predictors 
are also characteristics of opinion leaders, then these individuals can be utilised to help 
address the issue of genetics/genomics in healthcare. The role models in a community can 
help bring about rapid and sustained behaviour change; they can incorporate an innovation 
effectively (Valente and Davis, 1999). Opinion leaders are sought for advice more often than 
non-opinion leaders. This impact on diffusion has been named the 'contagious-disease model' 
because of the opinion leader's frequent interaction with others (Coleman et al, 1966). 
Diffusion of an innovation will not occur if opinion leaders are not approached by other 
individuals and if they do not actively approach others. The implementation of 
genetics/genomics into healthcare may be aided if the opinion leaders can be approached for 
advice by nurses they encounter.
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Status of opinion leaders
Whilst individuals with a higher status can have a greater influence than those of lower status 
due to their position (Feder and Savastano, 2006), when considering genetics/genomics on an 
everyday ward/practice level, I believe that peers could be just as effective. Peers work 
together, can provide assistance to one another and can share their experience of genetics in 
practice. DeCherney (1999) sums up the importance of interpersonal communication to drive 
diffusion by highlighting the need for one-on-one interactions not mass media campaigns (e.g. 
professional bodies taking a position on an innovation), which he describes as 'illusion at best 
and provoke[ing] cynicism at worst' (DeCherney, 1999). Whilst this is all very well, getting to 
the point of one-on-one interactions for all NHS nurses could prove problematic due to the 
sheer size of the NHS workforce. However opinion leaders and adopters could be engaged to 
help with this task, even on a small scale. Mass campaigns do have a function and can be very 
helpful. For example a 'Genetics in Nursing day* could, in the future play an important role in 
engaging staff in genetics/genomics.
5.2.3 Opinion Leadership within the Clinical Setting
There have been many studies that have focused on identifying opinion leaders within 
healthcare to promote behaviour change. Identifying the predictors of those most likely to 
adopt genetics/genomics into practice, may provide a tool by which opinion leaders may be 
sought. It may be discovered that those most likely to incorporate genetics/genomics are not 
opinion leaders, but they are almost certainly likely to be 'innovators' or 'early adopters'.
A study looking into the factors that influenced nurses' uptake of a postoperative pain 
assessment, found that those nurses (n=473) who had more innovative characteristics were 
more likely to adopt the innovation (Carlson, 2009). These nurses tended to be older (mean 
age was 40), had more nursing experience (average experience was 13 years), read nursing 
journals regularly, were certified in a specialist area and had a higher level of nursing 
education (Carlson, 2009). Opinion leaders tend to be innovators but years of expertise can 
make nurses informal opinion leaders (Carlson, 2009), instead of them being identify as 
definite opinion leaders. Interestingly, a study by Khoury and Blizzard (2011) found that 
American opinion leaders from the public and private sectors did not view nurses as leaders in 
the development of healthcare systems and delivery, due to their perceived lack of knowledge 
and management skills. Nurses are often excluded from high decision making levels and are 
often seen to lack a unified voice on key healthcare issues (Khoury and Blizzard, 2011; Ressler 
and Glazer, 2011). It might be that other opinion leaders from outside of the nursing field will 
need to be challenged as to what constitutes a leader and nurses might need to be better 
supported in the area of leadership training in order to become clear opinion leaders.
Page | 97
The Promoting Action on Clinical Effectiveness (PACE) project aimed to 'demonstrate the 
implementation of evidence-based practice within selected areas and to disseminate lessons 
learnt from the programme, both locally and to the wider NHS' (Locock etal, 2001 P.749). The 
same researchers also ran the Welsh Clinical Effectiveness National Demonstration Projects 
(NDPs). The Welsh Office wanted to 'improve awareness of effectiveness evidence and to 
improve the application of such evidence in practice' (Locock et al, 2001 P.749).
Neither study used a systematic approach to identifying opinion leaders before the study, but 
the opinion leaders were identified at informal and opportunistic times (Locock et al, 2001). 
The opinion leaders identified were described as 'having an international or national research 
reputation, someone who commands respect and knows what they are talking about or 
understands the realities of clinical practice' (Locock et al, 2001 P.751). Identifying nurses for 
the implementation of genetics/genomics will be important and could be informed by some of 
the above descriptions.
Opinion leaders and improving pre- implemented innovations
Opinion leaders can be used to improve an innovation that has already been implemented. 
Opinion leaders were pre-identified through a questionnaire and then recruited for a study to 
improve breast-feeding rates in New York. Opinion leaders attended workshops and each 
created an implementation strategy for their communities themselves (Sisk et al, 2004). 
Giving opinion leaders the freedom and respect to control the implementation of an 
innovation in their community setting may enable them to feel involved and needed. 
Interestingly in their study, breast-feeding rates did not increase between hospitals with 
opinion leaders and control hospitals (Sisk et al, 2004). Therefore opinion leaders do not 
always increase uptake of an innovation. The use of opinion leaders for the incorporation of 
genetics into nursing practice will need to be carefully considered, it might be that they are not 
always effective in all situations and settings.
Evidence based practice (EBP) is an established concept but there are several barriers that are 
preventing nurses from adopting the innovation (Cronje and Moch, 2010). Cronje and Moch 
believe that promoting innovativeness through education will encourage student opinion 
leaders, enabling them to enter social diffusion networks which will enable an already 
implemented innovation to be diffused further, instead of allowing it to stall (Cronje and 
Moch, 2010). I do believe that early education is one of the key factors in encouraging nurses 
to engage with genetics/genomics in their practice. As the critical mass of adopters takes hold 
it will become easier to practice and will become more entrenched in the nursing system 
(Cronje and Moch, 2010).
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The importance of opinion leaders supporting the innovation
In order for a new idea to be implemented, opinion leaders need to support the policies 
designed to help the diffusion of the innovation. If identified nursing opinion leaders do not 
agree with the implementation process, it would be unlikely that genetics/genomics would 
become widely implemented among nurses. This can be seen in the following studies. 
Caesarean delivery rates needed to be reduced across California hospitals. Opinion leaders 
were identified by a sociometric method. Caesarean rates did not decrease as a result of 
identifying opinion leaders and encouraging them to alter the methods at their individual 
hospitals. However, this study did not have the full support of its identified opinion leaders at 
the beginning of the study as less than 50% of opinion leader obstetricians were inclined to 
"support efforts to decrease the Caesarean delivery rate in California to 15%" (Kravitz et al, 
2003 P.2428). However it does need to be stated that just because opinion leaders are being 
used for the spread of an innovation does not automatically imply that the innovation is 
evidence based or well thought through (Carpenter and Sherbino, 2010). It is known that 
organisations can have opinion leaders who oppose change as well as innovative opinion 
leaders (Rogers, 2003), this will influence the spread of new ideas throughout an organisation. 
It is important that opinion leaders support the innovation and are involved in discussions 
prior to implementation.
5.2.4 The Effect of Opinion Leaders
'You don't have to be actively hostile to cause trouble - you can cause a lot of problems just by 
being neutral' (Project Manager - Locock et al, 2001).
The impact of opinion leaders on diffusing an innovation will vary depending on the cultural 
context, including communication flow and the community's perception of opinion leaders 
(Feder and Savastano, 2006). The effect of opinion leaders can also depend on the social 
system they are within. If the social system favours change then opinion leaders are often 
more innovative, however if the social system is resistant to new innovations, then opinion 
leaders tend to not adopt the innovation. Opinion leaders will to some extent conform to their 
social system which will affect the effectiveness they have (Cronje and Moch, 2010). The 
implementation of genetics/genomics in healthcare may depend on the effectiveness of 
opinion leaders and the role they play. However it has been concluded that opinion leaders, 
no matter how they were identified, have a significant impact on health improvement (Rogers, 
2003).
Page | 99
Effectiveness of opinion leaders in the clinical setting
A Cochrane Review aimed to 'assess the effectiveness of the use of local opinion leaders in 
improving the behaviour of health care professionals and patient outcomes' (Doumit et al, 
2009; Flodgren et al. 2011). Twelve trials, all using opinion leaders were reviewed. The review 
highlighted some of the problems from the 12 studies when faced with diffusing an innovation 
using opinion leaders. Those selected as opinion leaders differed in their teaching and their 
personal and professional practice (Doumit et al, 2009), although the 12 studies were different 
in relation to the innovation and healthcare setting. This is something to consider when 
identifying nursing opinion leaders as they may vary in their approach to different aspects of 
their role, but a variety among opinion leaders could be advantageous. The most recently 
updated Cochrane Review (Flodgren et al. 2011), commented that opinion leaders working 
alone or in combination with other interventions may successfully promote evidence based 
practice, but that the effectiveness does vary among the studies investigated. A study by 
Verkaik et al. (2011) found that when implementing new guidelines into a nursing home 
setting, the major facilitating factor was the presence of a local opinion leader. Opinion 
leaders are effective because they have knowledge of local conditions and community 
(Carpenter and Sherbino, 2010) and their social status and credibility enable them to support 
new ideas effectively (Verkaik et al, 2011). They are effective because they can translate 
evidence for policy and practice, model specific behaviours and can facilitate organisational 
and educational strategies (Waters, 2009; Verkaik et al. 2011).
If a nurse is identified as an opinion leader at the beginning of a future study into the 
implementation of genetics/genomics in healthcare, would they necessarily be identified as 
one a few years further on from the study? In one trial within the Cochrane Review, 8% and 
18% of local opinion leaders identified by pathologists and general surgeons respectively were 
re-identified again after two years (Doumit et al, 2009). If the implementation of 
genetics/genomics into healthcare is going to have a lasting and positive effect, there needs to 
be driven and optimistic individuals for years to come, especially as genetics/genomics 
advances quickly. However, it might be that once an innovation is integrated, opinion leaders 
are no longer needed within that environment or new opinion leaders need to be continually 
identified and supported.
Advantages and disadvantages of using opinion leaders
The authors of the Cochrane review concluded that opinion leaders were effective in 
promoting evidence-based practice and that the method was comparable to the distribution of 
education material and audits and feedback. However they did comment that 'identifying 
opinion leaders can be labour intensive, and issues regarding the reliability and validity of
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identifying opinion leaders might limit the wider use of opinion leaders as a knowledge 
transfer intervention' (Doumit et al, 2009 P.27). Whether reliability and validity of opinion 
leaders are outweighed by the effectiveness of opinion leaders may be an area that will need 
consideration in individual studies. I do believe that one-to-one contact, peer witnessing and 
support can instil a greater influence that education materials. If the role of the opinion leader 
is well defined, supported and regularly reviewed with good management structure of the 
implementation process in place, the method of using opinion leaders within a clinical setting 
should be successful.
Variables affecting the impact of opinion leaders
Opinion leaders are known to be either 'effective agents of change for organisations or prove 
to be major obstacles, but they can be a promising resource when they are properly involved 
by management in change initiatives' (Lam and Schaubroeck, 2000 P.995). The effect of 
opinion leaders can vary depending on their character and style of interaction with others. If 
the opinion leader has a single-minded commitment it can have an 'alienating effect on some 
colleagues, even though they continue to acknowledge the person in question as an expert' 
(Locock et al, 2001 P.753). The identified opinion leaders do need to gain a deep 
understanding of the project aims; some opinion leaders may use a project to pursue other 
long-standing agendas (Locock et al, 2001). Future approaches using opinion leaders will need 
to stay focused and opinion leaders will need to be enthusiastic about genetics/genomics 
within nursing in order to achieve this.
Opinion leaders are effective at diffusing an innovation and will be a useful tool to facilitate the 
integration of genetics/genomics into practice. However, how these opinion leaders are 
treated will determine the effectiveness of the innovation. Opinion leaders are often an 
unused resource in ensuring that patients receive evidence based care (Carpenter and 
Sherbino, 2010). Opinion leaders need to be respected for their role in the innovation and 
they need to be given the space if necessary in which to fail. Through failing comes learning 
and an understanding of better methods of incorporating innovations, ultimately these 
opinion leaders will enrich the culture in which they are placed (DeCherney, 1999). However, 
resources-stretched organisations like the NHS may not be so tolerant in letting opinion 
leaders fail.
Opinion leaders and other implementation methods
The effects of opinion leaders are varied, however many studies have found them to be a 
success (Flodgren et al. 2011). If opinion leaders are to be used when implementing 
genetics/genomics into nursing practice, do other methods need to be used alongside opinion
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leaders? A study completed to improve the prescription of lipid modifying therapy by primary 
care physicians for patients with ischemic heart disease, found that the use of opinion leaders 
alongside educational workshops for physicians significantly increased the proportion of 
ischemic heart disease patients receiving lipid therapy (Bloomfield et al, 2005). Opinion 
leaders can be effective, but it is possible that their impact could be greater if other methods 
are used alongside them. As previously mentioned in the Cochrane report the effect of 
opinion leaders was comparable to educational materials and educational outreach (Doumit et 
al, 2009; Flodgren et al. 2011). However, I believe that influence to incorporate genetics into 
practice from an opinion leader would be greater than that from educational materials, 
through the building of community and a peer support network. Therefore the literature 
appears to suggest that if different methods of innovation diffusion can be used 
simultaneously then maximum effect could be gained. Opinion leaders will have their own 
agenda and opinions on the innovation, whilst this can be advantageous it will be important 
not to limit the sources of innovation information and diffusion to opinion leaders in isolation.
Justification for the use of the Opinion Leadership theory
Opinion leaders have been used to implement new innovations in a broad range of areas 
including, HIV prevention (Kelly, 2004), social networking (Bodendorf and Kaiser, 2009) and 
pest management (Feder and Savastano, 2006). The Opinion Leadership theory may be 
associated with the Diffusion of Innovation to identify those nurses willing to adopt 
genetics/genomics into practice. The use of opinion leaders has been linked to increasing the 
speed of Diffusion of Innovations, by opinion leaders acting as role models for sustained 
behaviour change. Opinion leaders have not always been effective in every behaviour change 
strategy, but it is important that they are themselves fully engaged in the innovation and 
enthusiastic about its impact on their community. Through identifying the right opinion 
leaders, I feel that the Opinion Leadership theory could be a useful approach for the 
implementation of genetics/genomics into nursing practice. The use of opinion leaders in the 
implementation of innovations, such as the postoperative pain assessment by Carlson, 2009 
and the analysis of the uses of opinion leaders in different innovations by the Cochrane Review 
(Flodgren et al, 2011) shows that the use of opinion leaders will be transferable to this area of 
healthcare. The identified nursing opinion leaders of genetics/genomics hopefully will 
encourage their colleagues to utilise genetics/genomics. This theory allows the innovation to 
be implemented from the 'inside out' by members of the nursing peer group, making it more 
effective (Valente and Pumpuang, 2007).
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5.3 Stages of Change
5.3.1 Stages of Change - The Theory
The Stages of Change theory, also known as the Transtheoretical Model was developed by 
psychologists, James Prochaska and Carlo DiClemente in 1983, in an attempt to understand the 
range of perspectives on smoking behaviour change (Whitelaw et al, 2000). Prochaska and his 
colleagues have mainly used the Stages of Change theory to help people with psychological 
disorders and behavioural problems, including addictive behaviours (Norcross and Prochaska, 
2002). Although its main application has been in the field of addictive behaviours, I believe it 
can be applied to behaviour change among healthcare professionals, of which some examples 
will be given later.
The model specifies that behaviour change is a process that develops over time and through 
various stages (Prochaska and Norcross, 2001) (Fig. 5.11). Each stage is a period of time and 
includes various tasks needed to progress to the next stage. The time period will vary 
depending on the individual (Prochaska and Norcross, 2001).
The Stages of Change theory has been considered in terms of Rogers' Diffusion of Innovations 
theory (Rogers, 2003). The Stages of Change theory identifies a 'cascading' approach of an 
individual's behaviour towards an innovation in which individuals often weigh up costs and 
benefits of an innovation. An individual goes through the Stages of Change decreasing the 
'cons' and increasing the 'pros' of an innovation (Rogers, 2003). Recognition of the stage 
continuum in relation to behaviour change is important both for design of health promotion 
strategies and personal contact dynamics with participants (Samuelson, 1998). Most people 
do not successfully negotiate all the Stages of Change on their first attempt, especially if they 
are acting alone (Norcross and Prochaska, 2002). Individuals often do not follow the stages in 
a sequential manner but they often jump back stages and then progress through the stages 
differently the second time around. This is what Norcross and Prochaska (2002) consider a 
spiral pattern, this best represents how the majority of people change over time (Prochaska, 
1991). Prochaska (1991) believes that people learn from these relapse experiences rather than 
going in circles. It has been discovered however that a minority of people move from one 
stage to the next without relapsing (Prochaska, 1991).
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Fig 5.11. The six Stages of Change (Prochaska and Norcross, 2001)
( Precontemplation J
In the first stage an individual has no intention of changing their behaviour, they may wish to change, but this is 
very different from seriously considering change.
1
( Contemplation J
Individuals become aware that they have a problem and have considered overcoming it, but they have not 
committed themselves to take action.
I
( Preparation J
Individuals are prepared to take action in the next month and have unsuccessfully taken action in the last year.
1
C Action )
Individuals try and change their behaviour, environment and experiences. Individuals are placed in this stage if 
they have successfully altered their behaviour for between one day to six months.
1
( Maintenance J
I People who have altered their behaviour are trying to maintain their behaviour change.
c Termination D
Those in this stage are now comfortable with their behaviour change and no longer have to work to maintain their 
behaviour chanee.
People's level of readiness to change needs to be respected in order to gradually enable them 
to move through the phases (Jordan and Nigg, 2002). This to some extent is true, although 
when looking at health care needs of patients, it could be argued that time is sometimes 
limited. The precontemplation, contemplation, maintenance and termination are the most 
stable stages and the preparation and action are those stages where people are most likely to 
either progress or regress. It has been noted that at the two least stable phases, the amount
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of help the individual receives will influence their progression or regression (Prochaska, 2008). 
Every individual will differ in their readiness to change and the ways they go about doing this 
(Norcross and Prochaska, 2002). It will be important to bear this is mind when encouraging 
nurses to change their behaviour to incorporate genetics/genomics into their nursing practice. 
Interestingly, people often decide to undergo behaviour change at a specific time or date 
within the year, it might be New Year, a big birthday or a certain bank holiday. This is 
something that could be considered when beginning to implement genetics/genomics into 
nursing. Although it may appear insignificant, timing could have a significant impact on the 
success of the innovation.
The more we understand about behaviour change especially in relation to the cycle of the 
Stages of Change theory, then the easier it will be to create strategies that reduce the number 
of times people go through a cycle and will allow people to reach a more stable and 
maintained behaviour change (Prochaska, 1991). Prochaska (2008) believes that the Stages of 
Change model (Transtheoretical Model) can advance science based treatments because it can 
target those individuals who were always labelled noncompliant, unmotivated, resistant or not 
ready for new sciences and services. This could potentially also be applied to nurses when 
adopting genetics/genomics into their practice (Fig 5.12). However as previously mentioned, 
behaviour change among healthcare professionals is different to an individual undergoing for 
example, psychotherapy. The Stages of Change Theory is advantageous when compared to 
other change theories (Joseph et al, 1999) because:
• It encompasses those who are contemplating behaviour change as well as those who 
are changing
• It allows a longer time period for change, including the number of attempts made
• It provides guidance for practitioners on how to change behaviour at the different 
stages
• It not only measures behavioural change but also values self-efficacy and decisional 
balance
• It is a simplistic model and can be applied to professional education
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Fig 5.12. Stages of Change adapted to consider the incorporation of genetics/genomics into 
nursing practice
•Nurses may not see the relevance or important of genetic within their practice
•Nurses may not have received enough information about genetics within their 
practice
•Opinion leaders and adopters may be useful at this stage
•Nurses will start to see the benefits and relevance of genetics
•Some nurses maybe thinking of adopting genetics in the next 6 months
•Contact with someone with or at risk of a genetic illness may help them to see the 
benefits of adopting genetics into their practice
•Nurses will have an idea of how they will incorporate genetics into their practice
•They will be hoping to be encorporating genetics within the next month and can 
see the positives of their behaviour change
Action
•Nurses have been incorporating genetics into practice for between 1 day to 6 
months
•Colleagues will witness the behaviour change
Maintenance
• Nurses will be trying to continually use genetics in their practice
•They have begun including it in all areas of their practice
Termination
•Nurses automatically include genetics within their practice without thinking about 
it
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5.3.2 Stages of Change and healthcare
Shaping the behaviour of health care providers to use the most effective medical treatments, 
will ultimately improve patient care (Parker and Parikh, 2001). Various areas of healthcare 
change using the Stages of Change Theory have been studied, including heroin addiction and 
smoking during pregnancy (Snow, 2005). Finnell (2005) believes that the Stages of Change 
Theory can be used to explain when a person is ready to change and can guide the 
educator/healthcare professional in what aids behaviour change. When looking to alter the 
behaviour of healthcare professionals, educators need to remember that learners will all be at 
different stages which will depend on the subject topic, their familiarity and expertise with the 
topic (Parker and Parikh, 2001). It is important for the educator to identify what stage the 
learner is at and this should guide the type of learning and format of material delivery (Parker 
and Parikh, 2001) (Table 5.5). This will however be difficult in a large group or across an 
organisation. Having an understanding of the Stages of Change process and the position of the 
learners along the stages will put the educators in a better position to move learners along the 
stages (Parker and Parikh, 2001).
The level of knowledge provided will also change depending on the individual, for example it is 
better to provide basic knowledge to those individuals who are thinking about behaviour 
change, as this will prepare them for change. More in-depth knowledge can then be provided 
once they have started to alter their behaviour (Parker and Parikh, 2001). Some educational 
programmes may purely exist to prepare healthcare professionals to contemplate a change, 
for example providing nurses with enough genetic/genomic knowledge to think about 
adopting genetics/genomics. Therefore successful behaviour change following an individual 
educational change programme may vary depending on the initial aims.
Nurses play an important part in encouraging behaviour change, they can help patients to 
understand the need for behaviour change and help them to make that change (Westley and 
Briggs, 2004). Westley and Briggs (2004) studied the Stages of Change Theory to help patients 
use advanced care planning (ACP). Initially (precontemplation stage) patients were 
misinformed about ACP and were not keen to discuss it. Information material about ACP was 
provided. At contemplation stage patients had barriers to ACP even though they were aware 
of the pros and cons of the process. Nurses explained how the patient could overcome these 
barriers. Patients created an ACP at the action stage. Encouragement and clarification of the 
issues were useful at this stage. When a patient reached the maintenance stage, assurance of 
the choices they had made was important (Westley and Briggs, 2004). Nurses build up a good 
rapport and relationship with the patient to encourage them though the change stages. 
Nurses also have the skills and knowledge to explain the benefits and burdens of treatment
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choice. Westley and Briggs (2004) believe the Stages of Change model provides a good, 
practical way to organise interventions within patient care.
A study by Jenkins and Calzone (2012) studied the Stages of Change theory in relation to 
faculties' readiness to incorporate genomic content into the nursing curriculum. They found 
that the majority of respondents (total n=167) were either in precontemplation or 
contemplation stages (36.2%), with the rest in the preparation stage (4%), action stage (9%) 
and the maintenance stage (10%). This shows that the majority of nursing faculties are not 
ready to incorporate genetics/genomics into the nursing curriculum and hence need further 
support to realise the importance and relevance of such a change. The authors therefore 
believe that the presence of a nurse opinion leader to train nurse faculty champions in the 
field of genetics/genomics would be a useful step forward and is justified (Jenkins and Calzone, 
2012). Those in the preparation stage felt that having resources in this field would help them 
to alter their behaviour. This type of study shows how the Stages of Change theory can gain a 
'snap shot' of whether individuals or organisations are adopting an innovation and how 
advanced they are in their adoption. It can also yield some important findings about how to 
support those going through different Stages of Change.
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LeTourneau (2005) used the Stages of Change theory to look at the reaction to change by 
physicians. At the precontemplation stage physicians will talk about the change but are not 
willing to be involved. At the contemplation stage, physicians will not think about the 
implications of the change or see the change as relevant (LeTourneau, 2005). Rumours and 
misinformation about the change start to surface during the preparation stage and attitudes 
and opinion begin to be formed. Attitudes become clearly noticed at the action stage, 
negative attitudes are often formed if physicians feel they are not being listened to. Attitudes 
formed, whether positive or negative are continued at the maintenance stage (LeTourneau, 
2005). Physicians can become split into groups during the change stages, some might be at 
the contemplation stage whilst others have moved on to the action stage. LeTourneau (2005) 
recommends spending time in the area where physicians (or the group of individuals being 
studied) socialise, this allows insight to be gained on what the physicians are thinking and 
feeling about the change which might not be gained in a formal meeting. She says that talking 
to nurses and healthcare assistants can also help to understand how people are feeling and 
that both formal and informal approaches to behaviour change among physicians are useful, 
however this might not always be a practical approach.
5.3.3 Limitations of the theory
Despite Prochaska and other authors expressing the positives and reliability of the Stages of 
Change theory, many have also criticised it (Brug et al, 2005). According to Whitelaw et al 
(2000) it has become one of the most popular resources in the field of healthcare and health 
promotion, but they believe that there is less evidence to support the association of the model 
to behaviour change than is generally believed to be present. The Stages of Change model 
aimed to incorporate other existing theoretical frameworks such as the Social Learning theory, 
the Health Belief model and the Theory of Reasoned Action (Whitelaw et al, 2000). However 
its overuse in the area of health promotion could be preventing other useful models, such as 
the Health Belief model from being individually used and incorporated into behavioural 
change, therefore skewing approaches towards health promotion (Whitelaw et al, 2000., 
West, 2005., Bandura, 1997). West (2005) believes that the way the theory categorises people 
is not based on evidence and is actually damaging to the progress of other theories. Brug et al 
(2005) believe that the stages of the Transtheroretical Model have not been validated, leading 
researchers to adapt and change the stages to fit their study or measures (Brug et al, 2005). 
Littell and Girvin (2002) believe that, apart from the precontemplation stage, the stages do not 
emerge in any consistent manner and that most of the recent work in the area is based on the 
assumption that discrete stages exist and have been validated. The complex and interactive 
nature of stage allocation and transtheoretical processes makes the structuring and isolation
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of dependent and independent variables difficult. For example separating the general effects 
of the intervention from the specific influence of the Stages of Change model is challenging 
(Whitelaw et al, 2000). The descriptions of people and processes are not accurate and cannot 
be generalised (Littell and Girvin, 2002), although one could argue that with the amount of 
successfully applied research on the theory it can be generalised. Bandura (1997) believes that 
human behaviour is too multifaceted and multidetermined to be categorised into a few stages. 
He says you cannot therefore, fit people into prefixed stages. However this theory of 
behavioural change has been used for decades by psychologists and human biologists, 
therefore it provides a useful framework to study behaviour change.
The model has undergone many changes since it was first developed, however the reasons 
why it has changed are not clear (Joseph et al, 1999). West (2005) is very negative about the 
theory and believes that the theory should be 'put to rest' and replaced with a theory that is 
consistent and reflects the true observations of behaviour change, however he has not made 
clear any further suggestions as to what this could be. Not all individuals make coherent plans 
and intentions to change are not always clearly formulated. An individual's readiness or 
preparedness to change is not measured within the theory. West (2005) believes that 
Prochaska's Stages of Change Theory states the obvious, people who want to change are more 
likely to go about trying to change and those people who try to change are more likely to 
succeed. Indeed, this is what we see among early adopters. Moreover, moving an individual 
closer to taking change action will not necessarily result in behaviour change maintenance in 
the long run (West, 2005), although without encouragement it could be argued that an 
individual might never have the incentive or positive influence to try and change. The theory 
does not take into account situational determinants of behaviour. A trigger can cause 
behaviour change even in unmotivated individuals (West, 2005). Prochaska (1996) 
acknowledges that a significant life event (i.e. a heart attack) can cause an individual to 
consider a behaviour change. It has been stated that lasting behaviour change depends on the 
motivational forces present that favour the new behaviour whenever the opportunity is 
available. The Stages of Change theory does incorporate an explanation about how this 
happens (West, 2005) and this will be different for every individual. Although West makes it 
clear that he does not favour the theory he also does not refer to those examples where the 
theory has been successful. Others who have discussed the limitations of the theory have still 
mentioned its usefulness and success for over 20 years.
Social factors affecting the theory
Joseph et al, (1999) believe that the model does not take into account the personal history 
that individuals bring with them and that this can have an impact on a change programme. An
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individual's past history (e.g. experiences of behaviour change previously) should therefore be 
considered. Confounding influences are also seen in an individual's social context; the options 
that people have available to them for behaviour change are often limited by social and 
cultural aspects (Joseph et al, 1999, Littell and Girvin, 2002, Samuelson, 1998). I agree that 
socioeconomic context could make a difference, however if individuals all go through the same 
Stages of Change, then whilst socioeconomic factors might influence the speed of stage 
change, the actual stages remain the same. Littell and Girvin (2002) therefore believe that this 
generic categorisation and behaviour change brings limited understanding and that there is a 
reliance on a set of categories that do not reflect different qualitative states (e.g. other 
problems, external supports/stresses). The Stages of Change model has mainly focused on 
how social support activities relate to change rather than how they affect the assumptions of 
the model (Joseph et al, 1999). There is also no scope for example for explanation at the 
precontemplation stage as to why individuals are not considering making a behaviour change 
(Bandura, 1997). There is no room for understanding what individuals think and feel, although 
this could be overcome by the methodological design of a study, without changing the theory.
Clearer definitions and better understanding of motivation, intentions, readiness for change 
and preparation for change needs to be developed (Littell and Girvin, 2002). Littell and Girvin 
(2002) also believe that in the future the understanding of variation patterns and processes of 
change associated with culture and society need to be a priority and that readiness for change 
and change processes need to be considered differently for different people. The Stages of 
Change theory has been effectively applied to various health behaviour changes, however 
many believe that the theory should be applied relatively loosely and should not be seen as 
the only theory of behaviour change (Whitelaw et al, 2000., Brug et al, 2005).
Justification for the use of the Stages of Change theory
The Stages of Change theory provides an explanation of how individuals work through the 
behavioural change process. It provides the basis for a time period to be put on behaviour 
change and provides healthcare professionals and educators with guidance on how to 
influence behaviour change. Recognising the stages involved in behaviour change enables 
better design of health promotion strategies (Samuelson, 1998) and it is applied to this thesis 
to consider the integration of genetics into nursing practice. Although it is a simple model, 
which is considered a limitation by some, it has been used for over 20 years as a behavioural 
change theory. The theory has also been connected to the Diffusion of Innovation theory, 
through identification of an individual's attitude towards an innovation (Rogers, 2003). The 
theory was used in Jenkins and Calzone's (2012) study into nursing faculties' readiness to 
change, in relation to the incorporation of genetics. This and other studies, such as the use of
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Advanced Care Planning by patients (Westley and Briggs, 2004), shows how the theory is 
transferable. In this thesis it is used to aid the understanding of how individual nurses might 
progress through the stages of adopting genetics into their practice.
5.4 Theory of Planned Behaviour
5.4.1 Overview of Theory of Planned Behaviour
The Theory of Planned Behaviour (TPB) created by leek Ajzen in 1985 is an extension of the 
Theory of Reasoned Action created by Ajzen and Fishbein (1975), with the incorporation of an 
additional component 'perceived behavioural control' (Ajzen, 1991). The main focus of the 
TPB is an individual's intention to perform a behaviour. The theory assumes that behaviours 
are not within a person's control (Dwyer and Mosel Williams, 2002., Edwards et al, 2001). The 
Theory of Planned Behaviour (TPB) is one of the most studied social cognition theories and 
relates to both intention and behaviour change (Hardeman et al, 2002). According to Shankar 
et al (2007) the TPB is considered to be a complete theory of behaviour and the variables 
within the model are considered to incorporate the effect of other variables, but without being 
explicitly measured, for example personality and demographics. TPB states that the intention 
to act is influenced by one's attitude towards the behaviour, subjective norms and perceived 
behavioural control (Hardeman et al, 2002). These intentions are indicators of factors that 
influence the behaviour (Fig 5.13). Normally the stronger the intention to engage in the 
behaviour, the more likely it is to be performed. However, if an individual does not have the 
intention to perform a behaviour, trying to plan where and when to implement the innovation 
is pointless (Ajzen and Manstead, 2007). TPB can be useful for predicting many behaviours 
and behavioural intentions (Armitage and Conner, 2001). The TPB is often used as a 
benchmark for new developments to be tested against due to its clear constructs and 
standardised measurements (Skar et al, 2008).
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When people have the time to contemplate their behaviour choice, the best predictor is their 
intention to change. There are three components of predicting behaviour intention (Aronson 
et al, 2007; O'Boyle et a\, 2001):
1. The attitude one has towards the behaviour is related to the favourable or 
unfavourable appraisal of the behaviour an individual has. The TPB believes that only 
particular attitudes towards the specific behaviour can predict the behaviour outcome 
(Aronson et al, 2007). There are two types of attitude (Skar et al, 2008:
• Affective attitudes - what a person feels about the object (i.e. emotional)
• Cognitive attitudes - what a person thinks about the object (i.e. rational)
If the two attitudes are similar then the attitude and behaviour relationship is 
strengthened and prediction of intention and behaviour is improved (Skareta/, 2008).
2. Subjective norm is related to the social pressure to perform or not perform a given 
behaviour. It has been identified that personal attitudes towards the behaviour 
overshadows any perceived social pressure (Ajzen, 1991). To ascertain subjective 
norms, individuals are asked which important other individuals would approve or 
disapprove of them undertaking a certain behaviour. The more favourable the 
attitude from those important social persons, then the more likely an individual is to 
have intention and to perform a behaviour (Armitage and Conner, 2001).
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3. Perceived behavioural control refers to the observed ease or difficulty of performing 
the behaviour (Ajzen, 1991) and can be reflective of past experiences and can also 
predict future obstacles. This in turn affects people's intentions and can predict 
deliberate intention and behaviour (Aronson etal, 2007).
If an individual feels in control then they are more likely to try to perform a behaviour 
(Armitage and Conner, 2001). It may be that a person believes that future 
consequences are determined by their own behaviour but also believe that they have 
a low perceived behavioural control (PBC) (Ajzen, 1991). PBC should help implement 
intentions to adopt the behaviour into action and should predict behaviour (Armitage 
and Conner, 2001). If a person has complete control over behavioural performance, 
then the intentions to perform the behaviour should be enough to predict behaviour 
(Ajzen, 1991). The influence of PBC will depend on the amount of information given to 
individuals about the behaviour, the available resources or unexpected elements that 
enter the situation (Ajzen, 1991). Ajzen's theory states that:
Perceived behavioural control + behavioural intention ———*• predicts behavioural 
achievement
The more favourable the attitude and subjective norm towards the behaviour, the greater the 
perceived behavioural control. An individual's intention to perform the behaviour should 
therefore be stronger (Ajzen, 1991).
Salient beliefs
So called 'salient beliefs' are considered to be determinants of an individual's intentions and 
actions. These beliefs are linked to the three main predicting intentions in the TPB, 
behavioural beliefs to attitude, control beliefs to perceived behavioural control and normative 
beliefs to subjective norms (Fig 5.13). These beliefs help researchers to understand the factors 
that enable one person to engage in the behaviour and another to choose a different course of 
action (Ajzen, 1991) (Fig 5.14) (See appendix 2 for a more detailed description).
Normative beliefs
Normative beliefs are linked to subjective norm influencing factors in the TPB, but can also 
present as normative pressures, e.g. where nurses (individuals) feel under pressure from 
patients, colleagues, medical staff and hospital demands which could affect their intention and 
behaviour (Edwards et al, 2001). Normative pressures could have both a positive or negative 
effect on the uptake and continuation of the behaviour change. However Edwards et al (2007) 
in a later study comments that if nurses are aware that their practice is influenced by others
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then they can allow for normative influences in their decision making. The influence from 
others as well as the negative and positive influence of normative beliefs will be important to 
remember when encouraging nurses to incorporate genetics/genomics into practice.
Fig 5.14. Illustration of components of salient beliefs
Injective norms 
Pressure to engage in 
behaviour based on the 
perception of what others 
want vou to do
Descriptive norms 
Pressures to engage in behaviour 
based on the observed or 
inferred behaviour of others
Control beliefs
The basis for perceptions of 
behavioural control (Ajzen, 
1991). Influenced by 
information about the 
behaviour passed on from 
family and friends regarding 
their experience of the 
behaviour.
Behavioural beliefs
Influencing attitudes towards the 
behaviour
Normative beliefs
Linked to whether important 
individuals or groups would 
approve/disapprove of a 
particular behaviour
The effect of past behaviour on the uptake of a new behaviour is a reflection on all factors that 
determine new behaviour uptake. The relationship between the past and present behaviour is 
considered indicative of the stability and reliability of the behaviour and can be associated 
with the TPB's predictive validity (Ajzen, 1991). People often develop certain life patterns, 
financial commitments and obligations that keep them practising a certain behaviour and 
make it more difficult to change (Arnold et al, 2006). Rhodes and Courneya (2003) believe that 
past behaviour can have an influence over current intentions and future behaviour and 
therefore should be considered as having a significant effect on the TPB constructs. If past 
behaviour is considered an indicator of habit, then habit can have an influence on current 
behaviour (Rhodes and Courneya, 2003) and behaviour change models. Shankar et al (2007) in 
their study to predict self monitoring of blood glucose in those with type 1 diabetes propose 
that the decision to alter behaviour may in part be due to the environment one is in (i.e. 
whether in work or at home) and altered routines that play an important role in self 
monitoring behaviour. Therefore they conclude that perceived difficulty might play a more 
important role in the performance of frequently repeated behaviours i.e. blood glucose 
monitoring than perceptions of control (Shankar et al, 2007). In contrast to Rhodes and
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Courneya (2003), Shankar et al (2007) state within their study that intention was the only 
significant predictor of self monitoring behaviour, which they believe shows that familiar 
behaviours are not always under habitual control.
5.4.2 Theory of Planned Behaviour in healthcare
Archer et al (2008) studied the use of the TPB to incorporate professionalism training into 
medical students training through the use of an educational model. Archer et al (2008) believe 
that the TPB could be used to encourage medical professional education. They believe that 
institutions could make their curriculum more effective by understanding and addressing the 
factors that are preventing individuals from changing their behaviour regarding 
professionalism (Archer et al, 2008). They also suggest that future educational programmes 
should challenge any differences between social norms and intended behaviours and should 
create innovations within the curriculum to increased perceived behavioural control among 
students (Archer et al, 2008). The more confident and in control students are with regards to 
developing professional behaviours, then the more their positive attitudes and professional 
behaviour is expected to increase. Archer et al (2008) have stated that the TPB makes it clear 
that redesigning the curriculum will not solely change students' professional behaviour, it is 
also affected by external factors influencing behaviour such as sleep deprivation, time 
pressures and inadequate training.
Kortteisto et al (2010) assessed healthcare professionals' (n=806/2252) intention of using 
clinical guidelines using the TPB. They found differences between healthcare professionals 
related to their intention to undertake the behaviour. It was identified that the TPB variables 
are important for healthcare professionals considering using new guidelines. For physicians 
the factor associated with their intention of using the guidelines was the PBC but for nurses 
and other professionals the subjective norm was the most important factor (Kortteisto et al, 
2010). Normative beliefs that relate to social pressures seem to have an effect for nurses and 
other professionals. Specifically, context and guideline based factors either encouraged or 
hindered the intention to use the guidelines by physicians (Kortteisto et al, 2010). The main 
outcome was that different professional groups require different implementation strategies. It 
could be argued therefore that simply using similar implementation guidelines e.g. for nurses, 
doctors and physiotherapists may not be appropriate. Therefore when implementing 
genetics/genomics into various healthcare practices, a range of social pressures need to be 
considered, some will need to be overcome or exploited whilst others could be used as a force 
for change. Perkins et al (2007) describe the interventions and possible barriers to the 
alteration of clinicians' behaviour through the TPB (Fig 5.15). They believe that by 
understanding clinicians' attitudes, subjective norms and PBC, it will help to provide the
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necessary support to enable the development of an intervention that is most likely to impact 
behaviour.
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In other research, Ryu et al (2003) studied the knowledge sharing behaviour between doctors 
(n=286) and identified that subjective norms where the most influential factor affecting the 
intention of doctors to share information among colleagues. In this study, attitude and 
subjective norms were not as independent of one another as they were perceived to be, but 
attitude was the second most influencing factor for knowledge sharing among doctors (Ryu et 
al, 2003). Perceived behavioural control had a significant effect on behavioural intention to 
share knowledge; however perceived behavioural control still had less effect than attitude and 
subjective norm (Ryu eta/, 2003). From these findings, Ryu et al (2003) believe that managers 
of hospitals should create an environment which encourages knowledge sharing through 
creating positive subjective norms and attitudes. This could also be aided by gaining a greater 
understanding of different knowledge sharing behaviours among doctors perhaps attributed to 
different leadership styles and structure among different departments (Ryu et al, 2003). 
However Ryu et al (2003) did not explicitly state how you can "create" such an environment. It 
could rapidly increase behaviour change in all areas of healthcare if this was such an easy 
solution. It could be that different studies suggest that different elements of TPB are more
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important than others, perhaps depending on the behaviour being influenced or the 
measurement of behaviour change. Ramsay et al (2010) used the TPB as a process evaluation 
tool in trials of knowledge translation strategies. They focused the TPB on different test 
requesting behaviours, to see if doctor's cognitions predicted their test requesting behaviour 
(n=131). Information/educational booklets (intervention) were provided on the tests. Results 
showed differences between two tests in relation to intention, attitude and subjective norm. 
This shows that the intervention, including educational messages and testing rates in varying 
regions, may have changed behaviour and intention, due to enhancing attitudes and subjective 
norms (Ramsay et al, 2010). Through their study, Ramsay et al (2010) believe that the TPB can 
be used successfully in process evaluation and can provide information on the causal 
mechanisms of an intervention and on intervention development. This could be applied to 
genetics/genomics incorporation within nursing. Gaining information and effects of a 
particular intervention will allow evaluations on the intervention to be made without it 
needing to be tested on a wide scale. This will then aid the implementation of the intervention 
to allow it to change the behaviour of nurses as effectively as possible in order to facilitate the 
incorporation of genetics/genomics into nursing practice.
Like Ramsay et al (2010), a study by Edwards et al (2007) also concluded that the TPB was an 
excellent theory for the development of interventions, in this case an educational intervention. 
A peer educational programme (in antipyretics) was employed among paediatric nurses. The 
impact of peer support, peer education and informal education was shown through the 
changes in normative influence which were maintained over time. Peer support and education 
were maintained and highlighted as being important factors for behaviour change and 
sustainability of best practice (Edwards et al, 2007). Allowing nurses to have a better 
understanding of their practice of antipyretics created an improvement in their accuracy of 
perception of control, reduced the intentions to administer antipyretics, which continued to 
decrease over time (Edwards et al, 2007). This shows how the TPB can be applied to current 
behaviours, not necessarily new behaviours/interventions. The TPB could be used to improve 
practice/services, for example with the incorporation of genetics/genomics within medicine 
and family history taking. It is likely that the perceived behavioural change, salient beliefs and 
subjective norm would differ depending on whether one pursues an innovation or whether 
one is expected to adopt it.
5.4.3 Analysis of Theory of Planned Behaviour
The TPB has been subject to debate and criticisms, with many believing that it is limited (Ajzen, 
2011). Ajzen (2011) does recognise that considerable progress in the theory has occurred 
since it was created, but he believes that there is still clear support for it. He states that some
Page | 118
new ideas and findings can be incorporated into the theory, whereas others can be used to 
enrich our understanding of human social behaviour. Hardeman et al (2002) believe that the 
TPB has a valuable contribution to make to the development of effective interventions aimed 
at behaviour change. It is also useful as a framework to explain the motivation of some 
individuals which cannot always be taken for granted (Hardeman et al, 2002). Fishbein and 
Ajzen (2005) tend to focus on persuasive messages to change the beliefs that separate those 
who do not adopt the behaviour and those that do, whereas Hardeman et al (2002) believe 
that many techniques can be used to change beliefs. Hagger and Chatzisarantis (2009) state 
that the TPB does not distinguish between beliefs about outcomes that people decide to 
pursue and those that people feel socially pressured to accept. Both routes of choice could 
have very different effects on the outcome of the adopted behaviour as one is self-determined 
and the other is controlled. In the current study, the difference between whether nurses 
adopt genetics/genomics into their practice because they feel pressurised to do so or because 
they individually want to, may affect the enthusiasm and continuation of the behaviour change 
in the long term. Ajzen (2011) has stated that some intentions to change behaviour are 
dependent on factors out of an individual's control, which therefore affect methodological 
frameworks and limits the predictability of behaviour change. For example, in the current 
study, nurses intention to adopt genetics into their practice may be dependent on the pressure 
felt from colleagues and management and the access to genetics education resources. 
According to Conner and Armitage (1998), the impact of past behaviours, moral norms, self 
efficacy, self identity and affective beliefs are not variables, but should be included as such 
within the TPB.
One of the biggest variables that I feel is limited within the TPB model is the lack of 
consideration for the role of personality traits within behaviour change. Armitage and Conner 
(1998) have stated that the TPB describes the processes by which attitudes and beliefs affect 
behaviour change but do not describe the processes by which other variables, such as 
personality influence the TPB. The effect of personality and behaviour change has been 
studied within the role of exercise change. Rhodes et al. (2005) found that personality traits 
(neuroticism, extraversion and conscientiousness) were linked to the success of behaviour 
change and could explain the observed variance in the TPB. For example they found that those 
individuals with a high conscientiousness trait retain greater behaviour intention consistency. 
A similar finding was also presented by Hoyt et al (2009), who found that neuroticism was 
positively linked to the moderation of the intention-behaviour relationship. I believe that the 
personality traits of individual nurses may affect how they view and accept change and 
whether they choose to adopter genetics into their practice. It may be that personality traits
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do affect attitudes towards an innovation, the way external pressure is accepted and how an 
individual views control over behaviour change. Ajzen (2011) does acknowledge that these 
variables may influence the predictive validity of behaviour change and that individual 
differences may affect ones intention and capacity to change their behaviour.
The TPB helps to explain an individual's intention of performing a particular behaviour, based 
on an individual's attitude towards the innovation, subjective norm and perceive behavioural 
control. These indicators of those factors that influence behaviour will be useful in helping to 
understand what might prevent nurses from adopting genetics into their practice and may be 
useful predictors in identifying what type of nurses will utilise genetics more in their practice. 
Personality traits may also be useful indicators of those nurses who will adopt genetics. 
Openness to Experience is one such personality which is believed to be linked to adopter and 
opinion leader traits.
Justification for the use of the Theory of Planned Behaviour
The Theory of Planned Behaviour has been used extensively in health promotion initiatives and 
research. It seeks to explain individuals' intentions towards adopting a behaviour and 
variables that affect the uptake of behaviour change. It also provides insight into how these 
intention variables, such as perceived behavioural control and subjective norm can be 
manipulated in order to increase the uptake of the behaviour. The theory is an extension from 
the Theory of Reasoned Action (Ajzen and Fishbein, 1980) and surrounds the individual's 
intention of performing a behaviour. Although the TPB lacks involvement of personality 
variables and the role of pressure from others to adopt it still provides a useful framework for 
the predictability of behavioural change. The TPB has a theoretical basis in this study partly for 
this reason and because of previous work of direct relevance to this study. The NHS Genetic 
Education and Development Centre adopted the theory because it was felt to provide a 
comprehensive framework on which to base a research and development programme that had 
the ultimate aim of changing nurses' attitudes and behaviour in relation to genetics. The three 
strands of the programme reflected the three key elements of the TPB (Kirk et al. 2007a). The 
aim of this study is to identify adopters of genetics/genomics and to gain an understanding of 
why nurses do or do not adopt genetics/genomics into practice. In their study, Chen et al 
(2008) also used the Theory of Planned Behaviour as part of their theory based model. As 
identified, the theory can and has been applied to various areas of healthcare and as such I 
believe that the Theory of Planned Behaviour can be applied to promote the further 
integration of genetics/genomics into nursing practice and the identification of group 
characteristics that make this implementation successful.
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5.5 Openness to Experience
Openness to Experience is one of the supertraits forming the Five Factor Model of personality. 
This states that all personality types are explained in terms of varying degrees of neuroticism, 
extraversion, openness to experience, agreeableness and conscientiousness (McCrae, 1996., 
McCrae and John, 1992). Personality processes involve changes of thought, feelings and 
actions, which are parallel to differences in character and can be broadly summarised by the 
five factors (McCrae and John, 1992). McCrae and John (1992) state that the names of these 
factors are inherited from a published body of literature with published instruments. The Five- 
Factor Model extends from studies on personality structure completed by Cattell et at in 1970. 
It has become popular because it accommodates a wide array of personality constructs and 
has been related to many other personality variables (Ashton and Lee, 2005). The Five Factor 
Model was only derived in one language and it has been suggested that when applied to other 
languages a six factor model is superior, with the addition of honesty-humility (Ashton and 
Lee, 2005).
5.5.1 Traits within Openness to Experience
Openness has been described as explaining differences between individuals and the function 
and structure of the mind (McCrae, 1996). Openness to Experience is the single trait that will 
be focused on due to its association with people who are open to new ideas and innovative 
(Raggatt, 2006) which has been hypothesised as being a possible trait of adopter in the current 
study (Fig 5.16). Those people who have a high level of openness are able to make remote and 
unusual connections, are curious, innovative and imaginative (McCrae, 2007, King eta/, 2008., 
McCrae, 1987) as well as being open to new ideas, unconventional ideas and experiences 
(George and Zhou, 2001). The other four areas of the five factor model, neuroticism (anxiety, 
depression), extraversion (talkative, outgoing), agreeableness (trusting, generous) and 
conscientiousness (responsible, reliable) were not included as it was felt that these traits were 
more reflective of how others see individuals whereas Openness to Experience is about how 
an individual perceives new ideas and has been linked to the role of leadership previously 
(Popper and Amit, 2009, Zori et al, 2010).
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Fig 5.16. Traits of those who have a high level of openness (McCrae, 2007, King et al, 2008., 
McCrae, 1987, George and Zhou, 2001, Raggatt, 2006)
Open to new ideas, 
unconventional ideas and 
experiences




Curious, innovative and 
imaginative
Openness can be broken down into six descriptive areas; fantasy, actions, feelings, values, 
aesthetics and ideas (McCrae, 2007., McCrae and John, 1992) (Table 5.6). Openness is 
considered to be a universal dimension of personality, it can therefore be applied across 
cultures and languages (McCrae, 2007, McCrae and John, 1992).













Judges in unconventional terms
Aesthetically reactive







In terms of the present research, early adopters may be open to the experiences of adopting 
genetics/genomics in practice due to having greater imagination and empathy. The empathy 
displayed by nurses may also be related to their level of emotional intelligence (ability to 
perceive, control and evaluate emotions), which in turn may be a positive trait of nurse 
adopters of genetics/genomics. Those high in openness have favourable attitudes to 
education, science and change as well as being able to cope with distractions and uncertainty 
(McCrae, 1996). According to McCrae (1996) those who are open need complexity, variety, 
novelty and they appreciate new experiences whereas those people who are closed to 
experience need familiarity, simplicity, closure and utilitarianism. However open[ness] 
expression will vary among individuals due to the extent to which they express the other four
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variables. For example, open people are inquisitive, curious and conscientious. However if 
they have a low level of conscientiousness, their curiosity will be idle and the moment of 
interest will quickly pass them by (McCrae and John, 1992). According to McCrae (1996) 
openness does appear to be partially due to individual genetic basis, although life experiences 
must affect the extent of the traits, by either increasing or decreasing its prevalence.
Some academics have argued that five factors are not enough to summarise the various 
personality types, however those who are in favour of the Five Factor Model would say that 
the five factors are only meant to represent the 'highest hierarchical level of trait description' 
and therefore were not designed to explain all types of personality (McCrae and John, 1992). I 
agree that these are five broad categories but for ease of use and genera I isability, a defined 
and easy to apply number of categories are needed. Importantly, openness is not considered a 
measure of intelligence. An individual can score highly on openness to experience but have a 
low IQ (McCrae and John, 1992). However Harris (2004) found that there was a small to 
medium correlation between openness, achievement and intelligence, meaning that people 
high in openness and achievement may well have a higher level of intelligence. Harris (2004) 
therefore concludes that intelligence is related to this personality. However the causality that 
relates one variable to the other is unclear (i.e. whether intelligence is related to personality or 
vice versa). It might be that those nurses who have adopted genetics/genomics into their 
practice are either open to new ideas because they are intelligent, or open to new ideas 
because it is part of their personality.
5.5.2 Openness to Experience in society
McCrae (1996) states that Openness to Experience most centrally influences social and 
interpersonal behaviour. Personal traits in openness can have powerful influences over 
politics, culture, friends and family life. Political tendencies are often linked psychologically. 
Conservative individuals often have conventional morals, rigid and unadventurous behaviour 
and visually prefer simple and regular ideas (McCrae, 1996). Those who that lack openness 
can become patriotic. They obey the rules and expect others to do the same and advocate 
strict punishment if they do not conform. More liberal views are attractive to those who are 
open. However it needs to be pointed out that this is a generalisation. Van Hiel and Mervielde 
(2004) found that a high level of openness was strongly linked with conservative ideology, 
however this relationship is stronger for cultural conservatism than economic conservatism. 
When involved with public policy making, open and closed individuals will find it hard to work 
together as they enter into the relationship with different values and style. Therefore they will 
automatically get on better with those individuals who have a similar level of openness to 
themselves (McCrae, 1996). This is also the same when it comes to organisational settings.
Page | 123
George and Zhou (2001) looked at the openness to experience levels along with creativity level 
in 149 employees from a petroleum company. Those who had a high level of openness 
produce novel and creative ideas and solutions (n= 149/200), where as those who had a low 
level of openness followed tried and tested ways of achieving that increase levels of certainty. 
It has been shown that creativity is strongly and consistently related to Openness to 
Experience, although other personality factors will have an effect on the way Openness to 
Experience is expressed through creativity (McCrae, 1987). McCrae (1987) has suggested that 
those who are open to experience train their divergent thinking minds over time through 
practice. In contrast, such skills have been lost to the closed individual over a lifetime. 
Therefore, it could be that openness linked to divergent thinking is more strongly correlated in 
older people than younger (McCrae, 1987). Those who are interested in new ideas and have 
flexible cognitive processes may be more likely to develop a portfolio of varied experiences 
(McCrae, 1987). It might therefore be that the less open, older nurses are the most reluctant 
when it comes to implementing genetics/genomics.
It has been shown that open people tend to find those people who are less open than 
themselves boring and intellectually undemanding and closed people are bored due to the 
difficult and pretentious culture of open people (McCrae, 1996). Costa and McCrae (1988) 
have suggested this could be due to openness being linked to intelligence which is linked to 
cognitive abilities which are known to be stable. It therefore appears that age has little effect 
on personality, hence data collected from nurse adopters and opinion leaders is likely to be 
consistent and age independent. It might well be that nurse adopters and opinion leaders 
have close knit groups, due to their like-mindedness.
Openness to Experience and workplace creativity
It is believed that certain work place situations can stem an open person's creativity by 
constraining their potential (George and Zhou, 2001). Therefore one could carefully craft a 
work place environment that allows those who are open to experience to grow their creativity 
and thought processes, whilst also allowing those who are not open to experience to work 
within clearly defined structures and task orientated environments which allow them to feel 
secure. In conditions where following rules and conformity are encouraged, conscientiousness 
will increase, which will lower the level of openness in individuals (George and Zhou, 2001). 
Unsupportive co-workers can also limit creative behaviour and endorse conformity (George 
and Zhou, 2001). Communication from colleagues can encourage creative behaviour because 
it increases their knowledge and understanding of work processes and provides reassurance 
that their creative ideas will be heard and acted upon (George and Zhou, 2001). This will be 
where opinion leaders will be important within this body of work. Popper and Amit (2009)
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found that the way leaders interacted (i.e. were supportive or responsive) with 
supporters/followers influenced anxiety and openness to experiences in leaders which in turn 
were related to leadership experiences (n=286). Anxiety level was found to be a negative 
predictor of openness to experience and leadership relations. Openness to experience is 
common among leaders; however family conditions and leadership experiences also have an 
effect on leadership. It was found among nurses that those nurse managers with a strong 
open mindedness were more willing to allow staff nurses to incorporate suggestions that differ 
from their own into processes that govern practice (n=144). This therefore creates a more 
collaborative environment for all involved (Zori et al, 2010). However, this approach might 
work in a small unit or GP practice, but whether this type of work environment is feasible in a 
large NHS hospital environment is debatable. The NHS does work to strict guidelines and, 
alongside resource constraints, perhaps does not have the flexibility to support creativity.
King et al (2008) studied clinical experience, motivation and openness to experience compared 
to the development of expertise in paediatric rehabilitation therapists, through contrasting 
novices and experts. They found that those experts with less clinical experience had a greater 
level of openness and richer/deeper clinical experiences, similar to high experienced novices 
(n=71). Perhaps not surprisingly, low experienced novices had lower openness to experience 
and motivation (King etal, 2008). The highly experienced novices and low experienced experts 
did not differ in openness to experience and motivation. Therefore King et al (2008) suggest 
that openness to experience does not correlate with the development of proficiency. Despite 
the conclusion that King et al (2008) made, it could be argued that in order for the experts with 
lower experience to get to their work position required some level of openness to experience 
that would have been initially important in developing their expertise. It could be conjured 
that the reason the high experienced novices and low experienced experts had similar scores is 
because they are on a similar platform - the two balance each other out. King et al (2008) 
conclude by stating that openness to experience may be necessary in the development of 
expertise but does not provide a sufficient overall explanation. I agree with this statement as 
Openness to Experience is not the sole requirement for the gaining of expertise. It might be an 
important factor in whether a nurse chooses to adopt genetics into practice or is an opinion 
leader, but it is unlikely to be the sole characteristic of these individuals. A wider level of 
variables is required.
Restricting Openness to Experience
Openness to Experience can be restrained by the lack of resources and materials (Moss et al, 
2007). Companies often seek to employ individuals who are creative and think divergently. 
However if employers do not provide the needed resources, employees' capacity can be stifled
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(Moss et al, 2007). Employees of public service organisations who have a high level of 
openness to experience but feel as though they should conform to procedures are likely to be 
less committed to the organisation. However Moss et al (2007) found that when resources 
were increased (i.e. materials and equipment) open individuals were more committed to the 
company (n=1517). Basically the fewer resources the company has the less likely open 
individuals will feel as though they can be creative, which will impact upon their commitment. 
Nurses do have a number of genetic/genomic resources available to them, but the support and 
resources open to the opinion leaders may also be important. Resources such as staffing 
numbers, workload and educational opportunities may all affect an individual's openness to 
experience. If the leaders within the organisation provide confidence and hope, otherwise 
known as transformational leadership, then these types of leaders should promote 
opportunities for openness among their colleagues (Moss et al, 2007).
Justification for the use of the Openness to Experience
Openness to Experience is one of the Big Five personality traits (McCrae, 1996). Part of this 
theory has been discussed, due to its association with opinion leaders and adopters (McCrae, 
1996). Openness to Experience is considered to be the universal dimension of personality 
(McCrae, 1997) and may help to identify nurse genetic adopters. The Openness to Experience 
trait will be used to aid the identification of opinion leaders and adopters in this study, 
recognising the importance of including components of personality in order to determine if it 
is relevant to this subject area.
5.6 Linking the theories
The theories discussed here interlink and may each be relevant to understanding the diffusion 
of genetics/genomics into nursing practice. They are all important in their own right and all 
need to be considered, although some of the theories have a greater role to play in this 
research. The Diffusion of Innovations theory (Section 5.1, p77) and Opinion Leadership 
(Section 5.2, p94) are of particular relevance to the research due to the nature of the study 
aims. The Theory of Planned Behaviour (Section 5.4, pl!2) provides an understanding of how 
the attitude of an individual, the pressure from society and the perceived ease or difficulty of 
the behaviour affects the diffusion of an innovation. The Stages of Change theory (Section 5.3, 
p!03) provides a simple description of how an individual goes through the adoption of an 
innovation and Openness to Experience (big five model) (Section 5.5, p!21) may aid the 
understanding of why certain individuals adopt an innovation quicker than others. The 
theories can be interconnected at various points and placed in a possible sequential order.
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The theories can be placed in a possible sequential order depending on how they could be 
utilised in the implementation of genetics/genomics into nursing practice (Fig 5.18). The 
Diffusion of Innovations is the logical first theory due to the nature of the research, which is 
the implementation of genetics/genomics into nursing practice. Opinion leaders provide a 
means by which the innovation can be communicated to others and the Diffusion of 
Innovation theory and Opinion Leadership are closely related. Opinion leaders provide the 
theoretical link between the innovation and the individuals who will be implementing it. They 
can help to persuade and provide knowledge to those who are unsure about the innovation. 
Openness to Experience can be related to opinion leadership and early innovators as it may 
help to explain why some individuals adopt an idea before others do. When compared to the 
other four theories, Openness to Experience is different, however personality traits are 
inherent to an individual and are brought to every situation. Hence it is relevant for 
understanding the characteristics of those nurses who adopt genetics/genomics. The Stages of 
Change theory can help to explain the different levels of innovation implementation that 
people are at and provides a simple behaviour change path. The Theory of Planned Behaviour 
can help to explain the social pressures and attitudinal effects on an innovation. The Theory of 
Planned Behaviour could be considered the last link before the innovation is diffused, due to 
its ability to identify the perceived ease or difficulty of incorporating the innovation, the 
societal pressure towards the innovation and the overall ability to predict an individual's 
behavioural intention.
Sequential order of theories (Fig 5.17)
1. Diffusion of Innovations - The innovation is the beginning point. There needs to be an 
innovation in order to have an attitude towards it and a social pressure to perform the 
behaviour or not.
The persuasion and decision stages of the Diffusion of Innovations are associated with 
opinion leadership because it will require individuals to agree with the innovation and to 
begin to implement it. Opinion leaders also need to be open to experience in order to be 
successful in implementing the idea. Diffusion of Innovation is linked to the Stages of 
Change theory as the decision and implementation stages of the Diffusion of Innovation 
mirror the preparation and action stages of the Stages of Change.
2. Opinion Leadership - influence social pressure and the Stages of Change
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Opinion leadership is related to the Theory of Planned Behaviour through subjective norms 
because opinion leaders will impact social pressure to perform a certain behaviour, or 
subjective norm will impact who is considered an opinion leader.
3. Open to Experience - those more open to experience, may adopt the innovation 
quicker than others
4. Stages of Change - how people decide to implement an innovation
The Stages of Change Theory is connected to the Theory of Planned Behaviour through 
perceived behavioural control as the action and maintenance stages will be dependent on 
the perceived ease of performing the behaviour.
5. Theory of Planned Behaviour - attitude and social pressures affect whether the 
innovation is performed on a wide scale
The Theory of Planned Behaviour could influence the Diffusion of Innovations through 
attitudes and perceived behavioural control. Attitudes towards the innovation and social 
pressure will affect decisions to implement an innovation.















Chapter five provides an understanding of the way in which new ideas spread throughout a 
social system and the many influences that affect the rate of adoption. Each of the five 
theories has a unique identity and provides a different perspective on diffusion, although they 
can also be interlinked. The Diffusion of Innovation theory shows how new ideas are 
implemented into a network, which supports the main aim of the study to facilitate the 
incorporation of genetics/genomics into nursing practice. The non-adoption aspect of the 
innovation will also provide important analysis of the process of nurses adopting 
genetics/genomics into practice. Identifying opinion leaders are one of the main aims of the 
project. Opinion leaders are often used to promote behaviour change (Valente and 
Pumpuang, 2007) and it is hoped that this will be a useful tool of diffusion for 
genetics/genomics within nursing. Opinion leaders are often well respected staff members 
who would be an important influence for many nurses. The Theory of Planned Behaviour will 
aid the understanding of what influences nurses on adoption of new ideas. Some aspects of 
subjective norm (social pressure) will be addressed when identifying those individuals who 
have adopted genetics/genomics into practice. Openness to Experience (Five Factor Model) 
will aid the identification of the personality traits of nurse adopters of genetics/genomics. 
Understanding the relationship between the discussed theories and how they can be related 
to a potential process for genetic/genomic integration into nursing practice, allows for the 
identification of components that can be identified and measured with nurses in the hope of 
identifying those characteristics that are significant to genetic/genomic integration within 
practice. The study methodology, questionnaire design and data analysis will be discussed in 
Chapter six in the aim of identifying nurse genetic adopters and opinion leaders.
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Chapter 6. Methods
This study takes a mixed methods approach that was predominantly survey based and 
conducted in two phases. Phase one of the study involved asking genetic and healthcare 
experts for their views and opinions on four potential Genetic Indicators of Adoption (GIAs) 
that could be used to identify nurse adopters of genetics/genomics. A literature review and 
focus group also provided guidance for Phase one. Phase two of the study identified nurse 
adopters and opinion leaders of genetics/genomics in practice using the GIAs selected through 
the consensus of experts gained in Phase 1. This chapter will set out the aims of the thesis, the 




The initial research question of the thesis aims to identify adopters and opinion leaders of 
genetics/genomics within nursing. Characteristics of opinion leaders have been identified by 
Valente and Davis (1999) as those individuals who accelerate the Diffusion of Innovations (in 
this case the innovation of genetics and genomics); they act as role models and enhance rapid 
and sustained behaviour change. Opinion leaders often adopt an idea before the majority do 
(Valente and Pumpuang, 2007) and it is known that the first group to adopt an innovation are 
not opinion leaders but 'innovators' or the adopters of an idea (Rogers, 2003) (see chapter 5). 
Therefore as part of this thesis it is important to distinguish between nurse adopters and nurse 
opinion leaders when identifying nurses who may be willing to collaborate in promoting 
engagement in genetics and genomics. Nurses are being targeted as potential change agents 
in the present study because they are the largest sector of the NHS workforce and because it is 
likely that they spend the most time in direct contact with patients and their families. The 
scale for integrating genetics/genomics within nursing practice is large and there is a need to 
maximise the translation of evidence in a complex environment.
Through identifying the characteristics of these opinion leaders and adopters it is hoped that 
this information could be applied to nursing departments and initiatives to enhance the 
diffusion of genetics/genomics into nursing practice. The aims of the thesis are to:
1. Articulate the identifying characteristics of a nurse adopter of genetics/genomics 
through an expert consensus
2. Identify nurse adopters and opinion leaders of genetics/genomics
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3. Identify the factors and processes that might facilitate or inhibit the adoption of 
genetics/genomics into nursing practice
4. Apply knowledge and understanding about the identified groups gained through the 
study to three behaviour change theories in order to formulate potential applications 
for how the characteristics of those individuals who are adopting genetics/genomics 
could help inform the strategies of other societies and organisations seeking to engage 
nurses (and other health professionals) in genomic healthcare.
The research is split into two Phases (see Fig 6.1.) and seeks to answer the following research 
questions.
1. What are the identifying characteristics of a nurse adopter of genetics/genomics? 
(Phase land 2)
2. What sets nurse opinion leaders apart from nurse adopters? (Phase 2)
3. What are the barriers to adoption of genetics/genomics by nurse? (Phase 2)
4. How can an understanding of the characteristics of nurse adopters and opinion leaders 
be utilised within their practice field to promote the incorporation of 
genetics/genomics into nursing practice? (Discussion)
6.1.2 Literature Review
Databases and search terms
A literature review was undertaken between April 2009 and March 2012 in order to ascertain 
the research that has already been conducted in this topic area and to gain insight into various 
aspects of genetics/genomics in healthcare and behaviour change theories. The first phase of 
the literature search focused on the underpinning theories of the research. 
The databases searched were:
CINAHL Google Scholar Web of science
EMBASE Medline National Library for Health
Web of Knowledge Psychlnfo British Humanities Index
Pubmed Pubmed central Directory of Health Organizations
Cochrane Science direct Free Medical Journals
Mantis UK Pubmed central Healthcare Republic
Maternity and Infant Care Social Sciences Citation Index Business Source Premier 
ProQuest
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Fig 6.1. Flow diagram illustrating the two Phases of the study
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(Discussion)
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The search terms used within the above databases, were combined together along with 
various adjectives to include all research areas (see appendix 1 for literature search terms and 
statistics). Additional references were identified from reference lists on individual papers and 
sourced directly.
Exclusion and inclusion criteria
In literature reviews focusing on areas of healthcare (chapters three and four), papers were 
excluded if they focused on a participant group not involved in healthcare. For literature 
reviews focusing on education (chapter four) papers included studies that focused only on 
genetic/genomic education among healthcare professionals. Papers were limited to 
healthcare professionals' views towards genetics/genomics and genetic/genomic education 
resources available for healthcare professionals. The language of articles searched for was 
limited to English due to the lack of translational resources. This is thought to result in the 
exclusion of little relevant literature as for many journals the primary language is English. The 
date parameter for all literature reviews was set post 1990 due to genetics/genomics being an 
area that is constantly evolving, however if the search terms included recent scientific 
knowledge or newly formed organisations, the date was increased to 2000. Exceptions were 
made for theories or scientific discoveries that were well documented and were established 
pre 1990. An overview of the four literature reviews can be seen in Figure 6.2.
Fig 6.2. Literature reviews underpinning specific chapters of the thesis
Chapter 2: Genetics, genomics, health and society 
Development of genetics 
Importance of genetics 
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Legal, ethical and social issues of genetics
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Diffusion of Innovation 
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Opinion leaders 
Stages of Change theory 
Theory of Planned
Chapters: Nursing role 
and service provision
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historyLiterature 
reviews NHS and genetics - 
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Chapter 4: Genetic nurse education 
Genetic education provision for nurses 
Attitudes to genetic education 
Strategic approach to genetic education
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Strategy for grey literature searching
Grey literature includes policy documents, reports, dissertations, conference abstracts and 
theses (Cook et al, 2001) that have not been published through a peer-review process. 
Including grey literature in reviews has been criticised as it is thought by some that the validity 
of the data is not always known and that it is often not peer reviewed (Conn et al, 2003). 
However grey literature should be included in research reviews because in order to truly 
reflect the evidence base all available arguments and information need to be included, not just 
the obvious and easily available evidence. Excluding grey literature can over-represent studies 
with statistically significant findings. It has been shown that methodological rigor does not 
differ between published and grey literature (Conn et al, 2003). In this study, areas of grey 
literature have provided a different view and aspect to the argument and knowledge base. In 
nursing, grey literature is particularly important as many of the reports and professional policy 
documents are not available on standard databases. For example, without grey literature 
searching important documents such as the UK Government Department of Health's White 
Paper report into the potential of genetics (2003) and the Human Genomics Strategy Group's 
report into genomic technology (2012) would not have been identified. These reports are 
written by experts and expert advisory panels and often bring together viewpoints that are not 
found in research publications. Figure 6.3 shows the strategy for grey literature searching for 
this research project.






















*WorldCat - The Worlds largest network of library content and services. WorldCat connects to the 
collections and services of more than 10,000 libraries worldwide.
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6.1.3 Research Tools
A web based questionnaire was chosen as the main tool used for Phase 1 and 2 of the study 
because a large sample size needed to be targeted in order to gain a consensus on the 
identified behaviours and activities and to subsequently utilise them to identify nurse adopters 
and opinion leaders. This could have been achieved using other data collection methods such 
as a Delphi or Nominal Group approach. A Delphi approach would have allowed results to be 
anonymous among the group (Keeney et al, 2011), however this approach was deemed to be 
too lengthy and time consuming. A Nominal Group approach would have allowed participants 
to discuss the issues in a very structured way and then to share their consensus choice (Keeney 
et at, 2011), however this was decided to be too expensive and would have limited the number 
of participants. Due to the need to gain a consensus a quantitative method using an online 
questionnaire was deemed the most appropriate approach.
6.1.3.1 Advantages and disadvantages of questionnaires
The use of questionnaires as a data gathering method has both advantages and disadvantages. 
Questionnaires are a commonly used tool because they are often more precise and focused 
than other methods such as interviewing and observation (Jones et al, 2008). They are 
perhaps less likely to be prone to social desirability bias if they are not delivered face to face.
Advantages
Self-completion questionnaires (respondents complete the questionnaire in their own time 
without supervision) have several advantages. In particular; it is low in cost compared to face 
to face interviews (McColl et al, 2001) or Nominal group techniques. Questionnaires do not 
require travel costs, room hire and equipment costs. Questionnaires (dependent on how they 
are distributed) can target a large, diverse population. There is no limit on geographical area 
and to some extent sample size. Context and history effects are minimised due to the majority 
of respondents receiving the questionnaire at a similar time. As the respondents have no 
direct contact with the researcher, the effect of researcher bias is minimised and respondents 
may be more likely to be open and honest in their responses as they have no direct contact 
with the researcher and can be anonymous (McColl et al, 2001). Questionnaires provide 
minimal intrusion for a participant and produce quick and timely data in contrast to for 
example a Delphi survey (Burford etal, 2009).
Disadvantages
Although they are relatively quick to use at the data gathering stage, questionnaires are time 
consuming to develop. The process of questionnaire development is iterative, requiring
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checking (for content validity) and piloting and this can take many months. In the cases where 
questionnaires are returned hand written, transcription and deciphering respondents' 
handwriting can be time consuming and possibly expensive (Jones et al, 2008). The use of 
questionnaires relies on respondents having good literacy skills, sufficient for them to 
complete the questionnaire (McColl et al, 2001). Questionnaires come with the assumption 
that the researcher and respondent share the same interpretations about language and 
statement wording (Rattray and Jones, 2007). Self-completion questionnaires do not allow for 
an opportunity to pursue questions, clarify misunderstandings or understand unwillingness to 
answer a particular question. A questionnaire can easily be mislaid or forgotten about and 
often those that respond are those with an interest in the topic, therefore the view of 
respondents could differ significantly from those of non-respondents (McColl et al, 2001). 
Researchers are not aware who has actually completed the questionnaire and whether they 
have consulted others (McColl et al, 2001). Finally, questionnaires are also notorious for low 
response rates (Jones et al, 2008).
Enhancing response rate
There are various methods of enhancing response rates, such as formatting and incentives 
styles. Questionnaire length needs to reflect the research topic being addressed to a particular 
community. For example questionnaire length needs to be kept to the minimum length 
possible but if the topic is of particular and relevance or interest to the participant group then 
the length can be extended (McColl et al, 2001). Burford et al, 2009 suggests that if the 
questionnaire is being aimed at two different groups, wording of the questions may need to be 
different. Appearance and layout of the questionnaire can have an effect on the respondent's 
decision on whether to respond (Meadows, 2003). Maintaining a consistency throughout the 
questionnaire in relation to writing style, vertical response format and font size can help in 
response rates. It has also been shown that using the format of circling rather than a tick box 
can help with questionnaire response rates (McColl et al, 2001). The use of added colour to 
the questionnaire can also be beneficial and for open ended questions, using blank spaces 
instead of writing lines. Burford et al, 2009 suggest 'selling' the questionnaire to participants 
through the use of a covering letter and stressing confidentiality. Multiple contacts with 
participants can increase response rates in a similar way to reminders (follow up contact) by 
up to 10% (Burford et al, 2009). Incentives have proved to have a positive effect on response 
rates, with financial incentives being the most effective (McColl et al, 2001).
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6.1.3.2 Web Questionnaires
Web questionnaires, like postal questionnaires, have their advantages and disadvantages. The 
key issues of using web based questionnaire are IT literacy, financial cost and response rates. 
Using web questionnaires will assume that all respondents are IT literate in order to complete 
the questionnaire. This is also an issue for the researcher. In order to create a valid and 
reliable questionnaire online, some IT knowledge and understanding is required (Jones et al, 
2008). Even if a researcher has competent IT skills, technical problems and a range of different 
browsers cause the researcher to have little control over how the questionnaire appears to the 
respondent (Vehovar et al, 2008). Using an online questionnaire could therefore automatically 
limit the sample size and sampling method used. Having correct contact details for 
participants (if required) can also become an issue as well as having to manage an online 
system (Burford et al, 2009). Online questionnaires are synonymous with respondent drop- 
outs. Although a negative aspect of online questionnaires are respondents not completing 
questionnaires, web survey software can allow the researcher to measure the point of drop 
out and to still collect the date provided up to that point (Vehovar et al, 2008). Faster receipt 
of responses may be obtained from online questionnaires as opposed to paper based 
questionnaires (Burford et al, 2009) and there is also no risk of the questionnaire being lost in 
the post. It does not appear however that respondent answers to sensitive questions differ 
between online and paper questionnaire (McColl et al, 2001). Web questionnaires (used in 
both phase 1 and 2 of the study) have an advantage over other self-completion techniques 
because they are relatively cheaper than other methods such as postal questionnaires (Couper 
and Miller, 2009).
6.1.3.3 Validity and reliability of the questionnaire
Reliability refers to the reproducibility and consistency of the data being collected. It includes 
the homogeneity of the instrument and whether it is free from random error (Bowling, 2009). 
Repeatability can be assessed by test-retest methods, where the instrument is measured over 
a time period where nothing is expected to change (Bowling, 2009). Reliability can be 
measured through various statistical tests including Cronbach's alpha that measures the 
internal consistency of subscales (Bowling, 2009). Internal consistency is a form of reliability 
and involves measuring how connected the questions are to the particular concept (Meadows, 
2008).
Subscales were only present in questions one and 16 (openness to experience and opinion 
leadership scale) taken from previous published tools (see table 6.3, p!40) for which 
psychometric data is available, including internal consistency. Cronbach's alpha was calculated 
to test the reliability of these two questions using the Phase 2 data. The remainder of the
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questionnaire includes very diverse questions (e.g. free text, yes/no questions, ranking 
questions) that are measured in different ways and the use of Cronbach's alpha on these was 
therefore not appropriate. In addition the small sample size of the Phase 2 pilot questionnaire 
(n=14) would not have provided meaningful data. Test-retest reliability could have been 
employed for the Phase 2 questionnaire however, but could not be conducted as the 
questionnaire was completely anonymous, hence not allowing participants to be re-contacted.
Validity refers to whether an instrument measures what it aims to measure. Validity is 
achieved when an instrument has been satisfactorily tested repeatedly in the populations for 
which it was designed (Bowling, 2009). This is known as internal validity. A pilot study in 
Phase 1 and the use of previously used questionnaire questions and a pilot study in Phase 2, 
meant internal validity was verified. Content validity refers to whether the questions are 
understandable and relevant to the target group (Meadows, 2008; Burford et al, 2009), this 
was achieved in phase 1 and 2 of the current study through expert panels including ethics 
committees and expert colleagues.
External validity refers to the generalisability of research results to a wider population. 
External validity can be increased by increasing the sample size, which is turn increases the 
power of results, and a correct sampling technique to avoid bias. A poor response rate can 
also lower external validity as the results are less generalisable (Bowling, 2009). External 
validity is somewhat linked with questionnaire design and cannot always be controlled if 
dependent on sample size. External validity was verified in Phase 2 for those questionnaire 
questions that were previously used in other questionnaires. Face validity involves the 
investigator's subjective assessment of the relevance and presentation of the questionnaire 
(Bowling, 2002). Face validity was completed for both Phase 1 and 2 questionnaires, as the 
research team and experts in the field reviewed the questionnaire.
The methodological approach for Phases one and two will be discussed below, including 
questionnaire design, participant recruitment and data analysis. This includes the approach 
taken for the literature review, as this knowledge informed Phase 1 of the study.
6.2 Phase 1
6.2.1 Phase 1 Questionnaire
Phase 1 sought to gain consensus on behaviours and activities that would indicate whether a 
nurse has adopted genetics/genomics as a routine part of their role. Phase 1 aims were to:
1) Articulate a minimum number of activities/behaviours which experts could agree 
would identify nurse adopters of genetics/genomics
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2) Identify whether the basic tasks described are accurate for nurses in a variety of 
practice situations and whether others should be incorporated
3) Indicate whether and how criteria of an adopter should be revised for clarity
4) Inform future stages of the research process
In order to give meaning to the term 'adopter of genetics/genomics' and to ensure it was 
widely recognised and agreed upon by an expert community, a consensus was sought from 
experts in specialist genetic services. Without this consensus the term was liable to be subject 
to possible researcher bias. Phase 1 used a questionnaire and the data were then used to 
assist in the creation of the project's main survey tool to identify nurse adopters and opinion 
leaders within genetics and genomics.
6.2.1.1 Genetic Indicators of Adoption (GIAs)
The GIAs were selected for expert consensus and outline what indicates a nurse adopter of 
genetics/genomics. Three behaviours and activities (a, b and c) were selected from the UK 
Workforce Competences for Genetics in Clinical Practice for Non-Genetic Healthcare Staff 
(NGEDC, 2007) as they had been developed by a wide range of individuals in healthcare. The 
fourth behaviour/activity (d) was written specifically for the study, through collaborating with 
the supervision team and experts in the field of genetics and nursing, in order to have a 
behaviour that encompassed all areas of the nursing role and not limited to specific nursing 
roles and tasks.
GIAs - Genetic Indicators of Adoption
a. To know how to access genetic services and would make active use of them
b. To be able to provide information of support services to patients or their families 
with or at risk of a genetic condition
c. To ask patients relevant questions about their family history
d. To be open to the possibility of genetics/genomics in all aspects of care
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6.2.1.2 Selection of expert participants
The inclusion criteria of those asked to respond to the first questionnaire were very specific 
because the group of participants needed to be experts in the field of genetics/genomics and 
healthcare and has a particular focus on perspectives of nursing. It was felt that AGNC 
members could offer this level of expertise by virtue of their membership. The questionnaire 
was dealing with issues that were reasonable to expect members of the AGNC to have an 
opinion on. It could be argued that a sample of AGNC members was a purposive sample, the 
members of the AGNC were deemed to be typical of genetic and healthcare experts (Brett 
Davies, 2007). The Association of Genetic Nurses and Counsellors (AGNC) had a total 
membership of 310 at the date of questionnaire dissemination (05/2010) and these members 
include genetic nurses and counsellors. A sample size was calculated to identify the number of 
participants needed to give a statistically significant result, however the sample size calculated 
was large in relation to the number of participants expected to be recruited.
6.2.1.3 Sample size
The sample size was calculated through an online sample calculator
(www.survevsvstem.com/sscalc.htm). The sample size was calculated using the parameters 
detailed in table 6.1.












The required sample size was 172, to provide overall significant results. For detail of the 
sample size calculation see appendix 3.
6.2.1.4 Demographics
Demographic questions included in the questionnaire were restricted to relevant data items:
• whether respondents were practising genetic counsellors or nurses
• whether respondents were from a nursing background
• how long respondents had worked in genetic/genomic services
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Addington-Hall et al (2007) make it clear that it is easy to include questions that are interesting 
to the researcher but not necessarily essential for answering the study's hypothesis. I have 
aimed to include relevant questions only; hence the questionnaires have been kept to a 
minimum.
6.2.1.5 Phase 1: Developing the questionnaire
The aim of the initial questionnaire was to define a set of criteria for the identification of nurse 
adopters and opinion leaders of genetics/genomics. Genetic Indicators of Adoption (GIAs) 
were selected and modified from a number of statements that make up the UK Workforce 
Competences for Genetics in Clinical Practice for Non-Genetic Healthcare Staff (NGEDC, 2007). 
These were presented to the experts through a questionnaire. The Phase 1 questionnaire was 
created using Bristol University's Online Survey software (http://www.survey.bris.ac.uk/).
The questionnaire utilised a range of question formats (Table 6.2, See appendix 4, for full 
questionnaire). Question response options included scaled responses, open questions, 
scenario comments and ranked responses. Brannen (2005) suggests that mixing qualitative 
and quantitative approaches can address a variety of questions in a research proposal and that 
having a mixture of open and closed questions allows the researcher to gain a better 
understanding of the issues raised by the research area. There were three different variations 
of quantitative question format:
1) Closed questions (selected responses) -Selected responses (i.e. yes/no response) are 
known as being a simple approach for factual and opinion questions (Gillham, 2000). 
Closed questions are pre-coded before the questionnaire is disseminated and are a 
straight forward way of gaining a consensus.
2) Ranked responses- e.g. respondents were asked to rank from 1-8, various facilitators 
of genetic/genomic adoption. Ranked responses are useful for gaining knowledge on 
people's judgements and allows an understanding of the relative merits of the 
different items (Gillham, 2000).
3) Likert scales - e.g. respondents were asked to answer either strongly agree, agree, 
unsure, disagree or strongly disagree to various barriers towards genetic/genomic 
adoption. Scaled responses are commonly used, although people do not often use the 
whole scale and tend to be more or less positive than they actually are (Gillham, 2000).
Open questions have been used occasionally throughout the questionnaire; McColl and 
Thomas (2000) point out that open questions need to be kept to a minimum in self-completion 
questionnaires as respondents often do not fully answer these types of questions. However 
they have the advantage of gaining well-established views on the subject being asked (McColl
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and Thomas, 2000). Almost half of the questions in the questionnaire were open questions, 
they were included because it was believed that they would add depth and understanding to 
the quantitative responses.
6.2.1.6 Question content
For each GIA, respondents were asked;
a) Whether they thought all nursing staff could be expected to satisfactorily undertake 
the GIAs
b) If a nurse could be considered an adopter by demonstrating a certain activity and 
behaviour
c) If the GIA should be included as an indication that a nurse has adopted 
genetics/genomics into practice.



















• Yes/no questions 
• Likert scale 
• Open questions
• Yes/no questions 
• Likert scale 
• Open questions
• Yes/no questions 
• Likert scale 
• Open questions
• Yes/no questions 
• Likert scale 
• Open questions
• Yes/no questions 
• Likert scale 
• Open questions
• Yes/no questions 
• Open questions
• Ranked response 
• Open questions
It was anticipated that by asking these questions, I would get a clear indication of the 
necessary inclusion/exclusion of each activity and behaviour. Respondents were also asked 
whether all four GIAs applied to all nursing groups and if all GIAs should be used collectively to 
identify a nurse adopter. In addition participants were asked whether certain barriers and 
facilitators identified by Kirk et al (2008) were relevant to the (non) incorporation of
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genetics/genomics into nursing practice. Participants were asked to rank the facilitators and 
agree/disagree with the barriers.
For question five (see appendix 4) respondents were provided with a scenario and asked to 
illustrate what GIAs they would be considering in a nurse who has adopted genetics/genomics 
into their practice. The use of a scenario question followed by an open answer is one that 
Brett Davies (2007) advises not to use because he argues that none of us know how we would 
respond accurately when in a given scenario. However in this study I felt that due to the need 
for experts to make an informed statement of what they believed a nurse adopter of 
genetics/genomics would look like, a scenario was deemed appropriate.
6.2.1.7 Formatting the questionnaire
The online questionnaire was created using the Bristol Online Survey (BOS) software. The 
format of the Phase 1 questionnaire was restricted to the fixed layout of BOS, in terms of 
colour and logos (Fig 6.4). However, these limitations were far outweighed by the benefits, 
which included easy access to participants, time management and low costing. The format 
provides a layout that is simple to read and follow.
The initial page of the questionnaire included background information about the research, an 
explanation of why the participants had been chosen and questionnaire instructions. 
Participants were informed of the approximate length of time the questionnaire would take 
and issues surrounding confidentiality. Because the questionnaire was anonymous, return of a 
completed questionnaire was taken as an indication of consent.
6.2.1.8 Piloting
The piloting process was vital for assessing the validity and reliability of the questionnaire. It is 
known that pilot testing an instrument allows for the identification of measurement errors and 
can focus on minimising these (Kimberlin and Winterstein, 2008). The questionnaire was 
piloted with colleagues at the University of Glamorgan (n=5). This group was deemed suitable 
for piloting because they had experience in questionnaire design and were easily accessible. In 
the current study, piloting identified errors in grammar and software problems and allowed for 
alterations to be made in the questionnaire to provide more clarity in certain questions. I was 
able to change the wording on some questions and to add examples to questions where 
needed. Piloting also allowed a more exact estimation of the time it would take to complete 
the questionnaire. There were no overall negative comments received from the pilot or at the 
final data collection phase about the BOS website or the questionnaire itself.
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Fig 6.4. Screen shots of final questionnaire developed using Bristol Online Surveys
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Section 1: Background Information
This section contains details about you and is helpful lo find out about the respondents who complete this questionnaire.
1, Are you a practising Genetic Counsellor? (Optional) 
OYes ONo
2. Are you from a nursing background? (Optional) 
OYes ONo
3. Are you a practising genetic n 
O Yes O No
;e? (Optional)
4. Please indicata how long you have worked in genetic 





6.2.1.9 Distributing the questionnaire
The questionnaire was aimed specifically at experts in the field of genetics/genomics and 
healthcare. The Association of Genetic Nurses and Counsellors (AGNC) were approached 
through the association's Executive Officer and Chair. The members of this association work 
regularly in the field of genetics/genomics and healthcare and have an understanding of what 
needs to be improved in this area. The members were contacted via their AGNC area 
representatives and provided with the link for the online questionnaire (see invitation email, 
appendix 5). Members were not identified by geographical location. Therefore it is possible 
that participants were located in all four countries of the UK. The members had three weeks 
to complete the questionnaire. A reminder was then sent via area representatives and the 
AGNC's Yahoo site and the questionnaire remained live for a further two weeks.
Participants were informed that responses to the questionnaire were confidential and that 
completion of the questionnaire implied consent to be involved in the study. Each returned 
questionnaire was given a unique code to maintain confidentiality. The questionnaire was 
completed and submitted online, no email or postal contact was required between me and the 
participants.
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6.2.2 Phase 1 Data analysis
Consensus for agreement of the four identified GIAs was set at 75%, in line with a previous 
nursing and genetic competency consensus panel (Kirk et al, 2003). The data were pre-coded 
when downloaded from BOS (see appendix 6 for full coding), for example yes = 1, no = 2 and 
unsure = 3. Quantitative data were analysed in Microsoft Excel and included descriptive 
statistics (e.g. percentages). The Statistical Package for the Social Sciences (SPSS) program was 
used to calculate confidence intervals for quantitative questions involving the selected 
behaviours and activities. Chi-Squared analysis was performed to identify any differences in 
the views of participants in relation to their demographics. Facilitators in question 22 
(appendix 4) were presented as ranked responses from 1-7, with one being of highest 
importance and seven being the lowest. Each response option was given a corresponding 
weighting (for example, 1 (highest importance) = 7, 2 = 6, 7 (lowest importance) = 1) and then 
ranked in order depending on the total score for each facilitator. Question 21 was also 
analysed this way following data collection. Qualitative data were grouped into common 
themes and were coded for each question.
6.3 Phase 1: Focus Group Methodology
6.3.1 Focus group
A focus group was conducted to provide clarity and gain understanding of the questionnaire 
results, in particular to supply insight to the open questions. Genetic Counsellors from a 
regional genetics centre were contacted and potential participants were contacted by email, 
with a subsequent reminder email being sent at a later date. Participants were informed that 
the focus group would be recorded and that participants would remain anonymous. The focus 
group schedule included four main areas for discussion that were generated by the 
questionnaire responses (appendix 7). Participants were provided with a handout which 
included the background of the overall research including an explanation of the three research 
phases (appendix 8). A short description of the Phase 1 questionnaire was included along with 
some of the results for the activities and behaviour consensus.
6.3.2 Data analysis
As only one focus group was conducted, a small amount of data were collected which allowed 
for a relatively simple form of thematic analysis. Thematic analysis provides pattern 
recognition within the data, it allows themes to emerge which then become categories for 
analysis (Fereday and Muir-Cochrane, 2006). Thematic analysis does not take place in a step 
by step manner but each step of the analysis overlaps other steps. Themes often emerge from 
the researcher's questions and from the narratives of the participants (Rabiee, 2004). The
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transcript is read and listened to several times to allow the researcher to identify broad 
themes being developed throughout the focus group. An overview of the questions asked 
were as follows (see appendix 7 for the full protocol):
i. Demographics of focus group attendees 
ii. General questions about the activities and behaviours (GIAs) 
iii. Specific questions regarding activity b (support services) 
iv. Using activities and behaviours collectively to identify a nurse adopter of
genetics/genomics 
v. Differences in responses between demographic groups
Following the process of consolidating themes, the quotes were taken from the transcript and 
re-arranged depending on their theme placing (Rabiee, 2004). This enabled me to see how 
each theme developed and to be able to compare different individual's comments under the 
same theme. Rabiee (2004) produced a step-by-step guide to cutting and re-arranging 
transcripts which was applied to this focus group analysis.
6.4 Phase 2 Methodology: Adoption, non adoption and opinion 
leadership
Phase 2 sought to identify the characteristics and demographic indicators of nurse adopters 
and opinion leaders of genetics/genomics using the identified GIAs from Phase 1. Data were 
collected from oncology and practice nurses belonging to various nursing associations outside 
of the NHS via the use of an online questionnaire. A £50 Amazon voucher prize draw was 
included as an incentive to all participants. The draw was completed using an online random 
number generator and the voucher was sent via post to the winning participant.
6.4.1 Research tools
A questionnaire was considered appropriate for this Phase of the research because a large 
sample size was needed to gain a generalised characteristic profile of a nurse adopter and 
opinion leader of genetics/genomics in both oncology and practice nursing fields. Due to 
having to contact a wide variety of individuals throughout the country through various nursing 
associations, a web questionnaire was used. A web questionnaire allows people to be 
contacted directly and easily without the expense of postage. Participants also have the ease 
of completing the form online in their own time without having to post it back. For advantages 
and disadvantages of questionnaires, web questionnaires and reliability and validity of 
questionnaire, see 6.1.3.1, 6.1.3.2 and 6.1.3.3 respectively.
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6.4.1.1 Developing the questionnaire
Like the Phase 1 questionnaire, the Phase 2 questionnaire was also developed using Bristol 
Online Surveys (http://www.survey.bris.ac.uk/). A similar approach was taken in Phase 2 in 
terms of closed and open questions, ranked responses and scenario questions. In order to 
practice as nurses in the UK, individual's must achieve a minimum standard of literacy and 
numeracy, therefore needing to adapt the questionnaire to those less literate was not an 
issue. Every opportunity was taken to limit the potential for a low response rate (Meadows, 
2003). The questionnaire was designed to be as ascetically pleasing as possible, which 
included consideration for the colour scheme, question layout and length (McColl etal. 2001).
The questionnaire used questions that were adapted from previously used questionnaires, this 
provides questions which have already been validated and are reliable (Bowling, 2009). 
Bringing elements together to generate a 'new' tool to identify genetic nurse adopters and 
opinion leaders was a unique aspect of the study. Table 6.3 shows the questions in the Phase 
2 questionnaire that have been utilised from previous questions and the underpinning theory. 
The Big Five Factor Model questionnaire was a long questionnaire that included specific 
questions for each personality trait. For the purpose of this study, just the Openness to 
Experience questions were extracted and used.
When measuring perceived level of influence over others, a set of questions with its own 
overall calculating system was taken from Weimann et al (2007), which had originally been 
developed by Noelle-Neumann between 1983-1985. This enabled me to identify whether 
there was a connection between opinion leadership and influence over others. Two questions 
from a questionnaire developed by Chen et al. (2008) were used in the study originally 
focusing on health educators; they were altered to refer specifically to genetics/genomics 
within nursing. These questions aimed to identify whether adopters were more familiar with 
genetic/genomic resources and also whether a specific group of individuals found it easier to 
implement genetics/genomics into their nursing routine than others.
A set of statements originally developed by Brown et al (2007) for the management of obesity 
in primary care were adapted to be genetic/genomic and nursing specific, intending to identify 
whether genetics/genomics was being grasped as an important issue for participants. A set of 
questions from Grimshaw et al. (2006) for identifying opinion leaders were adapted from being 
specific for a science environment to be relevant for nursing practice. Two questions focusing 
on aspects of the Theory of Planned Behaviour by Francis et al. (2004) were modified for this 
study, so that each scenario was relevant to genetics/genomics in nursing rather than being for
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generic medicine scenarios. These questions aimed to identify whether they were external 
influences on a nurse's decision to use genetics/genomics, such as patients or colleagues.
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The remaining questions (2, 3, 7-15, 17, 18, 22-35) were developed 'in-house' in discussion 
with the supervision team and were reviewed by experts in the field of genetics/genomics and 
nursing. The questions were created to test the genetic/genomic knowledge and skills of 
nurses as well as the different activities associated with each GIA. No previous questionnaire 
identified, had sought to ask the same specific questions that were required for the current 
study. The questionnaire incorporated a range of different question formats and was much 
longer than the Phase 1 questionnaire. Both scenarios involved cancer but it was felt that both 
practice nurses and oncology nurses would be able to relate to them. Qualitative and 
quantitative questions were again mixed to allow for a deeper understanding of participant 
responses depending on the extent of information a particular question aimed for (Table 6.4) 
(See section 6.2.1.5). There are nine different sections to the questionnaire, each focusing on 
different identifying traits of individuals or influences affecting the incorporation of 
genetics/genomics into nursing practice.
Participants were asked 35 questions (appendix 9). Questions 1-4 focused on the personality 
and characteristics of the participant, such as asking questions relating to Openness to 
Experience levels and through the use of a validated personality strength scale (Weimann et al, 
2007). The personality strength scale was developed from testing many items relating to a 
perceived level of influence one has over others.
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Stages of adoption
Distinguishing adopters from non-adopters
Identifying opinion leaders
Barriers and facilitators for adopting 
genetics/genomics
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Interest and openness to genetics/genomics
Utilisation of adopters and opinion leaders
Demographics
Questionnaire types
• Likert scale 
• Open questions 
• Closed questions
• Likert scales 
• Scenario question 
• Open questions
• Likert scales 
• Open question 
• Closed questions
• Likert scales 
• Closed questions
• Open questions 
• Ranking question
• Likert scale 
• Scenario questions
• Likert scale 
• Closed question
• Closed question
• Likert scale 
• Closed questions
Questions 5, 6 and 7 sought information on participants' knowledge around genetic/genomic 
resources, beliefs about genetics/genomics and genetic/genomic application. Questions 8-15 
were questions focused on the four GIAs. There were two questions per GIA, questions 8 and 
9 to GIA a and 10 and 11 to GIA b etc. These questions are the proposed basis for identifying a 
nurse adopter of genetics/genomics from the participants and were generated based on the 
type of activity each GIA was requesting. The questions relating to the GIAs were piloted with 
experts in genetics and healthcare as well as practice and oncology nurses. Questions 9, 11 
and 14 were closed questions, which included red herrings within the possible question 
responses allowing me to identify whether an individual had genetic/genomic knowledge or 
whether they were answered at random. Questions 17-19 aimed to define the barriers and 
facilitators that help or hinder nurses from implementing genetics/genomics into their 
practice. Questions 20-21 sought to understand whether people around participants influence 
their engagement with genetics/genomics and if so, who those people are. Questions 22-25 
sought information about how interested participants were in genetics/genomics and how 
enthusiastic they were to implement more into their practice. Questions 26-27 aimed to 
provide insight into what or who would encourage them to adopt new ideas into their practice 
and who they would most likely go to for advice.
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Demographics
Participants were asked whether they were an oncology nurse or practice nurse and how long 
they had been practising in these positions. Their current grade and their highest level of 
academic achievement were also asked. Personal details were sought such as age, gender and 
ethnicity. All of the demographics asked were deemed to be potentially important in 
differentiating the characteristics of a nurse adopter and opinion leader of genetics/genomics. 
Participants were asked a slightly more unusual demographic question; which was whether 
any member of their family has been affected by a genetic/genomic condition. It was 
suggested at the focus group that an individual's experience of a genetic/genomic condition 
may be indicative of an opinion leader or an adopter.
6.4.1.2 Formatting the questionnaire
The initial online page of the questionnaire included details about confidentiality and 
anonymity surrounding the questionnaire, background information about the research, the 
potential outcome of the research and details about the prize draw for participants.
The format of the questionnaire, as in phase 1 was limited to the font and style that BOS 
provides, however this was still clear to follow and aesthetically pleasing to the participant. 
The questionnaire was easy to access for participants through the BOS website and it was 
assumed all of the participants would be able to access a computer and answer this simple 
click/type questionnaire format due to the questionnaire being disseminated mainly through 
email and the internet.
6.4.1.3 Piloting
Sixty postgraduate oncology and practice nurses were contacted to pilot the questionnaire 
through staff at the University of Glamorgan. The practice nurse pilot participants were 
contacted via email and the oncology nurse pilot participants were contacted via their 
university tutor. The participants were sent two reminders to complete the questionnaire, 
however it was not possible to remind the pilot participants directly as they were often 
distance learners.
Fourteen participants completed the pilot questionnaire online through Bristol Online Surveys 
(BOS). These results were then analysed to identify the determinants of an opinion leaders, 
adopters and non-adopters in order calculate a sample size for the main questionnaire. The 
majority of comments from pilot participants were positive with just a few changes made to 
grammar and clarity of certain questions.
Page | 150
In addition 16 experts who either worked in the field of genetics/genomics or in 
genetics/genomics within nursing were identified mainly through colleagues at the University 
of Glamorgan and were from both the UK and US. They were approached for their opinion on 
the questionnaire and on what they felt were the least and most significant activities and 
behaviours (GIAs) out of the four approved that should be used to identify an adopter of 
genetics/genomics. The experts were sent two reminders via email asking them to complete 
the questionnaire. Some expert participants requested a phone call so they could provide 
their comments in that way. Six experts replied providing their thoughts on the questionnaire 
and what GIAs they felt should be the minimum requirements of a genetic adopter. There 
were no major changes made to the questionnaire, most were grammar and clarity changes. 
Some changes ran throughout the whole questionnaire, for example it was pointed out that 
some practice nurses do not have a manager, so where this was applicable, the term manager 
was used instead. It was also requested that greater clarity was used when talking about 
specialist services, as it was unclear whether I meant genetic specialist services or other 
specialist services. It was also suggested that when asking how long the participant had been a 
practising nurse that it was made clear whether that included years as a student nurse. 
However, both the pilot participant and expert participant processes were positive with few 
changes being made to the questionnaire as a result of the pilot.
6.4.1.4 Distributing the questionnaire
Once ethical approval was received from the University of Glamorgan it was possible to 
disseminate the questionnaire. Ethical approval from NHS R&D was not required after 
informing them of the study that would take place. Participants were contacted through 
various general nursing, practice nursing and oncology nursing associations. Many 
associations contacted participants via their newsletters, website or members forums. The 
associations were contacted via email, outlining the aims of the research and the expectation 
of participants. The associations then contacted me explaining whether they were willing to 
offer help and if so how they intended to disseminate the questionnaire.
Areas of nursing contacted
Due to nursing being such a diverse field, oncology nurses and practice nurses were the two 
areas of nurses that were included in this study. These were deemed relevant for the study 
due to the expanding involvement of genetics/genomics in cancer care (e.g. inherited cancers, 
targeting treatments etc) and the unique role a practice nurse has in treating many family 
members and the early identification of diseases. Oncology and practice nurses were 




• Royal College of Nursing (ebulletin)
• Cancernursing.org
• RCN Practice Nursing Association
• Scottish Practice Nursing Association
• Nursing Times
• Wirral Practice Nurse Association
• RCN Cancer Nursing Association
• NHS National Genetics Education and Development Centre
• Tenovus (Welsh Cancer Charity)
Colleagues were asked whether they would disseminate the questionnaire through their 
contemporaries and associates. Universities who ran post registration oncology or primary 
care were contacted; there were two in Northern Ireland, two in Wales, five in Scotland and 12 
in England.
Contacts at each organisation were sent a dissemination document including my photo and 
background information, confirmation that University ethical approval had been received and 
a link to the questionnaire (see appendix 10). Criteria such as an individual's geographical 
location, age and practice grade were deemed irrelevant. Dissemination to members occurred 
in a variety of ways depending on the organisation and included email, newsletter, regular 
publication, website and forums. The dissemination of the questionnaire was solely reliant on 
the various organisations distributing the questionnaire to their members.
Reminders were sent to as many organisations as possible. It was not possible to send 
reminders to all nursing organisations as some published the initial participant call as an article 






The sample size was calculated using data from the pilot study (n= 14). It was created by 
comparing the four identified groups (non-adopter, adopters, opinion leader, adopters who 
are opinion leaders) (see section 6.4.2.2, p!54) with their demographic results (Questions 29- 
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32 and 34). The following power calculations have been based on completing One-Way 
ANOVA and t-tests following the results of the pilot study for each demographic question. The 
effect sizes were created after analysing the pilot data to gain an understanding of the results 
that were likely and achievable in a larger scale study. The effect sizes are based on what I 
believe are obtainable given the results of the pilot study. The standard deviations (SD) were 
also based on the pilot data in order to make estimations. Setting the power at 80% is 
common and refers to the percentage chance of detecting if the effect exists. Setting alpha at 
0.05 predicts that the significance level achieved will be 0.05 or 5%, which is a common 
significance level.
How long have you been practising as a qualified nurse? (Qu 29)
In order to detect a statistical effect size of 13 years with a SD of 11 with a power of 80% at 
alpha of 0.05, a sample size of 40 subjects would be needed.
At what grade are you currently practising? (Qu 30)
In order to detect a statistical effect size of 2 grades with a SD of 1.2 with a power of 80% at 
alpha of 0.05, a sample size of 20 subjects would be needed.
What is your highest level of academic achievement? (Qu 31)
In order to detect a statistical effect size of 2 achievements with a SD of 1.25 with a power of 
80% at alpha of 0.05, a sample size of 38 subjects would be needed.
Please indicate your age. (Qu 32)
In order to detect a statistical effect size of 5 years with a SD of 5.1 with a power of 80% at 
alpha of 0.05, a sample size of 58 subjects would be needed.
Are you or any members of your family affected by a genetic condition? (Qu 34)
In order to detect a statistical difference with a power of 80% at alpha of 0.05, a sample size of 
101 subjects would be needed.
Based on all these calculations the highest number of participants needed is 101 to ensure all 
questions could detect a significant difference between groups.
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6.4.2 Phase 2 data analysis
Through BOS each participant was provided with a unique participant number. All names and 
contact details provided for the prize draw were immediately separated from the results. As in 
Phase 1 the data were placed into a coding frame by BOS upon downloading (see appendix 
11). Organising the data sets and completing descriptive analysis (i.e. percentages) was 
completed in Microsoft Excel.
6.4.2.1 Missing results
For those participants who were missing less than 10% of data, depending on the type of 
question, the data was imputed. For questions that had more than one section (such as a, b,c 
et cetera) the mean of the participant's other responses was calculated and then inputed into 
the missing question. For questions where there was only one section, the mean from all 
other participants was calculated and then inserted for the missing participant's data (Foz- 
Wasylyshyn and El-Masri, 2005). For those participants who were missing more than 10% of 
data, the individuals were deleted from the data set (Foz-Wasylyshyn and El-Masri, 2005).
6.4.2.2 Criteria for adopters, opinion leaders, genetic opinion leaders and opinion 
leaders with an interest in genetics/genomics
Prior to data being analysed, the criteria for identifying sub groups of participants (e.g. opinion 
leaders, adopters, opinion leaders with an interest in genetics) was developed along with a 
scoring system. Each identifying question was given an individual score which when added to 
the other questions, provided an overall total score that needed to be achieved by participants 
in order to be placed into a particular group, therefore a set of questions and their answers 
defined each grouping. Some questions were to define more than one group. The responses 
were automatically pre-coded by BOS upon downloading. The coding of some questions had 
to be reversed in order to provide scores that worked on a low-high numerical system (ie, BOS 
may have coded an extremely important as 1 and an extremely unimportant as 5. These 
needed to be reversed so the highest number reflected the optimum answer available). 
Genetic opinion leaders (GOLs), those who are both adopters and opinion leaders, did not 
have their own individual scoring system. The adopter and opinion leader scoring system was 
used for these individuals and then if they scored according to the category cut off for both 
then they were considered a genetic opinion leader. The scoring system for adopters can be 
seen in table 6.5, opinion leaders in table 6.6 and opinion leaders with an interest in genetics 
in table 6.7.
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Interest in new 
areas of genetic
Answer/Response
'Agree' or 'strongly agree' for all questions apart 
from strongly disagree or disagree for 1G and 11.
'Very familiar' or 'completely familiar' for all 
questions apart from including somewhat familiar 
for 5B and 5E.
Either 'strongly agree' or 'agree'. 6c was not 
included in the scoring.
7i) the top three boxes 
7ii) 'somewhat likely' or 'extremely likely' 
7iv) the top five boxes
Had to answer '!' (very relevant) or '2'
At least two correct questions, with minus one 
being allocated to the red herrings*
Either 'extremely confident' or 'somewhat 
confident'
At least three correct questions, with red herrings 
allocated a minus one
Either '1 know about them and have used them', '1 
know about them and have recommended them 
to colleagues/patients' or '1 know the genetic 
counsellor that serves the local area by name'
At least two questions correctly, with minus one 
being allocated to the red herrings
Either 'frequently' or 'often'



































Top 20% of response 
options
Top 33.3% of 
response options
Adopters needed to 
see relevance of 
genetics to practice
Top 50% of response 
options
Top 33.3% of 
response options
To avoid random 
guessing, adopters 
had to get at least 2 
answers correct
Adopters need to 
feel confident about 
family history 
questions
To avoid random 
guessing, adopters 
had to get at least 3 
answers correct
Top 60% of response 
options
To avoid random 
guessing, adopters 
had to get at least 2 
answers correct
Adopters need to be 
talking to their 
colleagues regularly 
in they are 
considered to be 
truly interested in 
genetics/genomics
Adopters need to 
want to incorporate 
more 
genetics/genomics 
into practice to be 
considered full 
adopters
Adopters need to be 







At least option with a '1 have been asked to seek 









to be able to lead 
the incorporation of 
genetics/genomics
Adopters need to be 
able to act when 
asked for advice
*The red herrings were deliberate incorrect question responses which were included in various multi-answer 
genetic practice questions. They were included to try to limit random guessing and to make sure that respondents 
were truly competent in the GIAs.















more into everyday 
practice
24 
Interest in new 






The allocation of scores was pre-set by the 
original author of the question. Therefore an 
overall score was already provided. The top 
25% of this score was used.
The top two boxes selected for all questions
Either 'occasionally', 'often' or 'frequently'
Either 'definitely' or 'maybe'
Either 'definitely interested' or 'somewhat 
interested'
Either ' 1 have been asked to seek advice' at 
least three times or the above once along with 
answering '1 have been asked to seek advice 



























Top 25% of response 
options
Top 20% of response 
options
OLs need to be able 
to talk to colleagues 
about 
genetics/genomics 
in order to be able 
to influence others





OLs need to have 
some interest in 
genetic knowledge 
to influence others
OLs need to show 




Table 6.7. Scoring system for opinion leaders with an interest in genetics/genomics
(OLWIGs)OLWIGS relate to those individuals who are opinion leaders but also scored highly in 




























The allocation of scores was pre-set by the 
original author of the question. Therefore 
an overall score was already provided. The 
top 25% of this score was used.




'1 have been asked to seek advice and have 

























Top 25% of response 
options
Top 20% of response 
options
OLWIGs need to be talking 
to colleagues about 
genetics/genomics in 
order to have influence
OLWIGs who are definitely 
interested in incorporating 
more genetics/genomics 
into practice are above 
OLs in their 
genetic/genomic interest
OLWIGs need to be very 
interested in genetic 
knowledge to influence 
others in the field of 
genetics/genomics
OLWIGs need to have 
sought information when 





The inferential statistics were completed in SPSS and data were analysed in the groups that 
participants had been placed in, based on the above scoring system. Each group was 
compared against the other groups to identify any statistical differences between the groups 
(i.e. adopters against non adopters). Some of the questions with many parts (a ,b, c) had their 
scores totalled. For example, question five asked participants to rate their familiarity with six 
resources. The responses on the Likert scale were added together to give a combined score, 
because greater familiarity with more resources would be expected from adopters, opinion 
leaders and genetics opinion leaders.
All ordinal and scale questions being analysed first underwent a test for normality using the
Kolmogorov-Smirnov and Shapriro-Wilk tests. For data to be normal the normality test result
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needed to be greater than 0.05. If data were normally distributed then a t-test was used. 
However the majority of data were not normal, therefore the non-parametric, Mann- Whitney 
U test was applied. All nominal data were analysed using the Chi Square test. For results to 
have significance the probability accepted was <0.05. Question 18 was an exception due to 
the need for the variables to be ranked. The Friedman test was used in this case. The data 
provided by those categorised as genetic opinion leaders and opinion leaders with an interest 
in genetics/genomics was analysed descriptively due to small numbers in each group.
Qualitative data were analysed using a thematic content analysis, as in Phase 1. Qualitative 
data were largely analysed on a per question basis. However if the qualitative question was 
linked to a specific quantitative question then the results were analysed by groups, such as 
opinion leaders and adopters.
6.5 Ethical Approval
Ethical approval for Phase 1 of the project was gained from the Faculty of Health, Sport and 
Sciences' Ethical Committee at the University of Glamorgan on the 15th January 2010. 
Amendments were made to statistical calculations and to the study justification as requested. 
Ethical approval was also sought from National Research Ethics Service (NRES) due to the 
inclusion of NHS staff within the research phase. Following discussion with and review of 
documentation by NRES, they decided (19th March 2010) that Phase one of the project did not 
classify as research and that NRES approval was not needed (see appendix 12).
Ethical approval for Phase 2 was sought from the National Research Ethics Service (NRES), 
following discussion with and review of documentation, NRES classed the research as service 
evaluation on the 25th January 2011. Ethical approval was not required from NRES. Ethical 
approval was granted by the Faculty of Health, Sport and Sciences' ethical committee at the 
University of Glamorgan on the 26th May 2011 (see appendix 13).
Summary
The literature reviews have provided an underpinning knowledge for progressing into 
designing the research process. The main method of data collection used in the current study 
was quantitative through the use of a questionnaire. Questionnaires do have disadvantages to 
their use, however in the current study it was deemed to be the most efficient approach due 
to number of participants needed and the time frame in which this needed to be achieved. A 
focus group would provide the opportunity for a deeper understanding of expert's attitudes 
towards genetics/genomics within nursing practice. Phase 1 of the research will provide a 
foundation for Phase 2. Phase 1 involves asking experts what their idea of a genetic nurse
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adopter was and how they thought they could be identified. The information gained in this 
phase will aim to provide a greater understanding of how genetic nurse adopters could be 
identified. Having access to experts within the field to inform the final questionnaire will 
enhance validity of the questionnaire and reduced researcher bias within the study. The 
findings from both the Phase 1 questionnaire and focus group helped to construct the Phase 2 
questionnaire and its fundamental questions. The use of nursing associations provided 
straight-forward access to a large cohort of oncology and practice nurses. It could be argued 
that approaching nursing associations might limit participants to those who already have an 
interest in genetics/genomics or research as a whole, however I aimed to approach nursing 
organisations that were generic in order to limit this bias. The results from the methods 




Chapter 7 presents the results gained from phase 1 and 2, including both qualitative and 
quantitative data. Quantitative data will be presented in graphical and tabular form with 
qualitative data being presented in themes, including participant quotes. A summary of the 
results will be presented after each data collected phase.
7.1 Phase 1 Results
Phase 1 aimed to seek the opinions of experts in the field of genetics/genomics and nursing on 
what they believed constituted a nurse adopter of genetics/genomics. Thirty participants were 
provided with the proposed four genetic indicators of genetics/genomics (GIAs) and asked for 
their opinion on them. A focus group with genetic counsellors was also conducted and the 
results are presented following the quantitative data.
7.1.1 Demographics
Table 7.1 shows the demographic characteristics of the participants. The majority of 
respondents (93%) were genetic counsellors with the highest number of participants (33%) 
having worked in genetic services for between 1- 5 years.




From a nursing background
Time worked in genetic services


































* Participants could answer 'yes' to more than one of the career demographics which explains why the 
total is more than 100% **Response rate was 9.6% assuming all members were contacted
Although 30 individuals responded to the questionnaire, one participant did not complete the 
questionnaire and their data were removed from analysis.
Page | 160
7.1.2 Activities and behaviours
As presented in Chapter 6 (p!39), following the literature review and consultation with 
experts, four Genetic Indicators of Adoption (GIAs) were identified:
a. To know how to access genetic services and would make active use of them
b. To be able to provide information of support services to patients or their families with 
or at risk of a genetic condition
c. To ask patients relevant questions about their family history
d. To be open to the possibility of genetics/genomics in all aspects of care
Participants were asked questions relating to the four proposed GIAs to ascertain whether 
these behaviours and activities could and should be used to identify an adopter of 
genetics/genomics within nursing (Q. 7, 8,10, 11,13,14,16,17, Section 3 of appendix 4).
7.1.2.1. Using the GIAs to identify a nurse who has legitimately adopted 
genetics/genomics into their practice.
The majority of participants (n=29) agreed that if a nurse could demonstrate the GIA 
(extremely and somewhat likely) then they are considered to have adopted genetics/genomics 
into their practice (Fig 7.1). GIAs a, c and d achieved a consensus of between 100-93% (cut off 
of 75% for consensus), however GIA b obtained a slightly lower consensus of 87%.
Fig 7.1. If a nurse identifies themselves as having demonstrated a particular GIA, would you 









7.1.2.2. Using the GIAs as a requirement tool for nurses to be considered an adopter 
genetics/genomics
A consensus (>75%) was achieved for all GIAs to be included as one of the requirements 
needed for a nurse to have adopted genetics/genomics into practice (Fig 7.2) (n=29). GIAs, a, c 
and d obtained a consensus of between 96-93%, GIA b received a lower consensus of 76%.
Fig 7.2. Should each GIA be included as one of the requirements needed for a nurse to have 
adopted genetics/genomics into practice? (Q8,11,14,17) (n = 29).
120 -i
a - Accessing 
services
b - Support services c - Family history d - Genetics aware 
Activities and Behaviours
There is a consensus (96-93%) for GIAs a (accessing services), c (Family history) and d (Genetics 
aware) (Q. 8, 14, 17, Fig 7.2), which asked whether these GIAs, should be included in the 
requirements needed for a nurse to have adopted genetics/genomics into practice. When 
confidence intervals are calculated, the minimum calculated value was 81.04 for all three 
questions. Therefore the consensus gained at >75% for these questions can be considered a 
statistically confident result and one that can be applied across the total population group (n = 
310). Although GIA b (Fig 7.2) gained consensus (76%), the confidence interval calculation 
produced a minimum value of 60.77, therefore this result needs to be interpreted with caution 
and cannot be generalised to the overall population.
7.1.3 GIAs combined
Participants were asked about whether the four GIAs should be combined to identify nurse 
adopters (Fig 7.3).
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Fig 7.3. Do all GIAs need to be used collectively to identify a nurse adopter of 




No consensus (<75%) was reached by participants (Fig 7.3) in response to asking whether all 
four GIAs should be used collectively.
Qualitative responses
Participants were invited to explain their reasoning in a free text box if they had answered 'no' 
to a particular question. Some participants thought that GIA b (support services) stopped 
them from agreeing that all activities and behaviours should be used together.
"sometimes support groups and information can be hard to find for someone who 
doesn't work exclusively in genetics. Also have to be sure they are appropriate. If the 
nurse doesn't feel she/he has knowledge that would be acceptable" (4655736)
Other participants thought that it was more important for nurses to know when and how to 
ask genetics questions.
"// they at least know how to refer to genetics or ask us for advice" (4620181)
"in my experience it is most important for nurses to know when to ask genetic services 
questions e.g. no good knowing how to take a brilliant family history if you don't know 
what to do with that info" (4614545)
7.2 Comparative analysis
For each GIA (Figs 7.1-7.2) a chi-squared test was performed. Section A of Table 7.2 highlights 
the p value, Chi-square results and degrees of freedom for each question calculated between 
those participants with a nursing and non-nursing (MSc) background. Section B of Table 7.2 
shows separate chi-squared test results that analysed differences in views between those
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participants who have worked in genetic services for either; less than 1 year, 1-5 years, 6-10 
years, 11-15 years, 16-20 years, 21-25 years or over 25 years.
Table 7.2: Chi-squared results for analysis of views of those from a nursing background (n= 19) 
compared to those without a nursing background (n=ll) (A) and differences in years worked in 
genetic services (B) on participant views. All those questions not marked with yes/no/unsure 
had response options of'extremely likely', 'somewhat likely', 'not likely' and 'unsure'.
Question
Activity a: Accessing 
services
a. would expect nurse 
to do (Qu 6)
a .GIA demonstrating 
adoption (Qu7)
a. included as a 
requirement for 
adoption (Qu 8- 
Yes/no/unsure)
Activity b: Support 
services
b. would expect nurse 
to do (Qu 9)
b. GIA demonstrating 
adoption (Qu 10)
b. included as a 
requirement for 
adoption (Qu 11 - 
yes/no/unsure)
Activity c: Family 
history
c. would expect nurse 
to do (Qu 12)
c. GIA demonstrating 
adoption (Qu 13)
c. included as a 
requirement for 





d. would expect nurse 
to do (Qu 15)
d. GIA demonstrating 
adoption (Qu 16)
d. included as a 
requirement for 




Collective use (Qu 19 - 
yes/no/unsure)
(A)Nursing background status compared 
with views on activities and behaviours
Chi-square Degrees of 
freedom
P value*
(B) Categories of years worked 
compared with views on activities and 
behaviours
























































































*P value significant at 0.05. **Assumption is that all cells should have an expected count above 5, this is 
violated, which mean that results marked with ** should be interpreted with caution.
A significant difference (P=0.013) was identified between career backgrounds of respondents 
when asked if all four GIAs should be used collectively to identify a nurse adopter. The 
significance was due to a greater proportion of participants from a non-nursing background 
answering 'unsure' than the proportion from a nursing background answering 'unsure'. The 
majority of participants from a nursing background (67%) said that all behaviours and activities 
should be included to identify a nurse adopter of genetics/genomics, whereas only 27% of 
participants from a non -nursing (MSc) background believed this.
"I think a and b are essential, but maybe c and d less so" (4617092, non-nursing background)
Significant differences (p) were identified between participants from nursing and non-nursing 
backgrounds in two questions:
• would you expect all nursing staff to be able to satisfactorily know how to access 
genetic services and would make active use of them (Question 6)
• would you expect all nursing staff to be satisfactorily open to the possibility of 
genetics/genomics in all aspects of care (Question 15).
In question 6, 100% of participants who did not have a nursing background believed that 
nurses should be able to satisfactorily undertake the activity, compared to 39% of those who 
did have a nursing background. When asked if they would expect all nursing staff to be open 
to the possibility of genetics/genomics in all aspects of care 100% of those without a nursing 
background answered yes compared to 56% of participants with a nursing background 
answering yes and 33% answering no. This indicates that nursing background is an important 
factor. The number of years participants worked in healthcare were analysed to ascertain any 
difference between this variable and views on the GIAs. All Chi-Squared results for these 
questions were non-significant except for when participants were asked if they thought all 
GIAs should be used collectively to identify a nurse adopter of genetics/genomics (Q 19) (p = 
0.043). On average the greater the number of years worked (16-20 & 21-25) the more likely 
individuals were to agree that the GIAs should be used collectively.
7.3 Barriers and facilitators
Participants were asked their opinions on a list of potential facilitators (Table 7.3) and barriers 
(Table 7.4) involved in encouraging or preventing nurses from adopting genetics/genomics into
practice.
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Table?.3: The facilitating factors encouraging nurses to adopt genetics/genomics into practice 











Improving educators' awareness of genetic and genomic education
Links and access to genetic specialists for nurses
Improving educators' awareness of genetics and genomics
Clinical institutions that promote genetic and genomic learning
Educational institutions that promote the learning of genetics and genomics
Education programs that cover all aspects of genomics and genetics











Table 7.4: Participant responses to barriers preventing nurses from adopting 















The relevance of genetics and genomics is not explicit to nurses
Nurses don't understand genetics and genomics
Nurses have time constraints
Nurses don't know about genetics and genomics
Nurses are afraid of genetics and genomics
There is a lack of genetic and genomic role models for nurses
Nurses think genetics and genomics is not relevant
Nurses have no experience of patients asking about genetics and genomics
Nurses think that genetics and genomics is not important
Nurses believe the resources are not appropriate
Nurses think there is a lack of support from colleagues

















Tables 7.3 and 7.4 show similarities between the barriers and facilitators of genetic/genomic 
incorporation into nursing. Genetics/genomics awareness among educators is ranked highly as 
a facilitator and nurses not understanding genetics/genomics is seen as a considerable barrier. 
Resources and team attitudes were placed lower down in the rankings and education 
programmes and articles were ranked lower down in the facilitator rankings. However the 
data were limited in that participants could only select one item for each ranking for the 
facilitators.
7.4 Qualitative results
Free text boxes enabled participants to express their views and elaborate on their choice of
responses and were provided for a number of questions.
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What would define a nurse who has adopted genetics/genomics
(Participants were asked what activities and behaviours they would be looking for in a nurse 
who has adopted genetics/genomics (Qu5).)
Family history
There were 21 comments from participants about nurses who have adopted 
genetics/genomics being able to take a family history. Comments included:
"She was aware that genetics could have implications for the rest of the family" 
(4655980)
"Asking appropriate questions or providing appropriate family history information" 
(4627010)
"She had asked the 'right' questions of the patient" (4655980)
Contacting genetic services
Twelve participants thought that being able to contact genetic services would be important.
"An awareness of referral guidelines to genetic services" (4616231)
"Able to make appropriate referrals to genetic services, or contact service for advice if 
unsure" (4614656)
"Knowing when to refer to genetic services and including all relevant information when 
doing so" (4624575)
Awareness of qenetics/aenomics
Seven participants believed that nurses should have an awareness of genetics/genomics and 
the role that it plays in their practice.
"An awareness of considering genetic causes as part of aetiology" (4637073)
"The nurse is aware of the possibility of a genetic link with a patient's medical 
condition and the possible impact that this may have on the patient's care and the 
family as a whole" (4757779)
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Other activities and behaviours that should be considered
Participants were asked if they thought there were any activities and behaviours that had been 
missed that would be important in indicating whether a nurse had adopted genetics/genomics 
into their practice (Qu20).
Basic pedigree and inheritance patterns
Four participants thought that nurses should be able to draw a basic pedigree of genetic 
history.
"Ability to draw a basic pedigree when taking family history information" (4626188) 
"Explaining BASIC inheritance pattern where appropriate" (4655736)
Additional behaviours and activities
Other behaviours and activities suggested by participants related to information seeking, 
communication skills and issues around genetic testing:
"A corresponding awareness of some of the limits of genetic investigation both 
practically and ethically" (4637073)
"Knowing how to access internet sites to research possible genetic conditions" 
(4656995)
"listening and counselling skills should be continually developed throughout training" 
(4614450)
Nurses having an awareness of genetics/genomics throughout their practice and knowing how 
to contact genetic services with relevant questions seems important for these experts in 
nursing and genetics/genomics.
7.5 Phase 1 b Results summary
The results indicate that the majority of participants thought that all GIAs should be included 
in the criteria to identify an adopter of genetics/genomics. However, these results need to 
take into account the relatively small sample size (n=29) (for Phase 1 data collection this was 
an acceptable number due to it being a preliminary phase to the main data collection phase). 
Although most participants indicated that all four GIAs should be included individually in the 
criteria, only 52% of participants thought that all four GIAs should be used collectively to 
identify an adopter of genetics/genomics. Although this was a majority, a lower consensus on
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activity b (76%) (support services) may have prevented the consensus from reaching >75%. 
Some participants felt that GIA b could not be applied to all nursing groups and that the 
number of support services made this activity too complex. However only 2 participants (7%) 
answered not likely when asked 'if a nurse identifies themselves as having undertaken this 
activity, would you say he/she had adopted genetics/genomics into their practice?' This issue 
was raised in the subsequent focus group, which is discussed below.
7.6 Phase Ic Focus group results
7.6.1 Participant demographics
Participants were accessed through the Local Health Board's Medical Genetics service. Four 
genetic counsellors agreed to participate in the focus group. Table 7.5 shows the participant 
demographics, with two from a nursing background, one from a science background and one 
from a teaching background. The mean number of years worked in genetics by the 
participants was 12 years.
















7.6.2 Focus group themes/questions
Questions and themes were arranged prior to holding the focus group and were based on 
areas in the Phase 1 questionnaire that needed more exploration. The questions were all 
surrounding the four GIAs suggested for use to identify a nurse adopter in the Phase 2 
questionnaire.
7.6.3 Focus group results
The focus group provided useful information regarding the activities and behaviours and useful 
suggestions for Phase 2 of the research. Five distinct themes emerged, each with additional 
subthemes.
Exposure to genetics/genomics in nursing/midwifery specialities
Participants felt that some nursing areas do not always have the opportunity to use 
genetics/genomics and that it does not always easily fit into their role compared to other
nursing activities. It was clear that participants thought that some areas of nursing were more
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adaptable to genetics/genomics than others. Participants believed that there were some areas 
of nursing where genetics/genomics applies more to the role than other areas (for example 
Cystic fibrosis nurses) and therefore more likely to make associations between symptoms and 
the potential for an inherited condition.
"/ would say there are definitely some specialists where there is a stronger genetic link 
and it would be more of an obvious link" (P2)
"Like the CF nurses could very much point people to the right CF information" (P3)
Despite one participant commenting that some nurses would not want to overlap with the 
doctor's role, another thought that it is part of a nurse's role to alert the doctor to possible 
genetic links.
"But if you've got a nurse who's managing notes, as you said, perhaps being there as a 
chaperone as well and who's noted that there has been numerous fractures in this child 
or a family history, surely as a duty of care she should alert that doctor" (PI)
Genetic indicators of adoption (GlAs)
GIAs in general
Participants suggested that the GIAs could be worked into a sequential order of knowledge 
and ability. Participants believed that a, c and d were good indicator questions. Putting the 
GIA's in a sequential order might allow different degrees of genetic adoption to be identified 
and might make it easier for nurses to progress through the GIAs in a structured way.
"I'm thinking those nursing standards that were created and they're sort of listed a bit 
like that, getting to the more detailed as you go further down and b would probably be 
further down" (P3)
"but these (a, c, d) ones I think would be very good indicator questions" (P2)
GIA b fsupport services)
Participants believed that activity b (support services) would only apply to those nurses who 
have good genetic knowledge. The focus group results agreed with the Phase Ib 
questionnaire results when considering GIA b (support services), as both thought that this did
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not apply to nurses as well as the other GIAs. The focus group believed this was the least 
important GIA.
"/ think b obviously is, the other 3 I think are more important, that's the least important 
which is perhaps why people weren't as supportive" (P4)
"you are actually talking about people being pretty well qualified to give that 
information, not a sort of random nurse" (P3)
"c and d are asking, they are not providing information... b is another step on, you are 
providing the information, it's actually (P3)... doing something" (P2 & 3)
Nursing versus non nursing backgrounds
Participants were asked why they thought that opinions about the GIAs differed between 
those AGNC members who were from a nursing background and those who were not. 
Participants believed it was about what those from a nursing background expected of nurses in 
clinical practice today.
"Inside information I think it is called" (PI)
"Could it be sort of demographics that the members of the AGNC who are nurses tend to be 
the more long standing" (P3)
"when they did their nursing training...it was a sort of much different nursing role even now 
than nurses today are being taught and your expectations of what nurses should be able to 
do is probably higher than what they actually do now on the ground" (P3)
Engaging nurses in genetics/genomics
Getting the message of 'genetics' across
One participant felt that a prompt tool would be useful to help nurses remember how and 
when to use genetics/genomics. All participants agreed that if genetics/genomics was not in 
their regular nursing role they might find it hard to remember.
"Yeah they should get a poster in your outpatient clinic that says, you know, have you 
considered that this might be a genetic problem, remember to ask these questions. I 
don't know, I just think that the behaviours, that is something that would alter your 
behaviour, isn't it, if you weren't that way inclined or you might forget" (PI)
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Non-adopters
Participants thought that the reason that non-adopters do not perhaps use genetics/genomics 
in their practice is because they do not have the knowledge and genetics/genomics frightens 
them.
"I'm sure there probably would be a percentage of people who perhaps would 
consciously not engage because they find it scary" (P2)
"Cause I still think there are lots of myths and misconceptions about genetics " (P2)
What participants look for in an adopter
Participants explained about what they would look for in a nurse adopter of 
genetics/genomics.
"It is asking the right questions therefore you would hope then it would be followed 
through in terms of documenting it and flagging it" (P2)
"She would need to ask about the family history but she would also need to know when 
and who" (P4)
Suggested next steps in genetic/genomic implementation
Future of genetics/aenomics services and phase 2
When asked if there was any particular area of healthcare that they felt would be best suited 
towards identifying nurse adopters, they believed that primary care would be a good target for 
Phase 2 as they encounter a range of diseases and ages.
"Primary care is what you want to target" (PI)
"And your CF nurses would be another group of opinion leaders because they are very 
aware of the genetic link" (P2)
One participant mentioned how genetics/genomics is going to become part of all healthcare 
areas and how services will have to change to accommodate for these developments.
"If you are thinking about genetics in the future, genetic counsellors are going to move 
from a specialist centre I would predict [to] across the whole of medicine like BHF 
nurses, like the heart foundation nurse. I think they are going to be there in every 
aspect of [the] hospital, well healthcare and we in genetics will become much more 
rarefied and specialist probably, I'm talking 10/20 years down the line but I mean
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children are going to be born in 10 years time knowing their human genome you know, 
everything's going to genetic wise be on an exponential route upwards" (P3)
Genetic problems in nurses' families
When discussing the proposal to identify opinion leaders in Phase 2, it was suggested by 
participants that many of those interested in genetics/genomics might themselves have a 
genetic condition or have a family member affected. Therefore they felt that asking about 
participants' family genetic history might be a useful question in Phase 2.
"There will be a certain percentage albeit small that will have genetic problems in their 
own family that are already familiar with it" (PI)
"maybe that could be an extra question on your questionnaire, is there anybody in 
your extended family that you know has a genetic [problem]" (P2)
Additional themes
Role of genetic services
Participants were asked if they thought it would be feasible to have a named person in clinical 
genetics who they could contact. Some participants felt that they would not want nurses to 
phone genetic services for every family, whereas others would like them to learn from any 
information that they would provide.
"we wouldn't want phone calls with you know, for every family...they should have those skills, 
obviously if there is something slightly unusual or they're not particularly secure, confident 
about it by all means use us as a resource but I don't think exclusively everything should be 
filtered through genetics really" (P2)
"/ guess if they have contacted you once you would hope then that they would learn from that 
and that they would filter that back to their team, they wouldn't have to keep ringing us"(P4)
"/ think there could be more, I think people just from brief experience are perhaps a little bit 
fearful of contacting, for wasting our time...! think that could possibly be more encouraged" 
(P4)
Two useful points that were taken forward into the Phase 2 aspect of the study were to ask 
participants about their own family genetic history and to focus on practice nurses.
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Phase 1 Summary
The majority of respondents believe that if a nurse actively demonstrates the GIAs then they 
could be considered a nurse adopter. The findings indicate that the individual GIAs can be 
included in the next questionnaire to aid the identification of nurse adopters. GIA b did 
receive a lower consensus when compared to the other GIAs, however 87% of participants still 
believed that it should be used to identify an adopter of genetics/genomics. Finally, collective 
use of all four GIAs was raised as an issue, which as suggested in the focus group could be due 
to activity b. The majority of participants, both from the focus group and questionnaire, 
believed that nurses need to be aware and have some basic skills in genetics/genomics and 
that the GIAs are good for identifying nurse adopters of genetics/genomics. The aims of the 
research as a whole received a mainly positive attitude throughout both data collection stages 
of Phase 1, both in their willingness to complete the research and also comments received 
from the focus group participants and questionnaire participants. The GIAs used for Phase 2 of 
the research are:
a. To know how to access genetic services and would make active use of them
b. To be able to provide information of support services to patients or their families with
or at risk of a genetic condition
c. To ask patients relevant questions about their family history 
d. To be open to the possibility of genetics/genomics in all aspects of care
7.7 Phase 2 results
The total number of respondents who replied to the questionnaire was 99. However 11 of 
these had to be removed from that data set as 10% or more of the questionnaire responses 
were missing. Therefore 88 participant responses underwent statistical analysis. 
Demographics for participants can be seen in table 7.6.
7.7.1 Participant demographics
All participants were female and the majority (67%) were practice nurses. Four participants 
(4.5%) had a PhD. The majority of participants (41%) had a degree qualification. One 
participant was from New Zealand but the remaining participants were from countries making 
up the United Kingdom. See table 7.6 for the full demographic summary.
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Table 7.6. Phase 2 participant demographics
Demographic
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The questionnaire aimed to distinguish between respondents according to pre-defined 
categories (see methodology section 6.4.2.2 for a definition of the groups). The groups were 
as follows:
• Non adopters
• Non opinion leaders
• Adopters
• Opinion leaders (OLs)
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• Genetic opinion leaders (GOLs)
• Opinion leaders with an interest in genetics (OLWIGs)
See methodology section 6.2.1.5 (p!41) for an explanation of the identification of GIAs. 
Section 6.4.1.1 (p!47) discusses the types of questions used to identify adopters and opinion 
leaders (referred to as identifying questions) and section 6.4.2.2 (p!54) presents the scoring 
system for the different groups.
Most respondents will be placed in two groups; either an adopter or non adopter, either an 
opinion leader or non opinion leader, plus possibly a genetic opinion leader or an opinion 
leader with an interest in genetics. There is some overlapping of grouping, for example an 
individual could be a non adopter but be an opinion leader. For data analysis an individual was 
always analysed in the highest group they scored in (except OLWIGs and GOLs as no statistical 
analysis was completed). Table 7.7 shows a breakdown of the participant groups.























*The percentage does not add to 100 because participants could be in more than one group, for 
example someone could be an adopter and a non opinion leader, or an opinion leader and an opinion 
leader with an interest in genetics
The results were then analysed in six different ways:
1. Adopters v non-adopters
2. Opinion leaders (OLs) v non opinion leaders
3. Adopters v opinion leaders
4. Opinion leaders v non adopters
5. Genetic opinion leaders (GOLs)
6. Opinion leaders with an interest in genetics (OLWIGs)
Due to such small numbers in the genetic opinion leader and opinion leaders with an interest 
in genetics groups, no inferential statistics were performed for these groups. Descriptive 
statistics only were used.
Page | 176
7.7.3 Significant results
The significant results are described within each group analysis first by demographics, then 
identifying questions (only for adopters/non adopters and opinion leaders/non opinion 
leaders, see methodology section 6.4.2.2, p!54 for a description) and concluding with the non 
identifying questions. Adopters vs. non adopters are described first, followed by opinion 
leaders vs. non opinion leaders. Adopter vs. opinion leader data are then presented 
concluding with opinion leader vs. non adopter results. The genetic opinion leaders and 
opinion leader with an interest in genetics are described separately. Non significant results are 
presented in appendix 14.
7.7.3.1 Adopters v non adopters 
Demographics
Adopter (n= 24) and non adopter (n= 64) demographic data were statistically analysed to look 
for significant differences between these groups. Table 7.8 shows all the demographic 
questions that adopters and non adopters were asked, the significant questions are marked 
with an S and non significant questions are marked with NS. Non significant results are 
included in appendix 14.
Table 7.8. Demographic questions of significance between adopters and non adopters
Demographic





Length of time practising
Genetic disorders within 
the family
Ethnicity


































*P value significant at 0.05
Areas of nursing practice (Qu28)
Proportionately, there were twice as many oncology nurses in the adopter group (30.4%, n=7) 
than the non-adopter group (14.3%, n=9) (Fig 7.4). A Chi-square analysis showed that there 
was a significant difference in the distribution of adopters and non adopters in the different 
areas of nursing practice (p = 0.043).
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Fig 7.4. Areas of nursing practice for adopters and non adopters.
Adopters 
Non-adopters




Participants were asked a series of questions (see methodology, section 6.4.2.2, p!47) to 
distinguish those participants who were adopters from those who were not. As expected a 
large number of identifying questions were significant for this group. Table 7.9. shows all the 
adopter identifying variables that adopters and non adopters were assessed on, with the 
significant demographic questions marked with an S and non significant questions marked with 
a NS. The non significant questions are discussed further in appendix 14.
Table 7.9. Identifying questions of significance between adopters and non adopters
Identifying questions
Openness to Experience (Qul, Fig7.5)
Familiarity with genetic/genomic resources (QuS, Fig7.6)
Responses to genetic/genomic and career statements 
(Qu6, Fig7.7)
Sudden adult death scenario (Qu7, Fig7.8)
Relevance of genetics/genomics to patient group (Qu8, 
Fig7.9)
Areas of nursing care linked to genetics/genomics (Qu9, 
Fig7.10)
Confidence levels of talking a family history (QulO, 
Fig7.11)
Areas of knowledge needed when taking a family history 
(Qull)
Awareness of regional genetic centres (Qul2, Fig7.12)
Types of support services available to patients (Qul4, 
Fig7.13)
Talking to colleagues about genetics/genomics (0,u22, 
Fig7.14)
Incorporating genetics/genomics more into everyday 
practice (Qu23, Fig7.15)
Interest in new areas of genetic/genomic knowledge 
(Qu24, Fig7.16)
Seeking genetic/genomic knowledge for various people 
groups (Qu25, Fig7.17)

















































Openness to Experience (Qul)
The participants were asked a series of short questions that assessed their Openness to 
Experience {Qul). A Mann-Whitney analyses showed that adopters (Mean=40.167, SD=3.491) 
were significantly more likely to have a higher Openness to Experience score than non 
adopters (Mean=34.516, SD=3.422) (p<0.001) (Fig 7.5).


























Score range for openness to experience
41-50
Reliability testing
Upon reliability testing using the Cronbach's alpha test, the openness to experience question 
received a reliability score of 0.700 (Mean = 36.057, SD = 4.281). Therefore it can be deemed 
that question one does reliable test an individual's openness to experience level.
Familiarity with genetic/genomic resources (Qu5)
Six items tested participants' familiarity with particular genetic/genomic resources. Scores for 
all six sections were combined to provide an overall score for the question (max score = 24). 
When the six sections were combined to give an overall score, there was significance between 
the two groups, however one of the sections was not significant when they were analysed 
individually. The six genetic/genomic resources were as follows:
a. The UK genetic competency standard statements for nurses, midwives and health
visitors
b. NHS National Genetic Education and Development Centre 
c. Department of Health's white paper on genetics 
d. The local specialist genetics services
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e. Telling Stories Understanding Real Life Genetics website 
f. Human Genome Project
Mann-Whitney analyses showed that adopters (Mean =11.292, SD=2.866) were more likely to 
be in the highest achieved score range of 12-17 compared to non adopters (Mean=8.313, 
SD=1.531) (P = 0.000). It could be that adopters had greater familiarity of genetic/genomic 
resources than non adopters.










Score range for familiarity
18-24
Question 5c (NHS National Genetics Education and Development Centre) was not significantly 
different between groups (p=0.073), all of the non adopters and 95.8% (n=23) of adopters 
answered either 'never heard of them' or were 'somewhat familiar'. It can therefore be 
concluded that both groups did not have much familiarity with this resource.
Responses to genetic/genomic and career statements (Qu6)
Participants were asked for their level of agreement with six genetic/genomic and nursing 
statements. The six statements were as follows;
a. Nurses should regularly keep up to date with new areas of practice
b. Nurses should be able to decide which areas of knowledge they want to expand, whilst
not being at a cost to safe practice if other areas are de-prioritised 
c. Taking a patient's family history is an important aspect of my role 
d. Continued professional development in genetics should be encouraged for all nurses 
e. I have a good awareness of how genetics impacts on my own speciality 
f. Developments in genetics offer real potential to improve health outcomes for all
patient groups
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Points allocated to each response were combined to create an overall score. Question 6c 
proved to be an anomaly for question 6 as a whole. On reflection question 6c was deemed to 
not be generalisable to a variety of nursing roles as it was believed not every nurse would need 
to take a family history, (For example a nurse manager might not be involved in taking a family 
history). Therefore it was removed before data analysis was completed.
The combined scores for question six were significant (p<0.001). Mann-Whitney analyses 
showed that adopters (Mean=26.75, SD=1.648) were significantly more positive towards the 
genetic/genomic and career statements than non adopters (Mean=23.875, SD=2.347).


























5-10 11-20 21-30 
Score range for statements
Two topics within question six were not significant. Questions 6a (new areas of practice) and 
6b (areas of knowledge nurses want to expand) were not significant because all adopters and a 
high majority of non adopters answered either 'strongly agree' or 'agree'. Both of these 
statements are generic are not specific to genetics/genomics which could explain why they 
were not significant.
Sudden adult death scenario (Qu7)
Participants were provided with the following scenario:
A 23 year old patient is admitted with dizziness, palpitations and fainting episodes after 
exercising. The patient mentions to you that this has happened before during strenuous 
exercise.
Question seven consisted of three quantitative questions from which an overall score was 
calculated. The following questions were asked:
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How important would it be in this situation to take a family history?
If you felt you needed advice would you consider discussing the patient's situation with 
your colleagues?
How confident would you feel dealing with this scenario?
The highest overall score a participant could receive was 20, with three being the lowest. 
Mann-Whitney analysis showed that adopters (Mean=17.25, SD=2.472) were significantly 
(p=0.022) more likely to score higher on the sudden adult death scenario questions compared 
to non adopters (Mean=15.938, SD=2.777).




















Score range for scenario
15-20
The overall scores were significant but two out of three of the questions were not significant. 
Question 7ii (would you consider discussing patient's situation with colleagues) was not 
significant because all adopters and non adopters answered either 'extremely likely' or 
'somewhat likely'. Question 7iv (confidence in dealing with the scenario) was not significant 
because both adopters and non adopters responses were fairly evenly spread among the 
ranking system of 1-10. Therefore it could be concluded that family history was the more 
dominant indicator of significance for question seven.
Qualitative responses
Explanations provided for the patient's symptoms (Qu7iii)
Qualitative responses were given to this scenario based on the symptoms that were provided; 
dizziness, palpitations, fainting episodes after exercising from a 23 year old. Respondents were 
asked to provide possible explanations for the patient's symptoms. Twenty one adopters and 
53 non adopters responded to the question (n=74).
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Eight (38%) adopters gave a genetic explanation for the symptoms including;
Long QJ syndrome (Rl), Cardiomyopathy (R2) and WPW (Wolf Parkinson White) syndrome (R3)
Ten (18.8%) non adopters gave a genetic response for the symptoms including;
Cardiac risk in the young (R4), FH (family history) of heart disease (R5) and Genetic cardiac 
problem (R6)
There were explanations for the symptoms other than genetics of an inherited condition. 
Thirty four participants suggested that dehydration and lack of food and glucose levels could 
explain the symptoms. Blood pressure was given as a diagnosis for the patient by 21 
participants. Thirteen participants thought anaemia could be an explanation, six through 
pregnancy/period or drugs and five thought it could be a thyroid or hormonal problem.
The relevance of genetics/genomics to participants' patient group (Qu8)
Question eight asked participants about how relevant they felt genetics/genomics was to their 
patient group. The question was scored on a Likert scale, with one being not very relevant and 
six being very relevant. Mann-Whitney analysis showed that adopters (Mean=5.417, 
SD=0.776) were significantly (p<0.001) more likely to believe that genetics/genomics was more 
relevant to their patient group than non adopters (Mean=4.453, SD=1.038) (Fig 7.9).
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Areas of nursing care linked to genetics/genomics (Qu9)
Participants were given eight areas of nursing care and asked to select which ones were linked 
to genetics/genomics. Two 'red herrings' were provided, these being appendicitis and blood 
volume, which are not areas of nursing care associated with genetics/genomics (these options 
were given a score of minus one if they were endorsed). A Mann-Whitney test showed that 
adopters (Mean=4.917, SD=1.316) were more likely to score significantly (p = 0.023) higher in 
relation to areas of nursing care directly linked to genetics/genomics compared to non 
adopters (Mean=4.422, SD=1.152).
Adopters were more likely to say that 'cancer', 'cholesterol levels' and 'ethnic origin' were the 
areas of care linked to genetics/genomics, whereas more non adopters than adopters 
answered with 'medication', 'weight' and 'blood pressure' (Fig 7.10).

























Blood Ethnic Cholesterol Cancer 
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.... Areas of care linked to genetics
Confidence levels in asking patients about their genetic family history (QulO)
Participants were asked how confident they would feel about asking patients questions about 
their family genetic history, answers could range from 'extremely confident' to 'not relevant to 
my role' (QulO). A Man-Whitney analysis showed that adopters (Mean=4.375, SD=0.495) were 
significantly (p<0.001) more likely to be more confident in asking patients about their genetic 
family history compared to non adopters (Mean=3.688, SD=0.664). However, no participants 
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Resources that RGCs provide (Qul3)
Participants were asked what resources they thought that Regional Genetic Centres provided. 
Some adopters identified genetic screening (R7), family counselling (R8) and gene testing and 
family pedigree screening (R9). The most popular theme among adopters was 
testing/screening, where six adopters said that this was a provision of RGCs. Four adopters 
said they provided counselling, two adopters answered under the theme of determining risk 
and training/education. One adopter answered under the themes of advice/support and 
information.
Non adopters identified genetic marking (Rll), educational resources (R12) and counselling 
(and) determining risk (R14). Counselling was the most common theme among non adopters, 
with 11 non adopters responding under this theme. Nine non adopters responses were under 
the advice/support theme and eight non adopters answered with the testing/screening theme. 
Three non adopters answered within the theme of determining risk and two non adopters 
answered with the themes of training/education and information. Two non adopters said that 
they did not know what RGCs provided. Interestingly one non adopter commented that "we 
live in a very rural area of highlands in Scotland, this is just not an accessible service" (R15), 
which highlights that RGCs are not seen as practical or a source of support for everyone.
Types of support services available to patients and their families with or at risk of a genetic 
condition (Qul4)
Respondents selected from a list of five possible support services, including one red herring 
(medical insurance). A similar percentage of adopters (19%, n=4) and non adopters (19.4%, 
n=9) selected the red herring. The number of correct options selected was summed for each 
participant to give a score for awareness of support services (a minus one was applied if the 
red herring was ticked).
A Mann-Whitney analysis showed that adopters (Mean=2.875, SD=0.850) were significantly 
(p=0.001) more likely to be aware of the types of support services available to patients and 
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Opinions on incorporating genetics/genomics more into everyday practice (Qu23)
Participants were asked whether they would like to incorporate more genetics/genomics as 
part of their everyday practice, answers ranged from 'definitely' to 'not relevant' (Qu23) (Fig 
7.15). A Chi-Square analysis showed that there was significant (p=0.013) association between 
adopter status and opinions on incorporating more genetics/genomics into their practice.












Not relevant Unsure Definitely not Maybe Definitely 
Decisions on incoporating genetics into practice
• Adopters
i.'J Non adopters
Interest in new areas of genetic/genomic knowledge (Qu24)
Participants were asked about their interest in new areas of genetics/genomics within their 
practice, with responses ranging from 'definitely interested' to 'unsure' (Qu24). A Mann- 
Whitney analysis showed that adopters (Mean=3.5, SD=0.560) were significantly (p=0.021) 
more likely to be interested in new areas of genetic/genomic knowledge within their practice 
than non adopters (Mean=3.2/ SD=0.524) (Fig 7.16).
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Seeking genetic/genomic knowledge for various people groups (Qu25)
Participants were asked about whether they had been asked to seek genetic/genomic 
information for seven different groups of people and whether they had acted on this request. 
Three responses were available and scored as indicated (0,1, 2):
• I have never been asked to seek advice (0)
• I have been asked to seek advice (1)
• I have been asked to seek advice and have acted (2)
Participants were then given an overall score based on their seven answers. Adopters had to 
have a score of between 2-12 (with at least one of the answers being 'I have been asked to 
seek advice and have acted) and opinion leaders needed to have a score of between 3-12 (with 
at least three of the answers being 'I have been asked to seek advice') to be placed in these 
groups.
Participants were only given a score if their minimum result was 2 (at least one of the answers 
being 'I have been asked to seek advice and have acted'), therefore 8.3% (n=2) of adopters and 
62.5% (n=40) of non adopters did not qualify for a score. A Mann-Whitney analysis showed 
that adopters (Mean=3.792, SD=2.502) were significantly (p<0.001) more likely to seek 
genetic/genomic information for people than non adopter (Mean=1.203, SD=2.117).
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Fig 7.17. Adopters' and non adopters' provision of genetic/genomic information behaviour.
I Adopters
I Non adopters
No score 2-4 5-8 9-12 
Score of genetic information behaviour
Questions to determine additional influencing factors
Table 7.10 shows the analysis of the questions that were not used as adopter identifying 
questions (i.e. they were not used in the scoring system). Only the significant questions are 
listed in table 7.10 due to there being a large number of non significant non identifying 
questions. The non significant questions are presented in appendix 14.
Table 7.10. Non identifying questions of significance between adopters and non adopters
Non identifying questions
Ease of applying new knowledge into 
practice (Qul9b, Fig7.18)
Ease of talking to colleagues about 
genetics/genomics (Qul9d, Fig7.19)
Breast cancer scenario. Expectation of 
colleagues to follow up family with genetic 
services (Qu20ii, Fig7.20)
Bowel cancer scenario. Expectation from 
doctors to raise the possibility of a genetic 
link with them (Qu21iv, Fig7.21)
Patients encourage the incorporation of 
new areas of knowledge into practice 
(Qu26 9, Fig7.22)





















*P value significant at 0.05
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Ease or difficulty of achieving various genetics/genomics activities within practice action 
(Qul9)
Participants were presented with five practice actions, three of which involved 
genetics/genomics, three of which were significant. Response options ranged from 'extremely 
easy' to 'extremely difficult'.
Ease of applying new knowledge into nursing practice (Qul9b)
A Mann-Whitney analysis showed that adopters (Mean=3.208/ SD=0.658) were significantly 
(p=0.008) more likely to find it easier to apply new knowledge into nursing practice compared 
to non adopters (Mean=2.85, SD=0.606) (Fig 7.18).






Extremely easy Somewhat easy Somewhat
difficult 




Ease of talking to colleagues about genetics/genomics (Qul9d)
A Mann-Whitney analysis showed that adopters (Mean=3.083, SD=0.830) were significantly 
(p=0.006) more likely to find it easier to talk to colleagues about genetics/genomics compared 
to non adopters (Mean=2.546, SD=0.765) (Fig 7.19).
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Fig 7.19. Adopters' and non adopters' ease of talking to colleagues about genetics/genomics.
Adopters 
Non adopters
Extremely easy Somewhat easy Somewhat Extremely difficult
difficult 
Ease of talking to colleagues about genetics
Breast cancer scenario. (QuZOii)
Participants were given a scenario about a 42 year old patient with breast cancer who has 
concerns about younger members of her family, after her mother and sister died under the 
age of 40 from the disease. Participants were asked whether they felt that they were expected 
by colleagues to follow up the family with genetic services. Responses could range from 1 
(strongly disagree) to 6 (strongly agree).
A Mann-Whitney analysis showed that adopters (Mean=3.958, SD=1.781) were significantly 
(p=0.024) more likely to score higher in agreement towards the statement that 'they felt 
expected by colleagues to follow up a family with genetic services' compared to non adopters 
(Mean=2.969, SD=1.790) (Fig 7.21).
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Fig 7.20. Adopters' and non adopters' perceived expectation by colleagues to use genetic 





Scale of percieved expectation to follow up patients with genetic services
Qualitative responses linked to question 20ii
Referring patients to genetic specialist services (Qul5)
Participants were asked whether they had ever referred an individual to genetic specialist 
services and if not why not (Qul5). Only one adopter answered this question, stating:
"Patients with a strong family history of e.g breast (cancer) or familial hypercholesterolemia 
are identified but would be referred by the GP" - R2
Non adopter comments included:
"would be referred by GP" - R16
"/ am aware and often patients are referred by their specialist nurses" - R13
"involved in past with doctors who refer, never had to do it myself - R17
Bowel cancer scenario (QuZliv)
Participants were given a scenario about a 20 year old man who has abdominal pain, weight 
loss and diarrhoea. His uncle is aged 45 and is recovering from bowel cancer. Participants 
were asked about whether they felt an expectation from doctors to raise the possibility of a 
genetic link with them. Responses could range from 1 (strongly agree) to 7 (strongly disagree).
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A Mann-Whitney analysis showed that adopters (Mean=5.125, SD=1.918) were significantly 
(p=0.026) more likely to believe that doctors expect them to raise a genetic link compared to 
non adopters (Mean=4.063, SD=2.023) (Fig 7.22).







1 (strongly 2 3 4 5 67 (strongly 
agree) disagree) 
Scale of expectation from doctors to raise a genetic link
Patients encourage the incorporation of new areas of knowledge into practice (Qu26_9)
Participants were asked whether their patients encourage the incorporation of new areas of 
knowledge into practice (Qu26_9). A Chi-Square analysis showed that there was a significant 
(p=0.019) association between adopter status and whether patients encourage the 
incorporation of new areas of knowledge (Fig 7.23).
Fig 7.22. Adopters' and non adopters' views of encouragement from patients on incorporating 
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Barriers and facilitators to using genetics/genomics more in practice (Qul7&18)
Participants were asked to rank 11 (and an option of 'other') items that may prevent them 
from using genetics/genomics in their practice (QulS). Table 7.11 shows the mode (highest 
frequency) of participant rank for each barrier (l=prevents me the most, 11= prevents me the 
least) and the overall ranking order of each barrier for both adopters and non adopters. The 
main barrier for implementing genetics/genomics more into practice was time for adopters 
and for non adopters it was time and no local study sessions.
Table 7.11. Barriers to the incorporation of genetics/genomics into nursing practice
Barrier
Genetics is not relevant
1 don't understand genetics
My colleagues don't support 
my interest
There are no relevant 
resources to help me learn
There are too many time 
constraints
My boss doesn't think it's 
important
1 don't like science
There are no local study 
sessions
It's the doctor's job
Patients never talk to me 
about genetics
























































*There is more than one mode result for these barriers because the rank achieved equal frequency 
among participants
Participants were also asked about what had helped them to implement an idea they had in 
practice and what prevented them from implementing it (Qul7a&b). The themed responses 
from both adopters and non adopters are discussed below.
Qualitative responses
Barriers and facilitators to implementing new ideas in practice (Qul7a&b) 
Adopters
Work organisations financial issues and time were each identified as barriers (Qul7) to 
incorporating new ideas into practice by 50% of participants. The other two barriers were the 
influence of other people (16.6%) and resources (16.6%).
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Some of the other comments included:
'other priorities' - R32; 'apathy1 - R3; 'lack of evidence'- R33
The facilitators (Qul7a) that helped adopters when implanting new ideas were people (58.3%), 
ability to convince colleagues (33.3%), money, research and evidence and resources (=16.6%).
Some of the other comments included:
'willingness to be progressive' - R34; 'credibility1 - R18;'/ have Carte Blanche'- R30
Won adopters
The barriers that non adopters felt stopped them from implementing new ideas were time 
(34.4%), work organisations finances (31%), people (27.5%) and resources (20.6%).
Some of the other comments included:
'limitations of my accountability' - R28; 'some see those with new ideas as a threat' - R35; 
'open to this in my practice' - R36; 'barriers with the systems'- R14
The facilitators that helped non-adopters to implement new ideas into practice were people 
(56.2%), able to convince colleagues (37.5%), research and evidence (25%), experience (12.5%) 
and resources (6.25%).
Some of the other comments included:
'benefit to patient' - R37;'/ had a plan and was able to present this' - R38; 'organisation' - R39
Adopters and non adopters summary
Adopters scored significantly higher in the majority of the identifying questions compared to 
non-adopters. There was no significant difference in question 11 ('areas of knowledge needed 
when undertaking a family history') between adopters and non adopters, indicating a similarly 
average level of knowledge from both groups around family history taking. These results also 
reinforce and enhance the reasoning behind the development of these identifying questions 
for adopters. Only one demographic (areas of nursing practice) was significantly different 
between the two groups, showing that there were few defining demographic characteristics 
for adopters were identified in this study. Two significant additional influencing factors (non 
adopter identifying questions) were around the ease of achieving certain actions (Qul9) such 
as implementing new knowledge and talking to colleagues about genetics/genomics and also
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expectations felt from colleagues (Qu20ii) and doctors (Qu21iv) around genetic use within 
their practice. The main barrier for implementing genetics/genomics more into practice was 
time for adopters (23.4% more adopters ranked this barrier as one compared to non adopters) 
and time and lack of local study sessions for non adopters (23.4% and 21.9% more non 
adopters respectively ranked these barrier as one compared to adopters) (QulS). When 
participants thought of a time when they had tried to implement a new idea, both adopters 
and non adopters said that time prevented them and adopters also said financial issues 
(Q.ul7). However the biggest facilitator for implementing new ideas was people (Qul7a). The 
following section will describe the data analysis from the opinion leader and non opinion 
leader groups.
7.7.3.2 Opinion leaders v non opinion leaders
There were 19 (21.5%) participants identified as opinion leaders and 69 (78.4%) as non opinion 
leaders. Table 7.12 shows all the demographic questions that participants were asked, with 
the significant demographic questions marked with an S and non significant questions marked 
with an NS. Data for the non significant questions are presented in appendix 14.
Table 7.12. Demographic questions of significance between opinion leaders and non opinion 
leaders
Demographic
Area of nursing 
practice












































*P value significant at 0.05 
Current practising grade (Qu30)
Participants were asked at what grade they were currently employed (Qu30). A Mann- 
Whitney analysis showed that opinion leaders (Mean=3.053, SD=0.848) were significantly 
(p=0.005) more likely to be of a higher grade compared to non opinion leaders (Mean=1.362, 
SD=3.610) (Fig 7.24).
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Fig 7.23. Employment level of opinion leaders and non opinion leaders.
IOL
I Non-OL
Highest level of academic achievement (Qu31)
Participants were asked what their highest level of academic achievement was, ranging from 
diploma to PhD (Qu31). A Mann-Whitney analysis showed that opinion leaders (Mean=1.737, 
SD=2.705) were significantly (p=0.007) more likely to have a higher level of academic 
achievement than non opinion leaders (Mean=1.130, SD=2.640) (Fig 7.25).
Fig 7.24. Highest academic achievements of opinion leaders and non opinion leaders.






Opinion leader identifying questions
Table 7.13 shows all the opinion leader identifying questions that participants were asked, 
with the significant identifying questions marked with an S and the non significant questions 
marked with an NS. The non significant questions are presented in appendix 14.
Table 7.13. Identifying questions of significance between opinion leaders and non opinion 
leaders
Identifying questions
Level of perceived 
influence over others 
(Qu4, Fig7.25)
Opinion leadership scale 
(Qul6, Fig7.26)
Talking to colleagues 
about genetics/genomics
Opinions on incorporating 
genetics/genomics into 
everyday practice (Qu23, 
Fig7.27)




knowledge for various 
people groups























*P value significant at 0.05
Level of perceived influence over others (Qu4)
Participants were asked a range of statements to determine their perceived influence over 
others. Scores for individual statements were combined to give an overall score, ranging from 
75-152 (Qu4). A Mann-Whitney analysis showed that opinion leaders (Mean=143.632, 
SD9.465) were significantly (p<0.001) more likely to have a higher level of perceived influence 
over others compared to non opinion leaders (Mean=114.044, SD=15.504) (Fig 7.26).
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Fig 7.25. Perceived influence over others scores among opinion leaders and non opinion 
leaders.
75-94 95-114 115-134 135-152 
Score range for perceived influence
Opinion leadership scale (Qul6)
Participants were asked four individual questions. Answers were coded and the allocated 
scores were combined to give an overall score which would indicate their level of opinion 
leadership (Qul6). To be considered an opinion leader, respondents had to score between 16- 
20. A Mann-Whitney analysis showed that opinion leaders (Mean=17.579, SD=2.610) were 
significantly (p<0.001) more likely to have a higher opinion leadership score compared to non 
opinion leaders (Mean=8.913, SD=3.547) (Fig 7.27).
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Upon reliability testing using the Cronbach's alpha test, the opinion leadership scale received a 
reliability score of 0.852 (Mean = 15.570, SD = 3.593). Therefore it can be deemed that 
question 16 does reliable test an individual's opinion leadership level.
Opinions on incorporating genetics/genomics more into everyday practice (Qu23)
Participants were asked whether they would like to incorporate more genetics/genomics as 
part of everyday practice (Qu23). A Chi-Square analysis showed that there was a significant 
(p=0.023) association between opinion leader category and wanting to incorporate more 
genetics/genomics into their practice compared with non opinion leaders (Fig 7.28).
Fig 7.27. Opinion leaders' and non opinion leaders' opinions on incorporating 





Not relevant Unsure Definitely not Maybe Definitely 
Decisions on incorporating genetics into practice
Questions to determine additional influencing factors
Of the questions not used as opinion leader identifying questions, which are those questions 
that are not used as part of the opinion leader scoring system (p!54), only Openness to 
Experience was significant. All the non significant questions are discussed further in appendix 
14.
Openness to Experience (Qul)
Participants were given a range of statements about themselves, answers were allocated a 
score and combined together to give an overall score of their Openness to Experience (Qul). A 
T-test analysis showed that opinion leaders (Mean=37.895, SD=3.430) were significantly
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(p=0.034) more likely to have a higher level of Openness to Experience than non opinion 
leaders (Mean=35.551, SD=4.374) (Fig 7.29).
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Scores of openness to experience
Barriers to using more genetics/genomics in practice (Qul8)
Table 7.11 (p!95) set out the views of adopters and non adopters on the barriers to 
incorporating genetics/genomics into practice (Qul8). Table 7.15 shows the mode (highest 
frequency) of participant rank for each barrier (l=prevents me the most, 11= prevents me the 
least) and the overall ranking order of each barrier for both opinion leaders and non opinion 
leaders. The biggest barriers for opinion leaders and non opinion leaders are 'no local study 
sessions' and 'time' respectively.
Participants were provided with a 'free text' box and asked about what had helped them to 
implement an idea they had in practice and what prevented them from implementing it 
(Qul7a&b).
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Table 7.14 Barriers to the incorporation of genetics/genomics into nursing practice
Barrier
Genetics is not relevant
1 don't understand genetics
My colleagues don't support my 
interest
There are no relevant resources to 
help me learn
There are too many time constraints
My boss doesn't think it's important
1 don't like science
There are no local study sessions
It's the doctor's job
Patients never talk to me about 
genetics

























































*There is more than one mode result for these barriers because the rank achieved equal frequency 
among participants
Opinion leaders
The main barrier (Qul7a) for opinion leaders was organisation finances (41.6%), this was 
followed by time (33.3%), people (25%) and then resources (16.6%). Some of the other 
comments included 'motivation' (R40) and 'other priorities' (R32)
The main facilitator (Qul7b) that opinion leaders said encouraged them to incorporate new 
ideas into practice was people (75%), followed by the ability to convince colleagues (37.5%), 
financial (12.5%), resources (12.5%) and research and evidence (12.5%). Some of the other 
comments included 'willingness to be progressive' (R34) and 'credibility1 (RIB)
Non opinion leaders
The barriers that the non opinion leaders said prevented them from implementing new ideas 
into practice mirrored that of opinion leaders. The main barrier was organisational finances 
(37.9%) followed by time (34.4%), people (24.1%) and resources (20.6%). Other priorities were 
mentioned as a barrier as were I 'work over 3 sites, implementation [is] hard to communicate' 
(R41) and a 'lack of confidence [as recently returned to practice]' (R21).
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The facilitators that non opinion leaders said helped them to get new ideas incorporated into 
practice were people (45%), ability to convince colleagues (30%), research and evidence (25%), 
resources (10%) and experience (10%), finally financial (5%). Some of the other comments 
included the aid of 'assistance in putting plans forward'(R9) and being able to present a plan 
(R38).
Opinion leaders and non opinion leaders summary
Responses from opinion leaders were significantly different to non opinion leaders for just half 
of the questions selected to distinguish between opinion leaders and non opinion leaders. 
Opinion leaders had a higher perceived influence over others, had higher scores on the opinion 
leadership scale and were keen to incorporate more genetics/genomics into their practice. 
The opinion leaders had quite clear demographic differences compared to non opinion 
leaders, they tended to be of a higher grade and tended to have a higher level of education 
(academic achievement). They achieved a higher Openness to Experience score than non 
opinion leaders. Therefore, although the Openness to Experience question was selected to 
distinguish between adopters and non adopters, it appears that it could also differentiate 
opinion leaders from non opinion leaders. The biggest barrier to incorporating more 
genetics/genomics into practice was time for non opinion leaders (21.7% more non opinion 
leaders ranked this barrier as one compared to opinion leaders) and no local study sessions for 
opinion leaders (26.3% more opinion leaders ranked this barrier as one compared to non 
opinion leaders). In their own experiences, opinion leaders felt that finances were the biggest 
barriers for getting a new idea incorporated into practice and that people were the main 
facilitators. Non opinion leaders had the same main facilitator and barrier as opinion leaders, 
but they identified a second barrier which was time. The next section will present findings for 
the comparison of adopters and opinion leaders.
7.7.3.3 Adopters v opinion leaders
Table 7.16 shows that of all the demographic questions that participants were asked, only one 
was significant. The non significant questions are presented further in appendix 14.
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Table 7.15. Demographic questions of significance between adopters and opinion leaders
Demographic











































*P value significant at 0.05
Age of participants (Qu32)
A Mann-Whitney analysis showed that adopters (Mean=50.471, SD=5.467) were significantly 
(p=0.028) more likely to be older than opinion leaders (Mean=40.421/ SD=18.605) (Fig 7.30).








Table 7.17 shows all the questions that were significant. All the non significant questions are 
discussed further in appendix 14.
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Table 7.16. Questions of significance between adopters and opinion leaders
Questions
Openness to Experience (Qul, Fig7.30)
Level of perceived influence over others 
(Qu4, Fig7.31)
Familiarity with genetic/genomic resources 
(Qu5, Fig7.32)
Attitudes to genetic/genomic nursing 
statements (Qu6, Fig7.33)
Awareness and knowledge of regional 
genetic centres (Qul2, Fig7.34)
Seeking genetic/genomic knowledge for 






















Openness to Experience (Qul)
Participants were given a series of statements about themselves. Scores assigned to each 
answer were combined to give an overall Openness to Experience score (Qul). A T-test 
analysis showed that adopters (Mean=40.294, SD=3.478) were significantly (p=0.045) more 
likely to have a higher Openness to Experience score than opinion leaders (Mean=37.895, 
SD=3.430) (Fig 7.31).
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Score of openness to experience
Level of perceived influence over others (Qu4)
Participants were asked a series of statements which were combined to give an overall score 
of between 75-152 (Qu4). A Mann-Whitney analysis showed that opinion leaders 
(Mean=143.632, SD=9.465) were significantly (p<0.001) more likely to have a higher level of 
perceived influence over others than adopters (Mean=118.824, SD=9.976) (Fig 7.32).
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Fig 7.31. Adopters and opinion leaders perceived influence over others.
75-94 95-114 115-134 135-152 
Perceived influence over others
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Familiarity with genetic/genomic resources (Qu5)
Participants were asked about their familiarly with various genetic/genomic resources. For 
question explanation and scoring calculation, see p!79.
A T-test analysis showed that adopters (Mean=11.882, SD=2.667) were significantly (p=0.001) 
more likely to be familiar with the various genetic/genomic resources than opinion leaders 
(Mean=8.842, SD=2.218) (Fig 7.33).









6-11 12-17 18-24 
Familiarity with resources score
Some resources were not significant on an individual basis: Department of Health's White 
paper (Qu5c, p=0.076) [68.4% of opinion leaders answered 'never heard of them' along with 
58.8% of adopters who answered 'somewhat familiar'], local specialist genetic services (Q.u 5d,
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p=0.244) [11.8% of adopters and 26.3% of opinion leaders had never heard of them], telling 
Stories (QuSe, p=0.330) [with the majority of adopters and opinion leaders not being familiar 
with the resource],
Responses to genetic/genomic and career statements (Qu6)
Participants were asked for their level of agreement with various 'genetic/genomic and 
nursing' statements. Answers were assigned scores which were then combined to create an 
overall score. For question explanation and scoring calculation, see p!80.
A Mann-Whitney analysis showed that adopters (Mean=26.588, SD=1.460) were significantly 
(p=0.038) more likely to be positive towards the various genetics/genomics within nursing 
statements than opinion leaders (Mean=24.632, SD=3.201) (Fig 7.34).




















Scores of attitudes to genetic statements
Awareness and knowledge of Regional Genetic Centres (RGCs) (Qul2)
Participants were asked about their knowledge and understanding of regional genetic centres 
(Qul2). A Mann-Whitney analysis showed that adopters (Mean=3.177, SD=1.131) were 
significantly (p=0.018) more likely to have knowledge of their local RGCs compared to opinion 
leaders (Mean=2.211, SD=1.032)(Fig7.35).
Page | 208
Fig 7.34. Adopters' and opinion leaders' knowledge of RGCs.
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Knowledge of RGCs them
The free text responses (Qul3) linked to the above question are presented on p!85. 
Seeking genetic/genomic knowledge for various people groups (Qu25)
Participants were asked about whether they had been asked to seek genetic/genomic 
information for different people groups and whether they had acted on this request. For full 
question explanation and scoring system, see p!89.
A Mann-Whitney analysis showed that adopters (Mean=4.059, SD=2.794) were significantly 
(p=0.005) more likely to seek genetic/genomic information for individuals than opinion leaders 
(Mean-1.737, SD=2.705)(Fig 7.36).
Fig 7.35. Adopters and opinion leaders provision of genetic/genomic information behaviour.
I Adopters 
IOL
No score 2-4 5-8 9-12 
Seeking genetic information score
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Adopter and opinion leader summary
The adopters and opinion leaders only differed in one demographic, which was age, as 
adopters tended to be older than opinion leaders. Adopters and opinion leaders differed 
significantly on six non demographic questions. On five of these questions it was the adopters 
who were significantly more likely to answer the question more favourably. Opinion leaders 
had a higher overall score on one question which was that they had a higher perceived 
influence over others. Adopters were more knowledgeable about Regional Genetic Centres, 
were more familiar with genetic/genomic resources and were more favourable towards 
nursing and genetic/genomic statements. As expected, adopters tended to score higher on 
the questions used to identify adopters from non adopters, whereas opinion leaders scored 
higher on one of the questions used to identify opinion leaders from non opinion leaders. The 
next section discuses the statistical difference between opinion leaders and non adopters.
7.7.3.4 Opinion leaders vnon adopters
Table 7.18 shows the demographic questions that participants were asked, with significant 
being marked with an S. The non significant questions are presented further in appendixones 
14.
Table 7.17. Demographic questions of significance between non adopters and opinion leaders
Demographic
Area of nursing practice




Length of time practising
Genetic disorders within the 
family
Ethnicity


































*P value significant at 0.05
Current practising grade (Qu30)
Participants were asked at which grade they were currently practising (Qu30). A Mann- 
Whitney analysis showed that opinion leaders (Mean=3.053, SD=0.848) were significantly 
(p=0.003) more likely to be of a higher practising grade than non adopters (Mean=1.577, 
SD=3.183) (Fig 7.37).
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Highest level of academic achievement (Qu31)
Participants were asked for their highest academic achievement level, this ranged from 
diploma to PhD (Qu31). A Mann-Whitney analysis showed that opinion leaders (Mean=1.737, 
SD=2.705) were significantly (p=0.002) more likely to have a higher academic achievement 
than non adopters (Mean=0.827, SD=2.935) (Fig 7.38).
Fig 7.37. Academic achievement of opinion leaders and non adopters.
• OL
a Non-adopters
Diploma Degree Masters 
Academic achievement
PhD
Table 7.19 shows all the questions that were significant. All the non significant questions are 
presented in appendix 14.
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Table 7.18. Questions of significance between non adopters and opinion leaders
Questions
Openness to Experience (Qul, Fig7.38)
Breast cancer scenario (Qu20ii, Fig7.39)











Openness to Experience (Qul)
Participants were provided with character statements. Selected answers were scored and 
scores combined to give an overall total (Qul). A T-test analysis showed that opinion leaders 
(Mean=37.895, SD=3.430) were significantly (p<0.001) more likely to have a higher level of 
Openness to Experience than non adopters (Mean=34, SD=3.430) (Fig 7.39).
Fig 7.38. Opinion leaders' and non adopters' Openness to Experience scores.
84.4% 




n=5 : Non adopters
10-20 21-30 31-40 41-50 
Score of openness to experience
Breast cancer scenario. (Qu20ii)
Participants were presented with a scenario where a 42 year old patient was concerned about 
other family members' chances of developing cancer. See p!92 for a full description of the 
question. A Likert scale captured responses and ranged from 1 (strongly disagree) to 6 
(strongly agree). A Mann-Whitney analysis showed that opinion leaders (Mean=3.895, 
SD=1.792) were significantly (p=0.039) more likely to have a higher level of perceived 
expectation from colleagues to follow up families with genetics services than non adopters 
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Opinion leader and non adopter summary
Opinion leaders were practising at a higher grade compared to non adopters and were also 
significantly more likely to have a higher level of academic achievement. There were few 
differences between the two groups on their level of genetic/genomic knowledge and 
awareness, although opinion leaders felt a greater level of expectation from colleagues to 
follow up families with genetic services and they were also more likely to 'frequentl/ talk to 
colleagues about genetics/genomics. The two groups did differ in the Openness to Experience 
personality trait, with opinion leaders having a significantly higher level of the trait compared 
to non adopters. The next section discusses the identifying difference of genetic opinion 
leaders and opinion leaders with an interest in genetics.
7.7.3.5 Genetic opinion leaders
Genetic opinion leaders are opinion leaders who were also adopters.
Demographics
There were six genetic opinion leaders (GOLs) identified, hence due to the small number of 
participants in this group no statistical analysis was completed. Three of the GOLs were 
practice nurses and three were oncology nurses (Qu28). There was one GOL who was younger 
(36 years, Qu32) and less experienced (15 years as a nurse and grade 6, Qu29&30) than the 
rest. Of the remaining five GOLs, all were aged over 43 years (Q.U32) and had been nurses for 
between 24-35 years (Qu29). These five were all practising at grade seven and eight (Qu30). 
Of the three participants who responded to the question, they had been practising in their 
current role between 10-25 years (Qu28a). Two GOLs had a masters degree, three had 
degrees and one had a diploma (Qu31) and one GOL had been affected by a genetic condition 
either personally or through a family member (Qu34). Two of the GOLs also scored high 
enough on their opinion leader scores to be considered opinion leaders with an interest in 
genetics (OLWIGs). However because they were also adopters (which is a higher grouping to 
OLWIGs) they had a higher level of genetic/genomic knowledge to be considered for this group 
(see methodology, section 6.4.2.2).
When asked whether they had ever identified someone who should/could be referred to 
genetic services (Qul5), one GOL said that this was not relevant to their practice. All the other 
participants in this group had identified someone for referral anywhere from three times to 
over 200 times. All GOLs said that patients, other health professionals and attending study 
days encouraged them to incorporate new areas of knowledge into practice (Qu26). Four said
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that grade did not matter when asking for advice, however two did say that higher grades tend 
to ask other higher grades (Qu27).
The genetic/genomic resource that all the GOLs were the most familiar with was the local 
specialist genetic services (Qu5d) and one participant knew about the genetic competencies 
(Qu5a) but the rest of the resources were not familiar to the participants.
Barriers and difficulties with genetics/genomics within practice
Time constraints and no local study sessions were the biggest barriers to the GOLs for using 
genetics/genomics more in their role and the lowest ranking barriers was seeing 
genetics/genomics as the doctor's job and that it is not their decision to make (Qul8). Three 
GOLs found it difficult to attend study days that included genetics/genomics (Qul9a) and two 
found it difficult to get permission from senior nurses for access to new resources (Qul9c).
One GOL did not think that it was expected of her to highlight the need for more patient 
investigation (Qu20i) and two GOLs did not feel that colleagues expected them to follow up 
the patient with genetic services (Qu20ii). One participant did not think they would be 
fulfilling the requirement of their role by seeking follow up consultations for the family 
(Qu20iii).
Three GOLs did not believe that patients and relatives thought that they should be supporting 
referrals to specialist genetic services (Qu21i) and one said that doctors did not expect them to 
raise the possibility of a genetic link with them (Qu21iv). One GOL said that they would not act 
as they thought best if others disagreed with them (Qu21v), but three GOLs said they would 
not seek the opinions of others in the first place (Qu21vi).
7.7.3.6 Opinion leaders with an interest in genetics
Opinion leaders with an interest in genetics (OLWIGs) were opinion leaders who had scored 
highly but were not adopters. There were 11 OLWIGs in total.
Demographics
Nine opinion leaders with an interest in genetics (OLWIGs) were practice nurses, with only two 
being oncology nurses (Qu28). Of those OLWIGs that responded to the question (n=5), most 
had practised in their current role for between 12-20 years apart from one OLWIG who had 
been in their current role for seven years (Qu28a). When asked how long they had been 
practising as nurses, one OLWIG answered with five, one with 15 and the rest ranged between 
23-30 years (Qu29). The majority of OLWIGs (n=6) were a grade seven, one was a grade five 
and two at each grade six and eight (Qu30). Highest academic achievement had a similar
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spread of results, with one OLWIG having a PhD, one a diploma and four each had a masters 
degree and degree (Qu31). The age range was between 31-56 years, however most (n=8) 
were aged over 44 years (Qu32). Two OLWIGs had been either affected themselves by a 
genetic condition or had a family member affected (Qu34).
Only two OLWiGs had a score that would identify them as having a high Openness to 
Experience (Qul). Very few OLWIGs were familiar with any of the genetic/genomic resources 
(Qu5), although three participants were aware of the Human Genome Project (Qu5f) and two 
were familiar with the local specialist genetic/genomic service (QuSd). Equally all were either 
unaware of regional genetic centres and their services or were aware of the centres but not 
about their services (Qul2). Only one OLWIG thought genetics/genomics was not relevant to 
their practice (Qu8) and the same individual also said that they have never encountered an 
individual who should be referred to genetic services (QulSa). One participant also said that 
identifying people to refer to genetic services is not relevant to her practice and two said that 
they would not recognise when this was appropriate. Four OLWIGs identified having referred 
someone to genetic services (Qul5) from 3-30 occasions.
Barriers and perceived difficulties with genetics/genomics within practice
The biggest barriers to preventing OLWIGs from using genetics/genomics more in their role 
were that there were no local study sessions (QulSh) and that there are too many time 
constraints (QulSe). The barrier that prevented participants the least was feeling that 
genetics/genomics is not relevant (QulSa). Applying new knowledge into nursing practice was 
seen as fairly easy to do (Qul9b) although attending study days/courses that included 
genetics/genomics was the most difficult (Qul9a). Four OLWIGs strongly agreed that they 
would be fulfilling requirements of their role by seeking follow up genetic consultations for the 
family (QuZOiii) and six also strongly agreed that it is expected of them by colleagues to follow 
up the family with genetic services (Qu20i). The majority of OLWIGs agreed that their manager 
would approve of them highlighting the need for further patient investigation (Qu21ii) and 
that peer colleagues would seek further advice on the patient (Qu21iii). Interestingly all but 
one participant said that they would not seek the opinions of others (Qu21vi) over a patient. 
Also the majority (n=9) of OLWIGs said that grade does not matter when seeking advice from 
colleagues (Qu27). Peers (Qu26_l) and attending study days (Qu26_5) were the biggest 
encouragers for incorporating new areas of knowledge into practice for OLWIG's.
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7.7.4 Qualitative questions 
Characteristics of those who are open to new ideas (Qu2)
Participants were asked what characteristics they would think were typical of people who are 
open to new ideas and concepts (Qu2). Seventy responded and open mindedness was 
considered the top characteristic. Willingness to learn and thoughtfulness were considered 
less important characteristics (Table 7.20).
Single characteristics identified included:
"spiritual enlightment" - R8 (adopter/opinion leader)
"young in job" - R5 (non adopter/non opinion leader)
"grounded" - R22 (non adopter/non opinion leader)
"balanced work/home life" - R23 (non adopter/non opinion leader)
"people who read a lot of various journals and are interested in the world about them" 
- R24 (non adopter/non opinion leader)
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There were also some negative comments about the characteristics of those who are open to 
new ideas. These included naivety, being disorganised and "risky" (R13-non adopter/opinion 
leader).
Whilst the majority of people provided answers that fitted into themes, some people, perhaps 
based on particular experiences gave quite different characteristics of people e.g. being naive.
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Everyone has their own understanding of what characteristics people who are open to ideas 
have, this could be reflective of their own personality and relationships with others.
Seeking professional advice from those who are not open to change and new ideas (Qu3a)
Participants were asked an initial closed question (Qu3) as to whether they seek professional 
advice from those who are open to change and new ideas. If they answered 'no' then they 
were asked an open question about where they seek professional advice (Qu3a). Only six 
participants answered this question. The most common answer was 'peers' (n=3), with one 
individual saying 'review bodies' and another answering with 'like minded nurses'.
Personality type of the person who is asked for professional advice (Qu3i)
Following on from the previous question (Qu3a), participants were asked to describe the 
personality of those individuals from whom they seek professional advice (Qu3i). The total 
number of participants who answered this open question was 26. The highest ranking 
personality was to be approachable (Table 7.21).
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There were some more unusual comments, which did not fit into a theme, as can be seen 
below.
"sensible, but proactive" -R27 (non adopter/non opinion leader) 
"integrity" - R28 (non adopter/opinion leader) 
"dominant" - R29 (non adopter/opinion leader)
"can see the amusing side of complicated problems" - RIB (non adopter/opinion 
leader)
"broad" - R30 (adopter/non opinion leader)
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There were two individuals who commented about how they go about asking for professional 
advice;
"more than one colleague and they have different views and characteristics ask both 
and consider both answers" - R31 (non adopter/non opinion leader)
"will often go to a monitor evaluator for different perspective to me" - R18 
(adopter/opinion leader)
Participants had a clear idea of what characteristics were common among people who are 
open to new ideas and those who they ask for advice. Being approachable was the top 
characteristic of the individuals that participants seek advice from but approachable was 
ranked ninth for those who are open to new ideas. Being an outgoing person was ranked 
second for both questions but being confident was ranked second for the people whom get 
sought for advice but was ranked eighth in people open to new ideas. It does appear that the 
characteristics between people from whom advice is sought and those open to new ideas are 
seen differently by participants.
Overall results summary
The genetic indicators of adoption (GlAs) that were identified and verified in the Phase 1 data 
helped to identify genetic nurse adopters in the Phase 2 data. GIA b (support services) 
received a lower consensus than the other GIAs in Phase 1 but still aided the identification of 
adopters in Phase 2. The Phase 1 participants believed that to provide information of support 
services to patients (GIA b) was too difficult and specialised. However, most participants in 
Phase 2 could identify most of the support services available to patients, although genetic 
counselling was one of the least well known. Also many have referred patients to genetic 
specialist services but some participants did say the doctors often did this not the nurses. The 
Phase 1 focus group helped to identify useful suggestions for the Phase 2 questionnaire, such 
as the inclusion of a question to ask about participants about family genetic history.
The Phase 2 survey tool's main identifying questions for adopters appear to be appropriate, 
although only half the opinion leader identifying questions were significant. Age was the only 
demographic difference between adopters and opinion leaders, with Openness to Experience 
and level of perceived influence over others being the main characteristic differences. 
Adopters had more knowledge on genetics/genomics than opinion leaders. There were low 
numbers of GOLs and OLWIGs as expected. The majority of GOLs were older and were more 
experienced and all had identified someone for referral. The OLWIGs had a range of practising
grades and experiences although the majority were older. They had low Openness to
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Experience scores and a lack of familiarity with genetic/genomic resources. Fewer OLWIGs 
had identified someone for referral compared to GOLs and were less sure about when 
genetics/genomics was applicable in their practice.
Throughout the data, qualitative responses have helped to provide greater clarity and meaning 
to the quantitative results. The next chapter will discuss the results and their meaning in 
depth and will present ways of applying the results to make them applicable on a wider scale.
Summary 
Phase 1:
From the literature review and expert consultation, four GIAs were proposed:
a. To know how to access genetic services and would make active use of them
b. To be able to provide information of support services to patients or their families with or
at risk of a genetic condition
c. To ask patients relevant questions about their family history 
d. To be open to the possibility of genetics/genomics in all aspects of care
Expert survey confirmed 4 GIAs as being appropriate to identify nurse adopters of genetics 
Phase 2:
The survey identified 24 (27.3%) adopters (72.7% non adopters), 19 (21.6%) opinion leaders 
(78.4% non opinion leaders), 11 (12.5%) OLWIGs and 6 (6.8%) GOLs.
Key distinguishing characteristics of adopters were identified as:
Higher levels of Openness to Experience
Awareness and knowledge of Regional Genetic Centres
Has an interest in new areas of genetic knowledge
Sees the relevance of genetics to practice
Feels expectation from colleagues to use genetic services
Finds it easier to apply new knowledge into practice
Key distinguishing characteristics of OLs were identified as:
High Openness to Experience
High academic achievement
Had perceived influence over others
High professional grade
Keen to incorporate more genetics into practice
Two further groups were identified - OLWIGS and GOLs
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Chapter 8. Discussion
The previous chapter explored the analysis of results from the research, which included the 
statistical identification of adopters, opinion leaders (OLs) and genetic opinion leaders (GOLs). 
There are several interesting and original findings which will be discussed in this chapter along 
with the relevant literature. The Diffusion of Innovations, Theory of Planned Behaviour and 
the Stages of Change theories outlined in Chapter five are discussed in relation to how they 
can be applied to the wider implementation of genetics/genomics into nursing practice 
facilitated by the use of adopters and genetic opinion leaders. The discussion is presented 
using the Theory of Planned Behaviour as a basis for structure. Section one maps the 
identified characteristics for adoption/non adoption to the Theory of Planned Behaviour, 
including the role of subjective norms and perceived behavioural controls. The role of 
personality traits are also discussed in this section. Section Two focuses on the characteristic 
traits of the groups and limitations of the study will be explored. Strategies which could be 
used to overcome these limitations in future studies are also discussed. Section three discuses 
a possible strategy for the engagement of genetics/genomics into nursing practice. The 
chapter concludes with discussing how the aims of the study were reached and future steps 
for further integration of genetics/genomics into nursing practice are presented.
Overview
The Phase 1 research identified four key behaviours and activities (GIAs) which were used to 
identify nurse adopters of genetics/genomics in Phase 2. Of those completing the Phase 2 
questionnaire, 24 adopters were identified, with 19 opinion leaders and six genetic opinion 
leaders. In terms of psychological characteristics, adopters scored higher in Openness to 
Experience than both non-adopters and opinion leaders, suggesting that adopters are more 
open to new ideas and experiences and are innovative. Moreover in terms of the influence 
from those around them, adopters felt there was an expectation from doctors and colleagues 
to be using genetics/genomics in their practice and that patients encouraged them to 
incorporate new areas of practice knowledge. Adopters were also more familiar with 
genetic/genomic resources and were more positive towards statements about 
genetics/genomics within nursing practice, compared to non-adopters and opinion leaders. 
Unique characteristics were also identified in opinion leaders. Opinion leaders had more 
perceived influence over others, practised at a higher grader and had a higher level of 
academic achievement compared to non opinion leaders and non adopters (Chapter 7). The 
unique and significant findings mirror the strength of the study methodology and the study 
answered all of the initial aims listed below.
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As discussed in detail in Chapter 6, section 6.1, p!30, the aims of the study were to:
1. Articulate the identifying characteristics of a nurse adopter of genetics/genomics 
through an expert consensus
2. Identify nurse adopters and opinion leaders of genetics/genomics
3. Identify the factors and processes that might facilitate or inhibit the adoption of 
genetics/genomics into nursing practice
4. Apply knowledge and understanding about the identified groups gained through the 
study to the three behaviour change theories in order to formulate potential 
applications for how the characteristics of those individuals who are adopting 
genetics/genomics could help inform the strategies of other societies and 
organisations seeking to engage nurses (and other health professionals) in genomic 
healthcare.
Having studied the three main behaviour change theories, the Diffusion of Innovations (DOI), 
Stages of Change theory (SOC) and the Theory of Planned Behaviour (TPB), in depth (see 
Chapter 5, p77), I feel that the TPB provides the most appropriate framework around which to 
consider the findings of the study. The DOI and SOC do not provide enough detail on the 
external causes of behaviour change, whereas the TPB provides broader contextual variables 
such as subjective norms and perceived behavioural control. The SOC and DOI very much 
focus on the visible, set changes and do not include on a wide range of variables and do not 
encompass all that is needed to build a strategy, although do have some relevance. Therefore 
the findings in this chapter have been loosely mapped to the various stages and inputs of the 
TPB (Fig 8.1).
In section one, the findings are categorised into subjective norms, perceived behavioural 
control and behaviour intentions. There were no findings that could be mapped into the 
attitudes section of TPB. I feel that there are areas lacking in the TPB, such as personality traits 
and barriers and facilitators. Research by Hoyt et al (2009) shows the importance of the five 
factor personality model in the TPB (these are discussed more in detail when using TPB to 
inform a strategy (section 8.8.3 , p274)). Personality traits therefore have been placed at the 
beginning of this section as I believe that personality traits would pre-exist other variables in 
the TPB. Barriers and facilitators are placed at the end as they would affect the move from 
behaviour intention to behaviour change (Fig 8.1).
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Section 1. Identified characteristics related to adoption/non-adoption 
of genetics/genomics, mapped to the Theory of Planned Behaviour
8.1 Personality traits
I believe that personality traits pre-exist any attitudes or expectations of the innovation. The 
TPB does not include personality traits as an area that affects behavioural intention, however I 
feel it is an important aspect that has been overlooked (de Bruijin et al. 2009). Demographics 
have also been included in this section as I felt that demographic traits are an important 
variable in the TPB and should also be included as a pre-existing variable.
8.1.1 Openness to Experience
Openness to Experience was an important identifying trait among adopters and opinion 
leaders within this study and I believe that this characteristic could and should be used in the 
future identification of adopters and opinion leaders. However Openness to Experience is 
classed as a personality trait (part of the Big 5 Factor Model), which is a factor not made 
explicit in the TPB. I believe that the lack of integration of personality traits within the TPB is a 
limitation and one which may overlook an important aspect of change theory and the role that 
personality plays in the characteristics of those who are more likely to adopt a behaviour.
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8.1.1.1 Openness to Experience among adopters and non adopters
Openness to Experience was an important characteristic across the various groups. Adopters 
had a higher score of Openness to Experience than non adopters. According to McCrae (1996) 
adopters are more open to experience because they are imaginative, have favourable 
attitudes to education, science and change and they can cope with distractions. Some of the 
characteristics mentioned by McCrae (1996) were also seen in the adopters within this study. 
For example, they were open to learning about new areas of genetics/genomics and they 
found it easy to incorporate new areas of knowledge into their practice. Those who are open 
to experiences can have powerful influences upon others (McCrae, 1996), which can be seen in 
those adopters who are also opinion leaders (GOLs). George and Zhou (2001) argued that 
communication with colleagues was important as it helps foster creative ideas. A feature 
common in the present study among adopters was that they talked to their colleagues about 
genetics/genomics regularly (more than non adopters) and they found this easy. This could be 
linked to adopters' high level of Openness to Experience. Since there was no significant 
difference between adopters and non adopters in relation to grade and age, the results from 
the present study did agree with findings from both King et al. (2008) and Costa and McCrae 
(1988) that Openness to Experience did not significantly correlate with expertise or age and 
this highlights the need to not just target the older, more experienced nurses.
8.1.1.2 Openness to Experience among adopters and opinion leaders
Although initially used as an identifying question among adopters, Openness to Experience 
was also found to be a significant trait among opinion leaders. This had not been hypothesised 
as being important. There is little literature on the link between Openness to Experience (and 
the Five Factor model, which also includes extraversion, neuroticism, agreeableness and 
conscientiousness) and opinion leadership. On a general level of leadership, Judge et al. 
(2002) found that Openness to Experience is linked to leadership, but not as strongly as 
extraversion and conscientiousness. They believed Openness to Experience to be the least 
understood personality trait out of the five identified by Cattell et al. (1970). Openness to 
Experience was originally used in this study to identify adopters, on the basis of the work of 
McCrae (1987). In the present study, opinion leaders are good at influencing others and are 
open to new experiences, but not as significantly as adopters. However opinion leaders are 
still ahead of the majority in terms of being open to new experiences and this could still be 
used to target them as change agents. Interestingly adopters still had a higher Openness to 
Experience score than opinion leaders, indicating that they are more open to new ideas 
(including experiences) and to change than opinion leaders. This could be used as a 
distinguishing characteristic between the two groups. It may also be that a combination of
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traits as well as Openness to Experience may explain why adopters are more open to new 
ideas and change than opinion leaders which will need further clarification.
The findings from the current study do suggest that personality may have a significant role in 
the characteristics of adopters and opinion leaders. The findings seem to suggest that the TPB 
may be limited by its lack of focus on individual differences, such as personality that people 
bring to new experiences.
Some of the characteristics of nurse adopters of genetics/genomics that have emerged can be 
linked to the concept of emotional intelligence (El). Adopters can identify emotions (they feel 
an expectation from colleagues to implement genetics/genomics into practice), use their 
emotions to problem solve (they find it easier to apply new knowledge into practice) and can 
manage their emotions (they are keen to incorporate more genetics/genomics into practice) 
(see table 8.1, p228 for more details). Although it needs further investigation, as an overall 
personality theme generated by some of the research findings it has been included within the 
personality traits sections of the discussion.
8.1.2 Emotional intelligence
Although not explicitly measured in the present study, Emotional intelligence is classed as the 
ability to perceive, control and evaluate emotions. There is a debate among researchers about 
whether it can be taught or whether it is learnt (Salovey and Mayer, 1990). Mayer et al. (2008) 
describe four branches of El (Fig 8.2).
Fig 8.2. The four branches of emotional intelligence (Mayer et al. 2008)
Emotional Intelligence
Managing emotions so as to attain specific goals
Understanding emotions, emotions! language, and 
the signals conveyed by emotions
Perceiving emotions accurately 
in oneself and others
Using emotions to facilitate thinking
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These four subtypes of emotional intelligence (El) seem to be an important overarching 
characteristic of adopters. Adopters were identified as being confident in undertaking tasks, 
they feel expected by colleagues and doctors to undertake genetic/genomic tasks, feel 
encouraged by patients to incorporate new areas of practice and are high in Openness to 
Experience, which may indicate that adopters are high in El. Mayer et al. (2008) state that El is 
a mental ability not a social skill such as extraversion, therefore they suggest that it is not a 
learnt trait. This is different from other aspects of the study, such as Openness to Experience, 
education and awareness as they are social/knowledge skills and ones that can be acquired. 
Hence it might be that adopters have a high El level and are better at perceiving and managing 
their emotions as well as their colleagues' and patients' emotions. Bulmer Smith et al. (2009) 
believe that the concepts of El are fundamental to nursing practice and those leaders with a 
high El influence patient care and outcomes. It might therefore be reflected in genetic nurse 
adopters and GOLs within the current study, in relation to their confidence levels, accessing 
resources and the need for genetic/genomic awareness. Moreover El is correlated with the 
Big 5 Trait scales (Mayer et al. 2008) and El has been linked to high Openness to Experience 
(Mayer and Salovey, 1993). Therefore, it could be reasonable to assume that adopters with 
high Openness to Experience might be more likely to have high El. Those individuals with a 
high El are well adapted to regulate their own emotions and others and can often solve 
problems adaptively (Salovey and Mayer, 1990). This might be why adopters felt encouraged 
by patients to seek new practice knowledge; adopters could interpret their emotions to 
understand that patients are encouraging them in their efforts. Adopters also sought 
information for various people groups (patients, friend, relatives), which could be seen as a 
problem solving skill. Those with high El often recognise others' emotional reactions and 
choose empathic responses to them and choose socially adaptive behaviours in response 
(Salovey and Mayer, 1990). This might have been the case when adopters felt expectations 
from doctors and colleagues. In other words, they were responding with a socially adaptive 
behaviour as they recognised the emotional reactions in others and were perhaps trying to 
respond to that.
It does appear that El traits are not clearly defined due to the way that they are measured. It 
is an ability, not a standard personality trait (Caruso et al. 2002) and therefore like all 
personality characteristics, it is more complex than simply defining it as a 'trait. However, 
Mayer et al. (2008) do state that the composition of El traits vary depending on whether 
researchers believe in mental traits (i.e the ability to monitor one's emotions) or an eclectic 
mix of positive traits (i.e happiness, self-esteem). Since Salovey and Mayer have been leading
Page | 226
the research into El 2, their El branches are the ones mentioned in this section. The El test 
(MSCEIT) created by Mayer, Salovey and Caruso (Mayer et al. 2008) could be used in future 
research to identify if adopters can also be characterised by high El. There is little literary 
evidence to link high El and adopters, therefore Table 8.1 shows the four areas of emotional 
intelligence, how they are identified in the MSCEIT test and how adopters identified in the 
current study might be associated with them (see Table 5.2, p82 for characteristics of 
adopters).
Further research into El and nurse genetic adopters would be useful to establish a link 
between adopters and high El. Information from further research might help to explain some 
of the identified characteristics from the current study, such as adopters feeling a level of 
expectation from doctors and colleagues to use genetics/genomics in their practice. It would 
also help to narrow down possible characteristics and questions to be used in the future 
identification of nurse genetic adopters.
8.1.3 Participants identified characteristics of those open to new ideas
Participants identified what they believed the characteristics are of people who they think are 
open to new ideas and concepts. This also included the type of personality evident in the 
people from whom they seek professional advice. Being open minded was considered the top 
characteristic of people who are believed to be open to new ideas, and being approachable 
was a characteristic of people who were sought for advice. OLs being approachable is not a 
trait that appears widely in the literature (see Chapter 5, p95), although they are known to 
have respect but can be separate from the social group. However, Locock et al. (2001) 
believes that OLs can have a range of characteristics. General characteristics that have been 
identified by nurses (responding to this survey) may be useful in helping to identify adopters 
and opinion leaders in the practice setting, as these are the types of people who nurses 
themselves see as people of influence and knowledge.
! http://psychology.about.eom/od/personalitydevelopment/a/emotionalintell.htm
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Table 8.1. The four branches of Emotional Intelligence, identified by Caruso et al. (2002) and 
showing how adopters in the current study might be related to these branches
Branch MSCEIT (El test) identification Adopter traits in the current study
Identifying emotions
Ability to identify feelings and 
to express emotions 
accurately
Ability to identify emotions in 
faces, designs, music and stories
Adopters felt an expectation from
colleagues and doctors to
implement genetics/genomics
into practice, whether projected
or real
Adopters believed that patients
were a source of encouragement
for them
Adopters believed that family
history is important_________
Emotional facilitation of 
thought
Use emotions to redirect 
attention to important 
events, generate emotions 
that facilitate decision 
making and harness different 
emotions to encourage 
different approaches to 
problem solving
Imagine a situation where they
felt and emotion and then
describe it in non-emotional
language
Evaluate relevant and irrelevant
emotional information
Adopters were more confident in
asking patients family history
questions
Adopters found it easier to apply
new knowledge into practice
Adopters found it easier to get
permission to access new
resources
Adopters had higher Openness to
Experience scores
This was not an area that participants 
were questioned about in the current 
study
Understanding emotions
Ability to recognize causes of 
emotion and to understand 
relationships among 
emotions
Measured knowledge of 
complex emotions, how 
emotions alter/changes from 
initial emotional state and 
knowledge of emotional 
reactions of 2 people in similar 
situations
Evaluate effectiveness of various 
alternative responses in 
resolving an emotional situation 
involving others and managing 
self evaluated responses
Managing emotions
Stay aware of one's emotions 
and determine whether an 
emotion is clear or typical
Adopters were keen to 
incorporate more 
genetics/genomics into their 
practice
Adopters had an interest in new 
areas of genetics/genomics 
Adopters found it easier to 
implement new knowledge
8.1.4 Phase 2 demographics
The analysis of each of the identified groups' demographic variables did not reveal as many 
significant differences between the groups as were expected. For example it was hypothesised 
that adopters would have a higher level of education and perhaps be of a higher grade. A lack 
of demographic differences within the groups could have been due to chance, with 
comparable types of individuals completing the questionnaire through particular 
dissemination contacts. However it could also indicate that demographic differences might 
not be the identifying characteristics of these groups of individuals. The results showed that a 
significantly higher number of non adopters were practice nurses compared to adopters, this is 
somewhat surprising as it was hypothesised that practice nurses were used to working 
independently and would therefore have taken the initiative with genetics/genomics
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themselves. However it needs to be highlighted that more adopters than non adopters 
answered 'other' to areas of nursing practice, which may have affected overall results, in hind 
sight a free text box allowing participants to indicate their practice area may have been 
helpful. Opinion leaders were statistically more likely to have a higher academic achievement 
compared to both non opinion leaders and non adopters. This was identified particularly for 
the percentage of opinion leaders having a master's qualification compared to non opinion 
leaders. Opinion leaders were also statistically more likely to be of a higher grade than both 
non opinion leaders and non adopters, although the highest graded respondent was a non 
opinion leader, suggesting that grade is not a single failsafe determinant of OL status. 
Adopters were more likely to be in the oldest age range of 50-59 years than non adopters. 
Surprisingly there was no significant difference between the identified group for an individual 
and the number of years practised as a nurse. It was expected that opinion leaders in 
particular might have had more years practising as a nurse than other groups, as opinion 
leaders often have experience and expertise (Feder and Savastano, 2006). Having no 
difference in this demographic perhaps indicates that the number of years spent practising as 
a nurse are not important determinants for being an adopter or opinion leader and that other 
demographic differences should be sought, such as location of nursing training and current 
NHS trust area. It might also simply be that those who answered the questionnaire happened 
to have worked as a nurse for a similar amount of time. There were also no significant 
differences between the groups in terms of their personal genetic family history or ethnicity.
It appears therefore that the demographics selected in this study are not an important variable 
between the groups, especially between adopters, non adopters and opinion leaders, non 
opinion leaders. It was hypothesised that there would be differences between the main two 
groups (adopters and opinion leaders) according to Rogers (2003) and Feder and Savastano 
(2006). It is clear from these findings that demographics should not be relied upon heavily to 
identify adopters and opinion leaders, although it is possible that with a larger sample, 
statistically significant demographics differences could be identified.
8.2 Subjective norms
Subjective norms relate to the social pressure to either perform or not perform certain 
behaviours. Normative beliefs are related to this aspect of TPB. These beliefs are the 
expectations from others about the innovation. Subjective norms are associated with an 
individual's belief about the innovation and the motivation to adopt it into their behaviour. 
Expectations from colleagues and doctors as well as a level of encouragement from patients 
can be linked to the social pressure to perform a given behaviour and could inform an
individual's beliefs about the innovation.
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8.2.1 Expectations and support in the work place
8.2.1.1 Expectations from colleagues
When provided with a scenario around inherited breast cancer, almost twice as many adopters 
(41.7%) as non adopters (21.9%) strongly agree that they felt expected by colleagues to make 
sure the patient's family is followed up by genetic services. This could be due to several 
reasons; one being summed up by Lin et al. (2012) when studying the uptake of an innovation 
among physicians. In their study the adoption ratio among colleagues in the medical centres 
was positively related with the likelihood of other colleagues adopting the innovation, hence 
those people with colleagues around them who have adopted are more likely to adopt 
themselves. It could be that in the present study adopters were more likely to be surrounded 
by other adopters and hence felt expected to follow their colleagues. According to Dearing 
(2009) diffusion can occur through individuals witnessing the credibility of what colleagues are 
thinking and doing, as they may feel under social pressure to do as others are doing. It seems 
surprising that adopters would feel under pressure from the expectations of others as findings 
from the present study suggest that adopters were often enthusiastic (keen to incorporate 
more genetics/genomics into practice) and were individuals who were confident (more 
confident in asking patients family history questions) in themselves. It was hypothesised that a 
tendency to be influenced by expectations from colleagues would be associated as a trait of 
non adopters, as it could be believed that working alongside adopters would provide a level of 
expectation and that they might be using genetics/genomics out of a sense of duty. However 
this tendency to be influenced by expectation may not be a negative trait but just a sense of 
the 'social norm' in an environment where adopters co exist. Adopters may be more sensitive 
and responsive to this type of environment than non adopters. Adoption takes place at 
different rates, so perhaps those who feel under pressure to conform will do so later than 
those who embrace the innovation. This could be explained by the subjective norm aspect of 
the Theory of Planned Behaviour. Personal attitude towards behaviour is known to be more 
powerful than any social pressure (Ajzen, 1991) but the more favourable the attitude from 
important social persons then the more likely the individual is to complete a behaviour 
(Armitage and Conner, 2001). It could be that the adopters already have a positive personal 
attitude towards genetic services and their possible involvement with other adopters has 
increased this positive attitude. It might have been that these social pressures to utilise 
genetic services has induced a behaviour change in these nurses that has appeared over time, 
so that they have become adopters. Alternatively, perhaps adopters are more aware of what 
others are expecting of them or that they projected their own positive attitude onto 
colleagues and felt there was an expectation even though, in reality, there may not be.
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8.2.1.2 Expectations from doctors
When presented with a scenario based around inherited bowel cancer, adopters (58.4%) were 
more likely to strongly agree that doctors expected them to raise the possibility of a genetic 
link compared to non adopters (28.2%). This could be interpreted as a positive finding because 
doctors could be seen to be encouraging nurses to use genetics/genomics more and expect it 
from them. It is interesting that the adopters feel a sense of expectation from doctors and the 
non adopters do not. It could be that non adopters in the current study were in a particular 
environment that included few adopters, both nurses and doctors. This might be due to 
possible different relationships that adopters have with doctors compared to non adopters. A 
study by Castledine (2005), suggests that the relationship between doctors and nurses can 
vary and that nurses' autonomy has increased, bringing with it an increased sense of worth 
and ability. Nurses have more responsibility and accountability in their roles. Although there 
is no evidence, Castledine hypothesises that those nurses who are not as well prepared for this 
changing role may not be as adept at collaboration with doctors. It could be that non adopters 
have not adapted as well to a continuing change in role and as such doctors do not treat them 
in the same way as adopters, i.e. they know that if they expected non adopters to raise a 
genetic link with them that it would not happen. Adopters may instil a confidence in doctors 
that is expressed through the expectation that doctors place on them. However there are 
several explanations for these findings, which are outlined below.
Competition in the work environment
Expectations felt from colleagues could be explained through there being a possible level of 
competition between nurses, resulting in a perceived pressure by some to be keeping up to 
date with their peers. If that is the case, it is interesting that the only the adopters responded 
to that pressure. I feel that if there was competition between nurses, then it would be 
expected that not just adopters would feel a sense of pressure. For this reason, I feel that this 
explanation is less plausible compared to the following explanations.
Actual pressure to adopt
Pressures from those around adopters to incorporate genetics/genomics more in their practice 
might be a reality for adopters if they are surrounded by early adopters, GOLs or OLWIGs. The 
pressure then may be experienced as direct encouragement from colleagues or more indirectly 
as pressure to match the behaviour of peers. The environment adopters work in might well 
create a culture where one feels they should be constantly improving and being ahead. As 
mentioned before doctors (particularly those who have engaged with genetics/genomics) 
might well be aware of those nurses who are capable of using genetics/genomics and hence
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assume that they will undertake genetic/genomic tasks. Likewise colleagues of adopters might 
expect adopters to complete genetics-related tasks for them. When studying the concept of 
social norms, there are two aspects which need to be accounted for. One is the area of 
collective norms, these represent a society's code of conduct, whether it be a community or 
social grouping. The majority of people in that community believe and support a particular 
behavioural norm (Lapinski and Rimal, 2005). I do not think that this is the case in the present 
study, because of the statistical difference between the adopters and non adopters in the area 
of colleague and doctor expectation. If these expectations were coming from the whole 
community one would expect adopters and non adopters to have answered similarly, which 
was not the case. The other aspect of social norms is that of perceived norms, which relates to 
people's understanding of the norms in their community/society (Lapinski and Rimal, 2005). 
Each individual's interpretation is representative of the collective norm, hence this is different 
for each individual. Lapinski and Rimal (2005) do state that human behaviour is guided by 
perceptions about the popularity of the behaviour, therefore in the current study if adopters 
are surrounded by other adopters (or people who have a similar work ethic, enthusiasm or 
ambition), the utilisation of genetics/genomics into their practice will be much more 
favourable than if they were in an environment where there were not many adopters. It has 
been proposed by Valente and Raquel (2010) that early adopters are occasionally free from 
social norms that might inhibit them. This is an interesting point, if that was the case in the 
present study, it could be argued that the adopters did not feel an expectation from colleagues 
or doctors at all.
Projected pressure
The argument that I think is the most plausible is one where adopters put pressure on 
themselves; the pressure is internal but projected onto others. It might be that, adopters 
'believe' that colleagues and doctors are expecting them to be either highlighting a genetic link 
or to be making sure the patient is followed up with genetic services, that in reality may not 
exist. The concept of projection created by Freud and later developed by Jung, explains how 
individuals project negative or positive conscious qualities onto others (von Franz, 1995). This 
may lead to an overvaluation of the particular quality (in this case expectation) and the 
individual believes these projections to be truth (von Franz, 1995). This could explain why 
adopters feel an expectation from colleagues and doctors, where as non adopters do not sense 
this expectation. This finding could possibly be due in part to the environment that they work 
in. If it is one where people are highly motivated and continually learning, this could lead 
adopters to believe that they are expected to keep up with those around them, including 
incorporating new knowledge and skills into practice. Another factor could be that, the
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conscience of adopters may play a role in the internal pressure that they put on themselves. 
Jensen and Lidell (2009) found that conscience was a driving force for nurses to provide the 
best possible care for their patients and as such the nurses placed high demands on 
themselves. It might be therefore that adopters have greater conscience levels, which cause 
them to place higher demands on themselves, in engaging with new developments in clinical 
practice, which is manifested through a perceived expectation from others.
8.2.2 Encouragement from patients
More adopters (83.3%) than non adopters (56.3%) believed that patients encourage them to 
incorporate new areas of knowledge into practice. I believe that encouragement from patients 
is a different concept from the one of perceived expectation from doctors and colleagues. If 
adopters are more open and aware of genetics/genomics when treating their patients, 
perhaps when they have used their genetic/genomic knowledge for a patient and had positive 
results, this may encourage them to learn more. Non adopters on the other hand, might never 
have tried to incorporate with genetics/genomics in their practice. It could be therefore, that 
patients themselves are a source of social influence, through the encouragement they give to 
adopters. A patient may be quite direct in what they require or expect, which in turn might 
encourage nurses to incorporate new ideas into their practice, out of a sense of providing the 
best possible patient care. The Perceived Behavioural Control (PBC) concept of the Theory of 
Planned Behaviour (Chapter 5, pl!4) relates to the ease or difficulty of performing a behaviour 
(Aronson et al. 2007). The higher the PBC the more likely nurses are to believe they can help 
patients with their genetic/genomic knowledge. Hence they may feel they have more control 
over using genetics/genomics in their practice. This might explain why they find patients 
encouraging (Ajzen, 1991 and Armitage and Conner, 2001) because they are relaxed about 
using genetics/genomics and can focus more on the patient and the benefits the patients are 
gaining. It is a continual reciprocal circle of confidence and understanding which increases the 
level of encouragement from those who they are helping. Spence Laschinger et al. (2010) have 
suggested that nurses who are empowered are more likely to encourage assertiveness within 
their patients (a patient feels relaxed to express their views and opinions to the nurse), which 
often results in better outcomes for the patient. It is possible that adopters have experienced 
the positive outcomes of working closely with a patient and find this encouraging.
The empathy of adopters could also play a role in this finding, although it was not measured in 
the current study. Rogers (2003) does state that early adopters have greater empathy than 
late adopters (see Chapter 5, Table 5.3, p84). Ward et al. (2012) say that nursing is both an art 
and a science and that an empathic action is one that includes the understanding of the 
experiences, concerns and perspective of another person, which in nursing often includes the
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patient. Empathy is associated with improved patient outcomes and a greater satisfaction 
with care (Ward et al. 2012). It could be speculated that those nurses who are more 
empathetic provide their patients with a greater sense of compassionate care. The patients 
are therefore more relaxed and perhaps respond better to treatment thus encouraging nurse 
adopters to continue to provide better care and support for their patients. The role of 
empathy in identifying adopters is an area that needs further investigation perhaps through 
the incorporation of empathy into an adopter identifying tool. As discussed earlier it could be 
that nurse adopters may also have a greater level of emotional intelligence, which may be a 
contributing factor.
The findings from the current study suggest that subjective norm does play an important role 
in the adoption of genetics in nursing practice. A higher percentage of adopters felt increased 
levels of expectation from colleagues and doctors as well as feeling encouraged by patients 
compared to non adopters. This is speculated to be due to either work place competition, 
pressure to adopt or projected pressure as well as the role of empathy towards patients. Ajzen 
(1991) does state that personal attitudes towards a behaviour overshadow any perceived 
social pressure to adopt. Whilst personal attitude towards an innovation is an important 
factor, the role of subjective norms cannot be overlooked. Findings from the current study 
would suggest that further investigation is needed into the role of social norms, particularly 
the perceived level of expectation from those within a particular workplace community.
8.3. Perceived behavioural control
Perceived behavioural control (PBC) relates to an individuals' perceived ease or difficulty of 
implementing an innovation and of overcoming these obstacles. Control beliefs are linked to 
this variable of TPB, which is the information passed on by others about the innovation which 
affects whether an individual changes their behaviour or not. Nurses' awareness of 
genetics/genomics has been included in this section as a higher level of awareness in adopters 
might increase their likelihood of incorporating genetics/genomics, which in turn may affect 
the type of information passed onto non adopters. The impact of society and environment 
might also affect one's perception of implementing genetics/genomics and the support in 
overcoming obstacles.
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8.3.1 Genetic/genomic awareness and resources
8.3.1.1 Genetic/genomic awareness
Compared to opinion leaders, adopters had a higher level of genetic/genomic knowledge and 
awareness, which went beyond just the GIAs. Adopters were more familiar with 
genetic/genomic resources, were more positive towards the genetic/genomic nursing 
statements and had greater knowledge of regional genetic centres. Whilst adopters did score 
highly on questions relating to the four GIAs, they also scored higher on other questions, 
including awareness of various genetic/genomic resources (e.g. Telling Stories, local genetics 
services), being interested in new areas of genetics/genomics and talking to colleagues about 
genetics/genomics. The GIAs were important for identifying genetic/genomic awareness 
among nurses, however the inclusion of other aspects of genetics/genomics, also helped 
further distinguish the nurse adopter of genetics. Opinion leaders tended to score higher on 
personality traits but did not demonstrate a strong interest in or knowledge of 
genetics/genomics. These differences between adopters and opinion leaders could be used as 
a method to distinguish between the two groups. Rogers (2003) has stated that opinion 
leaders do tend to be a separate group to the innovators (in the present study the adopters) 
and this has been supported in the present study. The level of awareness around 
genetic/genomic resources might affect the perceived ease of difficulty of implementing 
genetics/genomics more into practice. If a nurse is aware of genetics/genomics and how it is 
applicable to his/her practice then it might be perceived as easier to add to that knowledge 
compared to a nurse who is not aware of the importance of genetics/genomics.
The Locus of Control theory developed by Rotter, could help to explain why adopters have a 
higher genetic/genomic awareness and genetic/genomic interest. Adopters could have a high 
internal locus of control meaning that they believe their own behaviour will have an impact on 
the situation outcome (Rotter, 1966), which would encourage them to seek new areas of 
knowledge in patient care. People with a high internal locus of control tend to choose to do 
activities in which they can demonstrate skill, something that would be expected from 
adopters (Rotter and Mulry, 1965). Having a higher locus of control means individuals believe 
they have greater control over events in their lives and are less likely to be phased or stressed 
by an event (Schmitz et al. 2000), possibly meaning that adopters feel a greater sense of 
control over their own practice. It could therefore be proposed that if adopters have a higher 
locus of control they are less stressed by their role, meaning they are more focused on learning 
new areas of practice and are more likely to have the enthusiasm to make patient care better. 
Future research would do well to establish the role of levels of control in the traits of nurse
adopters of genetics.
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8.3.1.2 Lack of familiarity with genetic/genomic resources and initiatives
Six resources and initiatives were used both to help identify adopters (as part of the scoring 
system) and also to gain an understanding of the general awareness of these resources. 
Specific resources and initiatives were used for this question (Qu6) as they either; 1) linked to 
previous nursing and genetic competencies (i.e., competency standard statements), 2) were 
deemed important educational resources (e.g., NHS National Genetics Education and 
Development Centre), 3) were important, high profile initiatives (e.g.. Human genome project) 
or 4) linked to the GIAs (e.g., local genetic specialist services). All were thought to be ones that 
nurses who were interested in genetics/genomics might have heard about. However, across 
all groups, there was a distinct lack of knowledge and awareness of these resources. For 
example whilst adopters were more familiar with various genetic/genomic resources than non 
adopters, it needs to be highlighted that all the non adopters and two thirds of adopters 
described themselves only as 'somewhat familiar' with the resources. Of all the opinion 
leaders (when compared to non OLs), only three (15.7%) were 'completely familiar' with any of 
the resources and six (31.5%) were 'very familiar' with the resources, however as these 
individuals had a lower awareness of genetic resources, they were not classed as GOLs. It 
could be argued that a lack of familiarity with genetic/genomic resources might increase the 
level of perceived difficulty around implementing genetics/genomics into practice. If a nurse is 
aware of the resources available for help and support then applying more genetics/genomics 
into their practice might not be so daunting.
Among opinion leaders and GOLs the resources that were the most familiar were the UK 
nursing genetic competency standards and the local specialist genetic services. Among 
adopters and Opinion Leaders with an Interest in Genetics (OLWIGs) it was genetic services 
and the human genome project. Considering that a study by Kirk et al. (2007c) identified that 
77.8% (n=198) of post registered nurses have not attended any training in genetics/genomics 
since qualifying, it is encouraging that any participants were familiar with the resources, but 
perhaps the lack of training and awareness explains why so few participants were aware of 
these resources. It might also be linked to the perceived relevance of genetics/genomics to 
the participants' practice as those who understand the relevance of genetics/genomics are 
more likely to agree with the greater use of genetics/genomics (Chen and Goodson, 2007) and 
hence know more about genetic/genomic resources. More needs to be done to raise 
awareness about these resources, in order to facilitate further engagement. When looking to 
understand the impact of the resources on nurses' use of genetics/genomics, it may also be 
helpful to consider the Stages of Change theory (Prochaska and Diclemente, 1983; Chapter 5, 
p!03) particularly the contemplation or preparation stage. As individuals begin to think about
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changing their behaviour, whether it be purposely or subconsciously, the impact and interest 
of such resources may accelerate and encourage the action stage of implementing an 
innovation. Having knowledge of these resources will also help them to direct colleagues to 
further genetic/genomic information and could provide a link between adopters and non 
adopters. This is especially apt as one of the biggest barriers identified for incorporating 
genetics/genomics into practice for both adopters and non adopters was that there were no 
local study sessions and adopters also said that there were 'no relevant resources' to help 
them. Given that such resources are available, this finding suggests that nurses are simply 
unaware of them. However it might be that nurses also require more guidance about how to 
use the resources or are not ready for self directed learning, this is something that could be 
approached in future studies and strategies.
8.3.2 Awareness of Regional Genetic Centres
Another source of information and education that needs to be utilised more is the regional 
genetic centres (RGC) (Chapter 3, p50). In a similar way to awareness of genetics/genomics, an 
awareness of RGCs may allow nurses to feel more supported, with access to help when 
required, which in turn might increase perceived behavioural control. A high proportion of 
participants were not aware of or had little knowledge of the RGCs. A third of adopters and 
GOLs were either unaware of the centres or were not aware of the services they offered, 
which is surprising given the role of RGCs in secondary (from primary care) and tertiary (from 
secondary care) referral. Over two thirds of opinion leaders and all of the OLWIGs were 
equally either unaware of the RGCs or of their services. This could be because the RGCs are 
not doing enough to promote their services, for example in local oncology units and GP 
practices or perhaps because contact with the RGCs is often made through the doctors of the 
departments and nurses may not be involved in this. However, other healthcare professionals, 
(including nurses) need to be aware of local screening services and specialist RGC services and 
to be able to make a referral if necessary (Eades et al. 2010), in order to provide better support 
for patients who already have a genetic condition or who are at risk. It is a cause for concern if 
many nurses are not even aware of their local regional genetic centre because they will not be 
able to complete the necessary roles that their job entails or use these centres as a source of 
information, education and advice.
8.3.3 Impact of society and environment
8,3.3.1 Confidence in undertaking genetic/genomic tasks
Adopters were more confident in asking patients about their family history and could 
understand the importance of doing so. In the current study, 37.5% (n=9) of adopters felt
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extremely confident in asking patients questions about their family history, only 9.4% (n=6) of 
non adopters answered the same. It could be speculated that an increased confidence level in 
undertaking genetic/genomic tasks might in turn increase the level of perceived behavioural 
control. A confident individual might therefore perceive the implantation of 
genetics/genomics with a level of ease.
It was highlighted in the Government's White Paper Report on genetics (Department of Health, 
2003) that healthcare professionals need to understand how a patient's family history can 
affect the likelihood of developing a disease. Kirk et al. (2007c) found that the majority of 
participants in their study looking into engaging nurses in genetics/genomics, did not rate 
themselves as very confident about any competence, however confidence was associated with 
using a competence (such as understanding the importance of taking a family history) more 
frequently and viewing it as important. Metcalfe et al. (2007) found that educational 
preparation in genetics/genomics could increase confidence levels in undertaking genetic 
competencies. Interestingly 90.8% (n=22) of adopters could see the importance of taking a 
family history when facing a possible sudden adult death scenario, 81.3% (n=52) of non 
adopters also understood the importance. It therefore appears that nurses are much more 
likely to accept the importance of taking a family history than to feel confident enough to ask a 
patient the relevant questions. These findings suggest an important gap between 
understanding and confidence among both non adopters and adopters of genetics/genomics. 
Kirk and Tonkin (2006) found that fewer than 10% of undergraduate nursing institutions (n=83) 
could say that their adult branch student nurses could competently identify patients who 
needed genetic services. It is not surprising therefore that the limited genetic education in 
nurse training will have an effect on nurses' confidence levels when undertaking these tasks in 
practice. The findings from this study mirror those of other studies. Bankhead et al. (2010) 
found that 96% (n=600) of practice nurses thought family history taking was part of their role 
but Metcalfe et al. (2010) found that 87% (n=286) of hospice nurses did not feel confident in 
taking a family history. The difference between the various studies findings, apart from each 
study focusing on different groups of nurses and asking different questions, could be explained 
by the Diffusion of Innovation theory (chapter 5, p77) as the innovation has to first be adopted 
and then put into practice (Dusenbury and Hansen, 2004 and Oldenburg et al. 1999). Perhaps 
the idea of taking a family history is seen as important and the notion has been adopted but 
the diffusion is halted at this stage due to limited confidence, knowledge and skills and so is 
not fully utilised in practice. Wadensten and Carlsson (2007) found that their innovation, 
which was the uptake of new practical guidelines, was acquired piece by piece and that it took 
time to understand the innovation, adopt it and then put it into practice. From the current
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findings it could be concluded that adopters are four times more likely to be putting their 
knowledge into practice concerning family history taking, that they have understood the 
importance of family history taking and are applying it.
8.3.3.2 Environment and network influences
The environment and social network that individuals are working in could impact upon 
information seeking behaviour and subsequently innovation dissemination (Jippes et al. 2010). 
A particular environment and social network might either increase or decrease the level of 
perceived behavioural control, depending on its influence. Some social networks may make it 
easier for colleagues to actively seek information and support this behaviour, which may allow 
individuals to perceive the implementation of genetics with a level of ease and others may not. 
Marshall (1989) found that out of those who had adopted their innovation, 73% (n=91) knew 
other colleagues who had also adopted. The degrees of interpersonal networks were 
important for the way people apply an innovation. This could be linked to the concept of small 
world models (six degrees of separation, Chapter 5, p90). Choi et al. (2010) believe that an 
innovation is more likely to spread in networks that are regular, so one person knows one 
person, who knows the next person et cetera. Once diffusion has started however, random 
networks, within which there are no common links become more efficient. Based on this 
theory, the type of network present in a particular nursing environment may affect how 
people see change and what is deemed as acceptable. The type of network found within 
nursing cannot be verified, as there is little identifiable literature available, but it is likely that 
this would change depending on the type of nursing specialism. Due to the limitations of 
sample size and a lack of wider evidence, no definite conclusions can be stated but in my 
opinion nurses working on a ward environment would more likely be in a cliquish network (a 
small world) whereas practice nurses would be perhaps more likely to be in a random network 
with other practice nurses, due to more time spent working as a solo practitioner (O'Donnell et 
al. 2010). Further research into networks could gain important information about the way an 
innovation diffuses among nurses.
Perceived behavioural control (PBC) relates to how easy or difficult one finds it to implement a 
particular behaviour. The findings of this study have highlighted some areas which may 
enhance or decrease PBC. Variables such as genetic/genomic awareness, familiarity with 
genetic/genomic resources and RGCs may affect how easy or difficult nurses find it to 
implement genetics/genomics into their practice. If nurses are encouraged and supported to 
become more familiar with resources this might enhance their keenness to implement 
genetics/genomics on a wider scale in their practice. Similarly the more aware they are of 
resources then it is possible that their confidence levels will increase along with a sense of
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increased genetic/genomic knowledge. Endorsing a positive environment with a network of 
genetic adopters and opinion leaders may also enable nurses to increase their perceived 
behavioural control towards genetics/genomics.
8.4 Behavioural intentions
Behavioural intentions are the intention that an individual has towards adopting the 
innovation into their behaviour. These as proposed in the TPB can be predicted through an 
individual's attitude towards the innovation, subjective norms and PBC. The findings of the 
current study have identified that actions of individuals identify behavioural intentions, rather 
than awareness and feelings related to PBC, subjective norms and attitudes. The identified 
GIAs have been included in this section as they help to identify the behavioural intention of 
nurses to adopt genetics/genomics. Participants' information seeking behaviour (seeking 
genetic/genomic information for individuals) is also mentioned as this could also been an 
indicator of behavioural intention.
8.4.1 The use of the GIAs and identifying questions
All of the Genetic Indicators of Adoption (GIAs) identified in Phase 1 by the genetic experts, 
were used in the main study questionnaire (Phase 2). I believe that the questionnaire used in 
Phase 2 could be adapted and used in the future identification of genetic nurse adopters. It 
could be speculated that the more GIAs that a nurse can achieve the more likely they are to 
have a higher intention of adopting genetics/genomics into their practice. The GIAs are and 
should be used as identifiers of behaviour intention because they indicate how far a nurse has 
gone to implement genetics/genomics into his/her practice and whether he/she is likely to 
proceed with utilising more genetics/genomics into practice.
The GIAs were originally decided upon without specifying any particular nursing area. 
Although Phase 2 focussed on oncology and practice nursing, the GIAs could be considered to 
be useful across nursing specialities. I believe that the four activities and behaviours that have 
been identified can and should be used to identify nurses who are engaged in 
genetics/genomics throughout different nursing specialisms and on a wider scale. The GIAs 
that were used to indicate those nurses who are engaged in genetics/genomics were:
a. To know how to access genetic services and would make active use of them
b. To be able to provide information of support services to patients or their families with or
at risk of a genetic condition
c. To ask patients relevant questions about their family history 
d. To be open to the possibility of genetics in all aspects of care
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There was less of a consensus (76%) from genetic experts about GIA b (to be able to provide 
information of support services to patients and their families with or at risk of a genetic 
condition) and this was subsequently discussed in the focus group. The focus group 
participants, although few in number agreed that GIA b was less important than the other 
three GIAs but when they put the GIAs into a step-by-step order, GIA b was still considered 
relevant. The two questions assigned to GIA b in the Phase 2 questionnaire (Qul5&14) were 
answered correctly by most participants. GIA b does have a place in the future identification 
of adopters due to the responses given by oncology and practice nurses in the Phase 2 
questionnaire. However, it perhaps does need to still be used with caution (i.e. not to be used 
as a single indicator of adoption) and needs to undergo further research in a larger scale and 
more diverse study, in the light of the comments about GIA b in Phase 1.
8.4.2 Information seeking behaviour
I believe that information seeking behaviour can be used as an indication of behavioural 
intention because it is likely that those individuals who seek genetic/genomic information for 
others are keen to pursue an integration of more genetics/genomics into their practice and 
have an interest to do so. Adopters on average sought more genetic/genomic information for 
various different people (including self and patients) than non adopters. This difference may 
be due to variation in confidence (which is discussed below) because if an individual lacks 
confidence they may not believe that they have the ability to seek genetic/genomic 
information. It may also depend on the type of patient group that individual nurses are caring 
for. Personality type and Openness to Experience levels could also affect an individual's 
likelihood of information seeking as high Openness to Experience levels means those 
individuals are curious, open to new ideas and make remote connections (McCrae, 1987). 
Those individuals with these character traits may be more willing to seek new information and 
utilise it and all adopters had high Openness to Experience. It would be interesting to explore 
the other areas; agreeableness, neuroticism, extraversion and conscientiousness of the 5 
factor model of personality (Chapter 5, p!21) in future studies to establish the scores of those 
who are high in Openness to Experience in the other four areas of personality traits as these 
other traits may also influence information seeking behaviour (Table 8.2).
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Table 8.2. The four remaining Big 5 Personality Factors and their relation to adopters and 
opinion leaders (OLs), based on traits identified by McCrae and John (1992).
Personality 
characteristics





It might be possible that this characteristic could be a positive or 
negative trait of adopters and OLs. Whilst adopters and OLs 
need to be trusting and generous of their time and skills with 
colleagues, being modest and agreeable with those around them 







I believe that it would be unlikely that adopters and OLs would 
be individuals with a high level of neuroticism due to adopters 
and OLs having the ability to influence others and be positive 
role models.
Adopters and OLs need to be able to connect with those around 
them, it is unlikely that those individuals who are hostile and 







Warmth could be related to a possible perceived empathy
identified in adopters.
Excitement seeking could be linked to Openness to Experience
and being active could be linked to adopters seeking
genetic/genomics information for individuals.
Being assertive and talkative could be linked to opinion







It could be argued that those individuals who are conscientious 
are likely to be adopters, perhaps because adopters have 
greater genetic/genomic awareness than others, which could be 
linked to their need to keep up to date with their practice. 
Those individuals who are efficient and responsible may well be 
adopters or OLs due to their ability to be organised and take 
responsibility for their own areas of practice.____________
Openness to Experience was chosen from among the five personality traits to be explored 
because it is a universal dimension of personality (McCrae, 1997), it has previously been linked 
to being a personality trait of early adopters (McCrae, 1996) and is also linked to those who 
are open to new ideas and experiences (McCrae, 1996). However further research into the 
other four areas of personality could provide interesting and informing information about the 
characteristics of nurse genetic adopters and opinion leaders.
8.5 Barriers and facilitators to incorporating genetics/genomics into 
practice
Barriers and facilitators related to the incorporation of genetics/genomics into nursing practice 
can be related to a nurses behavioural intention due to whether it enhances or diminished 
his/her intention. A nurse might have a strong intention to incorporate more 
genetics/genomics into his/her practice but if time and lack of study sessions are a barrier, 
then it could be considered likely that his/her intention might be decreased due to these 
barriers and vice versa for facilitators to the incorporation of genetics/genomics. The role of
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barriers and facilitators could be particularly applicable to those nurses who are on the cusp of 
genetic/genomic incorporation.
8.5.1 Phase 1 barriers and facilitators
The important barriers and facilitators to incorporating genetics/genomics into nursing 
practice identified in Phase 1 of this research can be related to previous research (Table 8.3). 
Ideally facilitators should be promoted and ways to reduce the barriers investigated to aid the 
incorporation of genetics/genomics into nursing practice. Research into barriers and 
facilitators to incorporating genomics into mainstream practice identified that the issue of 
subject relevance was forefront (Kirk et al. 2008).
Table 8.3: Comparisons between barriers identified in Phase 1 and other studies, with one 
being the highest barrier and 12 the lowest
Barrier
The relevance of 
genetics/genomics is not explicit to 
nurses
Nurses don't understand 
genetics/genomics
Nurses have time constraints
Nurses don't know about 
genetics/genomics
Nurses are afraid of 
genetics/genomics
There is a lack of genetic/genomic 
role models for nurses
Nurses think genetics/genomics is 
not relevant
Nurses have no experience of 
patients asking about 
genetics/genomics
Nurses think that 
genetics/genomics is not important
Nurses believe the resources are 
not appropriate
Nurses think there is a lack of 
support from colleagues
Nurses experience resistance to 
genetics/genomics from other 
team members




































































*() indicates barrier rank from 1-12 for the current study, Andrews, 2012 **() indicates barrier rank 
from 1-8 for Kirk et al (2008)
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In Phase 1 of the current study, improving educators' awareness of genetic and genomic 
education was the highest ranked facilitator for improving the incorporation of 
genetics/genomics into nursing; this might in turn facilitate both pre-registration and post- 
registration nurses to gain a greater understanding and awareness of genetics/genomics. 
Improving educators' awareness of the need for genetic and genomic education would help 
the highest ranked barrier (the relevance of genetics/genomics and genomics not being made 
explicit) to be overcome in student nurses. If genetic/genomic education was delivered 
effectively it would also help overcome the second highest ranked barrier (nurses don't 
understand genetics/genomics). Effective genetic/genomic education would impact other 
areas such as policy making. The lowest ranked facilitators (education programmes that cover 
all aspects of genetics/genomics and accessible articles on genetics/genomics) coincided with 
one of the lower ranked barriers (nurses believe the resources are not appropriate), which 
shows that accessibility and appropriateness of resources are less of a perceived barrier for 
nurses in relation to genetics/genomics. In understanding the ranking of the pre-defined 
facilitators, efforts can be made to focus on those facilitators that will enable nurses to 
incorporate genetics/genomics into practice. Equally, priority can be given to those barriers 
ranked the highest, although other less highly ranked barriers and facilitators still need to be 
considered as they could be easier to address and have an important impact in the long or 
short term.
It is possible that the barriers and facilitators are inter- related; acting on one may have an 
impact on the others, be it barriers or facilitators. Highest ranking facilitators could be used to 
overcome the highest ranking barriers, enabling genetics/genomics in nursing practice to be 
incorporated effectively. Participants in the focus groups felt that in some areas of practice 
(e.g. outpatients) it is impractical to expect nurses to use more genetics/genomics in their 
practice and that the interaction that would facilitate the use of genetics/genomics between 
nurses and patients is not always there. Focus group participants thought that nurses might 
be worried about 'stepping on the doctor's toes'; therefore they saw nursing in outpatients as 
one area where genetics/genomics may not be as relevant in the overall process of 
incorporating genetics/genomics into nursing practice. However it could be argued that 
outpatients is a rather unique area of nursing and that this area could be an important 
opportunity for family history assessments to be completed. Overall, participants felt that 
more teaching/education was needed to raise the profile of genetics/genomics in nursing 
practice (Table 7.3, p!66). I believe that this is the underpinning crux in getting 
genetics/genomics incorporated into nursing. The way in which this is achieved is also 
important and one way may be to create more study days, through the services of the NGEDC,
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or subsidised through organisations with specific interest in genetics/genomics. Study days are 
important because they provide an opportunity for nurses to interact with other nurses and 
discuss the topic being studied rather than studying alone at home using books and also allows 
the educator to assess and help their students.
Funk et al. (1995) were responsible for the creation of the 'Barriers scale' for research 
utilisation and parallels can be drawn between their work and this study in relation to 'genetics 
utilisation'. They suggested that to help overcome barriers (to research utilization), 
organisations need to evaluate components of the innovation process on a continual basis, 
then disseminate the evaluation information formed and prioritise the results within their 
organisations. Adopting this approach would allow for genetics/genomics to be continually 
seen as an important aspect of healthcare. That said engaging NHS managers in this 
evaluation process may not be straight forward because they do not always see the relevance 
of genetics/genomics and do not always have the time and expenses to make such an idea 
work. Funk et al (1995) also suggest that the innovation (research utilisation) needs to be 
altered to reflect the environment that it is being used in, it may be that different areas of 
nursing or NHS trusts have different barriers to address. They contend that it is important for 
educators, researchers, clinicians and administrators to collaborate on the innovation to make 
it successful. They do have a valid point. The revised nursing Genetic Competences (Kirk et al. 
ZOllb) allowed for collaboration between nurses and educators. However, the number of 
those who collaborated is not a reflection of the number of nurses and educators across the 
UK, which needs to be considered. The House of Lords report (2009) into genomic medicine 
facilitated an important collaboration between scientists, clinicians, politicians and patients.
8.5.2 Phase 2 barriers and facilitators
In Phase 2 the biggest barrier for incorporating genetics/genomics into practice for both 
adopters and non adopters was 'time', followed by there being 'no local study sessions'. 
Adopters also said that there were 'no relevant resources' to help them. This is different from 
the barriers identified by genetic specialists by both Kirk et al. (2008) and Phase 1 of this 
research. Specialists in the research completed by Kirk et al. (2008) highlighted the biggest 
barriers as being that nurses think 'genetics is not relevant' and that 'nurses don't know about 
genetics'. These were similar barriers identified by the Phase 1 research. It appears that 
nurses have a different idea about what stops them from incorporating genetics/genomics into 
practice, perhaps because as practising nurses they have different issues to deal with than 
genetic specialists. A study focusing on the hand washing practices of nurses using the Theory 
of Planned Behaviour found that environment played a big role in nurses' behaviour intention 
and that it was dependent on resource availability (O'Boyle et al. 2001). Resource availability
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has been highlighted as a barrier by both adopters and non adopters in the present study. 
Archer et al. (2008) state that the Theory of Planned Behaviour identifies that external factors 
also influence behaviour, which in this study includes the lack of local study sessions. The 
barriers that were the least concerning for non adopters were 'other' (not stated what they 
were) and that 'it is not their decision'. Adopters identified various barriers that were of least 
importance to them including 'it's the doctor's job' and 'I don't like science'. For the experts, 
barriers that were the least hindrance were 'lack of support from other colleagues' (Phase 1 of 
this study) and a 'lack of genetic role models' for participants (Kirk et al. 2008 study). The main 
barriers identified by Funk era/. (1995) as part of the barriers scale were:
Fl) Characteristics of the adopter: the nurse's research values, skills and awareness,
F2) Characteristics of the organization: setting barriers and limitations,
F3) Characteristics of the innovation: qualities of the research
F4) Characteristics of the communication: presentation and accessibility of the research.
The biggest barriers in Phase 2 of the research relate to two barriers on the Funk scale, 
characteristics of the organisation (time) and characteristics of the communication (resources 
and no study sessions). In the study by Kirk et al (2008) and Phase 1 of this study the barriers 
from the Funk scale which were most prominent were the characteristics of the adopters 
(relevance and nurses don't understand about it) and to some extent the characteristics of the 
communication (nurses don't know about it). Therefore it could be argued that the factors 
that experts in the field of genetic/genomic healthcare deem to be barriers are also barriers 
that nurses relate to. Table 8.4 shows how the individual participant groups could aid the 
reduction of the impact of the particular barrier, however many of these suggestions would be 
largely dependent on the financial situation. Adopters and GOLs are the main two groups that 
could change the perception of genetics/genomics within their workplace, the underpinning 
barrier which links them all is education, including study sessions. If there were more 
opportunities for effective nurse education in genetics/genomics, this would help address the 
other barriers around understanding and awareness, knowledge about the resources available 
and knowing how to implement genetic/genomics into their practice. However the input from 
adopters, GOLS, OLs and OLWIGS will require time and effort and workloads would need to be 
adjusted to facilitate their involvement in getting nurses better engaged with 
genetics/genomics.
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Table 8.4. The influence of participant groups on barriers and facilitators
Barriers and their link to the barrier 
scale (Funk et al. 1995) (F1-F4)
Time restraints (Phase 2) 
F2
No local study sessions (Phase 2) 
F4
Relevance of genetics/genomics not 
made explicit (Phase 1 and Kirk et al. 
2008) 
F3
Nurses do not understand 
genetics/genomics (Phase 1) 
F4
Nurses do not know about 
genetics/genomics (Kirk et al. 2008) 
Fl
Lack of resources (O' Boyle et al. 
2001) 
F1&F4
Environment (O1 Boyle etal. 2001) 
F2
Participant group influence
Adopters and GOLs could help to persuade managers to invest 
more time in genetics/genomics, both educationally but also 
allowing more time on the ward for genetic/genomic 
application. GOLs may need to encourage managers to work 
with external agencies to help provide study time.
Adopters, GOLs and OLWIGs could seek out relevant people to 
conduct a study session locally. They could also set up a small 
study 'circle' between themselves, through research and 
presentations.
This relevance could be obtained through nurses observing 
adopters and GOLs. Adopters could work with OLs and OLWIGs 
to increase the perceived relevance of genetics/genomics 
through practice focussed articles.
This is linked with needing more study days, something that 
the GOLs and OLWIGs could influence. Genetic/genomic 
training prior to qualification is also needed.
Implementing study sessions and highlighting the relevance will 
be key to overcoming this barrier.
There are resources, but they need to be better 
communicated. This could come through adopters and GOLs 
using these resources in their work environment and through 
study sessions.
Adopters, GOLs, OLWIGs and OLs can improve and change the 
environment in their workplace. It would be more effective if 
they all worked together to target the areas that need 
changing.
8.5.3 Encouraging facilitators and overcoming barriers
The top three facilitators that phase 1 participants thought would help nurses to incorporate 
genetics/genomics more into their practice were to;
1) Improve educators' awareness of genetic/genomics
2) To provide links and access to genetic specialists
3) To improve educators' awareness of genetics/genomics in healthcare
These facilitators are linked to the barriers in table 8.3, as these would help nurses to 
incorporate genetics/genomics more into their practice but the barriers need to be overcome 
first. It may be helpful for adopters and GOLs to collaborate with educators to improve their 
awareness of genetics/genomics and to demonstrate the importance of genetics/genomics in a 
clinical setting, although each group (adopters, GOLs) would need a different level of support 
in this. This would help to improve educators' awareness of genetics and of the need for 
genetic/genomic education. The links with genetic specialists could help adopters and GOLs to
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further their genetic/genomic knowledge and understanding, these links could be a useful 
asset in building a partnership between nurses and specialists. This facilitator can often be 
linked to one of the highlighted barriers. Nurses perceived that there is a lack of resources 
available, and so clearly these resources need to be better communicated to help nurses.
There were two main facilitators that Phase 2 participants identified. The support and 
enthusiasm of colleagues helped them to implement a new idea in their professional practice 
and the ability to convince colleagues of the importance of their idea. This also highlights the 
impact of adopters and GOLs in the workplace. It is difficult to know how the participant 
groups can encourage these facilitators themselves without outside help. Adopters and GOLs 
could be given support to help to convince colleagues of the importance of genetics/genomics, 
but adopters and GOLs would need support and enthusiasm for their ideas which might be 
difficult. This will likely depend on the type of environment they work in, the past experiences 
of introducing new ideas and the rapport that the individual has with their colleagues.
The role of the nursing professional bodies will be important in integrating genetics/genomics 
into nursing practice. However this does depend on the importance placed on 
genetics/genomics by each particular professional body. For example as previously discussed 
in Chapter 3 (p42) the Nursing and Midwifery Council (NMC) could be useful in pushing 
forward the role of genetics/genomics in nursing practice but in the NMC pre-registration 
standards, the genetic competencies (Kirk et al. 2011b) set out for nurses created by nurse 
educators, policy makers and patient representatives are not made compulsory for 
universities. The NMC and the Royal College of Nursing (RCN) could be doing more to promote 
the importance and inclusion of genetics/genomics both in pre-registration education but also 
for qualified nurses. The importance of genetics/genomics needs to be made explicit to these 
professional bodies if patients are to benefit from clinical advances. These bodies should be 
open to genetics/genomics and be aware of its impact in healthcare. It would also be 
important to identify GOLs and adopters in these bodies in order for the awareness of 
genetics/genomics to 'spread' throughout these organisations to allow them to champion 
genetics/genomics to the nurses that come under their association.
Time was the biggest barrier for nurses to incorporating genetics/genomics into practice 
followed by there being no local study sessions; these two barriers need to be carefully 
thought through as to how they can be overcome. Time is a challenge to overcome but if 
nurses could be provided with allocated study sessions, supported by professional bodies, 
which could be built into their continual developmental practice this would provide nurses
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with some time to learn more about genetics/genomics and would also help them to prioritise 
time.
The implementation of new healthcare initiatives, such as gene testing and pharmacogenetics 
will have an effect on how quickly genetics/genomics is incorporated into nursing practice. As 
discussed in Chapter 2 (p37), it is believed that these and other areas will change the way that 
healthcare is conducted. For example, Limdi and Veenstra (2009) predict that the next decade 
will see pharmacogenetics being very productive in healthcare and that nurses will need to 
understand the role of genetics in drug pathways (Lea et al. 2011). The knowledge needed to 
understand this and other areas of genomic healthcare development takes time to develop 
and preparations for this should be underway now.
It is my opinion that the barriers and facilitators discussed above will need to be overcome and 
utilised to help nurses understand and make use of these new and emerging areas of 
healthcare. It is quite likely that these barriers and facilitators have an impact on a nurses 
intention to incorporate genetics/genomics into practice and as such should be highlighted as 
important future areas to either improve or continue to support. This is dependent on 
professional bodies like the NMC, RCN and the National Genetics Education and Development 
centre (NGEDC) encouraging nurses and providing the training and directed information that 
they require and being advocates for the nurses. These bodies should help to engage nurses in 
the recommendations set out by the Task and Finish Group report on genetics/genomics in 
nursing and midwifery (2011), with two such recommendations being that 'NMC standards 
should be expanded to reflect the integration of genetics/genomics across all areas of nursing 
and midwifery' and 'education commissioners and providers should ensure that all resources 
are up to date, accessible and relevant'. The professional bodies are key to helping overcome 
the barriers and facilitators to implementing genetics/genomics.
The findings from the current study show that varying influences can have an impact on 
behavioural intentions. The GIAs are a useful and direct measure of a nurses intention to 
utilise genetics into his/her practice, as a nurse who is already addressing some of the GIAs is 
more likely to have a higher intention of incorporating more genetics/genomics into practice 
compared with a nurse who is not practising any of the identified GIAs. Information seeking 
behaviour can also be used to identify and encourage those individuals who are keen to 
increase their knowledge and practical application of genetics/genomics. Identifying barriers 
and facilitators that either enhance or inhibit behaviour intention is important, as they could 
explain why some individuals have a high behavioural intention where others do not. 
Addressing these barriers and supporting the facilitators may help improve behavioural
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intentions, although it needs to be considered that personality traits, PBC and subjective 
norms also have a role to play in behavioural intentions among nurses.
Summary
As shown through Section one the TPB is a largely sufficient theory for explaining whether 
individuals adopt genetics/genomics into practice. One of the main areas where the TPB is 
lacking is in the relevance of personality traits to the adoption of genetics/genomics. In the 
current study there were no findings that could be associated with personal attitudes towards 
the behaviour, but personality traits did seem to play an important role. Openness to 
Experience was a trait that was significant to the individuals being adopters and OLs. 
Emotional intelligence and empathy are traits that need further exploration in relation to the 
adoption of genetics/genomics. Subjective norms such as adopters perceived expectations 
from colleagues and doctors to complete a genetic activity could be indicative of a level of 
social pressure for three of the possible reasons discussed. Awareness of genetic/genomics, 
confidence in tasks and work environment in the current study all help to explain the 
perceived behavioural control (PBC) that individuals may feel towards the behaviour. These 
two areas of the TPB (PBC and subjective norms) along with personality traits, help to explain 
an individual's behavioural intention, which can be identified in the current study through the 
GIAs, information seeking behaviour and barriers and facilitators. I advise that the GIAs are 
tested on a wider scale, both in terms of participant number but also specific geographic 
variations and different areas of nursing practice. The findings from the current study shows 
that whilst the TPB is a good model for understanding behaviour change (explicitly nurses 
adoption of genetics/genomics), it should not be used as a finite model, but as a guide which 
can be adapted and enhanced.
Section 2. Characteristics of the identified groups
8.6 Group characteristics
The overall findings from this study can help to build a character profile of what adopters, 
opinion leaders, GOLs and OLWIGs appear to be. Figure 8.3 shows the profile of a nurse 
adopter of genetics/genomics. These individuals (compared to non adopters) had an overall 
interest in genetics/genomics, were familiar with certain genetics/genomics aspects and 



































































































































































































































































































































































































































































































































Nurse opinion leaders also have their own unique characteristics that differ from nurse adopters, 
shown in Figure 8.4. Opinion leaders had more demographic features than nurse adopters.
Fig 8.4. Characteristics of nurse opinion leaders
Keen to incorporate 
more genetics into 
practice







Score highly on the opinion 
leadership scale, which focuses on 
being an expert source of advice 
and being asked for information
High academic 
achievement
Perceived influence over 
others
The OL traits identified in the current study shows similarities to those opinion leaders described 
by Feder and Savastano (2006) (See Chapter 5, p95) (Table 8.5).
Table 8.5. Identified OL traits in the current study compared to OL traits identified by Feder and 
Savastano (2006)
Feder and Savastano (2006)
Status within a community
Expertise in their field
Links to external sources of information
Experience




Perceived influence over others
High academic achievement
Higher professional grade
Are a source of advice and expertise (opinion 
leadership scale)
High Openness to Experience
Keen to incorporate more genetics/genomics 
into practice
There were various differences identified between adopters and opinion leaders that were 
identified through statistical analysis. Adopters were significantly more aware of 
genetics/genomics and the available resources and services. Opinion leaders had more influence 
over others than adopters. Table 8.6 shows the differences between adopters in the two studies.
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Table 8.6. A comparison between characteristics identified by Rogers and characteristics 
identified in the current study (adaptation of Rogers (2003) Table 5.3, Chapter 5, p84).
Earlier adopters (Rogers 
2003)
Adopters (Andrews, 2012) 
(current study)
Socioeconomic characteristics
More years of formal 
education
More literate







Greater ability to deal with 
abstractions
More intelligent
Favourable attitude towards 
change
Favourable attitude towards 
science




High Openness to Experience
Understand relevance of genetics/genomics
Finds it easier to apply new knowledge
Keen to incorporate more genetics/genomics in 
practice






Greater exposure to mass 
media
Greater exposure to 
interpersonal channels
Seek information about 
innovations
Have greater knowledge of 
innovations
Higher degree of opinion 
leadership
Find it easier to get permission to access new 
resources
Confident in asking patients family history 
questions
Find it easier to talk to colleagues about 
genetics/genomics
Later adopters (Rogers, 2003)
Socioeconomic characteristics
Fewer years in education
Less literate
Less likely to move up the 
'social ladder'
Personality variables
Less likely to 'put themselves in 
others shoes'
Likely to have a strong set of 
beliefs
Less able to rationalise
Observe innovation in the here 
and now
Lower intelligence level
Are not so positive about 
change
Less inclined towards science
Less likely to cope with 
uncertainty and risk
Perceives to have less control 
over their future
Don't aspire so highly
Communication behaviour
Less social participation
Less connected to others
Interpersonal networks likely 
within their system
Not so exposed to mass media
Fewer interpersonal channels
Less likely to seek information 
about innovations
Less knowledge of innovations
Less likely to be an opinion 
leader
There were also differences between adopters and OLs (table 8.7). The adopters were more 
genetic/genomic literate, had higher Openness to Experience and tended to be older in years. 
The main difference in terms of OLs compared to adopters, where that OLs had a higher 
perceived influence over others.
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Table 8.7. Statistical differences between adopters and opinion leaders
Adopters
More familiar with genetic/genomic resources (p=0.001)
Sought genetic/genomic information for more people groups 
(p=0.005)
More knowledgeable about RGCs (p=0.018)
More favourable towards genetics/genomics and nursing 
statements (MW p =0.038)
Older in years (p=0.028)
Higher in Openness to Experience (p=0.045)
Opinion leaders
Higher perceived influence over 
others (p=0.000)
8.6.1 Identifying characteristics of opinion leaders
8.6.1.1 Lack of identifying characteristics among opinion leaders
There were six characteristics of opinion leaders that when analysed were significant compared to 
non opinion leaders. Four non-demographic characteristics that were representative of opinion 
leaders but not of non opinion leaders were: level of perceived influence over others, a high score 
on the opinion leadership scale, wanting to incorporate genetics/genomics into everyday practice 
and Openness to Experience. The literature on OLs outlined in Chapter 5 (p94) hypothesised that 
there would be more opinion leader characteristics identified than were detected in the current 
study. It was thought that other OL characteristics, such as the length of time practising and 
finding it easier to apply new knowledge into practice would also be significant for OLs. There 
appeared to be a lack of genetic/genomic involvement or awareness from OLs in their responses 
to the identifying questions. Whilst OLs scored significantly higher in having a perceived level of 
influence over others and the opinion leader scale question, the only genetic question that they 
scored significantly on compared to non OLs, was 'wanting to incorporate more 
genetics/genomics into practice'. Whilst the personality strength scale, originally developed by 
Noelle-Neumann (1985) and then further developed by Weimann (1991), showed that OLs do see 
themselves as having a level of influence over others, it does not appear that they have much 
influence in terms of genetic/genomic involvement within nursing practice. This could be 
explained by evidence showing that the personality strength scale is strongly related to general 
opinion leadership but not necessarily to monomorphic opinion leaders (those whose influence 
extents only to one area of interest) (Gnambs and Batinic, 2011). I believe that the most likely 
explanation is that for several OLs in this study, genetics/genomics has not become an area of 
importance for them.
8.6.1.2 Limited generalised opinion leadership identifying questions
At the beginning of the data collection phase, it was intended that the presence of other more 
specific genetic questions (such as wanting to incorporate more genetics/genomics into their
practice and talking to colleagues about genetics/genomics) would counter-balanced questions
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that identified just those individuals who were OLs for various causes, known as polymorphic 
opinion leaders. It is known that OLs who are confident in their leadership (based on the 
personality strength scale), are more likely to engage in community activities and will persuade 
others to follow their lead (Scheufele and Shah, 2000), but this could be related to any topic 
within the workplace, not based on a specific topic, such as genetics/genomics. Therefore one 
could conclude that the majority of OLs are not monomorphic (i.e. genetic opinion leaders), 
regardless of trying to identify this group. The opinion leader identifying questions could have 
included more known opinion leadership scales instead of the genetic/genomic based questions, 
however it was unclear what type of OLs would be identified as this type of research has not been 
conducted before. Further opinion leadership scales such as the monomorphic scale used by 
Flynn et al. (1996) could have been used, alongside those already used in the questionnaire. 
Although this is a rather lengthy scale, it has the advantage of being able to be made specific to 
the topic area.
The results of the present study do show that OLs lag behind adopters in some areas of 
genetic/genomic knowledge and application. There were only a few genetic specific questions 
where there was a significant difference between adopters and OLs; awareness of regional 
genetic centres, seeking genetic/genomic information and familiarity with genetic/genomic 
resources. Many of the GIAs also did not produce significance in favour of adopters (when 
compared against opinion leaders), but this was also the case between OLs and non OLs. These 
findings suggest that whilst adopters do have a greater level of genetic/genomic awareness it may 
not be such a great divide as it was originally thought it might be. This could reflect that 
genetics/genomics is still a relatively new concept in nursing.
8.6.2 Genetic opinion leaders (GOLs)
The survey conducted in this study has allowed for the identification of adopters and OLs as 
hoped, and it has also allowed for the identification of other intermediate groups, such as the 
GOLs and OLWIGs.
Six genetic opinion leaders (adopters who are opinion leaders, GOLs) were identified in this study. 
The identification of these GOLs challenges my initial hypothesis that the OLs identified were 
simply opinion leaders for various causes (monomorphic). I think that this small and specialist 
group of people are one of the most important groups identified in the study, as they have the 
capability to influence many colleagues on a topic that the GOLs have already adopted. These six 
individuals were older in years and had more nursing experience, they were pro-active in 
adopting genetics/genomics into practice, were not influenced by what others thought and 
believed that genetics/genomics was an expected component of their role. It could be that this 
group of nurses are what Rogers' (2003) referred to as 'innovators'. Rogers stated that these
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individuals are likely to have a higher degree of opinion leadership, a greater degree of social 
mobility and seek information about innovations and acquire greater knowledge. The one area 
where these GOLs differ from Rogers (2003) findings is that the GOLs were slightly older in age. 
Although GOLs were few in number (six out of 88 participants, 6.8%), I think they could be 
valuable in facilitating the incorporation of genetics/genomics into nursing practice. Although this 
number is small it is to be expected, as according to Rogers (2003) only 2.3% of a given population 
would be innovators (GOLs). GOLs make up 6.8%, hence the percentage of GOLs identified could 
be considered proportionate to the population size. They clearly have an interest in 
genetics/genomics and see it as important to their nursing role, but it also appears that perhaps 
due to their age and experience that colleagues listen to them and are guided by them (OL traits). 
These are the unique genetic champions that the study was hoping to identify. The GOLs 
therefore could be used as ambassadors and role models to support adopters on the 'ground' and 
encourage opinion leaders and non adopters to see the important in genetics/genomics within 
their area of practice. Due to their small number their sphere of influence across a geographical 
location would be limited but utilising virtual networks could help establish this. There are many 
online networks available for nurses (e.g practicenurse.co.uk) where GOLs could have an impact 
upon areas of nursing practice without being confined to a particular geographical area.
8.6.3 Opinion leaders with an interest in genetics (OLWIGs)
Opinion leaders with an interest in genetics (OLWIGs) also have the potential to influence others. 
Despite the fact that there were no significant differences between opinion leaders and non 
opinion leaders on the majority of the genetic questions, the OLWIGs scored highly on these 
questions. Whilst this group have not necessarily adopted genetics/genomics in their practice, 
they still have the potential to influence those around them with their interest in 
genetics/genomics. There was a greater range of demographic differences in this group than the 
GOLs and they did not feel that they were expected to input genetics/genomics into their 
practice, unlike the GOLs. They also did not feel the need to seek the opinion of others before 
acting. There are known to be different types of opinion leaders within a social system. Opinion 
leaders can sit at different points along a number of characteristic axes (Locock et al. 2001, 
Chapter 5, p96), including being supportive or hostile, optimistic or cynical. In term of genetic 
adoption, OLWIGs are ahead of opinion leaders, but not as advanced as GOLs or adopters. 
Specific individuals from this group could be further identified and educated to become GOLs. 
They could be partnered with the GOLs or adopters, with the adopters providing the 
genetic/genomic knowledge and the OLWIGs exerting influence over others.
The different groups identified have different skills to offer in relation to encouraging and 
supporting the incorporation of genetics/genomics into nursing practice and providing the right
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environment will allow their different strengths to flourish. These different groups can also work 
together to provide an overall advantage than each group working individually.
Whilst there was a limited number of GOLs and OLWIGs on whom to perform statistical analysis, 
distinguishing characteristics could still be identified from these groups. However it does need to 
be stated that these characteristics may not be generalisable to a larger population due to the 
small number of individuals identified in these groups. Table 8.8 shows the characteristics of both 
GOLs and OLWIGs.
Table 8.8. The distinguishing characteristics of Genetic Opinion Leaders and Opinion Leaders with 
an Interest in Genetics (not including adopter and opinion leader characteristics)
GOLs
Older in years
More experienced (higher grade)
Likely to have identified someone for referral to 
genetic services
Familiar with local specialist genetic services




Less likely to understand importance of identifying 
someone to refer to genetic services
Not familiar with genetic resources
8.7 Study limitations
The limitations of the study relate to the sample size, participant demographics and identification 
of the GIAs. For general advantages and disadvantages of the research methods utilised in the 
study, see Chapter 6 (section 6.1.3, p!35).
8.7.1 Sample size
The response rate to the Phase 1 survey of 9.6% was low, therefore the results cannot be 
generalised on a wider scale. The low response rate may have been improved by providing a 
dissemination document sent directly to AGNC members, rather than through area 
representatives. This approach was decided by the AGNC and I had no control over this aspect of 
the data collection. Moreover, participants could have been approached in a different way, 
perhaps through departmental contacts which might have allowed for a more direct approach to 
participants. However the AGNC did have access to the largest number of genetic specialists of 
any organisation or individuals in the UK. Furthermore, the follow up focus group provided 
another means of testing the GIAs and survey responses.
It is difficult to know exactly how many oncology and practice nurses were contacted for the 
Phase 2 survey; again because a third party was used for dissemination. However with the 
number of dissemination contacts approached, a participant number of 99 can be considered low. 
There were several dissemination contacts used and a reminder was sent, however questionnaire 
recruitment is known to be difficult (Jones et al. 2008). Usually questionnaire participation is
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increased when conducted face-to face (Gerrish and Lacey, 2006), although this would not have 
been feasible for this study. It was unfortunate that the UK Oncology Nursing Society could not 
disseminate the questionnaire as they were planning to disseminate their own questionnaire at 
the time. This could have accounted for a low response rate from oncology nurses (n=16/18%). 
In the future a second reminder could be sent to possible participants in a bid to increase the 
response rate and to perhaps enquire of the nursing organisations whether there is more than 
one way to contact their members, for example, to send information via a direct email and 
through online blogging. In a similar study, Chen et al. (2008) also had a low response rate 
(23.1%) for their web based questionnaire among health educators in the US.
8.7.2 Identifying the appropriate GIAs
Four Genetic Indicators of Adoption (GIAs) were identified and experts' views were sought on 
their appropriateness to help identify nurse adopters of genetics. Although there was a clear 
consensus among respondents to the survey to identify the GIAs (further supported by the focus 
group), had time permitted it would have been useful to hold further focus groups. These could 
have provided some broader insights into the nursing role in genetics/genomics. It would have 
been helpful to have had longer with the focus group than was possible, meaning that certain 
areas such as 'how to encourage nurses to incorporate genetics/genomics' and 'nursing hierarchy' 
could have been discussed further. The genetic counsellors' work commitments and clinic times, 
did limit the time available to spend on the focus group. There are 'pros' and 'cons' of using focus 
groups and questionnaires. Anonymous questionnaires reduce the bias from the researcher and 
participants can be more open and honest in their answers (McColl et al. 2001). Focus groups 
allow the researcher to identify the range of issues at the community level, but the researcher 
needs to guard against gaining information almost solely from a dominant member of the group 
(Kumar, 2011).
8.7.3 Participant demographics
Oncology and practice nurses were the only nursing specialists to be asked to complete the 
questionnaire, the results therefore cannot be generalised to the wider nursing population. It 
could be possible that nurse adopters of genetics from different nursing specialities have different 
characteristics; however it can be argued that the two specialities chosen were two distinctly 
different areas of nursing. There were a significantly higher percentage of practice nurses who 
were adopters than oncology nurses but due to the low numbers of oncology nurses statistical 
comparisons could not be made. To contact all nursing specialists would not have been feasible 
within this scope of study. These two areas of nursing were considered to be the most 
appropriate for the initial identification of nurse genetic adopters because of the role of oncology 
nurses in caring for people with inherited cancers and some aspects of pharmcogenetics (e.g.
Herceptin) and the role of practice nurses in dealing with families. Including more nursing
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specialisms may provide a broader insight into the characteristics of adopters and opinion leaders, 
as it might be that each specialism within nursing has different traits for adopters and opinion 
leaders. This is an area that could be explored in future work, but for practical reasons selected 
fields would need to be studied. For example children's nursing would be a useful specialism to 
study next due to the prevalence of genetic diseases in children (WHO, 2010).
No men completed the questionnaire, which was unfortunate but not unexpected due to ratio of 
females to males within the nursing profession (in 2007-2008 10.67% of nurses were male (NMC, 
2008)). It may be that within the two nursing specialisms chosen, males are less likely to be 
employed in these nursing areas. The UK Oncology Nursing Society stated that in 2011, 5.45% of 
members were male and 94.55% were female and the RCN Practice Nursing Association stated 
that out of their members, 90.36% were female and 9.63% were male. It is possible that the 
characteristics of male and female nurse adopters might vary. A study by Marshall and 
Gitosudarmo (1995) investigated the characteristics of opinion leaders (n=640) in eight different 
cultures, four western and four eastern found little difference. Although the research was 
completed with an undergraduate participant group, the researchers found a gender split of 
opinion leaders to be minimal (59% (n=378) males compared to 41% (n=262) females). This 
would suggest that the results of the current study would not have been very different if more 
men had participated. There is limited literature on gender differences among adopters. It may 
have been possible to try to contact male oncology and practice nurses when it was becoming 
clear that only females were responding to the questionnaire, by specifically asking the 
dissemination contacts if they could forward the questionnaire link to male nurses. However as a 
variety of dissemination contacts were used one could believe that every opportunity was made 
available for male oncology and practice nurses to complete the questionnaire, if they had wished 
to. In the future it may be useful to purposely create a direct strategy to identify male contacts in 
the areas of oncology and practice nursing.
8.7.4 Questionnaire scoring system
The scoring system used to identify adopters and OLs was created by giving each individual 
question a score, then combining this score it with scores for other questions to calculate an 
overall score (See Chapter 6, p!54). The scoring system was a logical approach for identifying 
adopters and opinion leaders from the data because it produced definable categories for each of 
the four groups identified (adopters, GOLs, OLs, OLWIGs), which could be reapplied in future 
studies. The scoring system took the highest and lowest score for each question to calculate an 
adopter or opinion leader scoring range. It could have been possible for some adopters and 
opinion leaders to have scored highly in one section of questions but below the threshold in 
another (See Methodology, section 6.10). This could have meant that some people were placed
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into a participant grouping that perhaps was not wholly reflective of their overall profile. 
However this might have been the case for only a few adopters and opinion leaders because there 
were a small number of individuals who were on the lowest level of the scores. Although it needs 
to be stated that adoption is a process that occurs over time and so one would expect to see a 
range of scores in each category. The scoring system was reliable and appropriate for this study 
as it identified numerous adopters and OLs, however this would need to be confirmed through 
further testing in the future. A larger sample size would allow further improvements to be made 
to the scoring system and cut-off points for each participant category.
Due to the nature of the questionnaire, the possibility of conducting reliability testing was limited. 
Cronbach's alpha was calculated to test reliability for questions one (openness to experience) and 
16 (opinion leadership scale). Both questions were taken from a previously used questionnaire 
and were shown to be reliable, question one received a Cronbach's score of 0.700 and question 
16 0.852. A Cronbach's score of 0.7 is deemed acceptable, with results higher than 0.7 being 
regarded as having good reliability (Hair et al, 1995, p641). However, it is hoped that the 
questionnaire developed for the current study will be used on a wider scale to identify nurse 
adopters and opinion leaders. I need therefore to elucidate that the questionnaire would need 
further reliability and validity testing to ensure that it is appropriate for the identification of these 
individual groups. Even when the data collected are not anonymous, however, test-retest 
reliability (Rust and Golombok, 1999, p64-73) would not be appropriate for this questionnaire, 
due to its nature of testing knowledge and skills, as it is hoped and expected that these will 
change (i.e. Improve) over time. Hence if participants were to re-complete the questionnaire 
after a 'wash-out' period (long enough to forget their answers to the previous questionnaire) 
after the first completion, it is possible that their results would alter. Due to the unique and 
diverse nature of the questionnaire, split-half reliability testing would also not be appropriate as 
many of the questions do not have an alternative item (another question that measure the same 
variable) by which to be compared (Rust and Golombok, 1999, p64-73). I believe that the most 
suitable approach to testing the reliability of the questionnaire would be through conducting 
further qualitative research. For example to conduct focus groups and interviews with nurse 
adopters, opinion leaders and GOLs who have been identified using the questionnaire, to directly 
verify their perceived adopter and opinion leader traits. Observational research in the known 
adopters and opinion leaders work environment may also prove or disprove their adopter and 
opinion leader status indicated via their questionnaire scores. However, I recognise that these 
approaches are time consuming.
Although face validity was conducted for this study, further validity testing would also be 
beneficial to future researchers utilising the current questionnaire. I believe that the most
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appropriate validity test would be through the continued use of the questionnaire, providing a 
greater number of data sets, from which the application, outcomes and interpretation of the 
questionnaire could be compared, which is a form of construct validity (Rust and Golombok, 1999, 
p64-73). This would allow the current study's hypothesis (including the use of change theories) 
relating to the use of the questionnaire to identify adopters and opinion leaders to be tested, 
providing a relationship between the questionnaire results/outcomes and the predictions of what 
the questionnaire was hoping to identify (i.e. characteristics of adopters and opinion leaders), 
otherwise known as the hypothesis.
The limitations for this study were such that the reliability and accuracy of the results were not 
challenged. The limitations mainly limited the generalisability of the results due to the low 
response rate, with more practice nurses than oncology nurses and the use of two nursing 
specialisms. However, as previously stated two nursing specialisms were specifically chosen for 
this study as being particularly appropriate. The results have allowed important and unique 
conclusions to be drawn which will aid and support the development of strategies to increase the 
incorporation of genetics/genomics into nursing practice.
Section 3. Informing a strategy for engagement
Section three focuses on how the findings from this study can help organisations to produce a 
strategy for engaging nurses in genetics/genomics. It is hoped that the four groups identified in 
the present study could be used to strategically enhance the uptake of genetics/genomics among 
nursing staff.
8.8 Applying the findings to developing a strategy for engagement
The characteristics of individuals identified from this study can be explained by the three theories 
focussed on in chapter 5; the Theory of Planned Behaviour (TPB), the Diffusion of Innovations 
theory (DOI) and the Stages of Change theory (SOC). I believe that DOI and SOC theories have 
some similarities. They both have a stage by stage approach to change, from non adoption 
through to adoption, but do not include possible influences on behaviour change. The TPB 
appears to recognise more of the complexities of behaviour change, with the inclusion of possible 
influencing factors such as behaviour and control beliefs. Therefore this discussion will draw on 
the TPB in particular to provide the overarching framework for engagement, with input from the 
SOC and DOI theories.
Each of the four groups identified (adopters, OLs, GOLs and OLWIGs) all have individual roles to 
play in enabling a strategy for the incorporation of genetics/genomics into nursing practice to be 
successful (Table 8.9). These individuals could be identified and targeted by organisations who 
want to increase the uptake of genetics/genomics within nursing, such as the NHS National
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Genetics Education and Development Centre. Through the use of a short, succinct questionnaire 
based on the findings from the current study, adopters, OLs, GOLs and OLWIGs could be identified 
(or just single groups if preferred) from within the target population. The individuals and their 
abilities can then be used to further advance and complement the strategy that the organisation 
wants to implement.
Table 8.9. The possible impact that each group could have on the incorporation of 
genetics/genomics into nursing practice
Group Possible impact
Genetic Opinion Leaderss GOLs are the group which could have the most impact, as they have the 
interest and knowledge in genetics/genomics and to act as role models. 
They could be used to help champion genetics/genomics within their 
workplace. ___________ ____ __________
Adopters Adopters could show others how to use genetics/genomics in their 
practice and why it is important to do so. They could be 'witnesses' for 
the genetic/genomic cause in nursing and raise awareness about its 
importance. They would need further investment with genetic/genomic 
resources and in keeping up to date with knowledge. ___ ______
Opinion Leaders with an 
Interest in Genetics
OLWIGs could be used in a similar way to the OLs but with the advantage 
that they have a greater interest in genetics/genomics. They could also 
be 'buddied' with adopters to help them to be more successful in 
implementing genetics/genomics in their workplace. OLWIGs would 
benefit from support to increase their knowledge of genetics/genomics.
Opinion Leaders Opinion leaders could be used for their ability to have influence over 
others. They could be 'buddied' with adopters in their department, to 
make the most of both of their skills. OLs could benefit from support on 
gaining awareness about genetics/genomics and its importance in 
practice.
Figure 8.5 shows my interpretation of Rogers' Diffusion of Innovation bell curve (Rogers, 1962, 
see p81). The Figure shows the breakdown of the participant groups identified in the current 
study. The GOLs are the top 2.5% of individuals in a community with the non adopters making up 
the bottom 16%. It does need to be mentioned that the percentage distributions used by Rogers 
in his bell curve are not necessarily reflective of the number of individuals within each group in 
the current study, but it provides the reader with an overall spread of the groups within a 
community- The findings of this study show a snap shot of time and only the innovators and early 
adopters have engaged with genetics/genomics.
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Fig 8.5. Bell curve showing the breakdown of participant groups from the current study (adapted 
from Rogers, 1962)
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Total adopters and non adopters equate to 100%. Non opinion leaders are not shown in this figure, hence 
the rest of the group percentages do not equate to 100%.
Each of the three theories are discussed to show how the four groups could be used in different 
scenarios and ideas of change. Neither are wrong or right but provide a different outlook as to 
how the four groups can be best used. The three theories are then considered together to 
provide a detailed, yet succinct plan of how the four groups could be used to enhance behaviour 
change among nurses.
8.8.1 Applying the findings to the Diffusion of Innovations theory and the 
Stages of Change theory
Due to the similarity in the way the Diffusion of Innovations theory and Stages of Change theory 
can incorporate and utilise the different participant groups, they are discussed together in this 
section. Table 8.10 shows the possible solutions at various points in the two theories to help 
nurses to adopt genetics/genomics, these are discussed in more detail below.
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Table 8.10. Possible solutions to help nurses to adopt genetics/genomics into their practice in 
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In the above table, the role of peer mentoring is included as it could be a useful approach to 
helping non adopters and OLs to see the relevance and importance of genetics/genomics for their 
practice. Holmes et al (2010) state that mentoring is an ancient concept of education and can be 
the 'cornerstone in reinvention'. However peer mentoring could develop and facilitate the 
development of personal learning networks (Holmes et al. 2010) and it should be used in 
conjunction with independent learning. In order for the approach to work, mentors do need to 
have the time and resources to bring to the role otherwise it simply will not work. I believe that if 
peer mentoring was managed well, it could be an important method to be utilised to help nurses 
gain genetic/genomic knowledge.
Diffusion of Innovations theory
The Diffusion of innovation (DOI) theory describes quite clearly how an innovation spreads across 
an organisation and the features of the innovation that enable individuals to adopt, such as the 
complexity of the innovation (Rogers, 2003). Figure 8.6 shows the way DOI works in relation to 
incorporating genetics/genomics into practice, through the initial intervention development stage 
to the trialling of the innovation and eventually the implementation of the innovation.
The four groups all have a role to play in Diffusion of Innovations strategy (Table 8.11). Adopters 
and GOLs can be effective at various steps along the Diffusion of innovation process to help and 
encourage those nurses who have not yet adopted to do so. Much of this will be through non 
adopters observing GOLs and adopters to see how they have incorporated genetics/genomics into 
their practice and how they work through various barriers such as the perceived complexity of 
genetics/genomics and compatibility of genetics/genomics with nursing practice. The expectation 
that adopters and GOLs feel from doctors and colleagues may also transfer to non adopters over 
time, if they are working in a close environment, or they create an internal pressure on
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themselves. This also relates to the small-world concept created by Watts and Strogatz (1998). 
Those in a cliquish network, often spread an innovation quicker than those in a random network. 
A cliquish network could be considered to be present on a nursing ward, hence the adopters and 
GOLs in this type of network should be able to encourage non adopters and 'witness' 
genetics/genomics in practice to them.
Table 8.11. The role of the four identified participant groups in the Diffusion of Innovations 








GOLs due to their influencing characteristics can help to persuade nurses 
to see the importance of genetics/genomics within their practice. GOLs 
can be observed by nurses implementing genetics/genomics and can 
allow non adopters to 'trial' the innovation. GOLs can continue to 
encourage nurses after they have adopted.
Adopters can showcase genetics/genomics to their colleagues to allow 
them to clarify, 'trial' and observe the innovation. Adopters can continue 
to support and encourage nurses after they have adopted 
genetics/genomics and they can work to continually maintain and update 
their knowledge.
OLWIGs can help to persuade nurses to adopt genetics/genomics into 
their practice and due to their interest in genetics/genomics can 
encourage non adopters at the persuasion and trialability stages.
OLs will be important at the 'persuasion' stage for helping nurses 
(including non adopters) to see the importance of genetics/genomics. OLs 
































































































































































































































































































































































































































































































































































































































































































































































































































































































Stages of Change theory
The Stages of Change theory (SOC) states that behaviour change is a process that develops over 
time and through various stages (Prochaska and Norcross, 2001). The SOC theory has a logical 
flow of six steps that people go through to change their behaviour. Rogers (2003) believes that an 
individual goes through the stages, decreasing the 'cons' and increasing the 'pros' of the 
innovation. Each stage is a time period which includes various tasks that need to be completed to 
advance to the next stage. This time period varies on the individual (Prochaska and Norcross, 
2001). Table 8.12 shows how the participant groups in this study fit within the various Stages of 
Change theory.
Table 8.12. Participant groups in relation to the Stages of Change theory









Nurses have not thought about adopting 
genetics/genomics
Nurses may have thought about 
genetics/genomics, but are not yet thinking of 
using it
Nurses are willing to adopt genetics/genomics and 
are planning how to do so
Nurses try and adopt genetics/genomics into their 
behaviour
Nurses are continuing to use genetics/genomics in 
practice
Nurses no longer have to work to maintain the use 
of genetics/genomics
Participant group
Laggards, score between 97- 
111/some OLs (non 
adopters)
Late adopters/OLs





*l do not agree with the concept of the termination of behaviour change when related to 
genetics/genomics within nursing. Genetics/genomics is a continually growing field and as such a nurse will 
always need to alter their use of genetics/genomics and keep abreast of new knowledge and developments 
as well as policy. There will be no point when genetics/genomics stops being relevant to healthcare 
practice.
GOLs and adopters will need to be showing non adopters what genetics/genomics in practice 
could look like. However Norcross and Prochaska (2002) suggested that every individual 
progresses through the stages differently and as such should not be pressurised into changing too 
quickly. New adopters may be useful in enabling other non adopters to see the importance of 
adopting and that it is not as daunting as perhaps originally thought. The 'community' of 
adopters and GOLs would increase and as such would provide a higher level of expectation within 
the community to use genetics/genomics more, it would possibly put a social pressure on non 
adopters.
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Table 8.13. The role of the four identified participant groups in the Stages of Change strategy for 








GOLs can use their genetic and influencing skills, to help non adopters to 
think about adopting genetics/genomics. At the contemplation stage, can 
provide education and practice support for non adopters. Shift supporting 
and mentoring from GOLs at the preparation and action stages would 
help non adopters to cement their decision to adopt genetics/genomics.
Adopters could help non adopters to think through the importance of 
genetics/genomics by showing them how genetics/genomics has altered 
their practice. Adopters could be used as shift support and mentors at 
the preparation stage to pass onto non adopters their knowledge and 
skills. This type of social support would continue at the action and 
maintenance stages
OLWIGs could use their interest in genetics/genomics to help non 
adopters at the contemplation and preparation stages to help increase 
their interest and subsequent knowledge in the field.
OLs would be useful at the contemplation stage to have influence over 
non adopters as they think about incorporating genetics/genomics. OLs 
should also be used at the action and maintenance stages to keep the 
interest in genetics/genomics high through their influence over others.
Figure 8.7 shows the stage of change in relation to how a nurse will be behaving at each stage and 
how GOLs and adopters can help at these stages.
Adopters and GOLs can be used within the Theory of Planned Behaviour to change the beliefs of 
non adopters, to provide information about the innovation and to highlight the positive aspects of 













































































































































































































































































































































































































































































































































































































































































































8.8.2 Applying the findings to the Theory of Planned Behaviour
The Theory of Planned Behaviour is often used to predict behaviours and behavioural intentions 
(Armitage and Conner, 2001) and is often used as a benchmark for new innovations (Skar et at. 
2008). The TPB shows that the intention to act on an innovation is influenced by an individual's 
attitude towards the innovation, subjective norm and perceived behavioural control (Hardeman 
et al. 2002). It is believed that the more favourable the attitude and subjective norm (belief about 
innovation) towards the innovation, the greater the perceived behavioural control (ease of 
adopting innovation), therefore an individual's intention to adopt the innovation should be 
stronger (Ajzen, 1991).
The TPB has several different avenues that can be explored in terms of adopters and GOLs being 
able to influence the uptake of the innovation. The attitude nurses have towards the behaviour 
could be altered through observing adopters, GOLs and OLWIGs which may help non adopters to 
see the positive consequences of changing their behaviour (Table 8.14). The belief about 
genetics/genomics and having the motivation to adopt genetics/genomics could be helped 
through pressure provided by adopters within a particular setting to start using 
genetics/genomics. This approach could have a positive influence on the subjective norms related 
to the innovation.
Perceived behavioural control (i.e. the perception of implementing an innovation and the ability 
to overcome obstacles) could be influenced by the information that is provided by GOLs, OLWIGs 
and adopters about the innovation and its ease of use, known as control information beliefs. The 
level of perceived behavioural control that someone has over their situation can help to predict 
their behavioural intentions, hence behavioural intentions can be influenced by perceived 
behavioural control but also by attitude towards the innovation and subjective norms.
One limitation of TPB is that it does not include personality traits as a variable in the predictor of 
behaviour adoption. Personality traits are important in explaining and understanding an 
individual's likelihood of behaviour change (Booth-Kewley and Vickers, 1994). As an example, 
Hoyt et al. (2009) identified that personality traits of activity and self-discipline were important 
aspects of exercise behaviour. They found that the five factor model of personality could be 
linked with TPB to predict exercise behaviour. Other studies have also linked the five-factor model 
with TPB (Picazo-Vela et al. 2010; de Bruijn et al. 2009). In response to these findings and 
suggestions, Ajzen (2011) stated that there may be stable differences among individuals that 
affect the relative importance of different predictors of TPB (i.e. subjective norms). Ajzen also 
states that factors, such as personality and demographics will indirectly influence behavioural 
intentions and outcomes and that the TPB does point to a range of background factors influencing 
behaviour. However, I disagree with Ajzen's statement about the way personality and
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demographics influence behavioural intentions. The impact of personality upon behaviour 
change does need to be made more explicit within TPB, especially when considering the adoption 
of genetics/genomics by nurses. It has been found in the current study that Openness to 
Experience (one of the Big five-factor of personality) is high among those who have adopted 
genetics/genomics and among those who can influence behaviour change in others. It does 
appear that Openness to Experience is the link between both TPB and personality traits. It 
appears that there is a need for a third method/theory for understanding behaviour change. This 
only reinforces the notion that changing an individual's behaviour is complex and cannot always 
be condensed into a generalised theory. Therefore when considering TPB as a behaviour change 
model in relation to genetics/genomics within nursing, personality needs to be given careful 
consideration and future research needs to be conducted on the role of personality in the TPB.
Table 8.14. The role of the four groups in the Theory of Planned Behaviour for the 
implementation of genetics/genomics into practice
Group Possible impact
Genetic Opinion Leaders GOLs can show non adopters the consequence of using genetics/genomics 
in their practice to alter attitudes towards genetics/genomics. They could 
also help to raise the level of expectation on non adopters with their skills 
in influencing others and their knowledge in genetics/genomics. GOLs can 
also showcase their use of genetics/genomics to non adopters to enhance 
behavioural intentions.
Adopters Adopters could highlight the positive consequences of using 
genetics/genomics in their practice and could increase the level of 
expectation on nurses to incorporate genetics/genomics. Adopters can 
also pass on their genetic/genomic information to non adopters to 
increase perceived behavioural control. Adopters could showcase their 
use of genetics/genomics to non adopters to enhance behavioural 
intentions.
Opinion Leader with an 
Interest in Genetics
OLWIGs interest in genetics/genomics can help this group to influence 
perceived behavioural control by them passing on their interest in 
genetics/genomics to non adopters. They can also help to raise the level 
of expectation on non adopters to apply genetics/genomics to their 
practice to improve subjective norms.
Opinion Leaders OLs could help to raise the level of expectation on non adopters to be 
using genetics/genomics due to their influence over others. Through the 
help of adopters they could help non adopters to gain genetic/genomic 
knowledge. _______________________
Those who have adopted genetics/genomics and become adopters and innovators can go back 
through the cycle and influence non adopters as early adopters and GOLs did for them. Thus 
there could be a continual process of influencing, witnessing and adopting. However there will be 
individuals who have good intentions to adopt genetics/genomics, but their behaviour does not 
change to reflect these intentions. Some of these reasons can be related to variable used to 
predict behaviour change. It has been shown by Rise et al. (2008) that planning behaviour change 
is a good predictor of whether someone will change their behaviour. For example, if a nurse has
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the intention to use genetics/genomics in his/her practice and has a plan in place as to how 
he/she will achieve this, he/she is more likely to proceed to the behaviour change. Planning helps 
to build a 'mental representation' of the behaviour and how it will look for that individual (Rise et 
at. 2008). Likewise setting goals to achieve behaviour change (which is linked to planning) has 
also shown to be important in predicting the leap from intention to change (Rise et al. 2008). This 
could include goals for nurses to seek genetic/genomic education or to begin to ask patients 
family history questions. Past behaviour also affects whether someone changed their intentions 
into a behaviour change (Rise et al. 2008; Smith, 2007). If a nurse has already tried to adopt 
genetics/genomics but had a negative experience or perhaps disliked science at school, even if 
they have positive intentions to adopt their past behaviour may prevent them. This can also 
include an individual's self-identity with the behaviour, the way that they perceive themselves in 
relation to the behaviour change required (Smith, 2007). Schwarzer (2008) believes that an 
individual's intention to adopt a behaviour needs to coincide with other factors that aid transition, 
such as overcoming perceived barriers and endorsing facilitators as seen in Figure 8.8. There are 
many reasons why an individual would have the intention to change their behaviour but to not 
complete the change. I believe that the identified barriers in this study could help explain the 
'drop out' rate between intention and action. Supporting the identified facilitators may help to 
improve the number of individuals moving from the intention stage to the change stage. The 
Theory of Planned Behaviour model (Fig 8.8) does not really account for those individuals who do 
not adopt a behaviour following the intention to do so. This is a limitation that I believe should be 
taken into account when organisations are encouraging nurses to adopt genetics/genomics into 
their practice.
Figure 8.8 shows the Theory of Planned Behaviour in relation to the various inputs that help or 
hinder a nurse from adopting genetics/genomics and illustrates how adopters and GOLs can be 































































































































































































































































































































































































































































































































































































































































































































































































































































































































8.8.3 Applying the characteristics of the groups and the three theories to 
develop an overall strategy for engagement in genetics/genomics
The three theories and the findings from this study have been integrated to develop potential 
applications to help to inform strategies for other organisations (Fig 8.9). The Theory of Planned 
Behaviour (TPB) is the main theory running centrally throughout the Figure, with the Diffusion of 
Innovations (DOI) and Stages of Change theory (SOC) being integrated with this. The behaviour 
steps (1-5) in Figure 8.9 are outlined below, with the pertinent theory indicated in parentheses.
1. The intervention needs the support and enthusiasm of all four groups, but especially the 
GOLs and adopters if it is to be successful. These groups are needed to encourage their 
colleagues to adopt the innovation and therefore their backing is vital. The intervention 
also needs to be clearly defined and structured with adopters and GOLs making clear the 
relative advantage (DOI) of the innovation on their practice.
2. The attitude, subjective norm and perceived behavioural control (TPB) all affect the 
behavioural intentions to adopt genetics/genomics into practice. The intervention stage 
(TPB) is linked to the contemplation stage (SOC). All four groups can have an impact at 
this stage. The relative advantage, available knowledge and innovation clarification (DOI) 
will affect attitudes (TPB) and could be enhanced by the adopters and GOLs in order to 
provide non adopters with positive perceptions of the innovation.
Persuasion and clarity (DOI) of the innovation could help nurses to acquire a degree of 
motivation about the adoption and increase the level of social normality (TPB) of the 
innovation. OLs and OLWIGs would be important in this variable as they have the ability 
to influence those around them. With the genetic expertise from adopters and GOLs the 
OLs and OLWIGs could also motivate non adopters and create positive beliefs about 
genetics/genomics.
Keeping the complexicity of the innovation to a minimum by perhaps using clear 
explanations and examples and showing how compatible the innovation is (DOI), showing 
how genetics/genomics ties in with the nursing code of practice and other areas of care 
could help nurses to increase their perceived behavioural control (TPB) linked to the 
innovation. It may be that those adopters and GOLs who have a high perceived 
behavioural control (TPB) over the innovation could help to influence those nurses who 
are struggling with their attitude towards the innovation, in terms of their appraisal of the 
new idea.
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3. Behavioural intentions (TPB) is linked to the preparation stage (SOC) and the decision 
stage (DOI). The opportunity to be able to trial the innovation (DOI) may be important at 
this stage. In that way non adopters can see how genetics/genomics may influence their 
practice and patient care. Adopters and GOLs could supervise and mentor this 'trial 
opportunity', with their knowledge and interest in genetics/genomics.
Facilitating individuals at the action stage (SOC) to observe (DOI) individuals who are at 
the action stage (SOC), including adopters and GOLs could help those at the decision stage 
(DOI) to progress towards implementation (DOI).
There may be a small number of GOLs and adopters and possibly OLWIGs who are either 
at the preparation stage (SOC) or the action stage who could impact on the attitude, 
social norms and perceived behavioural control (TPB) at the contemplation stage (SOC). 
That way there is constant influence by those who have recently been through the stage 
to impact those non adopters working through the stages before them. This could be 
helped by providing those individuals at the initial stage with the trial (DOI) opportunity, 
to help them to progress to the preparation stage (SOC).
4. At the behaviour (TPB) stage, the non adopters have decided to adopt genetics/genomics 
into their practice and can be linked to the action stage (SOC). GOLs, adopters and 
OLWIGs who are already at this stage could have influence over those at the preparation 
(SOC) and decision (DOI) stage. OLWIGs, due to their interest in genetics/genomics could 
influence non adopters with their interest and ability to influence those around them. 
Adopters and GOLs could encourage and support non adopters with their 
genetic/genomic knowledge and interest.
5. The routinizing/confirmation stage (DOI) is the stage after an individual has adopted and 
they are confirming their decision and skills. Those GOLs and adopters who are at the 
confirmation/routinizing stage (DOI) could help to work with managers and educators to 
overcome the barriers (TPB) to the incorporation of genetics/genomics into practice.
The redefining/restructuring stage (DOI) is the time when the innovation is altered if 
needed, before going through another 'round' of gaining adopters. The adopters and 
GOLs could also help at this stage to inform the intervention 'team' on how they could
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improve the clarity (DOI), complexity (DOI) and compatibility (DOI) of the innovation in 
order to make the transition from non adopter to adopter smoother and more successful.
The above steps help to explain and clarify figure 8.9 (p277) and are linked to the numbered 
behaviour change steps (diamonds 1-5) on the figure. The Theory of Planned Behaviour runs 
across the diagram, as the core theory. The Diffusion of Innovation and Stage of Change theories 
are linked to each stage of the Theory of Planned Behaviour. The left hand 'column' shows the 
factors influencing an individual's behavioural intentions and the broad vertical arrows running 
from top to bottom along the diagram indicate all of the various theory areas and study findings 
associated with the behavioural stage. The various arrows throughout the diagram highlight how 
each behaviour change stage is linked to other behaviour stages, external factors and the 
individual groups identified in the study. Each component is colour coded for clarity (see the key 
below).













































































































































































































































































































































































































































































































































































































































































































































































































































































































8.9.1 Strategy: Key considerations
I think any strategy involving a large workforce (NHS nurses) and an area that is not yet positively 
accepted (i.e. genetics/genomics) will take time to be implemented; it will not be an overnight 
'revolution'. In the current study, 27.3% (n=24) of the participants were considered to have 
adopted genetics/genomics into their practice. The fundamental input that will drive the 
incorporation of genetics/genomics into practice will be the provision of genetic/genomic 
education for pre and post registration nurses. As mentioned previously, Green et al. (2011) 
state, that education is the key to providing nurses with the skills and knowledge they need to 
utilise genetics/genomics within their practice. Hence the idea of implementing 
genetics/genomics into nursing practice could be deemed unworkable if genetic/genomic 
education is not available to support nurses in the request coming from researchers and 
politicians to implement genetics/genomics more into their practice. The NMC has made very 
limited reference to genetics/genomics in the revised nursing education guidelines (NMC, 2010) 
despite the Government's White Paper report (2008) highlighting the need for more 
genetic/genomic education among the NHS workforce. More recently the need for greater 
genetic/genomic education among nurses was highlighted again in the Task and Finish Group 
Report into genetics in nursing and midwifery (2011) and was put forward in their list of 
recommendations following the NMC 2010 guidelines.
Time and a lack of local study sessions were some of the main barriers to incorporating 
genetics/genomics more into practice. If these barriers are not addressed, then again any 
strategy will be flawed because the barriers to nurses are unlikely to change. The time to attend 
local study sessions on genetics/genomics needs to be provided, however the NHS workforce is 
already stretched (RCN, 2011). Therefore a distinctive approach to this problem needs to be 
created. This could include in-house study sessions and seminars, with educators and adopters 
perhaps meeting with nurses in their working environment and highlighting the importance of 
genetics/genomics in their own workplace with them. A work-based learning approach, such as a 
'witnessing' and buddying system could also help to overcome the barrier of time and lack of 
study sessions and may be more effective in educating nurses about the role of 
genetics/genomics within their practice. Online learning technologies will also be an important 
and useful resource in the continually advancing technologic age in educating nurses in 
genetics/genomics.
As the NHS is a public organisation with national accountability, any strategy will be dependent on 
cost and ease. It would be useful to have people who are fully employed to engage nurses and 
identify participant groups throughout the country. However the costs of this would be
Page | 278
challenging in the current fiscal climate. Another useful strategy, would be to create a short but 
direct questionnaire based on the findings from the current study and survey on a large scale 
throughout the NHS nursing workforce. In order to target nurses, as they are qualifying and to 
identify future OLs and adopters from those nurses who might not have had the opportunity to 
adopt genetics/genomics, to support and encourage them as they begin their careers. This would 
mean that a whole new generation of nurses would be targeted for genetic/genomic adoption 
and to be genetic 'role models' very early on in their career before habits and assumptions are 
made. I do think that in order for genetics/genomics to be given the 'push' it requires, strategic 
leadership within the nursing workforce is a necessity. This could include more allocated 
researchers/nurse researchers or project officers to support any strategy that is created and 
implemented.
There are recommendations that have arisen following this study which could continue to guide 
the implementation of genetics/genomics into nursing practice. Identifying some of the 
characteristics of adopters, opinion leaders, GOLs and OLWIGs could allow for these groups to be 
targeted in the future. It needs to be stated that the questionnaire in the current study has been 
used only on oncology and practice nurses and should be further tested on other areas of nursing 
before being deemed to be generalisable. Although I believe that the characteristics of adopters 
and OLs will alter little between different nursing areas, this cannot be stated for definite. The 
use of these identifying characteristics will hopefully help to enable genetics/genomics to be 
utilised in practice at a 'local' level, through employment and engagement of these participant 
groups. It is hoped that these groups of nurses who have direct communication and interaction 
with nurses at practice level could highlight the importance and functionality of 
genetics/genomics within their practice.
Potential applications of the study findings are made below and summarised in Figure 8.10, 
showing a strategy for identifying adopters, opinion leaders and GOLs in various nursing settings. 
This strategy might be less effective in small departments as fewer GOLs, OLs and adopters would 
be expected. However, if this approach was to be implemented on a wider scale then these 
individuals could influence nurses across other departments. Adopters would need 
encouragement and information on how to encourage others in order to witness their genetic 
adoption to others. Opinion leaders would need to be given information and education on 
genetic/genomic awareness and its importance, as they could influence others but not necessarily 
know much about genetics/genomics. It would be useful if adopters and opinion leaders work 
together to promote genetic/genomic implementation. These recommendations can be 
summarised under the subheadings of education, practice and research as outlined below.
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Education
It will be important to provide educators with the knowledge, awareness and ability to provide 
genetic/genomic education to both post and pre-registration students. Directing education at 
pre-registration nursing students will be essential for providing a foundation for the integration of 
genetics/genomics into practice on qualifying. Directed and purposeful education for adopters, 
GOLs and OLWIGs will help to support and nurture these individuals in their roles as mentors and 
ambassadors within their practice environment. These individuals can then pass on their acquired 
knowledge and skills to those around them. It will be important to provide 'on the job' education 
for nurses, so they can not only witness the importance of genetic/genomic knowledge but also 
apply it to their specialism. This could include providing nurses with patient experiences and 
stories of nurses who have witnessed the consequences of a lack of genetic knowledge and how 
this affects patients. This approach could help nurses to engage in genetics/genomics within their 
nursing field and appreciate its relevance.
Practice
It will be important to utilise the identified adopters and GOLs through employing their skills and 
knowledge at ward level. The idea of a mentoring or 'buddying' system could be a valuable 
approach towards enabling nurses to obtain genetic knowledge and understanding, which is both 
relevant and applicable to practice. Implementing genetics/genomics into nursing practice needs 
to become an evolution, not a revolution, hence the importance of implementing 
genetics/genomics at a peer level. Whilst gaining the support and backing of department heads, 
executives and organisations like the NMC is important, the role of the adopters and GOLs at 
ward level should not be underestimated. This innovation is a long, slow process and one that I 
believe will be best tackled through a peer support system within practice settings.
Research
It will be important to apply the questionnaire used in this study to a wider group and larger 
population of nurses. This could include different nursing specialisms and different geographical 
locations. This would also help to strengthen the reliability and validity of the questionnaire on a 
larger scale. The utilisation of adopters and GOLs for the implementation of genetics/genomics 
into nursing is something that needs to be piloted, initially on a small scale and monitored for 
effectiveness and areas for improvement. Focus groups could be held with identified adopters 
and GOLs to ascertain more about their individual traits, perceived barriers and favoured 
approaches towards supporting them in their role of diffusing genetics into nursing practice.
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Potential application of the study findings
Below is an example of how the findings from the current study could be used on a wider scale to 
identify adopters, GOLs and OLs to increase the uptake of genetics/genomics in nursing practice. 
This example would be dependent on finances, time and the approach the project team wanted 
to take to implement genetics/genomics into nursing, i.e. some research teams might only want 
to identify GOLs whereas others might want to identify all four groups.
Considerations for the possible future application of the study tool
• A shorter questionnaire could be created based on the specific characteristics identified 
from the current study. This would allow for a direct and relatively quick and inexpensive 
approach of identifying adopters and GOLs.
• For future studies, it would need to be decided from what area of nursing or geographical 
area adopters and GOLs will be identified. Other areas of nursing, different from the ones 
studied in this research (practice and oncology) may need further exploration. The aim of 
future studies will also depend on what the strategy is, for example whether OLs will be 
used to help adopters influence those around them or whether adopters and GOLs are 
the only groups that want to be identified.
• It is recommended to try and identify as many genetic opinion leaders (GOLs) as possible 
in future studies as this would be the best group of nurses to utilise. However it is 
acknowledged that there are few GOLS, hence they may be difficult to identify.
• If considering using the current study's survey tool for identifying just opinion leaders, 
those with a higher grade and greater academic achievement should be considered first. 
Those who score highly when influencing others and score highly on the leadership scale 
would also then be included.
• If considering using the current study's survey tool for future studies, Openness to 
Experience can be used to identify opinion leaders, but caution needs to be taken in this 
area as adopters would have a higher Openness to Experience score than opinion leaders.
Scenario Limitations
The findings highlight the importance of creating and/or nurturing an environment in which GOLS 
and OLs can mature. This would include providing the right support for these individuals, with the 
right education and resources available. Due to probability of identifying small numbers of GOLs, 
education and leadership training needs to be implemented for adopters and OLWIGs, to 
overcome this barrier of limited GOLs. This would most likely need to include genetics/genomics 
education and awareness for OLWIGs, to allow them to become adopters, and leadership training 
for adopters to develop their influencing skills. This should also include opportunities for
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adopters, GOLs and OLs to be able to network together which might perhaps enable adopters and 
OLs to become GOLs in the future.
Barriers to adopting genetics/genomics into nursing practice have been identified in this current 
study. The main barriers to incorporating genetics/genomics into practice were the lack of time 
and that there were no local study sessions. However, the barriers may be unique for each work 
location, identifying these barriers and working with staff to overcome them may make adopters 
and others more willing to explore genetics/genomics within their practice. This will need to be 
approached differently depending on the type of nursing area and geographical area. People and 
the ability to convince others of an idea were identified by participants as facilitators that helped 
them to implement a new idea. Again these might differ depending on the types of participants 
but to identify these facilitators and to invest in them will help to make the implementation of 
new ideas accessible.
Figure 8.10 outlines the positive feedback loop that would be created through the use of 
adopters, GOLs and OLs. These groups would continually be producing more adopters of 
genetics/genomics through their ability to be role models, through the OLs' and GOLs' ability to 
influence others and the adopters and GOLs expertise in genetics/genomics. The new adopters, 
GOLs and OLs would also be continually feeding back to those who are non adopters, this change 
in the new adopters would be witnessed by the laggards. A critical mass of genetic adopters 
could be achieved quicker through the use of these groups due to peer pressure that would be 
exerted on laggards.
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Fig 8.10. Potential application for the use of adopters, OLs and GOLs in the implementation of 
genetics/genomics into nursing practice based on their characteristics
1. Based on the characteristics identified in this 
study, a short and specific questionnaire needs to 
be created to identify GOLs, adopters and OLs* 
The strategy also needs to include creating an 
environment in which adopters, OLs and GOLs can 
develop and flourish.
5. The strategy will be ongoing, 
with the non adopters and laggards 
probably needing different types of 
encouragement and material than 
early adopters
2. Each group has distinguishing 
characteristics that need to be 
identified in the participating group 
using the specific questions from the 
questionnaire**
4. Over time new adopters or people with a 
potential to be adopters could also be 
incorporated into the network and given 
different sources of information and 
education
3. Those individuals identified would 
then need some sort of training or 
material along with encouragement. 
They could then be used as the 
'genetic points of contact' for their 
area/department***
Key (*) for Figure 8.10
The questionnaire would need to be specific, short and just focusing on the personality traits of 
opinion leaders, adopters and GOLs. An overall scoring system could be created, however due to the 
small number of GOLs identified in this study, I would imagine that the GOLs could be identified quickly. 
This therefore could be an effective way of identifying those individuals who need to be utilised.
**However, I do not think that those respondents who do not necessarily fit into the identified groups 
should be ruled out. Additional qualitative work (i.e focus groups) may help to further identify 
adopters, GOLs and opinion leaders.
***This would include the opportunity to meet other GOLs, OLs and adopters and to build a community 
in their field. The identified individuals would need help, possibly including financial provision to help 
overcome barriers to genetics and to build on the facilitators available. I suggest the need for some sort 
of link person that identified individuals can utilise. The strategy also needs to co-ordinate with other 
health professional strategies because it is known that the expectations of others, including doctors, are 
important.
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The above strategy and ideas for the implementation of genetics/genomics into nursing practice, 
whilst helpful to consider and aim towards, needs to be given more clarity. There are other 
aspects of study that I feel need to be completed before a definite strategy can be presented. 
This future research includes the development of a shorter and specific questionnaire and use 
with a larger group of nurses and from specialisms other than practice and oncology nursing. I 
believe that more needs to be investigated around the role of emotional intelligence and 
genetic/genomic adoption, as this seems to play an important role in the level of perceived 
expectation from others and possibly on the level of adoption itself. I also propose that it would 
be useful to look into all aspects of the Big 5 personality areas and not just Openness to 
Experience to see what effect the other four personality traits have on the level of adoption of an 
individual. It would also be useful to explore other opinion leadership scales (e.g. Flynn et al. 
2006) for the identification of opinion leaders, to know whether different scales identify different 
characteristics. I think that without these areas of research being addressed further, a strategy 
can only be partly proposed.
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Chapter 9. Conclusion 
9.1 Key findings
Key research finding: Through this research, it has been identified that nurses can be 
categorised in terms of their relationship to genetics in their practice, such that those most 
likely to adopt genetics will demonstrate distinguishing characteristics. Being able to 
identify such groups then establishes a way to promote greater integration of genetics into 
nursing practice through application of the appropriate change theories.
I believe that all four aims of the study have been appropriately answered. The characteristics of 
adopters and opinion leaders have been identified, nurse adopters of genetics were identified, 
barriers and facilitators were articulated and potential applications of the study findings have 
been formulated. Whilst there are limitations in this study, they do not lessen the important 
characteristics of adopters and opinion leaders that have been identified.
Aim 1: Identify the characteristics of a nurse adopter of genetics/genomics through an expert 
consensus
An expert consensus identified the genetic indicators of nurse adopters, which were subsequently 
used to identify adopters. The four Genetic Indicators of Adoption (GIAs) were validated as being 
indicative of genetic adopters and in the subsequent survey all quantitative questions relating to 
the GIAs were significant between adopters and non adopters. There was minimal overlap 
between those who were adopters and also opinion leaders (GOLs), hence the GIAs helped to 
provide separation of the groupings. It is hoped that these indicators could be used to identify 
adopters and possibly opinion leaders in the future. However it needs to be recognised that the 
GIAs are indicators only and not competencies. GIAs do not capture the ethical practicalities of 
incorporating genetics/genomics into nursing practice.
Aim 2: Identify nurse adopters and opinion leaders of genetics/genomics
The four separate groups and their characteristics that have been identified through this study, 
(adopters, GOLs, opinion leaders and OLWIGs) provide the basis for future studies to further 
develop the characteristics and to test them on a wider population (both in terms of numbers but 
also nursing speciality). There are underlying characteristics that have been discussed in this 
research. For example, the concept of emotional intelligence and adoption will need further
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investigation, it has been highlighted as a possible characteristic after the identification of 
different traits led to this conclusion.
One of the key findings from the research was the difference between the participant groupings. 
The adopters, opinion leaders, GOLs and OLWIGs did not intersect much and as such the groups 
should be viewed individually and not treated in the same way. There were few characteristics 
that identified opinion leaders, the majority were either demographic or personality traits. There 
was very little genetic/genomic inclusion, whereas the adopter traits tended to involve knowledge 
and awareness of genetics/genomics. This is a positive finding for several reasons. It means that 
the groups can be easily individually identified within a large group. Also, as both groups have 
different positive traits these could be used to advance the characteristics of the other groups, so 
as not to rely on just one type of individual within a social setting. The adopters could be 
'buddied' with opinion leaders; one providing the genetics/genomics knowledge and interest, 
with the other providing the ability to influence peers.
Another key finding was the expectation that adopters felt from colleagues and doctors to use 
genetics/genomics more (to use genetic services and highlight possible genetic links) in their 
practice, something that other groups did not relate with. This sense of expectation, if captured 
and used in the right way could be aimed at opinion leaders and non adopters, to help them to 
feel a sense of pressure at being left behind in this area of their practice. This is an area which 
needs investigating further, including the possible explanation of emotional intelligence among 
adopters as mentioned in the discussion. The theory of locus of control and emotional projection 
also need more exploration in future studies. This was highlighted as a possible explanation for 
adopters feeling greater expectation from colleagues and doctors, but does need further research 
to be more conclusive. I do believe that the impact of social networks and the environment 
should not be overlooked and that more specific research into the impact of these two areas are a 
necessity in order to understand genetic/genomic adoption in nursing more thoroughly.
Aim 3: Identify the factors and processes that might facilitate or inhibit the adoption of 
genetics/genomics into nursing practice
Some factors that have inhibited the implementation of genetics/genomics into nursing practice 
and those that facilitate it have been identified. This is also linked to what stops non adopters 
from adopting. Potential applications of the study findings for the further implementation of 
genetics/genomics have been presented. Whilst meeting the aims of the research, certain 
findings have been more interesting and key than others when considering implementing 
genetics/genomics into nursing practice with the utilisation of adopters.
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There was a surprising lack of knowledge about genetic/genomic resources. I expected there to 
be more awareness among adopters of the resources available to them. Adopters said that one 
of the barriers to them incorporating more genetics/genomics into their practice was a lack of 
resources, however I think it was their lack of awareness of the resources that was a barrier, not 
the physical lack of resources. Many participants were unaware of the resources available via 
Telling Stories, Understanding Real Life Genetics website and the NHS National Genetics 
Education and Development Centre for example. Promoting these resources and making them 
more known could be a relatively straight-forward and practical way of helping both adopters to 
incorporate more genetics/genomics into their practice and to help non adopters become aware 
of the importance of genetics/genomics. More does need to be done to help nurses to identify 
the resources that are already available to help them in their practice.
Aim 4: Apply knowledge and understanding about the identified groups gained through the study 
to the three behaviour change theories in order to formulate potential applications for how the 
characteristics of those individuals who are adopting genetics/genomics could help inform the 
strategies of other societies and organisations seeking to engage nurses (and other health 
professionals) in genomic healthcare.
Each of the three theories discussed in Chapter 5 of the thesis has a role to play in future 
genetic/genomic implementation strategies. The Diffusion of Innovations theory, the Stages of 
Change theory and the Theory of Planned Behaviour all bring different perspectives to inform 
strategies when considering the implementation of genetics/genomics in nursing practice. The 
adopters, GOLs and OLs all have different areas of influence depending on the theory being 
utilised. When the theories are all put together (Fig 8.9, Chapter 8, p277), the three groups play 
an important role in the attitude towards the innovation, the intention that those around them 
have to adopt genetics/genomics and the way the behaviour is eventually adopted. Each group 
has a seemingly different way that they can promote the incorporation of genetics/genomics into 
nursing practice. For adopters it appears to be the ability to 'get along side' their colleagues in 
the department and 'witness' the use and benefits of genetics/genomics to them. For OLs it is the 
possibility of teaming up with adopters to have a level of influence over colleagues (this might 
require a level of adoption of genetics/genomics on their part) and for GOLs it is that ability to 
combine their knowledge and interest in genetics/genomics with the ability to have influence 
over others and lead change in practice. I hope that the characteristics and other information 
gained from this project will go a long way in aiding the incorporation of genetics/genomics into 




Throughout completing the PhD, I have learnt much about the research process and how to 
complete research to a good standard, this is something that has improved consistently over time. 
There were a few aspects of the research process that I was not expecting. The length of time 
taken to complete various stages of the research, such as questionnaire design and data collection 
has surprised me as well as the difficulties of completing research within the NHS. I believed that 
the NHS approvals process would be centralised, but quickly learnt that this was not the case. 
Writing the questionnaire did prove demanding, I learnt about how questions can easily be 
misinterpreted by others and appreciated the role of piloting for overcoming these problems. 
Including the right questions which would provide useful data, but which were also easy to 
complete and understand, took longer than I imagined but realised that this is an important 
process as it is the crux of the research. I found the process of contacting and engaging 
participants challenging. It is always hoped that others will support the research that you are 
undertaking by helping you gain contacts. Using reminders and well known contacts did help to 
overcome the challenges and made me aware of ways to encourage participation.
If I could continue and complete a post doctoral study it would be helpful to take these findings 
forward. This could be done in different ways, some of which are discussed below in the next 
section. The characteristics of adopters, opinion leaders, GOLs and OLWIGs could be further 
identified in other areas of nursing or even other healthcare professionals. However, as 
genetics/genomics within nursing has been highlighted as being of importance and this research 
has been focused in that direction it would be prudent to continue in this area and seek new ways 
of implementing genetics/genomics into nursing practice using the identified characteristics. 
Some of the ways that this research could be furthered are discussed below. One of the most 
important possible next steps would be to liaise with known adopters and opinion leaders and to 
continually encourage them with the progress they are making. This could involve creating some 
sort of long term project or a working group but with nurse adopters, which could be interesting. 
Finding a process to continue and increase genetic/genomic education will be essential to help 
both adopters and opinion leaders and to acquire new adopters.
9.3 Future steps
Some key areas of the research need to be investigated further to gain a more comprehensive 
understanding of adoption of genetics/genomics into nursing practice. It would be useful to 
investigate a greater number of personality traits among the participant groups, including the full 
range of the five factor model of personality created by McCrae (1987). The Openness to 
Experience trait was used in this study without the other four traits (neuroticism, extraversion.
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agreeableness, conscientiousness), two traits in particular, extraversion and conscientiousness 
need further exploration in relation to the adoption of genetics/genomics. It would also be useful 
to see if a full personality profile could be built of individuals, which would make identification on 
a larger scale quicker and the insights gained might help inform the optimum environment to 
promote engagement amongst later adopters. As mentioned in the previous chapter, there are 
areas that have been loosely connected with the findings but need further exploration. 
Preliminary indication that Emotional Intelligence is a trait found in adopters has been discussed 
(Chapter 8, Section 8.1.2, p225) and further analysis is needed to confirm this hypothesis. It 
would be of interest to use the four branches of El to see if they are significant identifying traits of 
nurses who have adopted genetic/genomics into practice. The level of expectation felt by 
adopters from colleagues and doctors (Chapter 8, Section 8.2.1, p230) also needs further 
consideration. I have presented three possible explanations for this finding: 1) competition 
between nursing staff; 2) actual pressure from doctors and colleagues, and 3) projection of 
pressure being exerted by adopters themselves. However, all three need further research in 
order to understand the cause of this expectation on adopters.
Other areas needing further investigation
It has been identified by Sandstrom et al (2011) that the structure of an organisation also affects 
the implementation process. It would be useful to address this further as different NHS 
authorities may have varying policies, processes and staffing structures. Although we assume that 
different NHS trusts have similar procedures and structures, the varying characteristics of people 
in charge may well alter processes which could affect implementation of genetics/genomics on a 
larger scale. Similarly the organisational structure within a ward and department is likely to have 
an effect on diffusion of a new idea which again could come down to the characteristics of those 
in charge. It would be useful to identify various organisational structures, to gain greater 
knowledge on what structure is the most efficient and supportive of new ideas and how to target 
those which are not.
Various environmental and social factors may affect nurses' ability to utilise genetics/genomics 
within their practice and it would be useful to identify these. These different factors may vary 
between locations, but includes societal aspects such as financial constraints, support from senior 
staff and the social norms within a particular environment, which may in turn make the diffusion 
of genetics/genomics either easier or harder. Identifying the specific factors which contribute to 
the diffusion process could help those departments which are struggling to implement 
genetics/genomics to understand why they are struggling and how they overcome this. It may be 
that certain factors such as finance may play a role in diffusion, but will not be easily overcome.
Page | 289
The scoring system created for the purpose of the current study was not intended to identify 
various stages of adopters (i.e. early adopters and laggards). However, it would be useful to 
identify the different types of adopters in future studies, so that each different group could be 
utilised in a different way. This method would also increase the possible number of adopters 
within a given geographical area. This might also help future researchers to clearly identify those 
nurses who are very resistant to genetics/genomics and are clearly non adopters, which would 
help to understand what it is about these individuals that make them not want to incorporate 
genetics/genomics.
If genetics/genomics is going to be implemented into nursing practice on a wide scale, this will 
include areas of nursing other than practice nursing and oncology nursing. It will important to 
take the characteristics identified here and apply them to other areas of nursing to identify 
whether the characteristics change among nursing branches and specialisms. The characteristics 
may change depending on the role of the nurse in that branch, patient interaction and the 
responsibility that the nurse has for the patients. It could be argued that it would be unlikely for 
the personality traits among the groups to change between nursing specialisms, but the 
willingness to learn more about genetics/genomics, knowledge on resources and undertaking of 
the GIAs may change. Therefore it cannot be said that the characteristics identified in this study 
can be generalised to other areas of nursing without more research being undertaken. However 
they do provide an indication of possible outcomes and form a basis for comparison. Ethical 
practice is also important and something that has not been investigated in this study. However 
the incorporation of genetics/genomics into nursing practice may create ethical aspects to a 
nurse's practice that have not been previously considered. It will be equally as important to 
educate nurses on the role that ethics plays in genetic/genomic healthcare.
It is believed from this study that nurses currently do not have the pressure or compulsion to start 
using genetics/genomics in their practice, due to the lack of support from organisations such as 
the NMC. However I believe that there will come a time in the near future when nurses will not 
have a choice as to whether they incorporate genetics/genomics. National screening 
programmes, including those for genetic diseases are being utilised on a much wider scale, with 
more screening options becoming available. This only serves to reinforce the fact that 
genetics/genomics in healthcare is not going to decrease, but as medicine moves forward, will 
become more prevalent in the healthcare received by patients. Implementing genetics/genomics 
into nursing practice is a substantial undertaking but one that is improving slowly. This research is 
a step in a bigger process of creating a nursing workforce who are engaged and utilising 
genetics/genomics for the benefit of patient care.
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It's the year 2020, Esme is a second year student nurse working on a general surgical 
ward. She is being mentored by a known and identified nurse genetic adopter, Lois. Lois is 
known in her department as being someone who is interested in genetics/genomics, would 
like to increase her application in practice and is currently taking an online course about 
genetics for healthcare professionals. Esme notices that Lois will ask patients about their 
family history upon admission. At one particular patient admission, the patient mentions 
that her mother died quite young from colon cancer and her sister has been treated for 
stomach cancer. Lois asks her further questions about the prevalence of cancer and 
discovers that the patient's cousin died of endometrial cancer. With the permission of the 
patient, Lois contacts her local Regional Genetic Centre for advice and the genetic 
counsellor associated with her practice area. She also informs the clinicians treating the 
patient. Esme is told by Lois that the family history information she has just heard must be 
kept confidential to protect other family members. Esme is impacted by Lois' actions and 
tells her fellow students about what she has witnessed and how important taking and 
being aware of family history is in the role of a nurse. As a result of witnessing Lois' 
application of genetics/genomics in practice, Esme starts to seek more information about 
it and upon graduation also becomes known as a genetic nurse adopter in her career.
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Appendix 2. Additional Literature review details
Genetics, genomics. society and health - Different nursing branches and their roles
Nursing branch Nursing role
Adult Nursing Adult nurses provide care for all patients over the age of 18 with varying health issues 
(NMC, 2010; NHS Careers, 2010). These nurses can be based within a hospital, in the 
community or in people's homes. Adult nurses can also specialise and work in prisons, 
in the military and other specialist services. Their roles include looking after patients 
with life threatening illnesses, intensive care post surgery and heart attacks and provide 
psychosocial support to patients and their families (NMC, 2010). Long term nursing 
support is also required for many patients as well as palliative care.
Children's 
Nursing
Paediatric nurses provide care for children and adolescents of all ages. They care for 
sick children but also protect them from abuse or neglect, champion children's right 
and education the child and their family about their healthcare needs. Children's 
nurses work in the child's home, hospitals, day care centres and health clinics. They 
also have an insight into the physical and mental concerns of children and young people 





Learning disability nurses care for people of all ages with various physical and mental 
health conditions. These nurses work in care homes, patient homes and family homes. 
Their role includes helping patients with independent living such as finding a job, 
personal hygiene and using public transport. Learning disability nurses promote the 
patients' rights, autonomy, choices and social inclusion. These nurses can specialise in 




Mental health nurses care for patients of all age, with or at risk of mental health 
problems, which include neuroses, psychoses, psychological and personality disorders. 
These nurses work in hospitals, day services and patients homes and workplaces. Their 
role includes offering specific interventions, for example, psychological therapies, 
family therapies and group interventions. They uphold their patients' rights, are 
involved in patient detainment and provide support to patients' family and friends 
(NMC, 2010; ProNurse, 2010). Mental health nursing is recognised as having a breadth 
of roles, they have generic capabilities and need to be versatile (Hurley, 2009).
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Nursing Competencies in Genetics/Genomics 2010 (Kirk et al 2011b)
1. Identify clients who might benefit from genetic services and/or information through a 
comprehensive nursing assessment:
• that recognises the importance of family history in assessing predisposition to disease, and
• recognises the key indicators of a potential genetic condition,
• taking appropriate action to seek assistance from and refer to genetics specialists and peer 
support resources,
• based on an understanding of the patient pathways that incorporate genetics services and 
information.
2. Demonstrate the importance of sensitivity in tailoring genetic information and services to 
clients' culture, knowledge, language ability and developmental stage:
• recognising that ethnicity, culture, religion, ethical perspectives and developmental stage may 
influence the clients' 
ability to utilise these.
3. Advocate for the rights of all clients to informed decision making and voluntary action:
• based on an awareness of the potential for misuse of human genetic information and
• understanding the importance of delivering genetic education and counselling fairly, accurately 
and without coercion or personal bias,
• recognising that personal values and beliefs of self and client may influence the care and 
support provided during decision-making.
4. Demonstrate a knowledge and understanding of the role of genetic/genomic and other 
factors in maintaining health and in the manifestation, modification and prevention of disease 
expression, to underpin effective practice.
5. Apply knowledge and understanding of the utility and limitations of genetic testing and 
information to underpin care and support for individuals and families prior to, during and 
following decision-making, that incorporates:
• awareness of the ethical, legal and social issues related to testing and recording of genetic 
information,
• awareness of the potential physical, psychological and social consequences of genetic 
information for individuals, family members, and communities.
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6. Examine one's own competency of practice on a regular basis in order to:
• recognise areas where professional development related to genetics/genomics would be 
beneficial,
• maintain awareness of clinical developments in genetics/genomics that are likely to be of most 
relevance to the client group, and
• based on an understanding of the boundaries of one's professional role in the referral, provision 
or follow-up to genetics services.
7. Obtain and communicate credible, current information about genetics, for self, clients and 
colleagues:
• using information technologies and other information sources effectively to do so, and
• applying critical appraisal skills to assess the quality of information accessed.
8. Provide ongoing nursing care and support to patients, carers and families with genetic 
Healthcare needs:
• being responsive to changing needs through the lifestages,
• demonstrating awareness about how an inherited condition, and its implications for family 
members, might impact on family dynamics,
• working in partnership with patients, carers, family members and other agencies in the 
management of conditions,
• recognising the expertise of patients and carers with enduring genetic healthcare needs that 
develops over time and with experience.
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Diffusion of Innovation- Stages of diffusion
The diffusion of an innovation goes through five stages (Rogers, 2003);
1. Knowledge
Individuals will often seek out knowledge in something they are already interested in and often go 
through the process of selective perception where they interpret messages about the innovation 
based on their existing attitudes and beliefs. If an individual has knowledge that the innovation 
exists they are more likely to learn more about it and eventually adopt it (Rogers, 2003). Those 
who know about the innovation first are often highly educated, have higher social status, are 
more exposed to interpersonal channels and the mass media, more cosmopolitan and participate 
in society more than late knowers of an innovation (Rogers, 2003).
2. Persuasion
An individual at this stage seeks information about the innovation, decides what messages they 
think are credible and then decides how to interpret that information (Rogers, 2003). Individuals 
often want to know if their thinking around the innovation is on the "same track" as their peers. 
Rogers (2003) makes it clear that an individual's attitude towards an innovation does not always 
directly correspond with whether they chose to adopt or reject an innovation.
3. Decision
This stage is when an individual involves themselves in activities that lead to a decision to either 
accept or reject an innovation. Most people will trial the innovation before adopting it to see how 
useful it will be in their situation. It has been found that if the innovation is demonstrated it can 
speed up the decision making process; it can be helpful if the demonstrator is an opinion leader 
(Rogers, 2003). Often individuals have a 'threshold for adoption', which occurs when an 
individual will adopt an innovation due to knowing that a minimum number of other individuals in 
their communication network have adopted and are satisfied with the innovation (Rogers, 2003). 
At this stage there are two types of rejection:
a. Active rejection - an individual thinks about adopting the innovation and then decides
against it 
b. Passive rejection - an individual has never really thought about using the innovation
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4. Implementation
The implementation stage is when an innovation is put to use, this can occur for a long period of 
time, depending in what type of innovation is being implemented (Rogers, 2003).
5. Confirmation
An individual at this stage searches for reinforcement for the decision they have made to adopt 
the innovation, this may lead to the decision being reversed and the innovation being rejected 
(Rogers 2003), this is known as discontinuance. There are two types of discontinuance:
a. Replace discontinuance - an individual rejects the innovation for a better one e.g. email
has replaced postal mail 
b. Disenchantment discontinuance - an individual rejects the innovation because they are
dissatisfied with it
Diffusion of Innovations - Characteristics of Innovators
(see figure 5.5 p85 for a pictorial representation of this text)
a. Innovators are among the top 2.5% of the population who will be the first to adopt an 
innovation. Innovators have a shorter innovation decision period because they make use of 
technically accurate sources and channels about the innovation and place higher credibility 
in these sources. According to Rogers (2003) innovators may possess a type of mentality 
that enables them to cope with uncertainty and complex technical knowledge. 
"Venturesomeness" is a high priority for innovators and they must be able to accept 
occasional setbacks as not all ideas prove successful (Rogers, 2003). Innovators adopt an 
innovation due to curiosity and a need to want to try new things out, early adopters tend to 
adopt an innovation due to its advantages (Dearing, 2009).
b. The opinion leaders of society are known as early adopters account for the next 13.5%. The 
early adopters are those individuals who others go to check an idea with before they adopt 
it (Rogers, 2003). If early adopters have adopted an innovation then it is the "green light" 
for others in the social system to adopt the innovation, their approval is the main step 
forward in adoption of an innovation.
c. The next 34% are the early majority who tend to be 'deliberate followers'. These 
individuals adopt an idea just before the average individual of a system adopts and they are 
an important link within interpersonal networks for the diffusion process (Rogers, 2003).
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The early and late majority are influenced by the testimonies of those who have already 
adopted (Lovejoy et al, 2009).
d. The late majority innovators make up 34% of the population and tend to be sceptical of 
change, however through peer pressure they often yield. In order for the late majority to 
adopt, the innovation must conform with the social norms of a system, otherwise they are 
not convinced (Rogers, 2003). Norms are defined as behaviour patterns that are established 
throughout the social system, they provide a guide for acceptable behaviour of individuals 
within the social system, and these can be a barrier to innovations if they prevent change 
(Rogers, 2003). Any uncertainty still remaining around the innovation will discourage a late 
majority individual from adopting.
e. The last 16% are the laggards who are the last in a population to adopt an innovation and 
require a long decision making process to reach a decision to adopt an innovation (Rogers, 
2003). These individuals are often suspicious to change and constantly compare the new 
innovations to past ideas (Rogers, 2003). Laggards tend to adopt the innovation in order to 
keep with others around them who have already adopted (Lovejoy et al, 2009).
Diffusion of Innovations within Organisations
The Five stages of the innovation process are as follows (Rogers, 2003):
1. Agenda-setting - a general organisational problem creates a perceived need for an 
innovation, these are prioritised into importance. This stage involves identifying and 
prioritising needs and problems, searching the organisations environment to locate 
innovations of usefulness to meet the organisations problems (Rogers, 2003). This stage 
can take several years. Within this stage, a 'performance gap' can occur which is defined 
as 'a discrepancy between an organisations expectations and its actual performance' 
(Rogers, 2003, p 422), a performance gap can be enough to trigger the innovation 
process.
2. Matching - an organisations problem is matched against an appropriate innovation, 
ongoing processes can then be matched and designed. This stage is the main hurdle 
between initiation and implementation (Rogers, 2003).
3. Redefining/Restructuring - the innovation becomes implemented into the organisation 
and is no longer such a 'foreign character'. The innovation is restructured to suit the 
needs of the particular organisation, the organisations structure can also be modified to 
fit in with the innovation, both these changes usually occur during the innovation process
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within an organisation (Rogers, 2003). The change to an organisation or innovation can 
be so radical that it is called a 'Radical innovation', a new paradigm is then created for the 
organisation and can create a whole new industry.
4. Clarifying - the innovation is used more widely throughout the organisation, the meaning 
of the new idea becomes clearer to members of the organisation (Rogers, 2003).
5. Routinizing - an innovation has become incorporated into the organisation on a routine 
basis; it no longer has a separate identity. The innovation process is now considered 
complete, however discontinuance can still occur at this stage (Rogers, 2003).
Stages of change- The stages
a. Precontemplation
In the first stage an individual has no intention of changing their behaviour, they may wish to 
change, but this is very different from seriously considering change. Often at this stage, 
individuals are unaware of their need to change their behaviour, even if others around them can 
recognise the need (Prochaska and Norcross, 2001). The individual may also be uninformed about 
the consequences of a behaviour change or of the behaviour they are currently demonstrating, 
this could be the reason why they are still at this stage (Prochaska, 2008). Often at this stage, 
those people who seek information often do so under pressure from others (Norcross and 
Prochaska, 2002). A statement made from people in precontemplation stage may be: 'I guess I 
have faults, but there's nothing that I really need to change' (Norcross and Prochaska, 2002). For 
example in psychotherapy a therapists role at this stage of the behaviour change process is one of 
a nurturing parent joining with a resistant youngster who is both drawn to and repelled by the 
thought of becoming more independent (Prochaska and Prochaska, 2001).
Many people feel safe in this stage because they cannot fail here. Friends, family members and 
colleagues can help at this stage through observation and sometimes confrontation. Often a life 
event e.g. big birthday, birth of a child or a visit to the doctor can all spur an individual on towards 
recognising they need to change (Prochaska, 1996). It is important not to suggest behaviour 
activities to people at this stage, they should not feel pressurised into taking action too soon 
(Jordan and Nigg, 2002). In terms of genetics within nursing, nurses' at this stage will not see the 
relevance of genetics and will not think that they need to change their behaviour. It may be that 




"One of the most powerful forces in human behaviour is self-fulfilling prophecy. If a person 
believes something strongly enough and that something is within the realm of possibility, they will 
do everything in their power to make sure it comes true" M. Samuelson (1998)
Individuals become aware that they have a problem and have considered overcoming it, but they 
have not committed themselves to take action (Prochaska and Norcross, 2001). Individuals can 
often become 'stuck' in this stage for a long time (Prochaska and Norcross, 2001., Norcross and 
Prochaska, 2002), possibly due to individuals 'waiting for the magic moment', wishful thinking and 
the search for absolute certainty (Prochaska, 1996). However those who are seriously thinking 
about changing their behaviour in the coming six months are named contemplators, although 
how one measures this is not mentioned. A typical statement is 'I've been thinking that I might 
want to change something about myself (Norcross and Prochaska, 2002). A therapists at this 
stage would be acting as a teacher to their client in terms of encouraging the client to understand 
the insights into their own condition (Prochaska and Prochaska, 2001).
Emotional arousal, such as seeing the negatives of their behaviour and experiencing a social 
setting which includes the new form of behaviour e.g. a smoker sitting in the non-smoking section 
of the restaurant before a smoking ban can all encourage the individual to think about changing 
(Prochaska, 1996). Jordan and Nigg (2002) believe that it is important to provide as much 
information as possible to contemplators to assist them in making the right decision. Nurses at 
this stage will see the importance/relevance of genetics but will not have decided to adopt it. 
Nurses being made aware of the impact of genetics on some patients' lives and what can happen 
when they do not include genetics within their care could help.
c. Preparation
At this stage, individuals are prepared to take action in the next month and have unsuccessfully 
taken action in the last year (Prochaska and Norcross, 2001). People at this stage have generally 
taken some action within the preceding year and often has a plan of action (Prochaska, 2008). 
They often start thinking about the pros of the new behaviour rather than the cons (Prochaska, 
1996). At this stage, stimulus control is important in encouraging people to take small steps 
towards behaviour change (Jordan and Nigg, 2002). A therapist at this stage would be like an 
experienced coach to their client who can help the client to review their own plan (Prochaska and 
Prochaska, 2001). Nurses would be planning to start adopting genetics into their practice and will 
be feeling more positive about it.
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d. Action
Individuals try and change their behaviour, environment and experiences. Individuals are placed 
in this stage if they have successfully altered their behaviour for between one day to six months 
(Prochaska and Norcross, 2001). A common statement from someone in the action phase 'I am 
really working hard to change' (Norcross and Prochaska, 2002). This is the stage that is most 
visible to others and the individual should reward themselves (known as countering). It could be 
argued that this phase is the most documented and studied because it is the most visible. Having 
people around the individual who are supporting their changes will also help them with 
motivation (Prochaska, 1996). Jordan and Nigg (2002) believe that people at this stage often 
relapse because of the difficulty of maintaining the behaviour change as well as voices in their 
heads telling them to give up. Nurses will try and adopt genetics into their practice. Opinion 
leaders and adopters will need to encourage and help individuals, some will relapse and stop the 
behaviour.
e. Maintenance
"With behaviour change, there is no such thing as failure. Change occurs on a continuum; 
sometimes we leap, sometimes we crawl and sometimes we slip back but as long as we 
contemplate (visualise) positive change...it will occur!" M. Samuelson (1998)
People who have altered their behaviour are at the stage where they are trying to maintain this 
change. It terms of addictive behaviour, Prochaska and Norcross (2001) define it as 'working to 
prevent a relapse'. At these last two stages the therapist beomces a consultant figure to their 
client, someone who can provide support and advice when needed (Prochaska and Prochaska, 
2001).
In terms of changing nursing genetic behaviour, the maintenance stage could be seen as a nurse 
who has continued to use genetics within her practice and has not 'put it to one side' or stopped 
using genetics. This stage can last six months to a lifetime, countering, helpful relationships and 
commitment can all help the individual to continue with the maintenance stage (Prochaska, 
1996). Self-efficacy increases linearly from precontemplation stage to the maintenance stage 
(Jordan and Nigg, 2002).
f. Termination
People in this stage are now comfortable with their behaviour change and no longer have to work 
to maintain their behaviour change (Prochaska and Norcross, 2001). Some experts believed that 
termination is never reached, but that maintenance becomes less strict over time (Prochaska,
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1996). Nurses will not terminate using genetics in practice but it may become an automatic part 
of their role.
Theory of Planned Behaviour - Salient beliefs
So called 'salient beliefs' are considered to be determinants of an individual's intentions and 
actions. These beliefs help to understand the factors that enable one person to engage in the 
behaviour and another to choose another course of action (Ajzen, 1991) (Fig 13).
• Behavioural beliefs, these influence attitudes towards the behaviour,
• Normative beliefs, are linked to whether important individuals or groups would 
approve/disapprove of a particular behaviour. It has been said that people who are 
motivated to engage in behaviours that are identity related, do so to endorse a person's self 
identity (Terry et al, 1999). The extent to which group membership is important to an 
individual also affects the norm. When the group support the behaviour, the self-identity and 
strength of the norm relationship is stronger (Terry et al, 1999). There are two types of norms 
(Manning, 2009):
a. Injective norms - pressure to engage in behaviour based on the perception of what 
others want you to do
b. Descriptive norms - pressures to engage in behaviour based on the observed or inferred 
behaviour of others
Manning (2009) found that behaviour related to descriptive norm was stronger than the relation 
between behaviour and injective norms. Descriptive norm behaviour was also statistically 
significant whereas injective norm behaviour was not significant. Descriptive norms therefore will 
have the strongest influence when encouraging an individual to act in line with perceived norms 
(Manning, 2009). It will be important to remember that nurses' inferred and observed behaviour 
will have an impact on other nurses. Staff managers will need to be aware of their actions and 
unconscious attitudes. Descriptive norms often have a stronger impact on behaviour when the 
behaviour fulfils a short term need or is pleasurable compared to behaviour that is more thought 
out and has a useful function (Manning, 2009). In relation to genetics within nursing, it might well 
be that injective norms have more of an affect because the nature of the behaviour is academic, 
useful and well considered.
• Control beliefs are the basis for perceptions of behavioural control (Ajzen, 1991). Control
beliefs will also be influenced by information about the behaviour passed on from family and
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friends regarding their experience of the behaviour. These can have a positive or negative 
impact on the uptake of behaviour change by an individual. The greater the resources and 
opportunities an individual believes they have, and the fewer obstacles they anticipate then 
the greater their perceived control over the behaviour (Ajzen, 1991). An equation has been 
created to calculate the probability that the behaviour will produce the required outcome:
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Appendix 3. Phase 1 Sample Size Calculation
Sample size calculation:
Found at: http://www. survevsvstem.com/sample-size-formula.htm
C2
Ss = Sample size
Z = Z value = 1 .96 for a 95% confidence level
P = Percentage picking a choice, expressed as a decimal. 50% response distribution = 0.5
C = Confidence interval, expressed as a decimal. Margin of error of 5% = 0.05
Therefore:
Ss = 1.962 x(0.5')xri-0.5') Ss = 3.84x0.5x0.5 
0.052 0.0025
Ss = 3.84x0.5x0.5 Ss = 0.96 
0.0025 0.0025
Ss = 384
As a finite population is being sample an additional sample size needs to be calculated:
New ss = ss
1 +SS-1
Pop
Ss = Sample size, calculated above to be 384 
Pop = Population number, total population is 300* 
Therefore:
Newss= 384 Newss= 384
1 + (384-1) 1 + 383
310 310
Newss= 384 Newss = 384 
1+ 1.235 2.235
Newss= 171.8 
New ss = 172
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Appendix 4. Expert questionnaire (Phase 1)
Pagel
Welcome
First of all thank you for coming to the website to participate in this study.
I am looking at identifying the predicting factors of nurses most likely to adopt genetics into practice. I am 
conducting this research because I feel it is important to identify nurse adopters of genetics. It is hoped 
from this research that a model can be created to promote genetics within nursing and to increase the 
number of nurses who are adopters of genetics. This will in turn play an important role in the approach to 
implementing genetics into NHS nursing practice. This initial phase of the research is to understand the 
term 'an adopter of genetics' and to be able to link certain behaviours and activities to this term through 
experts in the field of genetics and nursing. When talking about genetics, I am referring to genetics and 
genomics. 
The research is being conducted by Verity Leach, a PhD student at the University of Glamorgan .
What happens next?
The questionnaire will take you approximately 15 minutes to complete. It contains both tick boxes and open 
questions. The questionnaire is split into 3 sections defined by topic questions.
By completing this questionnaire, you are agreeing to participate in this research. You can withdraw at any 
time before submitting the questionnaire.
Confidentiality
All information provided by you will be kept confidential and treated in accordance with the Data 
Protection Act. No specific details will be obtained however for you r own privacy, you may want to clear 
your browser history after completing the questionnaire.
When information from this research project is submitted for assessment and publication, no personal 
information to identify any participants will be available. Any information provided in open questions, 
which is personally identifiable, will be subject to change in subsequent publications to preserve anonymity.
Full ethical approval has been obtained through the University of Glamorgan (this project did not need 
NRES ethical approval).
Should you want more information, contact: 




Section 1: Background Information
This section contains details about you and is helpful to find out about the respondents who complete this 
questionnaire.
1. Are you a practising Genetic Counsellor?
r r
Yes No
2. Are you from a nursing background?
r r
Yes No
3. Are you a practising genetic nurse?
r r
Yes No
4. Please indicate how long you have worked in genetic services.












Scenario: You are observing nurses at work; for example this could be in a hospital or community setting. 
You are asked to identify whether the nurses have adopted genetics into their practice. E.g. The nurse 
phones the local genetic counsellor to discuss a patient who he/she thinks may benefit from a referral.
5. What behaviours or activities would you be looking for, that would define a nurse as having incorporated 
genetics into their practice?
Please note we are not asking you to define nursing competencies.
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Section 3
This section asks questions relating to your opinion and experience of genetics within nursing.
We have identified four minimum activities and behaviours that we think nurses could be demonstrating in 
order to be considered adopters of genetics and would like your thoughts on this list. They are generalised 
because we want to identify all nurse adopters of genetics.
The four activities and behaviours are as follows:
a. To know how to access genetic services and would make active use of them
b. To be able to provide information of support services to patients or their families with or at risk of a
genetic condition
c. To ask patients' relevant question's about their family history
d. To be open to the possibility of genetics in all aspects of care
The following section asks questions based on each behaviour or activity.
a. To know how to access genetic services and would make active use of them
6. Would you expect all nursing staff to be able to satisfactorily undertake the behaviour above?
err
Yes No Unsure
7. If a nurse identifies herself/himself as having demonstrated this behaviour, would you say she/he had 










8. Would you say this activity should be included as one of the requirements needed for a nurse to have 
adopted genetics into practice?
r r r
Yes No Unsure
If you answered no, please explain.——————————————————
_iLJ .if
b. To be able to provide information of support services to patients or their families with or at risk of a 
genetic condition
9. Would you expect all nursing staff to be able to satisfactorily undertake the activity above?
r r r
Yes No Unsure
10. If a nurse identifies herself/himself as having undertaken the above activity, would you say she/he had 









11. Would you say this task should be included as one of the requirements needed for a nurse to have 
adopted genetics into practice?
r r r
Yes No Unsure
If you answered no, please explain.
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c. To ask patients relevant questions about their family health history
12. Would you expect all nursing staff to be able to satisfactorily undertake the activity above?
err
Yes No Unsure
13. If a nurse identifies herself/himself as having undertaken this activity, would you say she/he had 









14. Would you say this activity should be included as one of the requirements needed for a nurse to have 
adopted genetics into practice?
r r r
Yes No Unsure
If you answered no, please explain.
d. To be open to the possibility of genetics in all aspects of care
15. Would you expect all nursing staff to be able to satisfactorily undertake the behaviour above?
r r r
Yes No Unsure
16. If a nurse identifies herself/himself as having demonstrated this behaviour, would you say she/he had 










17. Would you say this behaviour should be included as one of the requirements needed for a nurse to 
have adopted genetics into practice?
c r c
Yes No Unsure
If you answered no, please explain.
18. As a reminder the 4 activities and behaviours under consideration are:
a. To know how to access genetic services and would make active use of them
b. To be able to provide information of support services to patients or their families with or at risk of a
genetic condition
c. To ask patients relevant questions about their family health history
d. To be open to the possibility of genetics in all aspects of care
Do you think all 4 activities and behaviours apply across all nursing groups?
r r
Yes No
If no, please specify.
A
LiLJ




If you answered no, please explain.
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20. Do you think there are any other activities and behaviours, that we have missed or that you did not 
include in your answer to the scenario, that would indicate that he/she has adopted genetics into their 
practice at a basic level? Please comment.
Pages
Section 4
Various barriers and facilitators towards nurses incorporating genetics into practice were identified through 
the International Society of Nursing in Genetics.
21. Barriers
To what extent do you agree/disagree that the statements below represent barriers.(Please select one 
option for each barrier, a-i.)For example, if you believe that 'nurses think genetics and genomics is not 
relevant' is a barrier then please choose strongly agree.
a. Nurses think genetics and
genomics is not relevant
b. Nurses don't know about genetics
and genomics
c. Nurses think there is a lack of
support from colleagues






























e. The relevance of genetics and
genomics is not explicit to nurses
f. Nurses are afraid of genetics and
genomics
g. Nurses have time constraints
h. Nurses believe the resources are
not appropriate
i. Nurses think that genetics and
genomics is not important
j. There is a lack of genetic and
genomic role models for nurses
k. Nurses have no experience of
patients asking about genetics and
genomics
1. Nurses experience resistance to











































Please rank the following facilitators (a-g) from 1 to 7, based on their level of importance. Please use each 
option only once. (1 = highest level of importance, 8 = lowest level of importance) For example, if you
education' is the facilitator of highest importance then
n idL iudLuib \ £ nu j. u / udb u u m n ic i ui in u  LdiiLt: riedb b dtn
i.  think
that 'improving access to genetic and genomic pH r l-in ' k t p f rilit tnr nf io p<;t i nnrt-anro t
please choose number 1.


















b. Improving educators' awareness of
genetics and genomics
c. Clinical institutions that promote
genetic and genomic learning
d. Educational institutions that
promote the learning of genetics and
genomics
e. Accessible articles on genomics and
genetics ie. Written for lay and no
expert nurses
f. Education programs that cover all
aspects of genomics and genetics ie.
Science, practical application and ELSI














































23. If you have any comments or further thoughts, please use the space below.
Page?
Survey completed
Your survey has now been automatically submitted. 
Thank you for your input and time.
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Appendix 5. Phase 1 Respondent invitation email
16th September 2009
Dear Member of the AGNC,
My name is Verity Leach and I am a PhD student in Genetics and Healthcare at Glamorgan 
University, under the supervision of Professor Maggie Kirk, Dr Emma Tonkin and Dr Deborah 
Lancastle. I am contacting you to invite you to participate in preliminary research in the form of a 
questionnaire.
My PhD project is entitled "Genetics in Nursing. The predictors of those most likely to adopt 
genetics into practice". The project aims to identify traits that will predict whether nurses will 
adopt genetics and to understand how these can be used to advantage health care practice. It is 
hoped that stages of adoption can be identified and a greater understanding of non-adoption 
gained. Following on from identifying adopters of genetics, it is aimed that genetic opinion 
leaders can also be identified and these individuals encouraged to support and engage others in 
genetics.
An integral part of the research is to define the term an 'adopter of genetics'. Using the 
competence framework for non-genetics healthcare staff, we have narrowed down basic 
requirements that nurse adopters should be able to apply to their practice. They are generalised 
because at this stage we are identifying all adopters of genetics, from very early adopters to the 
more advanced adopters. Hence we would expect for advanced adopters to be doing more than 
the basic requirements. From defining the criteria of an adopter, nurses can be identified as 
being adopters or non-adopters and it will provide a platform for 349aribbean349g those 
advanced adopters.
The questionnaire should take between 5 and 10 minutes to complete. The information supplied 
by participants will be confidential and anonymous. Completion of the questionnaire is voluntary 
and completing the questionnaire is a declaration of consent.
Please feel free to contact me on 01443 483050 or vleach@glam.ac.uk. My postal address is: 
Genomics Policy Unit, Faculty of Health, Sport and Science, Aneurin Bevan Building, University of 























Are you a practising Genetic Counsellor?
Are you from a nursing background?
Are you a practising genetic nurse?
Please indicate how long you have worked in genetic services.
What behaviours or activities would you be looking for, that 
would define a nurse as having incorporated genetics into their 
practice? Please note we are not asking you to define nursing 
competencies.
Would you expect all nursing staff to be able to satisfactorily 
undertake the behaviour above?
If a nurse identifies herself/himself as having demonstrated this 
behaviour, would you say she/he had adopted genetics into their 
practice?
Would you say this activity should be included as one of the 
requirements needed for a nurse to have adopted genetics into 
practice?
If you answered no, please explain.
Would you expect all nursing staff to be able to satisfactorily 
undertake the activity above?
If a nurse identifies herself/himself as having undertaken the 
above activity, would you say she/he had adopted genetics into 
practice?
Would you say this task should be included as one of the 
requirements needed for a nurse to have adopted genetics into 
practice?
If you answered no, please explain.
Would you expect all nursing staff to be able to satisfactorily 
undertake the activity above?





























































































































activity, would you say she/he had adopted genetics into their 
practice?
Would you say this activity should be included as one of the 
requirements needed for a nurse to have adopted genetics into 
practice?
If you answered no, please explain.
Would you expect all nursing staff to be able to satisfactorily 
undertake the behaviour above?
If a nurse identifies herself/himself as having demonstrated this 
behaviour, would you say she/he had adopted genetics into their 
practice?
Would you say this behaviour should be included as one of the 
requirements needed for a nurse to have adopted genetics into 
practice?
If you answered no, please explain.
As a reminder the 4 activities and behaviours under 
consideration are: a. To know how to access genetic services and 
would make active use of them b. To be able to provide 
information of support services to patients or their families with 
or at risk of a genetic condition c. To ask patients relevant 
questions about their family health history d. To be open to the 
possibility of genetics in all aspects of care Do you think all 4 
activities and behaviours apply across all nursing groups?
If no, please specify.
Do you think all of the 4 behaviours and activities need to be 
used collectively to identify a nurse adopter of genetics?
If you answered no, please explain.
Do you think there are any other activities and behaviours, that 
we have missed or that you did not include in your answer to the 
scenario, that would indicate that he/she has adopted genetics 
into their practice at a basic level? Please comment.
Nurses think genetics and genomics is not relevant
Nurses don't know about genetics and genomics
Nurses think there is a lack of support from colleagues
Nurses don't understand genetics and genomics
The relevance of genetics and genomics is not explicit to nurses
Nurses are afraid of genetics and genomics
Nurses have time constraints
Nurses believe the resources are not appropriate
Nurses think that genetics and genomics is not important
There is a lack of genetic and genomic role models for nurses
Nurses have no experience of patients asking about genetics and 
genomics
Nurses experience resistance to genetics and genomics from 
other team members
Improving access to genetic and genomic education - '"Rank"'



















































































Clinical institutions that promote genetic and genomic learning - 
"'Rank'"
Educational institutions that promote the learning of genetics 
and genomics - '"Rank"'
Accessible articles on genomics and genetics "ie. Written for lay 
and no expert nurses" - "'Rank'"
Education programs that cover all aspects of genomics and 
genetics "ie. Science, practical application and ELSI" - "'Rank'"
Links and access to genetic specialists for nurses - "'Rank'"













Appendix 7. Phase 1 Focus group topic guide
Focus Group - Thursday 26th August, 11am
Explain the background of the research to the participants:
The overall aim of the project is to identify the characteristics and predictors of those most likely 
to adopt genetics into their practice, with the aim of creating a strategy to aid the incorporation 
of genetics into nursing practice. The focus group is expected to last between 1-1.5 hours, is 
there anyone that needs to leave earlier than this or who is stuck for time?
The research is split into 3 main phases. Phase 1 of the research has just been completed and 
involved participants from the AGNC completing an online questionnaire in order to gain an 
expert opinion on 4 selected activities and behaviours that we felt could be used to identify a 
nurse who has incorporated genetics into their practice. This focus group is situated at the end of 
phase 1 and from this the phase 2 questionnaire can be created. The aim of today is to explore 
some of the findings from the Phase 1 questionnaire.
Phase 2 of the research aims to identify characteristics of nurses who have incorporated genetics 
into their practice, using the identified activities and behaviours and other measures such as 
personality traits and scenario based questions. This will again be through the use of a 
questionnaire and will target 2 areas of nursing where genetics is having the biggest impact. 
Through this questionnaire it is hoped that characteristics of a nurse adopter are identified as well 
as characteristics of those individuals who are likely to encourage others to incorporate genetics. 
It is also hoped that the decision made by some to not incorporate genetics will be explored.
Phase 3 of the project will develop the findings into a strategy that could be used by organisations 
such as the NHS National Genetics Education and Development centre and the Nursing and 
Midwifery Council to enable the wider incorporation of genetics among nursing staff.
We are not looking for mini genetic counsellors or exemplar nurses, but we are looking for what 
behaviour shows a nurse is engaged in genetics.
The questionnaire:
The questionnaire sent to AGNC members focused mainly on seeking a consensus on the four 
behaviours and activities which were modified from the UK Workforce Competences for Genetics 
in Clinical Practice for Non-genetic Healthcare Staff. The activities and behaviours are:
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a. To know how to access genetic services and would make active us of them e.g. To know to 
phone genetic services or a counsellor
b. To be able to provide information of support services to patients and their families with or at 
risk of a genetic condition e.g. To know a few basic support services so they can direct patients to 
them, this may depend on their nursing specialty
c. To ask patients relevant questions about their family history e.g. if a patient with cancer 
mentions that a family member has also had cancer, to ask questions about their family's health 
history
d. To be open to the possibility of genetics in all aspects of care e.g. being genetic aware and 
always thinking could this be genetics
All behaviours and activities received a consensus individually to be used as a criteria for a nurse 
adopter of genetics. Activities and behaviours a, c and d received a consensus of between 93- 
96%, and activity b which a consensus of 76%. However a consensus was not reached for all 
activities and behaviours being used collectively to identify a nurse adopter of genetics. 59% of 
respondents thought that all activities and behaviours applied across all nursing groups, leaving 
34% who didn't agree and 17% who were unsure.
The main points that I would like to take away from today, are to gain a better understanding of 
your overall thoughts towards the activities and behaviours which should take about 30 mins, 
then to specifically focus on activity b which should take a further 15 mins and then to discuss 
whether the activities and behaviours should be used together which should take between 20-30 
mins.
Demographics:
Please can we start by you stating your background, whether you are from a nursing background 
or whether you came into genetic counselling via the MSc and do not have a nursing background. 
Please can you also state how long roughly you have been involved in genetic healthcare.
(3-4 mins)
As an introduction to the topic questions, what do you think about the 4 activities and behaviours 
being proposed to be used to identify nurse adopters of genetics? (5 mins)
General (15 mins)
• Is there anything you think is missing from these activities and behaviours? (5 mins)
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• Is it clear what the activities and behaviours mean? (3 mins)
• Do you think there are some areas of nursing where genetics is seen regularly or/and 
there is lots of potential for intervention or do you think all areas are equal? (2 mins)
• Do you think some nurses make a conscious decision to either incorporate genetics?, do 
you think some nurses make a decision not to adopt genetics because for example it is 
not encouraged, taught or required? If this is the case how do we distinguish conscious 
non-adopters from unconscious non-adopters? (5 mins)
Activity b (15 mins)
• What are your thoughts about this activity? (5 mins)
• Why do you think there was disagreement between the respondents? (2 mins)
• Do you think having knowledge of support groups is too specialist for nurses because of 
the variety and specialist nature of the support groups? Do you think there are certain 
nursing groups where this activity applies more than others? If so which groups and why? 
(5 mins)
• It was suggested by a participant that it would be better for nurses to have some central 
resources, or named person in clinical genetics? Do you think this is a feasible option? (3 
mins)
UsinR activities and behaviours collectively (11 mins)
• Do you foresee any issues in applying all 4 activities and behaviours collectively? (5 mins)
• Do you think some are better indicators for adoption than others? (3 mins)
• Is just 1 activity and behaviour sufficient? Fly on the wall scenario
• Nurses providing support services information to patients and their families (activity b) 
was the anomaly when using all the activities and behaviours collectively. Why do you 
think this was? (3 mins)
Demographic groups (15 mins)
Those from a nursing background had different views on the activities and behaviours compared 
to those not from a nursing background, although these were not statistically significant they still 
proved interesting.
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An increased number of nursing background participants thought all activities and behaviours 
should be included in the criteria for a nurse adopter compared to non-nurse background 
participants.
All those from a nursing background though that nurses should be open to the possibility of 
genetics in all aspects of care (activity d) compared to just over half of those from a non-nursing 
background.
Finally all participants from a nursing background thought that nurses should satisfactorily be able 
to know how to access genetic services and would make active us of them, compared to only 39% 
of participants not from a nursing background.
• Why do you think those participants from a nursing background had such 
different views on the activities and behaviours compared to those not from a 
nursing background? (5 mins)
• Do you have any final thoughts or comments?
That's the end of the focus group. Thank you very much for your time and participation in the 
focus group. The next steps in this research will be to analyse data from today's focus group, 
which will provide a clearer understanding and focus for the development of the Phase 2 
questionnaire. The next questionnaire should identify the characteristics of those nurses who 
have incorporated genetics into practice, which will hopefully provide a clearer strategy for the 
overall incorporation of genetics into all nursing practice.
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Appendix 8. Focus group handout
Focus Group - Thursday 26th August, 11am
Thank you very much for taking the time to come and participate in the focus group.
The overall aim of the project is to identify the characteristics and predictors of those most likely 
to adopt genetics into their practice, with the aim of creating a strategy to aid the incorporation 
of genetics into nursing practice.
The research is split into 3 main phases. Phase 1 of the research has just been completed and 
involved participants from the AGNC completing an online questionnaire in order to gain an 
expert opinion on 4 selected activities and behaviours that we felt could be used to identify a 
nurse who has incorporated genetics into their practice. This focus group is situated at the end of 
phase 1 and from this the phase 2 questionnaire will be created. The aim of today is to explore 
some of the findings from the Phase 1 questionnaire.
Phase 2 of the research aims to identify characteristics of nurses who have incorporated genetics 
into their practice, using the identified activities and behaviours and other measures such as 
personality traits and scenario based questions. This will again be through the use of a 
questionnaire and will target those areas of nursing where genetics is having the biggest impact. 
Through this questionnaire it is hoped that characteristics of a nurse adopter are identified as well 
as characteristics of those individuals who are likely to encourage others to incorporate genetics. 
It is also hoped that the decision made by some to not incorporate genetics will be explored.
Phase 3 of the project will develop the findings into a strategy that could be used by organisations 
such as the NHS National Genetics Education and Development centre and the Nursing and 
Midwifery Council to enable the wider incorporation of genetics among nursing staff.
The questionnaire sent to AGNC members focused mainly on seeking a consensus on the four 
behaviours and activities which were modified from the UK Workforce Competences for Genetics 
in Clinical Practice for Non-genetic Healthcare Staff. The activities and behaviours are:
a. To know how to access genetic services and would make active us of them
b. To be able to provide information of support services to patients and their families with or at 
risk of a genetic condition
c. To ask patients relevant questions about their family history 
d. To be open to the possibility of genetics in all aspects of care
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Appendix 9. Phase 2 questionnaire
Page!
Identifying the characteristics of nurse adopters and opinion leaders among practice and 
oncology nurses
Welcome
First of all thank you for coming to the website to participate in this study.
My name is Verity Leach and I am a PhD student at the University of Glamorgan under the 
supervision of Professor Maggie Kirk, Dr Emma Tonkin and Dr Deborah Lancastle. My research is 
focusing on nurse adopters of genetics within practice and oncology nursing. I am particularly 
interested in understanding the characteristics and attitudes of a nurse who has or is willing to 
adopt genetics into their practice.
What happens next?
The questionnaire should take around 15 minutes to complete. It contains both tick boxes, Likert 
scales and open questions. Some questions are labelled as optional, this is for ethical purposes 
and it would be helpful if you could answer as many questions as possible. By completing this 
questionnaire, you are agreeing to participate in this research. You can withdraw at any time 
before submitting the questionnaire.
Confidentiality
All information provided by you will be kept confidential and treated in accordance with the Data
Protection Act, however you may want to clear your browser history after completing the
questionnaire.
When information from this research project is submitted for assessment and publication, no
personal information to identify any participants will be available. Any information provided in
open questions, which is personally identifiable, will be subject to change in subsequent
publications to preserve anonymity.
Prize draw
For your chance to win £50 worth of Amazon vouchers, please leave your name and email address 
at the end of the questionnaire. Upon submission of the questionnaire, all identifying information 
will be separated from the questionnaire, leaving only a participant identification number.
Full ethical approval has been obtained through the University of Glamorgan (this project did not 
need NHS ethical approval).
Should you want more information, please contact:




1. Please tick the relevant answer for the following statements 
I am someone who
a. Is original, comes up with new ideas
b. Is curious about many different 
things
c. Is ingenious, a deep thinker 
d. Has an active imagination
e. Is inventive
f. Values artistic, aesthetic 
experiences
g. Prefers work that is routine
h. Likes to reflect, play with ideas
i. Has few artistic interests































































2. What characteristics would you say are typical of people you know who are open to new ideas and 
concepts? Please write down some key words to describe them (Optional)
3. Are colleagues who you think are open to change and new ideas likely to be the people from whom you
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would seek professional advice? Please tick the relevant option (Optional)
c x r r
Yes No Don't know
If no: From where do you seek professional advice? (Optional)
i. What type of personality does she/he have? (Optional)
4. Please tick the appropriate response for each statement
a. 1 usually rely on being successful in 
everything 1 do
b. 1 am rarely unsure about how 1 
should behave
c. 1 like to assume responsibility
d. 1 like to take the lead when a group 
does things together
e. 1 enjoy convincing others of my 
opinions
f. 1 often notice that 1 serve as a role 
model for others
g. 1 am good at getting what 1 want
h. 1 am often a step ahead of others























j. I often give others advice and 
suggestions
Page 3
5. Please rate your familiarity with the following resources. Please tick one option for each resource
a. The UK genetic competency
standard statements for nurses,
midwives and health visitors
b. NHS National Genetics Education
and Development Centre
c. Department of Health's White
Paper on Genetics
d. Your local specialist genetic services
e. Telling Stories Understanding Real
Life Genetics website



































6. Please indicate your response to each statement by ticking one option for each statement
a. Nurses should regularly keep up to



















b. Nurses should be able to decide
which areas of knowledge they want
r
to expand, whilst not being at a cost to
safe practice if other areas are de-
prioritised
c. Taking a patient's family history is
an important aspect of my role
d. Continued professional
development in genetics should be
encouraged for all nurses
e. 1 have a good awareness of how
genetics impacts on my own speciality
f. Developments in genetics offer real
potential to improve health outcomes






























A 23 year old patient is admitted with dizziness, palpitations and fainting episodes after 
exercising. The patient mentions to you that this has happened before during strenuous 
exercise.
7. How important would it be in this situation to take a family history?





Not at all important-6
a. If you felt you needed advice would you consider discussing the patient's situation with your 
colleagues?











b. What possible explanations would you provide for the patient's symptoms? Please give some 
very brief comments e.g. it might have been a hot day or they may have low blood sugar 
(Optional)
c. How confident would you feel dealing with this scenario? 















8. Do you think that the application of genetics is relevant to your patient group?











9. Which of the following areas of care are linked to genetics?
Please tick as many options as you like
(Optional)
(select all that apply)















Not at all confident
r
I would never ask
r Not relevant to my role
11. Which of the following questions should be included when taking a genetic history?
Please tick as many options as you like
(Optional)
(select all that apply)
Familial medical conditions
Whether the patient had received private or NHS treatment
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Births, pregnancy loss and deaths 
Ages of family disease onset
r c
bxposure to environmental toxins
Information about the patient's partners family
History of road traffic accidents
If partners are related in anyway
In a patient with e.g bowel cancer, asking about other cancers in the family
Comments: (Optional)
12. Regional genetic centres (RGC) are situated throughout the country and are concerned with the cause, 
course, diagnosis and treatment of genetic disorders and also provide education and resources for the NHS.
Which statement best represents you? 
(Optional)
r
I am unaware of Regional Genetic Centres and services
r
I am aware of Regional Genetic Centres but not about its services
r
I know about them and have used them
C
I know about them and have recommended them to colleagues/patients
C
I know the genetic counsellor that serves the local area by name
13. What resources can Regional Genetic Centres provide? (Optional)
14. What types of support services are available to patients and their families with or at risk of a genetic
condition?
Please tick as many options as you like
(Optional)






Patient support groups 
Personal and social care
15. Approximately how many times have you identified an individual who should/could be referred to 
genetic specialist services since qualifying? (Optional)
If you have never identified an individual to be referred is it because: (Optional)
C
I have never encountered an individual who should be referred
r
Not relevant to my practice
r





16. Please rate yourself on the following scales relating to your interactions with colleagues regarding 
clinical issues in your practice
Please tick the appropriate number for each statement











a. How many times have you given expert information to colleagues about clinical issues in 










b. How likely are you to be asked about current advances in nursing practice in your field 










c. Overall in your discussions with colleagues about clinical issues in your field, are you often 
used as a source of expert advice? (Optional)
r







17. Think of a situation where you have had an idea in your professional practice. 





If you were able to implement your idea, what enabled you to do this? (Optional)
18. Which issues/problems prevent you using genetics more in your nursing role?
Please rank statements in order of importance. With 1 = prevents me the most from using genetics in my 











































































e. There are r
too many time <
constraints
f. My boss r
doesn't think
it's important












never talk to j
me about
genetics
























































































19. How easy or difficult is it for you to achieve the following actions? 
Please tick one option for each action
a. Attend study days/courses that
include genetics in practice
b. Apply new knowledge into your
nursing practice
c. Get permission from senior nurses
for access to new resources
d. Talk to colleagues about genetics
e. Get senior nurses and
management to understand the





































A 42 year old patient with breast cancer mentions to you her concerns about her daughter's and 
granddaughter's chances of developing breast cancer. The patient tells you that both her mother and sister 
died under the age of 40 from the disease.
Bearing this in mind, please answer the following questions using the ranking scales




















b. I feel I will be fulfilling the requirements of my role by seeking follow up genetic 










A 20 year old man presents with abdominal pain, unexplained weight loss and regular diarrhoea. Upon completing his 
family history you discover that his mother's brother aged 45 is recovering from bowel cancer. 
Please answer the following questions, using the ranking scales

















































































24. Are you interested in new areas of genetic knowledge within your practice? (Optional)
Definitely interested 
Somewhat interested 




25. Have you ever sought genetic information for the following people? 
Please tick the relevant option(s)
a. Self
b. Family
c. Client / patients family
d. Fora colleague
e. 1 have never sought genetic 
information
f. Friend
g. Other (please specify)
1 have never 









1 have been 









1 have been asked 









26. Which of the following interventions/people encourage you to incorporate new areas of knowledge 
into your practice?
Please tick as many options as you deem necessary 
(Optional) 
(select all that apply)
Peers
Heads of department e.g line managers 
Contacts with specific professional services 
Other health professionals




Attending short presentations (e.g lunchtime seminars)
Patients
27. When you need advice for a particular patient or medical issue, who do you usually ask for advice? 
(Optional)
r
High grade asks low grade
r
Low grade asks high grade
r
Low grade asks low grade
r
High grade asks high grade
r
Grade doesn't matter, anyone is asked
Page 9







Please indiciate by stating the number of years you have been practising in this role (Optional)
29. How long have you been practising as a qualified nurse?
Please write the number of years you have been a practising qualified nurse 
(Optional)
If you are a student nurse, please indicate your current year of study below, then go to
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question 31. (Optional)
30. At what grade are you currently practising?








31. What is your highest level of academic achievement?









32. Please indicate your age in the text box (Optional)























White & black 377aribbean
r



























36. If you would like to be included in the prize draw for £50 worth of Amazon vouchers, please provide 
your name and email address in the text box below.
Please be aware that the information you provide will automatically be separated from your questionnaire 




Your survey has now been automatically submitted. 
Thank you for your input and time.
For your interest, below is a link to Diane's story about inherited bowel cancer and the impact upon her life: 
http://www.tellingstories.nhs.uk/transcript.asp?id=88
For more information on any of the topics raised please go to http://www.geneticseducation.nhs.uk/ and 
http://www.tellingstories.nhs.uk
Thank you for taking the time to complete this questionnaire. Please contact Verity Leach on 01443 483050 
or on vleach@glam.ac.uk for further information about the research.
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Appendix 10. Phase 2 Dissemination document
Are you an opinion leader? Do you consider yourself a role model? 
Are you open to new ideas?
My name is Verity Leach and I am currently in my final year studying 
towards a PhD under the supervision of Professor Maggie Kirk, Dr 
Emma Tonkin and Dr Deborah Lancastle at the Genomics Policy Unit, 
University of Glamorgan.
The PhD sets out to identify traits and factors that predict whether 
nurses will integrate genetics and genomics into practice (adoption) 
and aims to understand how these can be used to inform a strategy 
to promote and facilitate adoption. The research also aims to identify 
those oncology nurses who will encourage others to use genetics 
within their practice (opinion leaders), to identify what facilitates or inhibits the utilisation of 
genetics in oncology nursing practice and finally what stops non-adopters from engaging in 
genetics.
Kirk and Tonkin in 2009 comment that nurses and other healthcare professionals will need to 
engage with genomic healthcare as new advances emerge with increasing frequency, however 
they believe that nurses are in a good position to integrate new genomic knowledge into their 
practice. All nurses, regardless of speciality or setting, need to become genetically competent in 
order to provide services within their scope of practice (Green et al, 2011). The government has 
taken several steps to incorporate genetics into healthcare. Since the 2003 Genetics White Paper, 
millions have been spent on genetic research, there has been investment in the specialist genetic 
workforce and the NHS National Genetics Education and Development Centre was established. In 
2011, the Nursing & Midwifery Professional Advisory Board commissioned a task and finish group 
to issue recommendations on the future implications of genetics for nurses and midwives. The 
investment in genetics undertaken by these groups and others highlights the need for nurses to 
understand these new areas of healthcare and to be able to explain such understanding to their 
patients as genomic technology continually progresses.
I hope that results gained from this research will aid the formulation of a series of 
recommendations about the characteristics of those individuals who could be targeted as 
potential adopters and opinion leaders to be used to champion the incorporation of genetics into 
nursing practice. Recommendations from this research could help to inform the development of a 
strategy to promote the routine and consistent incorporation of genetics into nursing, for the 
benefit of patients and their families.
References
Government White Paper Report (2003) Our Inheritance, Our Future. Realising the potential of 
genetics in the NHS.
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implications for practice. Nursing Times 105(46): 19-23
Kirk, M and E, Tonkin (2009) Understanding the role of genetics and genomics in health 1: 
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Green, E.D., M.S. Guyer and National Human Genome Research Institute (2011) Charting a course 
for genomic medicine from base pairs to bedside. Nature 470: 204 - 213
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Is original, comes up with new ideas
Is curious about many different things
Is ingenious, a deep thinker
Has an active imagination
Is inventive
Values artistic, aesthetic experiences
Prefers work that is routine
Likes to reflect, play with ideas
Has few artistic interests
Is sophisticated in art, music or literature
Are colleagues who you think are open to 
change and new ideas likely to be the 
people from whom you would seek 
professional advice? Please tick the 
relevant option
The UK genetic competency standard 
statements for nurses, midwives and 
health visitors
NHS National Genetics Education and 
Development Centre
Department of Health's White Paper on 
Genetics
Your local specialist genetic services
Telling Stories Understanding Real Life 
Genetics website
Human Genome Project
Nurses should regularly keep up to date 
with new areas of practice
Nurses should be able to decide which 
areas of knowledge they want to expand, 
whilst not being at a cost to safe practice 
if other areas are de-prioritised
Taking a patient's family history is an 
important aspect of my role
Continued professional development in 
genetics should be encouraged for all 
nurses
1 have a good awareness of how genetics 
impacts on my own speciality
Developments in genetics offer real 
potential to improve health outcomes for 
all patient groups
How important would it be in this 
situation to take a family history? Please 
rank your answer with 1= extremely 
important and 6 = not at all important


























































































consider discussing the patient's situation 
with your colleagues? Please tick the 
appropriate option
How confident would you feel dealing 
with this scenario? Please rank your 
answer, with 1 = confident and 10= not 
confident
Do you think that the application of 
genetics is relevant to your patient group? 
Please rate, with 1= very relevant and 6 = 
not relevant
Which of the following areas of care are 
linked to genetics? Please tick as many 
options as you like










Would you feel confident asking patients' 
questions about their family genetic 
history?
Which of the following questions might be 
included when taking a genetic history? 
Please tick as many options as you like
Familial medical conditions
Whether the patient had received private 
or NHS treatment
Births, pregnancy loss and deaths
Ages of family disease onset
Exposure to environmental toxins
Information about the patient's partners 
family
History of road traffic accidents
If partners are related in anyway
In a patient with e.g bowel cancer, asking 
about other cancers in the family
Other














Not confident- 10 
Other









Not at all confident 
1 would never ask 
Not relevant to my role 
Other


















































situated throughout the country and are 
concerned with the cause, course, 
diagnosis and treatment of genetic 
disorders and also provide education and 
resources for the NHS. Which statement 
best represents you?
What types of support services are 
available to patients and their families 
with or at risk of a genetic condition? 





Personal and social care
Other
Approximately how many times have you 
identified an individual who should/could 
be referred to genetic specialist services 
since qualifying?
If you have never identified an individual 
to be referred is it because:
Please rate yourself on the following 
scales relating to your interactions with 
colleagues regarding clinical issues in your 
practice Please tick the appropriate 
number for each statement In general, do 
you talk to your colleagues about current 
advances in nursing practice?
How many times have you given expert 
information to colleagues about clinical 
issues in your field in the past six months ?
How likely are you to be asked about 
current advances in nursing practice in 
your field compared with your colleagues?
Overall in your discussions with colleagues 
about clinical issues in your field, are you 
often used as a source of expert advice?
Which issues/problems prevent you using 
genetics more in your nursing role?
Genetics is not relevant
1 don't understand genetics
My colleagues don't support my interest
There are no relevant resources to help 
me learn
There are too many time constraints
Genetic Centres and services 
1 am aware of Regional 
Genetic Centres but not about 
its services 
1 know about them and have 
used them 
1 know about them and have 
recommended them to 
colleagues/patients 
1 know the genetic counsellor 
that serves the local area by 
name 
Other
1 have never encountered an 
individual who should be 
referred 
Not relevant to my practice 
1 would not recognise when 
this was appropriate 
Other



























































My boss doesn't think it's important
1 don't like science
There are no local study sessions
It's the doctor's job
Patients never talk to me about genetics
It isn't my decision
Other
How easy or difficult is it for you to 
achieve the following actions?
Attend study days/courses that include 
genetics in practice
Apply new knowledge into your nursing 
practice
Get permission from senior nurses for 
access to new resources
Talk to colleagues about genetics
Get senior nurses and management to 
understand the importance of genetics in 
your role
It is expected of me to highlight the 
possible need for more in-depth patient 
investigation
1 feel it is expected of me by colleagues to 
make sure the patient's family is followed 
up by genetic services
1 feel 1 will be fulfilling the requirements of 
my role by seeking follow up genetic 
consultations for the family either directly 
or via my manager
Patients and relatives think 1 should 
support a referral to specialist genetics 
services
My manager would approve of me 
highlighting the need for further patient 
investigation
My peer colleagues would seek further 
advice on the patient
Doctors expect me to raise the possibility 
of a genetic link with them
1 would act as 1 thought best even if others 
disagree
1 would not seek the opinion of others in 
the first place
Have you ever talked to your colleagues 
about genetics?
Would you like to incorporate more 
genetics as part of your everyday 
practice?
Are you interested in new areas of genetic 






















































































































Have you ever sought genetic information 
for the following people?
Self
Family
Client / patients family
For a colleague
1 have never sought genetic information
Friend
Other (please specify)
Which of the following 
interventions/people encourage you to 
incorporate new areas of knowledge into 
your practice? Please tick as many options 
as you deem necessary
Peers
Heads of department e.g line managers










When you need advice for a particular 
patient or medical issue, who do you 
usually ask for advice?
Which area of nursing practice are you 
currently working?
At what grade are you currently 
practising? Please tick the correct box
What is your highest level of academic 
achievement? Please tick the box 
indicating your HIGHEST academic 
achievement
Please indicate your gender by ticking the 
correct box
Are you or any members of your family 
affected by a genetic condition?
Please indicate your ethnic background by 
ticking the correct box
Other
1 have never been asked to 
seek advice 
1 have been asked to seek 
advice 
1 have been asked to seek 
advice and have acted 
Other
High grade asks low grade 
Low grade asks high grade 
Low grade asks low grade 
High grade asks high grade 

































































































These questions were reversed by design of the previously used questionnaire
**This question had a unique scoring system created by the previous study in which it was used
***These q uestjOns were reversed by the researcher in this study, to aid the overall scoring system for 
adopters and opinion leaders
****This question was ranked, therefore the BOS scoring system was not adhered to
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Appendix 12. Phase 1 Ethics Approval Confirmation
University of Glamorgan
Prifysgol Morgan nwg
Faculty of Health, Sport and Science 
Cyfadran lechyd, Chwaraeon a Gwyddoniaeth
8th February 2010
Ms Verity Leach,





"Genetics and Genomics in Nursing. What are the 




I am writing to confirm that on the 1 5* January 2010, the Faculty of 
Health, Sport, and Science Ethics Sub Group approved your submission 
for ethical approval.
If you have any queries about the group's decision, please do not 
hesitate to contact me.
Yours sincerely,
Prof. Paul Rogers 
Chair / Ethics Champion
Professor/ Vr Athro Donna M Mead 
Dean of Fatulty/Deon y Cyfadran
University of Glamorg<ir./Pnfy!>gol Moryannwg, Pontypridd, CF37 1DL, UK/DU
Tel/Ffon 01443 483094 Fax/Ffaes 01443 383118
www.glam.acuk
Protessor/Yr Athro David Halton Vke-Cf lanceltor/ls-Ganghellor
Page | 387




South East Wales Research Ethics Committee Panel C










19 March 2010 
Dear Miss Leach 
Full title of study:
REC reference number:
Defining the behaviours and activities that identify a 
nurse who has adopted genetics/genomics in practice. 
What the experts think. 
10/WSE03/9
Thank you for seeking the Committee's advice about the above project and for attending 
today's REC meeting.



















Letter of invitation to participant 17 February 2010!
j Evidence of insurance or indemnity








These documents have been considered by the Committee during its meeting today and 
members were unanimous in their view that the project was a survey/service evaluation and 
should not be managed as research.
Therefore it does not require ethical review by a NHS Research Ethics Committee or 
approval from the NHS R&D office,
Canolfan Gwasanaethau Busnes I BH| Business Services Centre 
Ty Churchill J . *25 Churchill House
17 Ffordd Churchill 
Caerdydd. CF10 2TW 
Ffon. 029 20 37682Q WHTN: 1809 
Ffacs: 029 20 376826
17 Churchill Way
Cardiff. CF102TW
Telephone: 029 20 376820 WHTN: 1809
Fax: 029 20 376826
rhan o Bwrdd lechyd Lleol Addysgu Powys / part of Powys Teaching Local Health Board
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10/WSE03/9 =acs2of3
The Research Governance Framework (RGF) sets out the resoonsibiiities and standards 
that apply to work managed within the formal research context.
You may wish to check whether the project could be rev e.ved by the ethics committee 
within your own institution.
This letter should not be interpreted as giving a form of ethical approval to the project, but it 
may be provided to a journal or other body as evidence that ethical approval is not required 
under NHS research governance arrangements.
I 10/WSE03/9____Please quote this number on all correspondence
Yours sincerely
Dr B Patel
Vice- Chair, Panel C
South East Wales Research Ethics Committees
Enclosures: List of names and professions of members who we re present a: ire 
meeting and those who submitted written comments,
Copy to: Prof Brian Hobbs, University of Glamorgan, Room B5a, Directorate. Brecon 
Building, Treforest Campus, Pontypridd, CF37 1DL
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Appendix 13. Phase 2 Ethics Approval Confirmation
University of Glamorgan 
Prifysgoi Morgannwg
Faculty of Health, Sport and Science
Cyfao.an ; ecnyu, ChwatatKv. a Gwydcioniaeth
26 May 2011
V Leach
C/o Faculty of Health, Sport and Science,
University of Glamorgan
Dear Miss Leach,
Re: Genetics and Genomics within Nursing. What are the predictors of those most likely 
to adopt genetics into practice?
I am writing to confirm that on the 26 May 2011 the Faculty of Health, Sport and Science 
Ethics Sub Group approved your application for ethical approval via the fast track route.
If you have any queries about the decision please do not hesitate to contact me. 
Best wishes,
Professor Paul Rogers 
Chair
INVESTORS [ BUDOSOODWYR S 
IN PEOPLE I M6WN POHL
Professor/ Vr Athro Donna rVt Mead Q.B.£. 
Dean of Fa<u!ty/Oeon y Cyfadran
University of Giamorgan/Pr'fysgol Morgannwg, Pontypndd, CF37 1DL, UK/DU
T«l/rfon014d3 48309^ Fax/Ffacs 01443 483U8
www.9lam.dc.uk
JuHe 0 Lydcn tfice-Chanccltor/t$-Ganghe!lor
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W Al ES
Bwrdd iechyd Prifysgol 
Caerdydd a'r Fro




Welsh Health Telephone Network 1872
Direct ime/Llinell uniongyrchol
Ysbyty Athrofaol Cymru 
University Hospital of Wales
Heath Park, 
Cardiff, CF144XW 
Phone 028 2074 7747 
Fax 02? 2074 3838 
M!n:r.orn 02s £>'in 3632
Pare Y Mynydd Bychan, 
Caerdydd. CF144XW 
Ffon 029 2074 7747 
Ffscs 029 2074 3838 
Minicom 029 2074 3632













2'a Floor TB2 Room 1
Research & Development




Thank you for contacting the R&D office to enquire about registration and approval 
requirements for the above project, which you are undertaking for your PhD research project. 
Based on the information provided, we would consider that this project is not best defined as 
research. Additionally you have said that you would not be recruiting participants from NHS 
organisations Therefore, this study does not require R&D approval from Cardiff & Vale UHB.
This does not indicate that the project has been reviewed or approved by the Cardiff & Vale 
UHB R&D Office, but may be used as evidence that R&D approval is not required. Please 
note that the project should not be presented or described as research in an NHS setting
There is no requirement for you to seek a favourable opinion from sr\ NHS Research Ethics 
Committee {REO. However, if you wish to seek formal written confirmation that you may 
proceed without ethical review, please write to the South East Wales REC
May I take this opportunity to wish you success with your project, and if I can be of any further 




Carl Philips, South East Wales Research Ethics Committee
version 1 0 14-06-10
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Appendix 14. Non significant Phase 2 results
Non significant questions 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix 15. Presentations and Courses
All research training completed to date is listed below:
• British Library and Joint Information Systems Committee Young Researchers Project - 2009 - 
2012
I participated in a three year study into the information-seeking and research behaviours of 
'generation Y' doctoral students which has been commissioned by Education for Change.
• Presentation Skills Course - 16th June 2009 (University of Glamorgan)
This course focused on gaining and understanding the skills and techniques for being a good 
presenter.
• Researchers in Schools training - 1st July 2009 (External)
The Beacons for Wales initiative involved inspiring and teaching children about researchers and 
what research entails through a partnership between the researcher and school.
• Research Methods Module - Sept 2009 - May 2010 (University of Glamorgan)
This module explored research paradigms and methods and taught how to critically consider 
research.
• Cochrane Collaboration Course - 18th November 2009 (External)
The course aims were to gain an understanding about systematic reviews and how to use the 
Cochrane database.
• Examiner for the Research Methods Module for Undergraduate Nursing Students - March 
2010- Present (University of Glamorgan)
This role involves assessing individual presentations that the students make on a quantitative 
paper from a nursing journal.
• Researchers in Schools Teaching - 12th April 2010 (External)
Following on from the training, I taught children in the Bishop of Llandaff Church in Wales 
School about my research and genetics in general.
• How to be an effective researcher course - 16-17*" April 2010 (University of 
Glamorgan/external)
The course included how to improve researcher skills such as communication, planning and time 
management, problem solving, leadership and assertiveness.
• Postgraduate forum on Genetics and behaviour - Lancaster - 19th April 2010 (presented) 
(External)
This was a conference for postgraduates to present and discuss their work surrounding genetics 
and behaviour.
• Postgraduate Presentation Day - 7th May 2010 (presented) (University of Glamorgan) 
This provided a chance for postgraduates from all university faculties to present their work.
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• Summative Analysis Workshop - 13th July 2010 (University of Glamorgan)
This workshop provided the opportunity to learn the methodology behind summative analysis 
and how it can apply to various research interests.
» How to be an effective researcher course part 2 - 21st March 2011 (University of 
Glamorgan/External)
This course built on previous skills learned in part one of 'how to be an effective researcher* and 
included how to improve problem solving, leadership and assertiveness skills.
> Research ethics presentation - 6th April 2011 (University of Glamorgan)
This lecture was run by the ethics department within the Faculty of Health, Sport and Science and 
focused on the importance of ethics within research and the various processes of obtaining 
research ethics within both an academic and healthcare setting. 
> Postgraduate presentation day - 6th May 2011 (Presented) (University of Glamorgan)
I presented my research using an analogy of lovers and haters of Marmite, to highlight the 
difference between adopters and non adopters and the distinguishing characteristics that might 
distinguish between the two groups.
Page | 397
